data_5zcz_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5zcz _Structure_validation_residue.Date_analyzed 2019-08-16 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 120.676 0.274 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -164.47 79.38 0.37 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 -177.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 mp -79.27 108.91 13.13 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.824 -0.547 . . . . 0.0 112.084 -164.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -78.74 87.0 4.65 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.7 t -63.38 109.05 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -70.82 147.94 48.38 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 122.887 0.475 . . . . 0.0 110.208 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.547 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 177.747 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.5 mmt -140.38 161.24 38.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.63 127.14 35.87 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 t -96.63 -13.38 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.0 m -53.39 -41.43 65.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -67.32 -22.43 65.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.863 0.301 . . . . 0.0 111.697 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.05 -34.83 59.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.039 0.381 . . . . 0.0 110.871 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.3 -38.61 63.31 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -173.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -65.68 -22.07 66.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -174.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.31 -18.68 65.5 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.898 -176.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.1 t -80.21 129.92 67.87 Favored Pre-proline 0 N--CA 1.451 -0.423 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.88 140.67 57.67 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.634 2.889 . . . . 0.0 111.504 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.52 -21.26 41.89 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.1 t -78.05 127.91 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.77 -24.53 3.23 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 110.638 -0.134 . . . . 0.0 110.638 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -128.05 147.0 50.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.7 t -146.12 146.62 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -149.11 131.1 15.28 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -126.81 156.13 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.3 t -128.41 101.05 6.03 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.27 -22.34 66.84 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.316 -175.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -84.92 -29.04 25.48 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.555 0.162 . . . . 0.0 111.151 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -97.85 -9.84 25.71 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.412 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.22 23.1 78.47 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -114.76 158.16 22.23 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 117.723 0.762 . . . . 0.0 110.913 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.95 110.82 6.22 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.045 0.938 . . . . 0.0 109.121 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.4 mm? -108.35 150.7 26.99 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.7 m -134.73 164.38 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -139.03 89.27 2.34 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.22 -173.99 23.08 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.0 p -113.43 28.85 8.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.969 0.507 . . . . 0.0 110.517 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.89 170.23 16.35 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -80.32 155.55 74.27 Favored Pre-proline 0 N--CA 1.452 -0.366 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -59.11 -44.97 30.44 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.489 2.792 . . . . 0.0 112.091 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.425 ' HG2' ' H ' ' A' ' 49' ' ' LYS . 23.1 pttt -75.08 -29.02 60.54 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -175.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.08 76.6 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 121.233 -0.187 . . . . 0.0 110.565 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.9 tp -73.28 -51.38 17.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.619 0.247 . . . . 0.0 110.567 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.7 -23.15 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.189 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -80.78 -33.83 34.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.69 96.34 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.231 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -71.76 -25.79 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.812 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -73.92 -21.33 60.09 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -68.92 -24.32 64.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -89.68 -7.47 54.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.35 9.06 57.15 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -122.89 95.68 4.72 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.705 0.753 . . . . 0.0 110.796 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -66.88 168.15 10.28 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -155.27 117.66 4.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.252 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.21 106.94 3.03 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.158 0.583 . . . . 0.0 111.349 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.21 110.04 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.4 mt -80.96 74.44 7.95 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 CA-C-O 117.368 -1.301 . . . . 0.0 109.726 -179.195 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -147.54 83.96 1.55 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.35 170.03 9.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.346 0.594 . . . . 0.0 112.587 -173.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -151.4 96.65 2.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.61 1.164 . . . . 0.0 107.967 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.4 t -59.77 170.9 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -125.43 150.97 46.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.803 0 C-N-CA 123.701 0.667 . . . . 0.0 112.225 179.079 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.687 0.28 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.8 mtm -139.87 -175.33 4.18 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.404 ' C ' ' H ' ' A' ' 19' ' ' THR . . . -122.93 95.67 4.71 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -178.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.523 ' C ' ' H ' ' A' ' 20' ' ' LYS . 13.0 t -65.43 -1.51 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 123.012 0.525 . . . . 0.0 110.034 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.404 ' H ' ' C ' ' A' ' 17' ' ' ALA . 8.9 m -63.79 6.61 0.15 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.322 0.649 . . . . 0.0 110.772 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.523 ' H ' ' C ' ' A' ' 18' ' ' VAL . 98.4 mttt -120.39 6.95 10.63 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.849 0.46 . . . . 0.0 110.756 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -118.51 -1.41 11.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.81 -0.42 9.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -98.52 -12.73 20.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -85.26 -10.63 56.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.18 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -76.71 123.17 87.54 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 28' ' ' VAL . 52.7 Cg_exo -55.16 166.48 2.26 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.306 2.671 . . . . 0.0 111.207 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.81 -13.98 1.19 Allowed Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.412 -0.66 . . . . 0.0 112.54 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.404 ' H ' ' C ' ' A' ' 26' ' ' PRO . 70.8 t -79.27 159.3 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 118.373 1.087 . . . . 0.0 108.537 177.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -147.63 -18.56 0.37 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -146.25 163.58 35.01 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.2 t -150.92 152.6 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -144.82 152.83 40.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -153.11 178.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.5 t -147.16 102.25 3.48 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.15 -1.13 2.93 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.702 0.401 . . . . 0.0 111.745 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -116.6 1.64 12.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 117.986 0.357 . . . . 0.0 110.446 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -132.99 -10.07 3.01 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.8 -3.73 6.25 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -72.77 166.07 23.61 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 117.78 0.79 . . . . 0.0 109.883 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.401 ' C ' HD12 ' A' ' 41' ' ' LEU . . . -156.08 154.07 30.38 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.401 HD12 ' C ' ' A' ' 40' ' ' ALA . 5.3 mp -145.88 169.1 19.26 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.9 m -149.26 172.13 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -143.15 97.69 3.13 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -169.74 174.01 43.96 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.7 p -80.85 7.05 11.36 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.706 0.802 . . . . 0.0 111.844 -177.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.03 173.62 0.15 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.688 0.28 . . . . 0.0 111.084 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -122.96 162.57 38.36 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -60.19 -28.84 87.75 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.55 2.833 . . . . 0.0 111.923 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -88.18 3.32 49.75 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.398 0.279 . . . . 0.0 111.065 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.94 -0.68 6.59 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.7 tp -119.13 -0.74 11.01 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.1 t -124.09 -25.26 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -76.15 -12.69 60.15 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.87 -57.61 3.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.327 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.79 -24.02 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 110.546 -0.168 . . . . 0.0 110.546 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -79.4 -18.09 53.0 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -85.21 -20.21 30.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -83.76 -3.45 57.83 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 122.774 0.43 . . . . 0.0 110.184 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.75 2.35 72.44 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -134.0 81.93 1.95 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 117.517 0.659 . . . . 0.0 109.726 -178.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -60.72 168.95 2.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 110.407 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -153.91 105.19 2.73 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -66.39 170.93 5.37 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.58 -178.86 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 120.878 0.371 . . . . 0.0 110.246 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.6 mt -136.71 5.24 2.87 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.966 0.906 . . . . 0.0 108.843 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 117.043 -1.456 . . . . 0.0 108.976 179.527 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 77.8 mt . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -155.12 79.41 1.05 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -174.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.1 mp -77.73 103.84 7.91 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.269 -163.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -80.68 100.52 8.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 171.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.9 t -60.28 147.8 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.312 1.045 . . . . 0.0 111.427 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -58.93 162.54 4.09 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.189 1.395 . . . . 0.0 107.999 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.772 0 CA-C-O 119.67 -0.517 . . . . 0.0 114.039 -168.921 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.8 mtt -140.97 159.89 41.25 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.01 88.34 7.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.9 t -69.81 -14.57 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 122.493 0.317 . . . . 0.0 110.196 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -56.6 -39.59 73.83 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 122.264 -0.273 . . . . 0.0 110.808 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.65 -21.52 66.56 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 119.569 -0.253 . . . . 0.0 111.482 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.54 -39.78 51.84 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 117.852 0.297 . . . . 0.0 110.414 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.87 -32.65 59.81 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -60.29 -21.42 61.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 112.611 0.596 . . . . 0.0 112.611 -174.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -79.7 -17.99 52.31 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 118.157 0.435 . . . . 0.0 111.623 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.0 t -70.98 128.02 91.07 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 117.751 0.25 . . . . 0.0 110.438 -174.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -58.47 137.23 79.21 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.444 2.763 . . . . 0.0 110.86 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.08 -25.06 15.42 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.428 ' HA ' ' HA3' ' A' ' 44' ' ' GLY . 54.7 t -72.58 129.62 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -126.24 -25.91 3.44 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.737 -0.21 . . . . 0.0 110.678 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -130.42 148.61 52.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.7 t -146.51 147.65 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -146.43 129.25 16.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.43 158.72 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 120.89 0.376 . . . . 0.0 111.613 -174.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.0 t -126.86 101.93 6.8 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.6 mt -63.89 -25.26 68.07 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -173.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -85.16 -30.04 24.27 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.588 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -99.38 -11.03 21.54 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -175.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.14 24.49 76.99 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -98.6 154.73 17.71 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.76 0.78 . . . . 0.0 109.577 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.32 109.85 4.43 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.444 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.25 139.12 36.38 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.33 162.97 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -139.0 101.33 4.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 28' ' ' VAL . . . -156.73 -175.68 27.94 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -177.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.4 p -114.61 26.04 10.53 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 122.898 0.479 . . . . 0.0 109.801 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.22 167.88 21.06 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.713 -0.221 . . . . 0.0 110.613 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.15 144.53 71.66 Favored Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -56.01 -37.53 96.05 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.864 2.376 . . . . 0.0 111.457 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -75.62 -33.98 60.55 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.95 -33.64 76.02 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.5 tp -70.19 -50.44 40.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.66 -22.57 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -82.67 -32.28 28.21 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.48 -45.38 93.95 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.9 m -73.94 -23.89 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.099 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.405 ' OE2' ' HE2' ' A' ' 61' ' ' LYS . 42.6 tt0 -70.77 -19.6 62.69 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.02 -23.74 65.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -91.45 -13.57 32.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.85 10.37 57.71 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -131.12 88.18 2.57 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -175.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.405 ' HE2' ' OE2' ' A' ' 56' ' ' GLU . 88.5 mttt -64.44 178.47 0.72 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.612 0.765 . . . . 0.0 110.227 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -154.19 101.86 2.42 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.187 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -69.19 120.41 14.99 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.715 0.406 . . . . 0.0 110.918 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.7 m -59.06 130.02 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 175.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.5 mt -83.71 34.15 0.49 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 116.851 -1.547 . . . . 0.0 109.399 -178.792 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -160.24 77.52 0.64 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -174.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.3 mp -81.14 127.24 32.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.532 0.333 . . . . 0.0 111.699 -166.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -99.75 96.01 7.32 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 t -66.35 107.42 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 123.228 0.611 . . . . 0.0 111.957 -175.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -78.14 148.32 34.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 174.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.622 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.545 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 60.5 mtt -145.24 161.95 38.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.67 94.35 0.78 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.64 -13.35 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.5 m -54.64 -38.24 66.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 122.674 0.39 . . . . 0.0 110.7 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.56 -23.26 67.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.54 -0.267 . . . . 0.0 111.675 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.42 -22.79 40.86 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 117.729 0.241 . . . . 0.0 111.051 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.95 -33.49 16.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.503 0.138 . . . . 0.0 111.241 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -64.41 -26.57 68.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -169.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -81.18 -9.96 59.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 119.364 0.984 . . . . 0.0 111.801 -177.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.3 t -73.61 130.67 83.37 Favored Pre-proline 0 N--CA 1.452 -0.34 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.64 140.53 65.74 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.763 2.975 . . . . 0.0 112.172 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.16 -20.98 39.86 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 119.833 -0.426 . . . . 0.0 112.121 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.1 t -68.82 130.34 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 117.578 0.689 . . . . 0.0 109.463 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -120.24 -36.98 3.13 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -134.44 155.72 49.83 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.4 t -135.12 148.78 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -144.0 104.15 4.11 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.1 m -125.27 155.54 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.3 t -128.36 101.33 6.17 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.88 -18.07 63.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.301 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -83.77 -30.83 26.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.206 0.203 . . . . 0.0 110.64 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -102.96 -10.47 18.96 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -176.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.23 20.44 75.04 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -102.2 155.37 18.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.98 121.38 9.65 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -118.58 153.62 33.95 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.94 166.57 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -135.81 89.55 2.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.83 177.55 38.87 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -177.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.9 p -95.28 26.88 3.54 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.188 0.595 . . . . 0.0 110.11 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.05 169.71 17.47 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -110.03 158.23 35.63 Favored Pre-proline 0 N--CA 1.452 -0.351 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -55.61 -46.0 35.24 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.82 3.013 . . . . 0.0 112.796 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -74.68 -13.93 60.68 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.405 -177.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.44 -35.49 15.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.219 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tp -76.44 -48.43 19.68 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.386 0.136 . . . . 0.0 111.11 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.7 t -68.29 -23.06 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 119.619 -0.229 . . . . 0.0 111.475 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -77.54 -37.61 50.47 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.104 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.65 -48.6 81.02 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.815 -0.175 . . . . 0.0 110.913 -176.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -72.32 -26.09 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.795 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -76.77 -28.57 55.74 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.598 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -70.24 -23.57 62.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -83.59 -4.48 58.6 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 177.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.99 7.5 58.55 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -115.18 90.94 3.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 117.298 0.549 . . . . 0.0 111.237 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -66.18 114.15 5.07 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.9 88.61 2.69 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.43 141.45 38.29 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.466 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.1 m -59.3 139.67 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 123.661 0.784 . . . . 0.0 111.167 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.08 28.04 2.96 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 116.98 -1.486 . . . . 0.0 109.561 -179.163 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 67.1 mt . . . . . 0 N--CA 1.451 -0.409 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -153.81 80.08 1.14 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.7 mp -77.85 108.04 10.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.677 -164.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 14.7 tmtt? -93.06 96.77 10.27 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 174.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.2 t -64.36 133.92 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -85.34 149.04 25.73 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.648 0.379 . . . . 0.0 110.114 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.54 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 179.359 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 58.4 mtt -139.27 161.31 37.75 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.58 89.65 2.75 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.8 t -74.44 -21.97 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.7 m -57.47 -39.23 75.93 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 122.37 -0.206 . . . . 0.0 110.549 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.56 -22.41 66.96 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 119.645 -0.216 . . . . 0.0 111.533 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.78 -38.94 37.24 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.471 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.05 -32.45 65.07 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -63.02 -21.96 66.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -175.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -70.34 -14.99 62.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.211 0.46 . . . . 0.0 111.147 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.9 t -78.53 127.55 80.26 Favored Pre-proline 0 N--CA 1.451 -0.413 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -175.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.63 140.4 94.71 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 123.462 2.775 . . . . 0.0 110.975 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.76 -20.85 42.44 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.996 -0.441 . . . . 0.0 111.996 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.33 128.26 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -110.62 -42.16 4.13 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -135.47 154.96 51.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.6 t -140.46 149.41 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -139.1 99.21 3.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 m -95.76 155.87 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.7 t -127.47 98.74 5.34 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.0 mt -66.66 -19.82 65.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -173.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -84.05 -32.21 24.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.443 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -103.43 -9.85 19.06 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 117.872 0.306 . . . . 0.0 111.223 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.81 21.73 76.68 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -98.66 155.04 17.52 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.04 125.6 10.28 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.986 0.422 . . . . 0.0 111.184 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -107.54 153.06 23.41 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.4 m -132.38 164.7 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -137.28 88.98 2.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.61 -176.61 35.72 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.8 p -117.31 29.51 7.84 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.385 0.674 . . . . 0.0 109.893 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.22 167.08 21.92 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.805 0.336 . . . . 0.0 110.854 -176.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -76.77 149.58 80.74 Favored Pre-proline 0 N--CA 1.451 -0.425 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.079 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -55.45 -49.42 16.16 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.379 2.719 . . . . 0.0 112.185 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -74.79 -19.6 60.13 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.04 -34.81 71.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.919 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.0 tp -75.47 -43.66 48.25 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 83.0 t -65.25 -24.84 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 123.189 0.596 . . . . 0.0 111.816 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -87.27 -28.94 22.02 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.968 0.349 . . . . 0.0 111.176 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.91 -47.02 87.48 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 122.345 -0.222 . . . . 0.0 110.991 -177.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.89 -21.32 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -68.76 -21.02 64.38 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.44 -29.15 67.73 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -83.78 -9.37 58.84 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.59 11.13 48.54 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 119.619 -0.545 . . . . 0.0 111.74 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -128.72 142.54 50.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 117.758 0.779 . . . . 0.0 110.434 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -85.23 172.45 11.15 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 171.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 5' ' ' LYS . . . -149.54 77.51 1.34 Allowed 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.11 117.68 4.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.863 -175.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -57.45 126.0 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.749 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.5 mt -84.08 31.28 0.5 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.741 0.416 . . . . 0.0 109.93 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 117.239 -1.363 . . . . 0.0 110.199 -178.284 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 60.2 mt . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 121.012 0.434 . . . . 0.0 110.437 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -148.03 78.74 1.45 Allowed 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 -169.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -77.46 114.84 16.71 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.225 -164.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 75.8 tttt -96.1 98.82 10.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.296 1.039 . . . . 0.0 108.907 175.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.4 t -61.75 115.58 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 120.843 0.354 . . . . 0.0 110.19 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -69.96 151.77 45.22 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.446 0.698 . . . . 0.0 110.032 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.653 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.91 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 69.7 mtm -144.83 160.42 41.3 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.0 90.77 4.19 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.69 -13.5 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.8 m -52.91 -37.7 61.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.12 0.568 . . . . 0.0 110.792 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -64.2 -22.35 66.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.15 -25.0 34.73 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 117.858 0.299 . . . . 0.0 110.994 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.12 -33.52 24.3 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 117.455 0.116 . . . . 0.0 110.862 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -63.56 -22.5 66.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -71.09 -16.13 62.56 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.599 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 72.5 t -80.32 127.31 76.69 Favored Pre-proline 0 N--CA 1.45 -0.433 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.64 141.22 97.38 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.651 2.901 . . . . 0.0 111.232 177.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.8 -19.62 50.39 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.855 -0.498 . . . . 0.0 111.855 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.0 t -74.14 123.41 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 117.387 0.593 . . . . 0.0 109.426 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -129.41 -26.67 2.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -130.6 132.12 45.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.262 0.553 . . . . 0.0 110.139 176.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 83.9 t -144.73 147.72 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -136.43 122.84 20.7 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 m -130.56 156.23 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.145 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.5 t -126.86 102.45 7.03 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.5 mt -62.71 -18.05 61.81 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.101 0.56 . . . . 0.0 111.486 -174.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -84.58 -31.46 24.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 117.597 0.181 . . . . 0.0 111.244 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -102.16 -10.39 19.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.55 21.68 77.72 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -100.3 155.64 17.67 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 117.726 0.763 . . . . 0.0 109.437 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.26 115.1 6.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.509 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -97.48 152.01 19.42 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.87 150.51 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -141.29 62.66 1.46 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.2 -176.83 14.57 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.3 p -98.65 26.49 5.56 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.804 0.842 . . . . 0.0 111.104 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.12 164.9 25.66 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.795 0.331 . . . . 0.0 111.097 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -82.32 135.61 47.05 Favored Pre-proline 0 N--CA 1.451 -0.413 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -56.04 -35.49 94.78 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.268 2.645 . . . . 0.0 111.833 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -74.85 -28.45 60.68 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 122.17 0.188 . . . . 0.0 111.203 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.92 -33.59 45.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 tp -64.92 -45.36 86.17 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.07 -23.28 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 122.693 0.397 . . . . 0.0 110.617 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -87.52 -29.0 21.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 122.401 -0.187 . . . . 0.0 110.989 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.29 -47.27 84.19 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 122.376 -0.202 . . . . 0.0 111.104 -178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.2 m -72.37 -20.86 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -69.42 -21.29 63.76 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -69.47 -25.35 64.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -84.04 -9.73 58.41 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.03 15.38 39.2 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 178.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -130.54 144.49 51.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 117.581 0.69 . . . . 0.0 111.509 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -80.16 175.28 10.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 168.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 5' ' ' LYS . . . -148.05 78.32 1.44 Allowed 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 174.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -53.61 107.6 0.27 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.456 0.702 . . . . 0.0 111.297 -175.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.8 m -58.19 110.42 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 123.871 0.868 . . . . 0.0 110.03 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.7 mt -84.04 35.34 0.53 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.084 0 CA-C-O 117.091 -1.433 . . . . 0.0 109.97 -178.061 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.1 mt . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -167.14 78.78 0.19 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -174.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.4 mp -77.87 124.65 28.26 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.894 -0.503 . . . . 0.0 112.324 -165.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -101.33 90.29 4.05 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.5 t -68.15 134.33 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 122.583 0.353 . . . . 0.0 111.657 -175.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -88.72 150.2 23.09 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 173.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.667 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 178.782 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 62.3 mtm -102.01 121.81 42.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.21 82.94 5.98 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.1 t -103.0 -17.35 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.0 m -54.15 -50.66 66.46 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.622 0.369 . . . . 0.0 111.401 -175.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -67.17 -21.32 65.8 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 119.493 -0.289 . . . . 0.0 111.655 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.43 -25.23 59.31 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.092 0.405 . . . . 0.0 111.793 -176.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.04 -48.44 20.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -178.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -65.58 -20.96 66.53 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -173.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -72.47 -14.44 61.67 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.264 0.484 . . . . 0.0 111.675 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 54.5 t -74.27 134.7 76.74 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 58.8 Cg_exo -55.86 131.15 44.25 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 123.595 2.863 . . . . 0.0 111.165 177.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.36 -22.11 38.86 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.852 -0.499 . . . . 0.0 111.852 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.9 t -77.86 130.64 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -126.98 -24.77 3.41 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.781 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -127.9 148.77 50.5 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.0 t -144.98 150.06 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -145.64 125.86 13.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.1 m -131.35 156.0 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.348 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.5 t -128.72 98.8 5.11 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.51 -17.98 64.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.863 -175.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -80.48 -29.94 37.42 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.502 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -99.95 -9.56 22.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 176.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.43 22.84 78.57 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -99.1 156.41 16.96 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 117.417 0.608 . . . . 0.0 110.734 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.64 109.71 5.32 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.539 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.412 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.2 mm? -101.63 151.77 21.61 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.0 163.16 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -138.33 79.69 1.75 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.98 -172.39 17.19 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 47.6 p -117.05 28.0 8.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.683 0.393 . . . . 0.0 110.284 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.58 171.4 14.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.343 -0.244 . . . . 0.0 110.343 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -79.64 141.3 55.92 Favored Pre-proline 0 N--CA 1.454 -0.239 0 O-C-N 122.439 -0.163 . . . . 0.0 111.027 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -54.59 -36.99 90.69 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 123.669 2.912 . . . . 0.0 113.08 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -74.17 -35.02 63.98 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.494 -177.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.17 -33.25 75.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.799 -175.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.2 tp -67.77 -50.89 54.71 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.679 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.9 t -68.03 -30.08 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 110.553 -0.166 . . . . 0.0 110.553 -177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -76.13 -33.73 59.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -177.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.82 -48.57 78.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.319 0.104 . . . . 0.0 110.87 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -72.37 -23.8 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -72.79 -25.57 61.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -71.22 -25.72 62.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -89.35 -4.43 58.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.88 5.1 61.31 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -108.28 90.36 3.27 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 117.157 0.479 . . . . 0.0 111.073 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -71.01 155.65 40.58 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -162.39 111.33 1.41 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.483 0.182 . . . . 0.0 110.585 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -73.91 123.0 23.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.658 0.383 . . . . 0.0 110.65 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.6 m -59.42 135.16 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.31 74.66 3.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.285 -1.34 . . . . 0.0 109.555 -179.283 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.3 mt . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -157.31 77.1 0.85 Allowed 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -174.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 mp -79.89 113.49 18.09 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.706 -165.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -99.45 89.63 4.24 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.8 t -66.35 132.89 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 123.597 0.759 . . . . 0.0 112.323 -174.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -91.23 147.74 22.84 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 172.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.523 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.748 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.403 ' CG2' HD22 ' A' ' 35' ' ' LEU . 14.6 p . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 69.2 mtm -99.48 119.25 37.72 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.43 88.12 6.26 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 t -100.96 -12.8 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 111.417 0.155 . . . . 0.0 111.417 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.9 m -50.36 -47.18 56.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -173.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -67.5 -22.78 65.44 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.146 -0.346 . . . . 0.0 111.771 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.06 -25.28 60.86 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 118.062 0.392 . . . . 0.0 111.094 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.3 -39.57 22.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -66.91 -25.16 66.24 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -173.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -81.25 -12.73 59.03 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.295 0.498 . . . . 0.0 112.144 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.7 t -76.28 128.07 83.44 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -54.75 139.46 77.42 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.473 2.782 . . . . 0.0 111.036 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.49 -20.25 47.73 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.3 t -76.38 131.92 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -122.86 -28.18 4.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.5 mttp -132.89 152.08 51.93 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.8 t -142.34 148.08 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -145.37 127.05 15.22 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.4 m -131.71 155.19 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 120.596 0.236 . . . . 0.0 110.483 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.4 t -128.3 112.31 14.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.403 HD22 ' CG2' ' A' ' 15' ' ' VAL . 87.9 mt -66.22 -25.27 66.83 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -175.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -83.34 -31.9 26.55 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.601 -176.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -101.2 -9.7 21.05 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 117.582 0.174 . . . . 0.0 110.982 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.72 23.15 73.94 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -94.75 156.44 16.38 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 117.646 0.723 . . . . 0.0 110.077 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.55 108.67 4.77 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.529 0.732 . . . . 0.0 110.118 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.4 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.5 mm? -101.67 150.51 23.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.105 0.962 . . . . 0.0 108.678 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.71 164.44 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -137.47 92.02 2.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.71 -172.93 29.73 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -177.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 48.9 p -117.51 29.72 7.7 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.226 0.61 . . . . 0.0 110.24 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.18 170.91 14.56 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.648 0.261 . . . . 0.0 110.747 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.86 137.28 66.21 Favored Pre-proline 0 N--CA 1.451 -0.381 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -54.54 -42.79 64.94 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.414 2.742 . . . . 0.0 112.503 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -76.02 -28.3 57.68 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.054 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.02 76.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 121.323 -0.151 . . . . 0.0 110.609 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tp -71.18 -48.48 51.41 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.5 t -68.91 -22.79 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.47 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -85.97 -33.75 21.04 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.222 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.42 -44.61 95.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 121.416 -0.114 . . . . 0.0 111.019 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.0 m -69.8 -27.6 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.403 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -77.01 -25.25 52.43 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -69.55 -22.19 63.57 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -91.84 -6.81 50.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.34 10.63 55.64 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -124.84 89.77 3.13 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 117.646 0.723 . . . . 0.0 110.509 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.76 163.32 21.93 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -158.59 115.31 2.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.479 0.18 . . . . 0.0 110.736 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -72.39 111.57 7.7 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.449 0.3 . . . . 0.0 111.075 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.0 m -58.26 118.16 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.05 71.01 9.09 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.378 -1.296 . . . . 0.0 110.037 -178.966 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.6 mt . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -159.42 78.82 0.73 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -173.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.6 mp -79.25 102.62 8.67 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.868 0.366 . . . . 0.0 111.489 -165.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -92.48 94.03 8.87 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.5 t -65.73 136.4 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.476 1.11 . . . . 0.0 112.524 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -88.97 149.02 23.48 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.701 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.967 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 56.5 mtm -103.05 122.54 44.85 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.65 90.2 7.86 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.32 -14.76 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 122.129 0.172 . . . . 0.0 111.325 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.1 m -54.46 -47.35 73.04 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -173.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -66.74 -22.92 66.04 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.285 0.493 . . . . 0.0 112.11 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.42 -24.57 60.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 118.011 0.369 . . . . 0.0 111.295 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.77 -40.63 18.54 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -66.69 -24.06 66.21 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -172.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -80.54 -12.78 59.48 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.336 0.516 . . . . 0.0 111.974 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.1 t -73.13 128.5 87.64 Favored Pre-proline 0 N--CA 1.451 -0.416 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -54.21 131.58 45.76 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.643 2.895 . . . . 0.0 111.2 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.22 -19.85 52.16 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 119.83 -0.428 . . . . 0.0 112.05 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.4 t -74.53 129.52 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -117.77 -30.61 5.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -134.77 152.48 51.79 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.3 t -142.48 149.47 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -145.69 129.23 17.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.28 156.76 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 120.619 0.247 . . . . 0.0 110.371 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.6 t -126.69 101.38 6.61 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.3 -20.34 66.02 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -174.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -83.89 -31.13 25.87 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.424 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -101.73 -9.8 20.53 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.597 0.18 . . . . 0.0 111.382 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.14 21.85 75.79 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -96.38 156.09 16.49 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.06 125.11 12.82 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.147 0.579 . . . . 0.0 109.479 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -117.94 152.32 35.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.046 0.939 . . . . 0.0 108.64 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.47 165.23 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -136.68 86.44 2.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.69 -172.64 24.22 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.8 p -117.48 28.66 8.32 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.188 0.595 . . . . 0.0 110.513 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.12 169.84 17.22 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.678 0.275 . . . . 0.0 110.92 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -76.3 144.33 74.52 Favored Pre-proline 0 N--CA 1.452 -0.369 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.308 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -57.33 -38.78 93.7 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 123.294 2.663 . . . . 0.0 112.11 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -75.51 -37.19 60.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.431 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.43 -34.29 75.14 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -176.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 tp -71.52 -56.87 5.06 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.481 0.181 . . . . 0.0 110.613 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.2 t -67.64 -21.69 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 122.3 0.24 . . . . 0.0 111.542 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -86.56 -32.48 20.66 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.622 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.72 -44.33 96.74 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.668 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.6 m -68.83 -27.21 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -77.68 -21.68 51.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -69.7 -24.28 63.55 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -90.51 -7.17 53.64 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.09 0.16 61.91 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -107.65 91.05 3.49 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 117.663 0.732 . . . . 0.0 110.74 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.91 163.34 19.83 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 177.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -156.14 112.67 3.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.59 0.233 . . . . 0.0 110.982 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -71.21 108.28 4.63 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.8 m -58.27 119.52 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.9 mt -81.12 72.11 8.13 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.145 0 CA-C-O 117.181 -1.39 . . . . 0.0 109.377 -179.802 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -153.39 77.97 1.14 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -175.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 mp -78.53 101.46 7.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.316 -167.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -88.08 98.53 11.59 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.3 t -63.43 133.01 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 122.824 0.45 . . . . 0.0 110.927 -175.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -83.2 148.56 27.36 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.404 0.682 . . . . 0.0 109.715 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.57 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.69 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 72.6 mtm -150.82 162.47 40.68 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.58 91.59 0.6 Allowed 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.8 t -68.91 -14.44 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 36.0 m -52.51 -37.81 58.25 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.924 0.49 . . . . 0.0 111.352 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -62.55 -22.35 66.26 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.79 -25.66 30.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 118.04 0.382 . . . . 0.0 111.173 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.69 -35.95 51.64 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -177.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.73 -22.86 66.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -175.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -68.34 -18.06 64.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.274 0.488 . . . . 0.0 112.165 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.432 HG21 ' HA ' ' A' ' 51' ' ' LEU . 60.1 t -79.77 129.02 72.43 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-N 118.052 0.387 . . . . 0.0 110.069 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -54.93 139.27 79.03 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 123.581 2.854 . . . . 0.0 111.413 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.41 -21.13 42.36 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.1 t -74.5 128.69 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -124.28 -26.9 3.88 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.793 0.27 . . . . 0.0 110.855 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -133.05 150.35 52.12 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.5 t -144.84 148.52 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -147.43 127.71 13.89 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 m -130.68 155.14 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 117.852 0.296 . . . . 0.0 110.871 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.1 t -129.02 100.07 5.51 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.98 -18.32 65.18 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.044 0.538 . . . . 0.0 112.126 -174.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -81.54 -29.89 33.34 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.927 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -103.62 -8.36 20.05 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.658 0.208 . . . . 0.0 111.229 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.03 23.47 78.07 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -96.91 155.56 16.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 117.737 0.769 . . . . 0.0 109.75 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.74 110.98 4.88 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.31 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.59 151.11 22.0 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.1 m -135.06 163.99 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 174.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -137.5 93.82 2.85 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.01 -171.22 26.68 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.9 p -114.28 28.15 8.96 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.787 0.435 . . . . 0.0 110.127 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.68 170.06 16.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.662 0.268 . . . . 0.0 110.875 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -90.61 148.56 38.91 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.487 177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -57.76 -39.2 89.26 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.652 2.901 . . . . 0.0 112.915 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -75.35 -22.89 57.23 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.281 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.39 -35.09 58.81 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.315 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.432 ' HA ' HG21 ' A' ' 25' ' ' VAL . 10.7 tp -75.55 -46.01 34.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 121.32 -0.152 . . . . 0.0 111.079 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 63.7 t -67.19 -22.37 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 110.563 -0.162 . . . . 0.0 110.563 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -87.16 -30.04 21.33 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.08 -46.2 91.62 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.5 m -68.77 -19.91 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.475 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.444 ' OE1' ' HE2' ' A' ' 61' ' ' LYS . 45.7 tt0 -69.15 -20.4 64.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -68.84 -26.37 65.12 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -82.78 -11.39 58.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.9 8.14 59.39 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -132.69 101.87 5.46 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 117.286 0.543 . . . . 0.0 111.611 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.444 ' HE2' ' OE1' ' A' ' 56' ' ' GLU . 97.0 mttt -67.56 172.04 5.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -152.87 119.35 5.6 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.501 0.191 . . . . 0.0 110.62 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -68.84 109.04 3.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.512 0.725 . . . . 0.0 111.586 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.6 m -58.81 108.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.0 mt -80.65 76.58 7.52 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 117.276 -1.345 . . . . 0.0 109.602 -177.625 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.5 mt . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -153.15 81.36 1.2 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.7 mp -75.12 103.46 5.3 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.45 -167.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -88.43 105.78 17.82 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.8 t -64.72 134.43 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 122.93 0.492 . . . . 0.0 111.146 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -85.12 146.19 27.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.617 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.708 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -147.4 161.65 40.6 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.628 0.371 . . . . 0.0 110.021 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.5 115.91 5.63 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.007 0.523 . . . . 0.0 110.36 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.7 t -69.48 -11.94 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.228 1.011 . . . . 0.0 111.239 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.6 m -48.72 -40.63 29.12 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -174.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.87 -23.37 67.32 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -174.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.9 -25.12 32.76 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.039 0.381 . . . . 0.0 110.848 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.29 -31.57 24.83 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -59.18 -23.2 62.04 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 121.232 -0.187 . . . . 0.0 111.428 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -72.01 -17.74 62.02 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.29 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.1 t -79.55 127.75 77.22 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -57.3 139.08 89.04 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.302 2.668 . . . . 0.0 111.112 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.01 -21.18 38.33 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.5 t -70.91 129.16 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -128.07 -27.63 2.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -131.48 150.23 52.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.6 t -146.06 151.06 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -145.31 127.83 16.04 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.1 m -131.73 156.01 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.192 -178.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.7 t -127.98 101.26 6.23 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 176.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.6 mt -66.04 -22.03 66.41 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -83.93 -31.34 25.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.386 0.539 . . . . 0.0 111.499 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -102.22 -8.5 21.25 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.61 0.186 . . . . 0.0 111.187 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.32 20.62 73.53 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -98.76 154.16 18.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.51 128.15 12.4 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.632 0.253 . . . . 0.0 110.54 -177.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -113.58 153.05 29.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.961 0.904 . . . . 0.0 109.456 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.08 163.28 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 174.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -141.31 95.59 2.85 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.79 -179.07 35.31 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.2 p -94.73 26.81 3.34 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.466 0.306 . . . . 0.0 110.58 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.09 174.03 10.56 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -107.92 155.73 39.44 Favored Pre-proline 0 N--CA 1.452 -0.326 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -58.89 -37.49 93.38 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.2 2.6 . . . . 0.0 111.972 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -73.98 -16.69 61.07 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 119.815 -0.135 . . . . 0.0 111.144 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.68 -33.63 14.98 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.9 tp -70.87 -59.64 2.68 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.546 -176.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.0 t -67.64 -22.45 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 122.19 0.196 . . . . 0.0 110.941 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -81.84 -33.72 30.52 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 122.27 -0.269 . . . . 0.0 110.532 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.11 -46.51 90.31 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.281 0.086 . . . . 0.0 110.984 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.45 -22.83 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -77.19 -22.4 52.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.381 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -70.05 -24.17 63.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -83.26 -9.05 59.34 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.82 10.56 34.78 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 119.364 -0.687 . . . . 0.0 113.063 175.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -131.8 125.65 32.41 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.589 1.195 . . . . 0.0 111.573 -177.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -69.88 167.06 18.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.579 177.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -153.82 95.64 1.9 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -66.78 105.4 1.56 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.124 0.57 . . . . 0.0 111.542 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.0 m -58.96 109.02 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.9 mt -80.88 74.16 7.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.288 -1.339 . . . . 0.0 109.208 -179.734 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.8 mt . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -159.73 78.74 0.7 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -176.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.7 mp -77.25 103.07 6.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.73 -164.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -79.92 96.42 6.37 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.0 t -65.1 128.62 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 120.737 0.304 . . . . 0.0 110.368 -176.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -75.47 145.33 41.53 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.452 0.701 . . . . 0.0 110.021 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.525 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 178.232 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -149.5 160.65 43.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.35 111.82 11.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.9 t -68.13 -8.02 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 123.066 0.546 . . . . 0.0 110.026 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.3 m -41.84 -38.35 1.5 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.564 1.146 . . . . 0.0 112.928 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.27 -23.56 66.77 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 122.016 -0.428 . . . . 0.0 111.704 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.79 -24.25 33.51 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.62 -34.85 27.43 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -61.86 -22.13 65.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -175.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -75.57 -15.92 60.31 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.4 t -77.67 128.93 78.27 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 118.299 0.5 . . . . 0.0 110.001 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.89 139.83 84.74 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.534 2.823 . . . . 0.0 111.112 177.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.92 -21.48 39.36 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 176.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.6 t -80.23 132.66 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -127.8 -29.95 2.56 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.513 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -133.99 152.02 51.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.1 t -144.48 150.33 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -177.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -141.83 125.94 17.36 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.0 m -133.14 158.54 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 120.462 0.173 . . . . 0.0 111.371 -175.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.7 t -126.47 104.45 8.15 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 176.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.4 mt -63.7 -20.86 66.06 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -173.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -84.1 -32.4 24.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.572 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -101.68 -9.66 20.7 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -175.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.9 24.15 72.81 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.056 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -95.79 154.4 17.24 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.96 108.72 3.85 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.12 152.17 23.12 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.4 m -132.18 163.73 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -137.82 89.88 2.45 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -159.28 -169.83 23.1 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.7 p -118.22 28.03 8.61 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.986 0.514 . . . . 0.0 110.206 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.67 168.89 18.93 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 17.4 m-20 -78.82 154.31 78.12 Favored Pre-proline 0 N--CA 1.451 -0.412 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 47' ' ' ASP . 76.0 Cg_exo -59.02 -46.63 21.52 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.625 2.884 . . . . 0.0 112.15 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -75.74 -32.35 59.97 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.935 -0.12 . . . . 0.0 111.151 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.62 -32.43 74.08 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 121.432 -0.107 . . . . 0.0 110.755 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.2 tp -69.21 -50.97 42.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 121.155 -0.218 . . . . 0.0 110.488 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.3 t -69.35 -28.21 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 122.508 0.323 . . . . 0.0 111.077 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -75.1 -31.89 61.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.55 -54.97 40.34 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 122.43 0.292 . . . . 0.0 111.42 -177.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -72.51 -23.82 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 121.403 -0.119 . . . . 0.0 111.029 -177.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -72.74 -22.37 60.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -70.94 -25.07 62.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -79.95 -9.58 59.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.0 11.3 34.77 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 119.588 -0.562 . . . . 0.0 111.888 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -129.82 114.85 16.42 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 117.886 0.843 . . . . 0.0 110.692 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.6 169.68 3.75 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -152.54 92.94 1.73 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -68.45 104.62 1.95 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 122.947 0.499 . . . . 0.0 111.331 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.7 m -58.24 113.53 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.05 76.25 6.79 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 CA-C-O 117.025 -1.464 . . . . 0.0 109.067 -177.282 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 N--CA 1.449 -0.506 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -156.31 76.41 0.9 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.0 mp -76.16 109.43 9.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -165.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 57.5 tttt -81.38 98.4 8.18 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.666 0.787 . . . . 0.0 109.218 173.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.4 t -70.47 107.97 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 117.797 0.271 . . . . 0.0 110.567 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -73.21 118.66 16.44 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.59 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.166 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.45 -0.453 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 74.8 mtm -142.3 160.12 40.87 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -177.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.73 92.0 5.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.38 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.6 t -70.46 -12.74 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.2 m -52.45 -42.23 63.98 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 122.927 0.491 . . . . 0.0 112.208 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -66.27 -22.26 66.3 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.36 -24.69 62.14 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.093 0.406 . . . . 0.0 110.518 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.06 -35.04 24.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -65.19 -22.78 66.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -176.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -74.02 -14.51 61.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.41 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.0 t -78.44 128.12 78.71 Favored Pre-proline 0 N--CA 1.451 -0.402 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -55.28 138.87 80.61 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.377 2.718 . . . . 0.0 111.066 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.6 -19.6 51.73 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.1 t -75.48 129.62 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -122.52 -28.27 4.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -133.26 150.4 51.92 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.0 t -145.29 149.54 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -146.36 126.42 13.72 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -131.45 156.07 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.35 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.4 t -129.2 102.91 6.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.56 -18.69 64.13 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.06 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -78.6 -29.79 46.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -100.36 -11.16 20.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.748 -0.093 . . . . 0.0 110.748 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.28 20.92 67.88 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -101.49 158.49 16.03 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.925 0.362 . . . . 0.0 110.463 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.1 110.7 5.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -101.07 152.65 20.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.64 162.23 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 175.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -142.23 86.46 1.97 Allowed 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.62 -173.54 26.17 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -177.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.8 p -112.59 28.1 9.06 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.623 0.369 . . . . 0.0 110.496 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.03 168.01 20.82 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -78.67 138.57 58.35 Favored Pre-proline 0 N--CA 1.45 -0.47 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -55.41 -36.44 93.99 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.266 2.644 . . . . 0.0 111.928 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -76.23 -32.7 59.04 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 121.387 -0.125 . . . . 0.0 110.72 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.35 -33.2 71.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tp -65.9 -55.76 15.25 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.539 0.209 . . . . 0.0 110.757 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 50.5 t -68.14 -22.96 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.738 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -75.9 -37.14 59.12 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.899 -0.321 . . . . 0.0 110.245 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.2 -47.72 83.19 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.332 0.11 . . . . 0.0 110.815 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.5 m -73.03 -25.1 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.875 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -76.07 -23.47 55.04 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -70.25 -24.98 63.16 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -79.76 -10.73 59.82 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.3 7.23 59.51 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -115.32 98.6 6.85 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -61.79 158.95 14.65 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -155.1 78.83 1.04 Allowed 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.96 139.23 40.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -58.15 137.4 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 122.612 0.365 . . . . 0.0 110.569 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.8 mt -83.98 76.1 10.08 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.06 -1.448 . . . . 0.0 109.337 179.351 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 30.9 mt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -161.71 79.62 0.56 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -171.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.0 mp -80.13 125.39 29.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.721 -0.612 . . . . 0.0 111.838 -164.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -101.14 89.07 3.67 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 172.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.32 115.46 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 122.889 0.476 . . . . 0.0 110.47 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -70.75 148.41 47.97 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.26 0.624 . . . . 0.0 109.882 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.625 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.013 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 11.1 mmm -140.7 160.17 40.62 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.44 110.17 16.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.88 0.472 . . . . 0.0 111.247 -178.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.2 t -91.04 -16.52 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 31.6 m -55.78 -43.57 76.9 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -174.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.66 -21.6 66.1 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.305 -0.247 . . . . 0.0 111.23 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.69 -27.44 60.4 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.854 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.88 -33.47 22.8 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.864 0.302 . . . . 0.0 111.77 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -62.85 -21.7 66.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -173.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -78.03 -18.42 55.88 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -173.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.3 t -78.88 130.67 69.46 Favored Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-N 118.976 0.807 . . . . 0.0 110.224 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -55.27 141.89 80.03 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 124.071 3.181 . . . . 0.0 111.56 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.16 -21.87 39.81 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.2 t -71.29 127.68 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.24 -27.54 3.8 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.437 0.162 . . . . 0.0 111.437 -177.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -133.82 152.63 51.93 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.3 t -143.02 147.09 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.24 129.44 14.62 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.4 m -130.93 155.99 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 117.959 0.345 . . . . 0.0 110.624 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.1 t -129.4 101.32 5.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.7 mt -64.47 -20.05 65.94 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.234 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -82.3 -31.47 29.96 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 110.666 -0.124 . . . . 0.0 110.666 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -101.86 -10.03 20.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.35 21.92 78.58 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -98.95 155.56 17.35 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.589 0.694 . . . . 0.0 109.933 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.14 108.56 4.83 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.404 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.6 mm? -104.18 150.31 24.48 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.39 162.79 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 173.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -139.01 86.23 2.12 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.63 -171.01 20.35 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.8 p -115.8 28.1 8.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 122.851 0.46 . . . . 0.0 110.227 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.35 159.31 32.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -83.82 152.77 63.39 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -60.24 -36.68 87.16 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.536 2.824 . . . . 0.0 112.121 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.5 pttt -69.65 -19.65 63.61 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 119.744 -0.169 . . . . 0.0 110.758 -175.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.64 -34.79 15.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.168 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 tp -75.21 -49.48 19.24 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.911 -0.315 . . . . 0.0 111.666 -174.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.07 -25.82 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 121.201 -0.2 . . . . 0.0 110.878 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -80.95 -32.02 34.69 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.09 -45.32 94.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.538 0.335 . . . . 0.0 111.219 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.0 m -71.78 -24.03 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.004 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -75.13 -20.95 59.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.83 -23.73 63.35 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -88.36 -7.93 55.88 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.82 12.73 49.23 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -128.15 100.82 6.0 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.94 0.87 . . . . 0.0 112.045 -175.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -71.1 167.15 19.9 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -160.55 117.26 2.39 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.84 119.23 14.68 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.643 0.377 . . . . 0.0 110.913 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.2 m -59.41 117.55 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.8 mt -82.39 31.8 0.4 Allowed 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.747 0.419 . . . . 0.0 110.005 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.341 -1.314 . . . . 0.0 109.165 179.567 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 45.7 mt . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -161.64 81.15 0.58 Allowed 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 -173.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.0 mp -79.97 109.43 14.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.827 -0.546 . . . . 0.0 112.007 -166.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -83.43 90.16 7.15 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 171.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.9 t -62.05 109.65 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -70.4 146.02 50.69 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.189 0.596 . . . . 0.0 110.208 -178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.577 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 178.96 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 11.2 mmm -137.03 160.68 38.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.231 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.05 110.45 16.59 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.995 0.518 . . . . 0.0 110.145 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.1 t -95.94 -21.02 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.9 m -56.49 -40.91 75.74 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.186 -0.321 . . . . 0.0 111.73 -176.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.54 -21.52 66.71 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 119.524 -0.274 . . . . 0.0 111.566 -177.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.99 -27.02 39.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.07 0.395 . . . . 0.0 110.689 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -85.52 -34.41 21.55 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 121.161 -0.216 . . . . 0.0 110.67 -177.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -62.55 -22.2 66.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.474 0.175 . . . . 0.0 111.474 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -79.6 -13.98 59.14 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 119.633 -0.223 . . . . 0.0 111.57 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.2 t -79.32 126.48 81.25 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -56.67 140.9 91.49 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.682 2.921 . . . . 0.0 111.513 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.67 -21.69 39.79 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.862 -0.495 . . . . 0.0 111.862 176.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.69 129.66 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -27.47 4.75 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 121.284 -0.167 . . . . 0.0 111.05 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -133.18 153.08 51.86 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 174.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.0 t -143.06 147.42 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.96 128.52 15.07 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.71 153.84 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.904 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.2 t -131.46 100.81 5.28 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.6 mt -64.97 -19.0 65.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 121.92 0.088 . . . . 0.0 110.952 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -82.03 -31.24 31.06 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -103.05 -10.18 19.12 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.55 22.36 79.02 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -98.56 155.15 17.43 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 117.618 0.709 . . . . 0.0 109.889 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.69 108.38 4.01 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.416 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.3 mm? -108.4 150.74 26.96 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.4 m -135.64 163.1 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 174.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -138.1 93.36 2.75 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.46 -172.8 29.29 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.7 p -111.27 28.59 8.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 122.87 0.468 . . . . 0.0 109.957 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.25 173.35 9.6 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -104.03 153.57 38.77 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -58.58 -36.96 96.61 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.481 2.787 . . . . 0.0 112.179 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.0 pttt -68.68 -21.03 64.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.513 -0.18 . . . . 0.0 110.513 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.43 -34.27 14.91 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 121.239 -0.184 . . . . 0.0 110.725 -178.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.5 tp -74.68 -47.74 29.97 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.28 -176.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.0 t -68.1 -35.72 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -69.23 -31.85 70.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.46 -55.05 38.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 121.946 0.098 . . . . 0.0 110.932 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.8 -23.92 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 121.181 -0.208 . . . . 0.0 110.698 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -73.56 -23.71 60.0 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -70.6 -24.41 62.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -83.91 -7.82 59.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.19 8.53 57.68 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -125.14 94.98 4.32 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 117.829 0.814 . . . . 0.0 111.04 -176.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -67.33 168.24 10.98 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -158.18 113.71 2.7 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -67.8 120.36 14.01 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.689 0.395 . . . . 0.0 110.818 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.446 ' C ' ' H ' ' A' ' 66' ' ' ALA . 14.4 m -60.09 111.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 172.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.7 mt -80.66 33.41 0.31 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.446 ' H ' ' C ' ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 117.298 -1.334 . . . . 0.0 108.937 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 74.0 mt . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.69 0.281 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -159.97 77.74 0.66 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -177.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.71 113.52 16.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -165.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 72.3 tttt -79.39 84.95 5.24 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.196 0.998 . . . . 0.0 108.36 173.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.59 108.93 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -71.09 148.62 47.31 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.956 0.502 . . . . 0.0 110.149 -178.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.624 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.999 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.5 mmt -140.57 159.79 41.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.69 90.3 5.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.7 t -69.14 -21.23 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.1 m -55.82 -37.27 68.44 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 122.335 0.254 . . . . 0.0 111.297 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.97 -22.42 66.8 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 119.597 -0.24 . . . . 0.0 111.336 -177.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.15 -24.26 32.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.023 0.374 . . . . 0.0 110.916 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.15 -48.13 12.54 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -66.33 -22.98 66.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -171.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -73.44 -15.49 61.34 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 118.255 0.48 . . . . 0.0 112.012 -176.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.3 t -76.96 129.35 78.93 Favored Pre-proline 0 N--CA 1.45 -0.426 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.85 140.51 47.79 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.473 2.782 . . . . 0.0 111.582 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.63 -20.82 44.59 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -78.77 130.97 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -125.15 -30.19 3.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -134.81 149.45 50.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.1 t -145.27 148.17 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -146.68 120.22 9.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 m -131.11 156.07 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.2 t -128.34 101.56 6.28 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.8 mt -63.83 -16.1 60.46 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.328 0.651 . . . . 0.0 112.124 -174.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -75.58 -36.51 60.33 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.207 0.458 . . . . 0.0 111.576 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -104.54 -8.19 19.2 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.784 0.265 . . . . 0.0 111.662 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.64 22.82 68.8 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.466 -0.63 . . . . 0.0 113.603 175.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.37 155.86 17.02 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.342 1.071 . . . . 0.0 108.825 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.52 110.17 4.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.4 mm? -104.55 153.27 21.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.23 162.01 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -138.75 79.23 1.72 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 177.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.56 -170.78 20.04 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.5 p -115.11 28.05 8.97 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.742 0.417 . . . . 0.0 110.589 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.46 172.16 13.01 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -102.5 140.68 21.33 Favored Pre-proline 0 N--CA 1.453 -0.297 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -50.68 -36.61 51.45 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 124.416 3.41 . . . . 0.0 115.357 -175.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.2 pttt -69.49 -18.09 63.66 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.686 0.676 . . . . 0.0 110.69 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.89 -34.42 16.08 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.691 -0.403 . . . . 0.0 111.498 -175.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.9 tp -70.87 -50.4 35.6 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.802 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.8 t -68.27 -22.95 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.269 -176.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -86.77 -34.33 19.64 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.011 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.33 94.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.848 -0.16 . . . . 0.0 110.634 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.81 -23.64 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.513 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.404 ' OE2' ' HE2' ' A' ' 61' ' ' LYS . 35.3 tt0 -74.71 -21.84 59.16 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -69.37 -23.46 63.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -93.2 -5.91 48.97 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.81 6.45 59.36 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -116.52 90.1 3.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.705 0.752 . . . . 0.0 110.776 -177.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.404 ' HE2' ' OE2' ' A' ' 56' ' ' GLU . 99.6 mttt -68.57 165.74 18.53 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 5' ' ' LYS . . . -158.12 117.03 3.14 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.51 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -73.89 111.62 9.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.113 0.565 . . . . 0.0 110.845 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -58.65 136.47 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.9 mt -94.3 32.16 1.59 Allowed 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.278 -0.264 . . . . 0.0 111.174 -178.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 116.972 -1.489 . . . . 0.0 109.308 177.782 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 58.1 mt . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -156.91 78.81 0.91 Allowed 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 -174.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.2 mp -80.46 106.63 12.62 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -163.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -80.58 84.54 6.14 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 171.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.2 t -66.29 132.54 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 O-C-N 122.522 -0.111 . . . . 0.0 110.713 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -88.58 142.97 27.26 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.716 0 CA-C-O 119.656 -0.525 . . . . 0.0 112.047 -178.692 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 60.6 mtt -136.54 160.19 39.51 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.21 93.03 9.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.4 t -66.85 -12.42 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.1 m -50.14 -39.34 42.98 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.132 0.573 . . . . 0.0 111.674 -177.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -63.31 -22.74 67.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -176.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.84 -25.51 32.54 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 117.902 0.319 . . . . 0.0 110.616 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -82.46 -32.85 28.7 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -64.5 -23.25 67.21 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -77.05 -11.98 59.88 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.612 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.1 t -78.84 129.72 72.66 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.61 136.38 73.84 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.398 2.732 . . . . 0.0 111.226 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.92 -20.9 39.64 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.98 128.75 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -125.37 -26.34 3.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -131.88 152.1 51.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.7 t -140.44 148.56 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -144.14 86.93 1.86 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.5 m -96.12 155.5 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.5 t -128.2 100.72 5.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.8 mt -64.54 -19.24 65.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.144 -174.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -83.3 -27.2 29.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -97.82 -11.44 23.29 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 119.806 -0.14 . . . . 0.0 111.167 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.08 20.55 74.91 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -109.12 156.18 20.13 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.32 110.23 6.46 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 41' ' ' LEU . 2.4 mm? -109.66 151.49 26.81 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.47 166.08 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -134.22 84.66 2.13 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.6 -172.27 23.73 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -176.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.1 p -112.73 29.32 8.04 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.643 0.777 . . . . 0.0 110.525 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.65 172.7 11.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.583 0.23 . . . . 0.0 110.724 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -103.06 157.88 32.87 Favored Pre-proline 0 N--CA 1.453 -0.308 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -57.76 -39.47 87.1 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.585 2.856 . . . . 0.0 112.352 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 pttt -72.41 -17.11 61.83 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.116 -176.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.8 -37.76 13.43 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.298 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.5 tp -76.25 -49.66 16.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.033 -176.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.71 -24.92 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 116.982 -0.099 . . . . 0.0 110.736 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -83.71 -29.81 27.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.92 -46.41 89.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.52 -23.84 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -74.06 -21.03 60.09 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -68.87 -23.34 64.2 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -92.53 -6.04 50.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.88 9.32 57.42 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -121.54 92.88 3.84 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.801 0.8 . . . . 0.0 111.546 -175.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.95 169.46 4.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -153.54 117.53 4.79 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.733 0.301 . . . . 0.0 110.608 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -71.59 110.51 6.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.492 0.717 . . . . 0.0 110.819 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -58.26 113.86 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.0 mt -82.87 34.62 0.45 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.443 0.297 . . . . 0.0 110.532 -177.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 116.885 -1.531 . . . . 0.0 109.615 -179.2 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 64.2 mt . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.481 ' HE2' ' OE1' ' A' ' 39' ' ' GLU . 82.2 tttt -156.21 81.25 0.99 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -175.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 62' ' ' ALA . 8.3 mp -75.73 102.57 5.46 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.955 -167.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -85.48 102.86 13.84 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.4 t -65.24 135.88 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 123.271 0.628 . . . . 0.0 110.814 -177.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -77.36 146.96 36.37 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.549 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.209 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -137.7 158.98 43.23 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.415 ' HB2' ' HE3' ' A' ' 20' ' ' LYS . . . -78.11 93.61 4.56 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.4 t -66.35 -15.3 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.9 m -54.43 -35.67 63.18 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.201 0.6 . . . . 0.0 110.788 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 17' ' ' ALA . 96.6 mttt -58.58 -26.32 63.5 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 119.727 -0.177 . . . . 0.0 111.337 -177.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.69 -25.97 28.04 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 117.735 0.243 . . . . 0.0 110.71 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -83.52 -34.7 25.24 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -177.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -63.22 -22.04 66.61 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -73.37 -12.06 60.69 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 122.483 -0.135 . . . . 0.0 111.221 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.4 t -78.9 130.86 68.84 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -56.06 129.69 36.25 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.997 3.131 . . . . 0.0 112.226 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.33 -26.34 12.09 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 112.156 -0.377 . . . . 0.0 112.156 174.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.497 ' HA ' ' HA3' ' A' ' 44' ' ' GLY . 61.1 t -71.91 129.14 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -126.94 -23.46 3.64 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.825 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -128.33 151.59 49.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.6 t -144.38 151.51 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -140.17 96.12 3.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.7 m -96.4 156.04 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.407 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.0 t -127.54 102.13 6.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.8 mt -64.4 -18.97 65.19 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.753 -174.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -83.71 -30.63 26.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 117.821 0.282 . . . . 0.0 110.727 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -98.26 -13.82 20.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 121.53 -0.068 . . . . 0.0 110.82 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.9 19.61 65.73 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.481 ' OE1' ' HE2' ' A' ' 3' ' ' LYS . 98.9 mt-10 -102.1 157.39 16.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -178.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.29 118.95 9.15 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.661 0.267 . . . . 0.0 110.337 -177.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.77 152.7 20.56 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -133.85 164.49 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.708 0.289 . . . . 0.0 111.01 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -138.67 99.35 3.79 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 28' ' ' VAL . . . -160.74 -175.14 31.43 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.8 p -112.42 25.52 11.42 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.546 0.338 . . . . 0.0 110.226 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.5 170.12 17.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 122.415 -0.178 . . . . 0.0 110.956 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -88.2 156.64 51.46 Favored Pre-proline 0 N--CA 1.452 -0.356 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -56.16 -37.02 97.22 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.551 2.834 . . . . 0.0 112.468 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -70.04 -41.15 74.61 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.284 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.86 -31.32 66.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -176.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.2 tp -73.22 -60.73 2.1 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 111.461 0.171 . . . . 0.0 111.461 -178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.1 t -69.57 -23.06 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 122.192 0.197 . . . . 0.0 111.481 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -79.02 -34.75 43.68 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.67 -55.12 37.0 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.807 -0.179 . . . . 0.0 110.882 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.63 -24.56 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -72.61 -37.41 68.1 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -72.21 -23.25 61.21 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -75.36 -4.48 39.57 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 176.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.8 4.1 58.01 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 119.246 -0.752 . . . . 0.0 113.055 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -135.22 114.11 11.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.578 1.189 . . . . 0.0 111.072 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.27 169.17 2.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . . . -155.91 100.08 2.02 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.527 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -69.68 106.28 3.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.951 0.5 . . . . 0.0 111.58 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.7 m -58.78 106.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 174.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.8 mt -80.62 76.95 7.48 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 116.87 -1.538 . . . . 0.0 109.512 -178.267 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 75.6 mt . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -159.65 76.58 0.67 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -176.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.5 mp -78.43 122.78 26.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.693 0.282 . . . . 0.0 111.451 -166.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -99.48 91.37 4.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.6 130.09 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 122.469 0.308 . . . . 0.0 110.555 -175.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -78.37 146.86 34.39 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.638 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.998 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -135.89 159.64 41.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.24 95.95 2.2 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.8 t -67.74 -13.8 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.4 m -54.01 -36.35 62.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.7 0.4 . . . . 0.0 110.438 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -59.22 -23.4 62.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 119.773 -0.156 . . . . 0.0 111.078 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.26 -32.95 26.15 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.52 -36.42 60.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -66.5 -21.43 66.18 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -174.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -78.26 -17.14 57.06 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.7 t -78.64 128.06 78.44 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.845 -177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -55.44 141.43 82.24 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.703 2.935 . . . . 0.0 111.465 177.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.57 -22.6 32.32 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.7 t -76.29 129.97 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -124.69 -27.02 3.72 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -132.78 149.55 52.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.8 t -145.81 149.68 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -146.23 126.69 14.09 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 m -129.18 154.63 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-O 120.801 0.334 . . . . 0.0 110.52 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.406 ' HG ' ' HD2' ' A' ' 37' ' ' LYS . 37.5 t -128.27 104.6 7.83 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 178.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.9 mt -64.07 -23.32 67.28 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 122.593 0.357 . . . . 0.0 111.93 -173.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -84.68 -41.67 16.05 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 118.269 0.486 . . . . 0.0 110.544 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.406 ' HD2' ' HG ' ' A' ' 34' ' ' SER . 95.9 mttt -82.48 -10.99 58.79 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.789 -0.187 . . . . 0.0 110.685 -176.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.58 21.71 67.19 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -99.1 156.63 16.85 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 117.634 0.717 . . . . 0.0 110.257 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.85 108.47 4.0 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.58 149.16 24.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.3 m -135.93 162.31 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -139.15 95.49 2.95 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.34 -175.75 33.7 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -177.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.0 p -106.02 26.71 9.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 122.681 0.392 . . . . 0.0 110.515 -178.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.03 170.69 15.79 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -92.92 156.52 40.5 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.14 -50.69 12.22 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.872 3.048 . . . . 0.0 112.204 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -70.47 -30.48 67.31 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 121.126 -0.23 . . . . 0.0 110.889 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.01 -33.48 75.91 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.8 tp -74.11 -52.6 12.1 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.486 0.184 . . . . 0.0 110.61 -177.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.61 -25.46 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.813 -0.176 . . . . 0.0 111.3 -177.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -72.06 -33.14 67.73 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.083 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.25 -49.44 75.71 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.155 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 m -72.78 -23.59 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 117.705 0.229 . . . . 0.0 110.853 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -69.13 -34.11 74.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -70.85 -23.18 62.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -80.61 -8.08 59.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.86 12.56 52.62 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.569 -0.613 . . . . 0.0 111.569 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -124.51 111.17 15.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 117.777 0.788 . . . . 0.0 111.114 -176.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.72 165.62 8.14 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -162.66 79.57 0.49 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.646 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -71.35 127.92 34.18 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -60.73 135.29 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 175.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.4 mt -108.46 59.48 0.61 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.057 0 CA-C-O 117.042 -1.456 . . . . 0.0 108.944 -179.125 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.2 mt . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.0 tttt -161.8 77.46 0.52 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -175.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.5 mp -79.08 122.51 26.31 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 121.83 -0.544 . . . . 0.0 111.77 -166.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -100.15 92.95 5.46 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 175.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.6 t -65.56 132.52 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 122.772 0.429 . . . . 0.0 111.567 -174.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -80.06 144.38 33.22 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.537 0.735 . . . . 0.0 109.751 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.621 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 178.182 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 120.658 0.266 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -129.55 161.53 30.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.9 91.14 0.45 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.88 -14.15 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.4 m -54.28 -36.89 64.14 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.013 0.525 . . . . 0.0 110.5 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.71 -29.25 67.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 121.357 -0.137 . . . . 0.0 111.198 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.43 -24.43 50.39 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 117.622 0.192 . . . . 0.0 110.807 -177.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.48 -39.08 20.97 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.8 tttt -67.82 -22.13 65.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -173.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -73.28 -17.78 61.28 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.657 0.662 . . . . 0.0 111.743 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.6 t -76.25 128.71 82.08 Favored Pre-proline 0 N--CA 1.449 -0.492 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.26 139.92 53.04 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.67 2.913 . . . . 0.0 111.691 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.88 -21.56 35.95 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 177.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -77.48 116.36 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -116.48 -24.17 7.96 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.15 148.9 51.14 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -145.89 148.25 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -146.89 120.9 9.38 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 m -131.63 155.9 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.649 -177.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.6 t -129.41 104.03 7.25 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.8 mt -64.19 -18.5 64.54 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.576 0.35 . . . . 0.0 111.081 -176.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -84.22 -29.97 26.1 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 117.462 0.119 . . . . 0.0 111.029 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -100.04 -10.6 21.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 121.924 0.09 . . . . 0.0 111.06 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.33 19.4 70.47 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -100.72 154.94 18.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.35 119.17 7.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -117.12 151.73 36.23 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.87 162.44 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -139.16 84.7 2.02 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.7 -177.45 29.85 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.9 p -93.31 28.09 2.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.037 0.535 . . . . 0.0 110.708 -178.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.05 173.97 10.0 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 122.375 -0.203 . . . . 0.0 111.063 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -107.12 156.62 37.15 Favored Pre-proline 0 N--CA 1.452 -0.337 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -56.92 -52.79 6.02 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.728 2.952 . . . . 0.0 112.906 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -71.3 -32.49 68.69 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 121.124 -0.231 . . . . 0.0 110.898 -176.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.2 -33.13 75.06 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.6 tp -71.93 -51.52 21.72 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.976 -178.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.5 t -68.94 -27.93 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 121.379 -0.128 . . . . 0.0 111.007 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -67.97 -33.18 74.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.17 -55.82 21.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.075 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.26 -23.61 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -175.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.18 -34.82 68.73 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 120.601 -0.439 . . . . 0.0 109.841 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -71.55 -23.46 61.76 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -74.83 -8.48 56.57 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.24 12.55 51.5 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -127.69 98.41 5.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 117.115 0.458 . . . . 0.0 110.347 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -62.4 161.55 11.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -161.5 92.81 0.9 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.107 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -77.82 129.42 35.4 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -60.94 135.02 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.1 mt -109.34 31.33 5.84 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.5 0.32 . . . . 0.0 110.217 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 116.752 -1.594 . . . . 0.0 109.179 -178.738 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.516 ' HG2' ' H ' ' A' ' 2' ' ' LEU . 9.5 ttm . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.516 ' H ' ' HG2' ' A' ' 1' ' ' MET . 72.5 mt -117.44 150.97 38.02 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.084 0.402 . . . . 0.0 110.932 -176.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -164.47 79.38 0.37 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 -177.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 mp -79.27 108.91 13.13 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.824 -0.547 . . . . 0.0 112.084 -164.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -78.74 87.0 4.65 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.7 t -63.38 109.05 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -70.82 147.94 48.38 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 122.887 0.475 . . . . 0.0 110.208 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.27 66.45 2.4 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 94.1 mtp -67.55 -36.93 81.92 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.341 0.256 . . . . 0.0 111.238 -176.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 46.7 p -138.81 166.04 25.46 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 83.2 m 48.44 36.2 6.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.034 0.534 . . . . 0.0 111.129 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -67.01 -10.81 53.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 121.857 0.063 . . . . 0.0 110.922 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -82.91 -8.84 59.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.6 m -130.05 -169.71 2.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.471 0.709 . . . . 0.0 109.335 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.8 p -139.88 154.18 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.5 mmt -140.38 161.24 38.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.63 127.14 35.87 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 t -96.63 -13.38 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.0 m -53.39 -41.43 65.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -67.32 -22.43 65.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.863 0.301 . . . . 0.0 111.697 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.05 -34.83 59.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.039 0.381 . . . . 0.0 110.871 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -74.3 -38.61 63.31 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -173.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -65.68 -22.07 66.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -174.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.31 -18.68 65.5 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.898 -176.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.1 t -80.21 129.92 67.87 Favored Pre-proline 0 N--CA 1.451 -0.423 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -52.88 140.67 57.67 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.634 2.889 . . . . 0.0 111.504 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.52 -21.26 41.89 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.1 t -78.05 127.91 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.77 -24.53 3.23 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 110.638 -0.134 . . . . 0.0 110.638 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -128.05 147.0 50.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.7 t -146.12 146.62 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -149.11 131.1 15.28 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -126.81 156.13 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.3 t -128.41 101.05 6.03 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.27 -22.34 66.84 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.316 -175.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -84.92 -29.04 25.48 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.555 0.162 . . . . 0.0 111.151 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -97.85 -9.84 25.71 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.412 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.22 23.1 78.47 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -114.76 158.16 22.23 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 117.723 0.762 . . . . 0.0 110.913 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.95 110.82 6.22 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.045 0.938 . . . . 0.0 109.121 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.4 mm? -108.35 150.7 26.99 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.7 m -134.73 164.38 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -139.03 89.27 2.34 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.22 -173.99 23.08 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.0 p -113.43 28.85 8.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.969 0.507 . . . . 0.0 110.517 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.89 170.23 16.35 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -80.32 155.55 74.27 Favored Pre-proline 0 N--CA 1.452 -0.366 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -59.11 -44.97 30.44 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.489 2.792 . . . . 0.0 112.091 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.425 ' HG2' ' H ' ' A' ' 49' ' ' LYS . 23.1 pttt -75.08 -29.02 60.54 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -175.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.08 76.6 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 121.233 -0.187 . . . . 0.0 110.565 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.9 tp -73.28 -51.38 17.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.619 0.247 . . . . 0.0 110.567 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.7 -23.15 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.189 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -80.78 -33.83 34.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.69 96.34 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.231 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -71.76 -25.79 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.812 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -73.92 -21.33 60.09 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -68.92 -24.32 64.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -89.68 -7.47 54.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.35 9.06 57.15 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -122.89 95.68 4.72 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.705 0.753 . . . . 0.0 110.796 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -66.88 168.15 10.28 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -155.27 117.66 4.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.252 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.21 106.94 3.03 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.158 0.583 . . . . 0.0 111.349 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.21 110.04 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.4 mt -80.96 74.44 7.95 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 CA-C-O 117.368 -1.301 . . . . 0.0 109.726 -179.195 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.3 mt -59.58 136.62 58.04 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -147.54 83.96 1.55 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.35 170.03 9.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.346 0.594 . . . . 0.0 112.587 -173.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -151.4 96.65 2.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.61 1.164 . . . . 0.0 107.967 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.4 t -59.77 170.9 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.414 ' C ' ' H ' ' A' ' 9' ' ' MET . 7.8 tp10 -125.43 150.97 46.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.14 -1.87 1.24 Allowed Glycine 0 CA--C 1.527 0.803 0 C-N-CA 123.701 0.667 . . . . 0.0 112.225 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.47 ' HA ' ' HE1' ' A' ' 9' ' ' MET . 6.1 tpt -69.22 -15.08 63.3 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 117.935 0.868 . . . . 0.0 110.015 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.0 p -86.96 174.38 8.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.5 m 50.35 9.0 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.168 0.987 . . . . 0.0 113.29 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -61.6 175.84 0.57 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.078 0.399 . . . . 0.0 110.501 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 -130.05 -7.67 4.38 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 70.9 m -143.12 84.26 1.82 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 10.7 p -56.85 164.68 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.271 -177.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 75.8 mtm -139.87 -175.33 4.18 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.404 ' C ' ' H ' ' A' ' 19' ' ' THR . . . -122.93 95.67 4.71 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -178.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.523 ' C ' ' H ' ' A' ' 20' ' ' LYS . 13.0 t -65.43 -1.51 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 123.012 0.525 . . . . 0.0 110.034 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.404 ' H ' ' C ' ' A' ' 17' ' ' ALA . 8.9 m -63.79 6.61 0.15 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.322 0.649 . . . . 0.0 110.772 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.523 ' H ' ' C ' ' A' ' 18' ' ' VAL . 98.4 mttt -120.39 6.95 10.63 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.849 0.46 . . . . 0.0 110.756 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -118.51 -1.41 11.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.81 -0.42 9.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -98.52 -12.73 20.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -85.26 -10.63 56.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.18 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -76.71 123.17 87.54 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 28' ' ' VAL . 52.7 Cg_exo -55.16 166.48 2.26 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.306 2.671 . . . . 0.0 111.207 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.81 -13.98 1.19 Allowed Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.412 -0.66 . . . . 0.0 112.54 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.404 ' H ' ' C ' ' A' ' 26' ' ' PRO . 70.8 t -79.27 159.3 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 118.373 1.087 . . . . 0.0 108.537 177.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -147.63 -18.56 0.37 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -146.25 163.58 35.01 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.2 t -150.92 152.6 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -144.82 152.83 40.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -153.11 178.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.5 t -147.16 102.25 3.48 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.15 -1.13 2.93 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.702 0.401 . . . . 0.0 111.745 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -116.6 1.64 12.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 117.986 0.357 . . . . 0.0 110.446 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -132.99 -10.07 3.01 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.8 -3.73 6.25 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -72.77 166.07 23.61 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 117.78 0.79 . . . . 0.0 109.883 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.401 ' C ' HD12 ' A' ' 41' ' ' LEU . . . -156.08 154.07 30.38 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.401 HD12 ' C ' ' A' ' 40' ' ' ALA . 5.3 mp -145.88 169.1 19.26 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.9 m -149.26 172.13 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -143.15 97.69 3.13 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -169.74 174.01 43.96 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.7 p -80.85 7.05 11.36 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.706 0.802 . . . . 0.0 111.844 -177.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.03 173.62 0.15 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.688 0.28 . . . . 0.0 111.084 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -122.96 162.57 38.36 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -60.19 -28.84 87.75 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.55 2.833 . . . . 0.0 111.923 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -88.18 3.32 49.75 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.398 0.279 . . . . 0.0 111.065 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.94 -0.68 6.59 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.7 tp -119.13 -0.74 11.01 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.1 t -124.09 -25.26 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -76.15 -12.69 60.15 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.87 -57.61 3.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.327 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.79 -24.02 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 110.546 -0.168 . . . . 0.0 110.546 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -79.4 -18.09 53.0 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -85.21 -20.21 30.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -83.76 -3.45 57.83 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 122.774 0.43 . . . . 0.0 110.184 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.75 2.35 72.44 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -134.0 81.93 1.95 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 117.517 0.659 . . . . 0.0 109.726 -178.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -60.72 168.95 2.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 110.407 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -153.91 105.19 2.73 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -66.39 170.93 5.37 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.58 -178.86 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 120.878 0.371 . . . . 0.0 110.246 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.6 mt -136.71 5.24 2.87 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.966 0.906 . . . . 0.0 108.843 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 117.043 -1.456 . . . . 0.0 108.976 179.527 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ttm . . . . . 0 N--CA 1.47 0.575 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 77.8 mt -86.73 152.92 22.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -155.12 79.41 1.05 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -174.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.1 mp -77.73 103.84 7.91 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.269 -163.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -80.68 100.52 8.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 171.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.9 t -60.28 147.8 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.312 1.045 . . . . 0.0 111.427 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -58.93 162.54 4.09 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.189 1.395 . . . . 0.0 107.999 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.68 44.31 0.37 Allowed Glycine 0 CA--C 1.526 0.772 0 CA-C-O 119.67 -0.517 . . . . 0.0 114.039 -168.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.587 ' CG ' ' CG ' ' A' ' 60' ' ' TYR . 95.8 mtp -63.1 -28.96 70.43 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.341 -0.506 . . . . 0.0 110.302 169.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 67.4 p -81.18 155.78 26.01 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -164.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.9 m 46.06 26.99 0.47 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.627 1.971 . . . . 0.0 113.844 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.497 ' CG ' ' H ' ' A' ' 13' ' ' HIS . 15.5 p-10 -90.66 -59.98 2.04 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 116.595 -2.042 . . . . 0.0 109.131 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.497 ' H ' ' CG ' ' A' ' 12' ' ' ASN . 75.2 m-70 -126.71 -37.41 2.15 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 122.989 0.516 . . . . 0.0 110.413 167.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.6 m -134.26 -169.47 2.33 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 114.766 -1.106 . . . . 0.0 113.489 -166.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.43 156.32 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 125.714 1.606 . . . . 0.0 107.859 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.8 mtt -140.97 159.89 41.25 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.01 88.34 7.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.9 t -69.81 -14.57 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 122.493 0.317 . . . . 0.0 110.196 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -56.6 -39.59 73.83 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 122.264 -0.273 . . . . 0.0 110.808 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.65 -21.52 66.56 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 119.569 -0.253 . . . . 0.0 111.482 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.54 -39.78 51.84 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 117.852 0.297 . . . . 0.0 110.414 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.87 -32.65 59.81 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -60.29 -21.42 61.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 112.611 0.596 . . . . 0.0 112.611 -174.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -79.7 -17.99 52.31 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 118.157 0.435 . . . . 0.0 111.623 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.0 t -70.98 128.02 91.07 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 117.751 0.25 . . . . 0.0 110.438 -174.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -58.47 137.23 79.21 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.444 2.763 . . . . 0.0 110.86 177.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.08 -25.06 15.42 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.428 ' HA ' ' HA3' ' A' ' 44' ' ' GLY . 54.7 t -72.58 129.62 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -126.24 -25.91 3.44 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.737 -0.21 . . . . 0.0 110.678 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -130.42 148.61 52.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.7 t -146.51 147.65 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -146.43 129.25 16.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.43 158.72 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 120.89 0.376 . . . . 0.0 111.613 -174.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.0 t -126.86 101.93 6.8 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.6 mt -63.89 -25.26 68.07 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -173.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -85.16 -30.04 24.27 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.588 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -99.38 -11.03 21.54 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -175.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.14 24.49 76.99 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -98.6 154.73 17.71 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.76 0.78 . . . . 0.0 109.577 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.32 109.85 4.43 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.444 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.25 139.12 36.38 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.33 162.97 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -139.0 101.33 4.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.428 ' HA3' ' HA ' ' A' ' 28' ' ' VAL . . . -156.73 -175.68 27.94 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -177.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.4 p -114.61 26.04 10.53 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 122.898 0.479 . . . . 0.0 109.801 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.22 167.88 21.06 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.713 -0.221 . . . . 0.0 110.613 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.15 144.53 71.66 Favored Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -56.01 -37.53 96.05 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.864 2.376 . . . . 0.0 111.457 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -75.62 -33.98 60.55 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.95 -33.64 76.02 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.5 tp -70.19 -50.44 40.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.66 -22.57 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -82.67 -32.28 28.21 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.48 -45.38 93.95 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.9 m -73.94 -23.89 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.099 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.405 ' OE2' ' HE2' ' A' ' 61' ' ' LYS . 42.6 tt0 -70.77 -19.6 62.69 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.02 -23.74 65.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -91.45 -13.57 32.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.85 10.37 57.71 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.587 ' CG ' ' CG ' ' A' ' 9' ' ' MET . 40.7 m-85 -131.12 88.18 2.57 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -175.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.405 ' HE2' ' OE2' ' A' ' 56' ' ' GLU . 88.5 mttt -64.44 178.47 0.72 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.612 0.765 . . . . 0.0 110.227 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -154.19 101.86 2.42 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.187 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -69.19 120.41 14.99 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.715 0.406 . . . . 0.0 110.918 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.7 m -59.06 130.02 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 175.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.5 mt -83.71 34.15 0.49 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 116.851 -1.547 . . . . 0.0 109.399 -178.792 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.9 mt -90.04 151.78 21.48 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -160.24 77.52 0.64 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -174.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.3 mp -81.14 127.24 32.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.532 0.333 . . . . 0.0 111.699 -166.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -99.75 96.01 7.32 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 t -66.35 107.42 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 123.228 0.611 . . . . 0.0 111.957 -175.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -78.14 148.32 34.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 174.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.63 67.82 1.11 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.6 mmt -69.92 -34.75 73.89 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 117.305 0.553 . . . . 0.0 110.858 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.3 p -136.33 162.78 32.06 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.2 m 44.72 33.76 1.03 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.232 0.613 . . . . 0.0 110.603 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -68.22 -13.34 62.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.15 0.58 . . . . 0.0 111.742 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -85.35 -8.59 58.38 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.9 m -129.67 -174.95 3.44 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.0 p -140.65 154.83 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 60.5 mtt -145.24 161.95 38.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.67 94.35 0.78 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.64 -13.35 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.5 m -54.64 -38.24 66.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 122.674 0.39 . . . . 0.0 110.7 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.56 -23.26 67.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.54 -0.267 . . . . 0.0 111.675 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.42 -22.79 40.86 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 117.729 0.241 . . . . 0.0 111.051 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.95 -33.49 16.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.503 0.138 . . . . 0.0 111.241 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -64.41 -26.57 68.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -169.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -81.18 -9.96 59.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 119.364 0.984 . . . . 0.0 111.801 -177.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.3 t -73.61 130.67 83.37 Favored Pre-proline 0 N--CA 1.452 -0.34 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.64 140.53 65.74 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.763 2.975 . . . . 0.0 112.172 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.16 -20.98 39.86 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 119.833 -0.426 . . . . 0.0 112.121 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.1 t -68.82 130.34 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 117.578 0.689 . . . . 0.0 109.463 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -120.24 -36.98 3.13 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -134.44 155.72 49.83 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.4 t -135.12 148.78 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -144.0 104.15 4.11 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.1 m -125.27 155.54 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.3 t -128.36 101.33 6.17 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.88 -18.07 63.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.301 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -83.77 -30.83 26.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.206 0.203 . . . . 0.0 110.64 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -102.96 -10.47 18.96 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -176.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.23 20.44 75.04 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -102.2 155.37 18.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.98 121.38 9.65 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -118.58 153.62 33.95 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.94 166.57 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -135.81 89.55 2.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.83 177.55 38.87 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -177.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.9 p -95.28 26.88 3.54 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.188 0.595 . . . . 0.0 110.11 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.05 169.71 17.47 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -110.03 158.23 35.63 Favored Pre-proline 0 N--CA 1.452 -0.351 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -55.61 -46.0 35.24 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.82 3.013 . . . . 0.0 112.796 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -74.68 -13.93 60.68 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.405 -177.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.44 -35.49 15.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.219 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tp -76.44 -48.43 19.68 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.386 0.136 . . . . 0.0 111.11 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.7 t -68.29 -23.06 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 119.619 -0.229 . . . . 0.0 111.475 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -77.54 -37.61 50.47 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.104 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.65 -48.6 81.02 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.815 -0.175 . . . . 0.0 110.913 -176.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -72.32 -26.09 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.795 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -76.77 -28.57 55.74 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.598 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -70.24 -23.57 62.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -83.59 -4.48 58.6 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 177.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.99 7.5 58.55 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -115.18 90.94 3.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 117.298 0.549 . . . . 0.0 111.237 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -66.18 114.15 5.07 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.9 88.61 2.69 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.43 141.45 38.29 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.466 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.1 m -59.3 139.67 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 123.661 0.784 . . . . 0.0 111.167 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.08 28.04 2.96 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 116.98 -1.486 . . . . 0.0 109.561 -179.163 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ttm . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 67.1 mt -105.2 157.37 17.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.879 0.471 . . . . 0.0 110.251 -176.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -153.81 80.08 1.14 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.7 mp -77.85 108.04 10.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.677 -164.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 14.7 tmtt? -93.06 96.77 10.27 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 174.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.2 t -64.36 133.92 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -85.34 149.04 25.73 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.648 0.379 . . . . 0.0 110.114 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.31 62.65 1.75 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 59.9 mtt -67.37 -60.89 2.21 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 117.011 0.406 . . . . 0.0 111.508 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.2 p -135.6 166.3 23.55 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.565 0.221 . . . . 0.0 110.696 -176.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.9 m 46.61 32.75 1.77 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.451 0.701 . . . . 0.0 111.076 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -68.62 -9.58 50.72 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.203 0.201 . . . . 0.0 110.504 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -77.59 -8.22 57.53 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.4 m -129.01 -175.36 3.53 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.222 0.609 . . . . 0.0 109.48 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.8 p -137.71 155.35 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 58.4 mtt -139.27 161.31 37.75 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.58 89.65 2.75 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.8 t -74.44 -21.97 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.7 m -57.47 -39.23 75.93 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 122.37 -0.206 . . . . 0.0 110.549 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.56 -22.41 66.96 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 119.645 -0.216 . . . . 0.0 111.533 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.78 -38.94 37.24 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.471 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -73.05 -32.45 65.07 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -63.02 -21.96 66.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -175.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -70.34 -14.99 62.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.211 0.46 . . . . 0.0 111.147 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 71.9 t -78.53 127.55 80.26 Favored Pre-proline 0 N--CA 1.451 -0.413 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -175.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -58.63 140.4 94.71 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 123.462 2.775 . . . . 0.0 110.975 177.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.76 -20.85 42.44 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.996 -0.441 . . . . 0.0 111.996 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.33 128.26 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -110.62 -42.16 4.13 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -135.47 154.96 51.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.6 t -140.46 149.41 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -139.1 99.21 3.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 m -95.76 155.87 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.7 t -127.47 98.74 5.34 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.0 mt -66.66 -19.82 65.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -173.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -84.05 -32.21 24.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.443 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -103.43 -9.85 19.06 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 117.872 0.306 . . . . 0.0 111.223 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.81 21.73 76.68 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -98.66 155.04 17.52 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.04 125.6 10.28 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.986 0.422 . . . . 0.0 111.184 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -107.54 153.06 23.41 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 175.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.4 m -132.38 164.7 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -137.28 88.98 2.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.61 -176.61 35.72 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.8 p -117.31 29.51 7.84 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.385 0.674 . . . . 0.0 109.893 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.22 167.08 21.92 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.805 0.336 . . . . 0.0 110.854 -176.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -76.77 149.58 80.74 Favored Pre-proline 0 N--CA 1.451 -0.425 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.079 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -55.45 -49.42 16.16 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.379 2.719 . . . . 0.0 112.185 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -74.79 -19.6 60.13 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.04 -34.81 71.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.919 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.0 tp -75.47 -43.66 48.25 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 83.0 t -65.25 -24.84 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 123.189 0.596 . . . . 0.0 111.816 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -87.27 -28.94 22.02 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.968 0.349 . . . . 0.0 111.176 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.91 -47.02 87.48 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 122.345 -0.222 . . . . 0.0 110.991 -177.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.89 -21.32 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -68.76 -21.02 64.38 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.44 -29.15 67.73 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -83.78 -9.37 58.84 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.59 11.13 48.54 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 119.619 -0.545 . . . . 0.0 111.74 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -128.72 142.54 50.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 117.758 0.779 . . . . 0.0 110.434 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -85.23 172.45 11.15 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 171.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 5' ' ' LYS . . . -149.54 77.51 1.34 Allowed 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.11 117.68 4.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.863 -175.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -57.45 126.0 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.749 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.5 mt -84.08 31.28 0.5 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.741 0.416 . . . . 0.0 109.93 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 117.239 -1.363 . . . . 0.0 110.199 -178.284 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.742 ' HG2' ' H ' ' A' ' 2' ' ' LEU . 9.7 ttt . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.742 ' H ' ' HG2' ' A' ' 1' ' ' MET . 60.2 mt -79.78 161.66 25.57 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.012 0.434 . . . . 0.0 110.437 -174.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -148.03 78.74 1.45 Allowed 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 -169.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -77.46 114.84 16.71 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.225 -164.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 75.8 tttt -96.1 98.82 10.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.296 1.039 . . . . 0.0 108.907 175.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.4 t -61.75 115.58 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 120.843 0.354 . . . . 0.0 110.19 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -69.96 151.77 45.22 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.446 0.698 . . . . 0.0 110.032 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.18 52.66 1.86 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 57.2 mtt -68.32 -38.55 81.66 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.55 0.675 . . . . 0.0 111.899 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.404 ' H ' ' HE2' ' A' ' 60' ' ' TYR . 68.8 p -139.47 163.04 33.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.298 0.499 . . . . 0.0 111.25 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 64.5 m 42.17 33.68 0.41 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.232 1.013 . . . . 0.0 113.004 173.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -69.38 -7.14 34.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.034 0.379 . . . . 0.0 110.859 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -76.48 -12.8 60.1 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.2 m -131.24 -175.13 3.59 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 122.945 0.498 . . . . 0.0 109.73 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 p -132.72 154.62 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 69.7 mtm -144.83 160.42 41.3 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.0 90.77 4.19 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.69 -13.5 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.8 m -52.91 -37.7 61.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.12 0.568 . . . . 0.0 110.792 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -64.2 -22.35 66.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.15 -25.0 34.73 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 117.858 0.299 . . . . 0.0 110.994 -178.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.12 -33.52 24.3 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 117.455 0.116 . . . . 0.0 110.862 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -63.56 -22.5 66.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -71.09 -16.13 62.56 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.599 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 72.5 t -80.32 127.31 76.69 Favored Pre-proline 0 N--CA 1.45 -0.433 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -177.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.64 141.22 97.38 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.651 2.901 . . . . 0.0 111.232 177.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.8 -19.62 50.39 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.855 -0.498 . . . . 0.0 111.855 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.0 t -74.14 123.41 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 117.387 0.593 . . . . 0.0 109.426 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -129.41 -26.67 2.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -130.6 132.12 45.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.262 0.553 . . . . 0.0 110.139 176.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 83.9 t -144.73 147.72 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -136.43 122.84 20.7 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 m -130.56 156.23 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.145 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.5 t -126.86 102.45 7.03 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.5 mt -62.71 -18.05 61.81 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.101 0.56 . . . . 0.0 111.486 -174.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -84.58 -31.46 24.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 117.597 0.181 . . . . 0.0 111.244 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -102.16 -10.39 19.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.55 21.68 77.72 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -100.3 155.64 17.67 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 117.726 0.763 . . . . 0.0 109.437 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.26 115.1 6.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.509 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -97.48 152.01 19.42 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.87 150.51 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -141.29 62.66 1.46 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.2 -176.83 14.57 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.3 p -98.65 26.49 5.56 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.804 0.842 . . . . 0.0 111.104 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.12 164.9 25.66 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.795 0.331 . . . . 0.0 111.097 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -82.32 135.61 47.05 Favored Pre-proline 0 N--CA 1.451 -0.413 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -56.04 -35.49 94.78 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.268 2.645 . . . . 0.0 111.833 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -74.85 -28.45 60.68 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 122.17 0.188 . . . . 0.0 111.203 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.92 -33.59 45.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 tp -64.92 -45.36 86.17 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.07 -23.28 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 122.693 0.397 . . . . 0.0 110.617 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -87.52 -29.0 21.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 122.401 -0.187 . . . . 0.0 110.989 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.29 -47.27 84.19 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 122.376 -0.202 . . . . 0.0 111.104 -178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.2 m -72.37 -20.86 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -69.42 -21.29 63.76 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -69.47 -25.35 64.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -84.04 -9.73 58.41 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.03 15.38 39.2 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 178.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.404 ' HE2' ' H ' ' A' ' 10' ' ' THR . 64.9 m-85 -130.54 144.49 51.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 117.581 0.69 . . . . 0.0 111.509 -176.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -80.16 175.28 10.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 168.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 5' ' ' LYS . . . -148.05 78.32 1.44 Allowed 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 174.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -53.61 107.6 0.27 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.456 0.702 . . . . 0.0 111.297 -175.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.8 m -58.19 110.42 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 123.871 0.868 . . . . 0.0 110.03 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.7 mt -84.04 35.34 0.53 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.084 0 CA-C-O 117.091 -1.433 . . . . 0.0 109.97 -178.061 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ttm . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.1 mt -90.56 149.31 22.21 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -167.14 78.78 0.19 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -174.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.4 mp -77.87 124.65 28.26 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.894 -0.503 . . . . 0.0 112.324 -165.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -101.33 90.29 4.05 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.5 t -68.15 134.33 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 122.583 0.353 . . . . 0.0 111.657 -175.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -88.72 150.2 23.09 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 173.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.27 58.79 4.71 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.4 mmt -68.02 -34.37 76.36 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 117.222 0.511 . . . . 0.0 111.577 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.8 p -136.76 167.43 21.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 117.963 0.347 . . . . 0.0 111.009 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 67.1 m 48.2 36.23 6.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.572 0.749 . . . . 0.0 111.459 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -67.43 -15.38 63.64 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.487 0.13 . . . . 0.0 110.932 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -85.09 -8.12 58.79 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.2 m -130.81 -171.23 2.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.17 0.588 . . . . 0.0 109.682 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -82.02 158.69 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 62.3 mtm -102.01 121.81 42.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.21 82.94 5.98 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.1 t -103.0 -17.35 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.0 m -54.15 -50.66 66.46 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.622 0.369 . . . . 0.0 111.401 -175.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -67.17 -21.32 65.8 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 119.493 -0.289 . . . . 0.0 111.655 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.43 -25.23 59.31 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.092 0.405 . . . . 0.0 111.793 -176.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.04 -48.44 20.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -178.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -65.58 -20.96 66.53 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -173.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -72.47 -14.44 61.67 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.264 0.484 . . . . 0.0 111.675 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 54.5 t -74.27 134.7 76.74 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 58.8 Cg_exo -55.86 131.15 44.25 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 123.595 2.863 . . . . 0.0 111.165 177.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.36 -22.11 38.86 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.852 -0.499 . . . . 0.0 111.852 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.9 t -77.86 130.64 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -126.98 -24.77 3.41 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.781 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -127.9 148.77 50.5 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.0 t -144.98 150.06 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -145.64 125.86 13.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.1 m -131.35 156.0 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.348 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.5 t -128.72 98.8 5.11 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.51 -17.98 64.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.863 -175.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -80.48 -29.94 37.42 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.502 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -99.95 -9.56 22.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 176.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.43 22.84 78.57 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -99.1 156.41 16.96 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 117.417 0.608 . . . . 0.0 110.734 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.64 109.71 5.32 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.539 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.412 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.2 mm? -101.63 151.77 21.61 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.0 163.16 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -138.33 79.69 1.75 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.98 -172.39 17.19 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -178.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 47.6 p -117.05 28.0 8.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.683 0.393 . . . . 0.0 110.284 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.58 171.4 14.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.343 -0.244 . . . . 0.0 110.343 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -79.64 141.3 55.92 Favored Pre-proline 0 N--CA 1.454 -0.239 0 O-C-N 122.439 -0.163 . . . . 0.0 111.027 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -54.59 -36.99 90.69 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 123.669 2.912 . . . . 0.0 113.08 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -74.17 -35.02 63.98 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.494 -177.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.17 -33.25 75.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.799 -175.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.2 tp -67.77 -50.89 54.71 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.679 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.9 t -68.03 -30.08 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 110.553 -0.166 . . . . 0.0 110.553 -177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -76.13 -33.73 59.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -177.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.82 -48.57 78.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.319 0.104 . . . . 0.0 110.87 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -72.37 -23.8 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -72.79 -25.57 61.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -71.22 -25.72 62.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -89.35 -4.43 58.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.88 5.1 61.31 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -108.28 90.36 3.27 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 117.157 0.479 . . . . 0.0 111.073 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -71.01 155.65 40.58 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -162.39 111.33 1.41 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.483 0.182 . . . . 0.0 110.585 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -73.91 123.0 23.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.658 0.383 . . . . 0.0 110.65 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.6 m -59.42 135.16 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.31 74.66 3.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.285 -1.34 . . . . 0.0 109.555 -179.283 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttt . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.3 mt -90.68 139.05 31.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -157.31 77.1 0.85 Allowed 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -174.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 mp -79.89 113.49 18.09 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.706 -165.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -99.45 89.63 4.24 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.8 t -66.35 132.89 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 123.597 0.759 . . . . 0.0 112.323 -174.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -91.23 147.74 22.84 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 172.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.33 78.26 1.37 Allowed Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.1 mmt -71.75 -35.58 70.16 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.891 0.346 . . . . 0.0 111.316 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 78.6 p -135.69 168.76 18.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.581 0.229 . . . . 0.0 110.985 -176.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.2 m 48.82 36.54 8.24 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.269 0.627 . . . . 0.0 110.929 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -66.37 -6.59 14.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.4 0.28 . . . . 0.0 111.374 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -83.96 -7.01 59.52 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.0 m -130.14 -175.58 3.67 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 122.982 0.513 . . . . 0.0 109.824 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.403 ' CG2' HD22 ' A' ' 35' ' ' LEU . 14.6 p -83.46 160.35 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 69.2 mtm -99.48 119.25 37.72 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.43 88.12 6.26 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 t -100.96 -12.8 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 111.417 0.155 . . . . 0.0 111.417 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.9 m -50.36 -47.18 56.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -173.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -67.5 -22.78 65.44 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.146 -0.346 . . . . 0.0 111.771 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.06 -25.28 60.86 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 118.062 0.392 . . . . 0.0 111.094 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.3 -39.57 22.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -66.91 -25.16 66.24 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -173.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -81.25 -12.73 59.03 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.295 0.498 . . . . 0.0 112.144 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.7 t -76.28 128.07 83.44 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -54.75 139.46 77.42 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.473 2.782 . . . . 0.0 111.036 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.49 -20.25 47.73 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.3 t -76.38 131.92 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -122.86 -28.18 4.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.5 mttp -132.89 152.08 51.93 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.8 t -142.34 148.08 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -145.37 127.05 15.22 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.4 m -131.71 155.19 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 120.596 0.236 . . . . 0.0 110.483 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.4 t -128.3 112.31 14.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.403 HD22 ' CG2' ' A' ' 15' ' ' VAL . 87.9 mt -66.22 -25.27 66.83 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -175.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -83.34 -31.9 26.55 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.601 -176.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -101.2 -9.7 21.05 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 117.582 0.174 . . . . 0.0 110.982 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.72 23.15 73.94 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -94.75 156.44 16.38 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 117.646 0.723 . . . . 0.0 110.077 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.55 108.67 4.77 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.529 0.732 . . . . 0.0 110.118 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.4 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.5 mm? -101.67 150.51 23.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.105 0.962 . . . . 0.0 108.678 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.71 164.44 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -137.47 92.02 2.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.71 -172.93 29.73 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -177.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 48.9 p -117.51 29.72 7.7 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.226 0.61 . . . . 0.0 110.24 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.18 170.91 14.56 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.648 0.261 . . . . 0.0 110.747 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.86 137.28 66.21 Favored Pre-proline 0 N--CA 1.451 -0.381 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -54.54 -42.79 64.94 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.414 2.742 . . . . 0.0 112.503 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -76.02 -28.3 57.68 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.054 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.02 76.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 121.323 -0.151 . . . . 0.0 110.609 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tp -71.18 -48.48 51.41 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.5 t -68.91 -22.79 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.47 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -85.97 -33.75 21.04 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.222 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.42 -44.61 95.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 121.416 -0.114 . . . . 0.0 111.019 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.0 m -69.8 -27.6 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.403 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -77.01 -25.25 52.43 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -69.55 -22.19 63.57 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -91.84 -6.81 50.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.34 10.63 55.64 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -124.84 89.77 3.13 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 117.646 0.723 . . . . 0.0 110.509 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.76 163.32 21.93 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -158.59 115.31 2.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.479 0.18 . . . . 0.0 110.736 -178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -72.39 111.57 7.7 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.449 0.3 . . . . 0.0 111.075 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.0 m -58.26 118.16 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.05 71.01 9.09 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.378 -1.296 . . . . 0.0 110.037 -178.966 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.6 mt -90.87 152.96 20.54 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -159.42 78.82 0.73 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -173.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.6 mp -79.25 102.62 8.67 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.868 0.366 . . . . 0.0 111.489 -165.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -92.48 94.03 8.87 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.5 t -65.73 136.4 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.476 1.11 . . . . 0.0 112.524 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -88.97 149.02 23.48 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.5 68.52 3.1 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.4 mmt -70.15 -37.55 75.28 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.6 p -139.0 168.86 18.9 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 117.911 0.323 . . . . 0.0 111.231 -175.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 64.2 m 47.63 36.98 6.03 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.456 0.702 . . . . 0.0 111.014 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -66.99 -4.19 9.02 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 121.931 0.092 . . . . 0.0 110.843 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -86.79 -9.03 56.77 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.2 m -130.82 -173.86 3.21 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.304 0.642 . . . . 0.0 110.174 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -84.39 159.64 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 56.5 mtm -103.05 122.54 44.85 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.65 90.2 7.86 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.32 -14.76 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 122.129 0.172 . . . . 0.0 111.325 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.1 m -54.46 -47.35 73.04 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -173.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -66.74 -22.92 66.04 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.285 0.493 . . . . 0.0 112.11 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.42 -24.57 60.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 118.011 0.369 . . . . 0.0 111.295 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.77 -40.63 18.54 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -66.69 -24.06 66.21 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -172.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -80.54 -12.78 59.48 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.336 0.516 . . . . 0.0 111.974 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.1 t -73.13 128.5 87.64 Favored Pre-proline 0 N--CA 1.451 -0.416 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -54.21 131.58 45.76 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.643 2.895 . . . . 0.0 111.2 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.22 -19.85 52.16 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 119.83 -0.428 . . . . 0.0 112.05 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.4 t -74.53 129.52 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -117.77 -30.61 5.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -134.77 152.48 51.79 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.3 t -142.48 149.47 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -145.69 129.23 17.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.28 156.76 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 120.619 0.247 . . . . 0.0 110.371 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.6 t -126.69 101.38 6.61 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.3 -20.34 66.02 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -174.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -83.89 -31.13 25.87 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.424 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -101.73 -9.8 20.53 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.597 0.18 . . . . 0.0 111.382 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.14 21.85 75.79 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -96.38 156.09 16.49 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.06 125.11 12.82 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.147 0.579 . . . . 0.0 109.479 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -117.94 152.32 35.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.046 0.939 . . . . 0.0 108.64 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.47 165.23 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -136.68 86.44 2.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.69 -172.64 24.22 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.8 p -117.48 28.66 8.32 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.188 0.595 . . . . 0.0 110.513 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.12 169.84 17.22 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.678 0.275 . . . . 0.0 110.92 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -76.3 144.33 74.52 Favored Pre-proline 0 N--CA 1.452 -0.369 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.308 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -57.33 -38.78 93.7 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 123.294 2.663 . . . . 0.0 112.11 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -75.51 -37.19 60.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.431 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.43 -34.29 75.14 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -176.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 tp -71.52 -56.87 5.06 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.481 0.181 . . . . 0.0 110.613 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.2 t -67.64 -21.69 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 122.3 0.24 . . . . 0.0 111.542 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -86.56 -32.48 20.66 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.622 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.72 -44.33 96.74 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.668 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.6 m -68.83 -27.21 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -77.68 -21.68 51.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -69.7 -24.28 63.55 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -90.51 -7.17 53.64 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.09 0.16 61.91 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -107.65 91.05 3.49 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 117.663 0.732 . . . . 0.0 110.74 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.91 163.34 19.83 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 177.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -156.14 112.67 3.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.59 0.233 . . . . 0.0 110.982 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -71.21 108.28 4.63 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.8 m -58.27 119.52 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.9 mt -81.12 72.11 8.13 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.145 0 CA-C-O 117.181 -1.39 . . . . 0.0 109.377 -179.802 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.2 ttp . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 77.9 mt -89.12 154.43 20.17 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -153.39 77.97 1.14 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -175.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 mp -78.53 101.46 7.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.316 -167.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -88.08 98.53 11.59 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.3 t -63.43 133.01 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 122.824 0.45 . . . . 0.0 110.927 -175.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -83.2 148.56 27.36 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.404 0.682 . . . . 0.0 109.715 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.8 76.55 1.21 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.3 mmt -69.14 -74.77 0.12 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.908 0.354 . . . . 0.0 111.365 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.6 p -138.19 169.76 17.23 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.701 0.4 . . . . 0.0 110.329 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 75.6 m 49.2 37.41 11.06 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.558 0.343 . . . . 0.0 110.736 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -65.87 -4.39 6.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.29 0.636 . . . . 0.0 110.988 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -84.8 -6.32 59.35 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.558 0.343 . . . . 0.0 110.457 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.8 m -115.63 171.04 7.99 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 p -153.49 151.67 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 72.6 mtm -150.82 162.47 40.68 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.58 91.59 0.6 Allowed 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.8 t -68.91 -14.44 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 36.0 m -52.51 -37.81 58.25 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.924 0.49 . . . . 0.0 111.352 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -62.55 -22.35 66.26 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.79 -25.66 30.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 118.04 0.382 . . . . 0.0 111.173 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.69 -35.95 51.64 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -177.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.73 -22.86 66.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -175.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -68.34 -18.06 64.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.274 0.488 . . . . 0.0 112.165 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.432 HG21 ' HA ' ' A' ' 51' ' ' LEU . 60.1 t -79.77 129.02 72.43 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-N 118.052 0.387 . . . . 0.0 110.069 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -54.93 139.27 79.03 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 123.581 2.854 . . . . 0.0 111.413 178.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.41 -21.13 42.36 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.1 t -74.5 128.69 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -124.28 -26.9 3.88 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.793 0.27 . . . . 0.0 110.855 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -133.05 150.35 52.12 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.5 t -144.84 148.52 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -147.43 127.71 13.89 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 m -130.68 155.14 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 117.852 0.296 . . . . 0.0 110.871 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.1 t -129.02 100.07 5.51 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.98 -18.32 65.18 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.044 0.538 . . . . 0.0 112.126 -174.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -81.54 -29.89 33.34 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.927 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -103.62 -8.36 20.05 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.658 0.208 . . . . 0.0 111.229 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.03 23.47 78.07 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -96.91 155.56 16.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 117.737 0.769 . . . . 0.0 109.75 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.74 110.98 4.88 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.31 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.59 151.11 22.0 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.1 m -135.06 163.99 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 174.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -137.5 93.82 2.85 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.01 -171.22 26.68 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.9 p -114.28 28.15 8.96 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.787 0.435 . . . . 0.0 110.127 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.68 170.06 16.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.662 0.268 . . . . 0.0 110.875 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -90.61 148.56 38.91 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.487 177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -57.76 -39.2 89.26 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.652 2.901 . . . . 0.0 112.915 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -75.35 -22.89 57.23 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.281 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.39 -35.09 58.81 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.315 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.432 ' HA ' HG21 ' A' ' 25' ' ' VAL . 10.7 tp -75.55 -46.01 34.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 121.32 -0.152 . . . . 0.0 111.079 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 63.7 t -67.19 -22.37 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 110.563 -0.162 . . . . 0.0 110.563 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -87.16 -30.04 21.33 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.08 -46.2 91.62 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.5 m -68.77 -19.91 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.475 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.444 ' OE1' ' HE2' ' A' ' 61' ' ' LYS . 45.7 tt0 -69.15 -20.4 64.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -68.84 -26.37 65.12 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -82.78 -11.39 58.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.9 8.14 59.39 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -132.69 101.87 5.46 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 117.286 0.543 . . . . 0.0 111.611 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.444 ' HE2' ' OE1' ' A' ' 56' ' ' GLU . 97.0 mttt -67.56 172.04 5.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -152.87 119.35 5.6 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.501 0.191 . . . . 0.0 110.62 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -68.84 109.04 3.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.512 0.725 . . . . 0.0 111.586 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.6 m -58.81 108.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 174.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.0 mt -80.65 76.58 7.52 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 117.276 -1.345 . . . . 0.0 109.602 -177.625 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.5 ttp . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.5 mt -89.25 154.21 20.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -153.15 81.36 1.2 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.7 mp -75.12 103.46 5.3 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.45 -167.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -88.43 105.78 17.82 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.8 t -64.72 134.43 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 122.93 0.492 . . . . 0.0 111.146 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -85.12 146.19 27.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.74 60.5 3.55 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.6 mtp -68.04 -64.71 0.81 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.847 0.323 . . . . 0.0 111.668 -176.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.9 p -136.66 166.12 24.3 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.539 0.209 . . . . 0.0 110.963 -176.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 82.3 m 46.73 33.96 2.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.306 0.642 . . . . 0.0 110.634 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -68.08 -4.49 13.73 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.695 0.798 . . . . 0.0 111.023 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -72.56 -8.2 53.97 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.536 0.334 . . . . 0.0 111.116 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.2 m -129.88 179.84 5.62 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.269 0.227 . . . . 0.0 110.41 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -153.12 138.8 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -147.4 161.65 40.6 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.628 0.371 . . . . 0.0 110.021 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.5 115.91 5.63 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.007 0.523 . . . . 0.0 110.36 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.7 t -69.48 -11.94 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.228 1.011 . . . . 0.0 111.239 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.6 m -48.72 -40.63 29.12 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -174.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.87 -23.37 67.32 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -174.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.9 -25.12 32.76 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.039 0.381 . . . . 0.0 110.848 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.29 -31.57 24.83 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -59.18 -23.2 62.04 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 121.232 -0.187 . . . . 0.0 111.428 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -72.01 -17.74 62.02 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.29 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.1 t -79.55 127.75 77.22 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -57.3 139.08 89.04 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.302 2.668 . . . . 0.0 111.112 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.01 -21.18 38.33 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.5 t -70.91 129.16 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -128.07 -27.63 2.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -131.48 150.23 52.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.6 t -146.06 151.06 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -145.31 127.83 16.04 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.1 m -131.73 156.01 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.192 -178.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.7 t -127.98 101.26 6.23 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 176.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.6 mt -66.04 -22.03 66.41 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -83.93 -31.34 25.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.386 0.539 . . . . 0.0 111.499 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -102.22 -8.5 21.25 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.61 0.186 . . . . 0.0 111.187 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.32 20.62 73.53 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -98.76 154.16 18.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.51 128.15 12.4 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.632 0.253 . . . . 0.0 110.54 -177.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -113.58 153.05 29.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.961 0.904 . . . . 0.0 109.456 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.08 163.28 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 174.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -141.31 95.59 2.85 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.79 -179.07 35.31 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.2 p -94.73 26.81 3.34 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.466 0.306 . . . . 0.0 110.58 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.09 174.03 10.56 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -107.92 155.73 39.44 Favored Pre-proline 0 N--CA 1.452 -0.326 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -58.89 -37.49 93.38 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.2 2.6 . . . . 0.0 111.972 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -73.98 -16.69 61.07 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 119.815 -0.135 . . . . 0.0 111.144 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.68 -33.63 14.98 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.9 tp -70.87 -59.64 2.68 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.546 -176.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.0 t -67.64 -22.45 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 122.19 0.196 . . . . 0.0 110.941 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -81.84 -33.72 30.52 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 122.27 -0.269 . . . . 0.0 110.532 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.11 -46.51 90.31 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.281 0.086 . . . . 0.0 110.984 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.45 -22.83 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -77.19 -22.4 52.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.381 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -70.05 -24.17 63.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -83.26 -9.05 59.34 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.82 10.56 34.78 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 119.364 -0.687 . . . . 0.0 113.063 175.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -131.8 125.65 32.41 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.589 1.195 . . . . 0.0 111.573 -177.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -69.88 167.06 18.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.579 177.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -153.82 95.64 1.9 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -66.78 105.4 1.56 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.124 0.57 . . . . 0.0 111.542 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.0 m -58.96 109.02 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.9 mt -80.88 74.16 7.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.288 -1.339 . . . . 0.0 109.208 -179.734 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttp . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.8 mt -90.05 150.47 22.07 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -159.73 78.74 0.7 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -176.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.7 mp -77.25 103.07 6.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.73 -164.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -79.92 96.42 6.37 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.0 t -65.1 128.62 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 120.737 0.304 . . . . 0.0 110.368 -176.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -75.47 145.33 41.53 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.452 0.701 . . . . 0.0 110.021 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.79 59.86 1.21 Allowed Glycine 0 C--N 1.335 0.525 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 84.0 mtp -67.45 -44.92 77.48 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 117.046 0.423 . . . . 0.0 111.677 -174.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.9 p -139.01 166.53 24.26 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 82.7 m 46.95 33.62 2.33 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.058 0.543 . . . . 0.0 110.833 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -67.48 -4.6 11.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.549 0.339 . . . . 0.0 110.58 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -76.59 -9.86 58.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.064 0.146 . . . . 0.0 110.699 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.8 m -131.15 -179.63 5.45 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.9 p -149.27 138.86 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -149.5 160.65 43.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.35 111.82 11.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 20.9 t -68.13 -8.02 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 123.066 0.546 . . . . 0.0 110.026 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.3 m -41.84 -38.35 1.5 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.564 1.146 . . . . 0.0 112.928 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.27 -23.56 66.77 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 122.016 -0.428 . . . . 0.0 111.704 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.79 -24.25 33.51 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -82.62 -34.85 27.43 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -177.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -61.86 -22.13 65.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -175.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -75.57 -15.92 60.31 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.4 t -77.67 128.93 78.27 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 118.299 0.5 . . . . 0.0 110.001 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.89 139.83 84.74 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.534 2.823 . . . . 0.0 111.112 177.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.92 -21.48 39.36 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 176.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.6 t -80.23 132.66 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -127.8 -29.95 2.56 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.513 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -133.99 152.02 51.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.1 t -144.48 150.33 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -177.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -141.83 125.94 17.36 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.0 m -133.14 158.54 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 120.462 0.173 . . . . 0.0 111.371 -175.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.7 t -126.47 104.45 8.15 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 176.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.4 mt -63.7 -20.86 66.06 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -173.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -84.1 -32.4 24.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.572 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -101.68 -9.66 20.7 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -175.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.9 24.15 72.81 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.056 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -95.79 154.4 17.24 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.96 108.72 3.85 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -105.12 152.17 23.12 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.4 m -132.18 163.73 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -137.82 89.88 2.45 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -159.28 -169.83 23.1 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.7 p -118.22 28.03 8.61 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.986 0.514 . . . . 0.0 110.206 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.67 168.89 18.93 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.401 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 17.4 m-20 -78.82 154.31 78.12 Favored Pre-proline 0 N--CA 1.451 -0.412 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 47' ' ' ASP . 76.0 Cg_exo -59.02 -46.63 21.52 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.625 2.884 . . . . 0.0 112.15 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -75.74 -32.35 59.97 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.935 -0.12 . . . . 0.0 111.151 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.62 -32.43 74.08 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 121.432 -0.107 . . . . 0.0 110.755 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.2 tp -69.21 -50.97 42.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 121.155 -0.218 . . . . 0.0 110.488 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.3 t -69.35 -28.21 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 122.508 0.323 . . . . 0.0 111.077 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -75.1 -31.89 61.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.55 -54.97 40.34 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 122.43 0.292 . . . . 0.0 111.42 -177.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -72.51 -23.82 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 121.403 -0.119 . . . . 0.0 111.029 -177.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -72.74 -22.37 60.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -70.94 -25.07 62.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -79.95 -9.58 59.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.0 11.3 34.77 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 119.588 -0.562 . . . . 0.0 111.888 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -129.82 114.85 16.42 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 117.886 0.843 . . . . 0.0 110.692 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.6 169.68 3.75 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -152.54 92.94 1.73 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -68.45 104.62 1.95 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 122.947 0.499 . . . . 0.0 111.331 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.7 m -58.24 113.53 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.05 76.25 6.79 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 CA-C-O 117.025 -1.464 . . . . 0.0 109.067 -177.282 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.75 ' HG2' ' H ' ' A' ' 2' ' ' LEU . 18.8 ttt . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.75 ' H ' ' HG2' ' A' ' 1' ' ' MET . 87.5 mt -87.91 151.15 23.03 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -156.31 76.41 0.9 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -175.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.0 mp -76.16 109.43 9.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -165.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 57.5 tttt -81.38 98.4 8.18 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.666 0.787 . . . . 0.0 109.218 173.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.4 t -70.47 107.97 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 117.797 0.271 . . . . 0.0 110.567 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -73.21 118.66 16.44 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -93.28 85.81 1.13 Allowed Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.6 mtt -68.93 -33.43 73.73 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 122.513 0.325 . . . . 0.0 111.395 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.9 p -136.71 170.34 16.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.748 0.309 . . . . 0.0 111.471 -175.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 64.6 m 54.84 39.22 31.35 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.771 0.828 . . . . 0.0 111.908 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -66.21 -6.86 15.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -84.77 -10.24 57.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 118.008 0.367 . . . . 0.0 110.881 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.5 m -130.3 -178.78 4.9 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.621 0.248 . . . . 0.0 110.358 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -141.09 155.0 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 74.8 mtm -142.3 160.12 40.87 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -177.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.73 92.0 5.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.38 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.6 t -70.46 -12.74 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.2 m -52.45 -42.23 63.98 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 122.927 0.491 . . . . 0.0 112.208 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -66.27 -22.26 66.3 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.36 -24.69 62.14 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.093 0.406 . . . . 0.0 110.518 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -84.06 -35.04 24.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -178.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -65.19 -22.78 66.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -176.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -74.02 -14.51 61.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.41 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.0 t -78.44 128.12 78.71 Favored Pre-proline 0 N--CA 1.451 -0.402 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -55.28 138.87 80.61 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.377 2.718 . . . . 0.0 111.066 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.6 -19.6 51.73 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.1 t -75.48 129.62 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -122.52 -28.27 4.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -133.26 150.4 51.92 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.0 t -145.29 149.54 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -146.36 126.42 13.72 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -131.45 156.07 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.35 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.4 t -129.2 102.91 6.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.56 -18.69 64.13 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.06 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -78.6 -29.79 46.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -100.36 -11.16 20.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.748 -0.093 . . . . 0.0 110.748 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.28 20.92 67.88 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -101.49 158.49 16.03 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.925 0.362 . . . . 0.0 110.463 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.1 110.7 5.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -101.07 152.65 20.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.64 162.23 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 175.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -142.23 86.46 1.97 Allowed 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.62 -173.54 26.17 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -177.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.8 p -112.59 28.1 9.06 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.623 0.369 . . . . 0.0 110.496 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.03 168.01 20.82 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -78.67 138.57 58.35 Favored Pre-proline 0 N--CA 1.45 -0.47 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -55.41 -36.44 93.99 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.266 2.644 . . . . 0.0 111.928 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -76.23 -32.7 59.04 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 121.387 -0.125 . . . . 0.0 110.72 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.35 -33.2 71.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tp -65.9 -55.76 15.25 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.539 0.209 . . . . 0.0 110.757 -178.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 50.5 t -68.14 -22.96 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.738 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -75.9 -37.14 59.12 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.899 -0.321 . . . . 0.0 110.245 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.2 -47.72 83.19 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.332 0.11 . . . . 0.0 110.815 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.5 m -73.03 -25.1 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.875 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -76.07 -23.47 55.04 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -70.25 -24.98 63.16 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -79.76 -10.73 59.82 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.3 7.23 59.51 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -115.32 98.6 6.85 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -61.79 158.95 14.65 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -155.1 78.83 1.04 Allowed 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.96 139.23 40.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -58.15 137.4 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 122.612 0.365 . . . . 0.0 110.569 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.8 mt -83.98 76.1 10.08 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.06 -1.448 . . . . 0.0 109.337 179.351 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ttm . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 30.9 mt -113.78 144.5 42.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -161.71 79.62 0.56 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -171.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.0 mp -80.13 125.39 29.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.721 -0.612 . . . . 0.0 111.838 -164.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -101.14 89.07 3.67 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 172.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.32 115.46 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 122.889 0.476 . . . . 0.0 110.47 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -70.75 148.41 47.97 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.26 0.624 . . . . 0.0 109.882 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -90.22 60.14 3.4 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 94.3 mtp -67.69 -35.76 79.41 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.898 0.349 . . . . 0.0 111.067 -177.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 44.1 p -138.2 166.23 24.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.2 m 46.71 35.07 2.82 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.237 0.615 . . . . 0.0 111.102 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -67.6 -12.97 61.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -90.54 -7.51 52.7 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.136 0.426 . . . . 0.0 109.941 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.6 m -128.7 -171.15 2.4 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.0 p -137.03 152.71 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 11.1 mmm -140.7 160.17 40.62 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.44 110.17 16.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.88 0.472 . . . . 0.0 111.247 -178.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.2 t -91.04 -16.52 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 31.6 m -55.78 -43.57 76.9 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -174.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.66 -21.6 66.1 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.305 -0.247 . . . . 0.0 111.23 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.69 -27.44 60.4 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.854 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -84.88 -33.47 22.8 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.864 0.302 . . . . 0.0 111.77 -176.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -62.85 -21.7 66.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -173.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -78.03 -18.42 55.88 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -173.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.3 t -78.88 130.67 69.46 Favored Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-N 118.976 0.807 . . . . 0.0 110.224 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -55.27 141.89 80.03 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 124.071 3.181 . . . . 0.0 111.56 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.16 -21.87 39.81 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.2 t -71.29 127.68 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.24 -27.54 3.8 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.437 0.162 . . . . 0.0 111.437 -177.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -133.82 152.63 51.93 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.3 t -143.02 147.09 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.24 129.44 14.62 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.4 m -130.93 155.99 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 117.959 0.345 . . . . 0.0 110.624 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.1 t -129.4 101.32 5.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.7 mt -64.47 -20.05 65.94 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.234 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -82.3 -31.47 29.96 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 110.666 -0.124 . . . . 0.0 110.666 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -101.86 -10.03 20.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.35 21.92 78.58 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -98.95 155.56 17.35 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.589 0.694 . . . . 0.0 109.933 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.14 108.56 4.83 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.404 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.6 mm? -104.18 150.31 24.48 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.39 162.79 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 173.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -139.01 86.23 2.12 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.63 -171.01 20.35 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.8 p -115.8 28.1 8.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 122.851 0.46 . . . . 0.0 110.227 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.35 159.31 32.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 m-20 -83.82 152.77 63.39 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -60.24 -36.68 87.16 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.536 2.824 . . . . 0.0 112.121 -179.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.5 pttt -69.65 -19.65 63.61 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 119.744 -0.169 . . . . 0.0 110.758 -175.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.64 -34.79 15.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.168 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 tp -75.21 -49.48 19.24 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.911 -0.315 . . . . 0.0 111.666 -174.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.07 -25.82 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 121.201 -0.2 . . . . 0.0 110.878 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -80.95 -32.02 34.69 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.09 -45.32 94.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.538 0.335 . . . . 0.0 111.219 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.0 m -71.78 -24.03 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.004 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -75.13 -20.95 59.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.83 -23.73 63.35 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -88.36 -7.93 55.88 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.82 12.73 49.23 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -128.15 100.82 6.0 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.94 0.87 . . . . 0.0 112.045 -175.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -71.1 167.15 19.9 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -160.55 117.26 2.39 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.84 119.23 14.68 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.643 0.377 . . . . 0.0 110.913 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.2 m -59.41 117.55 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.8 mt -82.39 31.8 0.4 Allowed 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.747 0.419 . . . . 0.0 110.005 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.341 -1.314 . . . . 0.0 109.165 179.567 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 ttm . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 45.7 mt -117.18 150.09 39.31 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -161.64 81.15 0.58 Allowed 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 -173.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.0 mp -79.97 109.43 14.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.827 -0.546 . . . . 0.0 112.007 -166.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -83.43 90.16 7.15 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 171.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.9 t -62.05 109.65 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -70.4 146.02 50.69 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.189 0.596 . . . . 0.0 110.208 -178.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.78 62.09 3.37 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 92.5 mtp -68.03 -34.92 77.39 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.612 0.206 . . . . 0.0 110.998 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.2 p -138.29 165.24 27.22 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.9 m 46.09 36.75 3.3 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.017 0.527 . . . . 0.0 111.153 177.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -66.68 -12.37 58.06 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -91.43 -5.68 53.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.0 m -127.6 -169.08 1.99 Allowed 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -141.06 155.2 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 11.2 mmm -137.03 160.68 38.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.231 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.05 110.45 16.59 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.995 0.518 . . . . 0.0 110.145 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.1 t -95.94 -21.02 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.9 m -56.49 -40.91 75.74 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.186 -0.321 . . . . 0.0 111.73 -176.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.54 -21.52 66.71 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 119.524 -0.274 . . . . 0.0 111.566 -177.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.99 -27.02 39.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.07 0.395 . . . . 0.0 110.689 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -85.52 -34.41 21.55 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 121.161 -0.216 . . . . 0.0 110.67 -177.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -62.55 -22.2 66.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.474 0.175 . . . . 0.0 111.474 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -79.6 -13.98 59.14 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 119.633 -0.223 . . . . 0.0 111.57 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.2 t -79.32 126.48 81.25 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -56.67 140.9 91.49 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.682 2.921 . . . . 0.0 111.513 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.67 -21.69 39.79 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.862 -0.495 . . . . 0.0 111.862 176.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.69 129.66 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -27.47 4.75 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 121.284 -0.167 . . . . 0.0 111.05 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -133.18 153.08 51.86 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 174.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.0 t -143.06 147.42 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.96 128.52 15.07 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.71 153.84 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.904 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.2 t -131.46 100.81 5.28 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.6 mt -64.97 -19.0 65.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 121.92 0.088 . . . . 0.0 110.952 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -82.03 -31.24 31.06 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -103.05 -10.18 19.12 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.55 22.36 79.02 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -98.56 155.15 17.43 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 117.618 0.709 . . . . 0.0 109.889 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.69 108.38 4.01 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.416 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.3 mm? -108.4 150.74 26.96 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.4 m -135.64 163.1 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 174.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -138.1 93.36 2.75 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.46 -172.8 29.29 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.7 p -111.27 28.59 8.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 122.87 0.468 . . . . 0.0 109.957 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.25 173.35 9.6 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -104.03 153.57 38.77 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_exo -58.58 -36.96 96.61 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.481 2.787 . . . . 0.0 112.179 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.0 pttt -68.68 -21.03 64.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.513 -0.18 . . . . 0.0 110.513 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.43 -34.27 14.91 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 121.239 -0.184 . . . . 0.0 110.725 -178.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.5 tp -74.68 -47.74 29.97 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.28 -176.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.0 t -68.1 -35.72 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -69.23 -31.85 70.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.46 -55.05 38.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 121.946 0.098 . . . . 0.0 110.932 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.8 -23.92 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 121.181 -0.208 . . . . 0.0 110.698 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -73.56 -23.71 60.0 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -70.6 -24.41 62.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -83.91 -7.82 59.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.19 8.53 57.68 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -125.14 94.98 4.32 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 117.829 0.814 . . . . 0.0 111.04 -176.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -67.33 168.24 10.98 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -158.18 113.71 2.7 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -67.8 120.36 14.01 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.689 0.395 . . . . 0.0 110.818 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.446 ' C ' ' H ' ' A' ' 66' ' ' ALA . 14.4 m -60.09 111.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 172.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.7 mt -80.66 33.41 0.31 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.446 ' H ' ' C ' ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 117.298 -1.334 . . . . 0.0 108.937 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ttm . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 74.0 mt -115.71 149.84 37.77 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.69 0.281 . . . . 0.0 110.587 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -159.97 77.74 0.66 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -177.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.71 113.52 16.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -165.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 72.3 tttt -79.39 84.95 5.24 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.196 0.998 . . . . 0.0 108.36 173.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.59 108.93 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -71.09 148.62 47.31 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.956 0.502 . . . . 0.0 110.149 -178.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.02 47.17 1.83 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 86.4 mtp -67.51 -29.93 69.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.278 0.539 . . . . 0.0 110.353 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.4 p -133.17 163.48 29.19 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.7 m 45.99 33.7 1.74 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.148 0.579 . . . . 0.0 111.145 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -68.85 -19.1 64.24 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 117.855 0.298 . . . . 0.0 111.72 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -91.43 -5.78 53.8 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.0 m -127.53 -167.87 1.81 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.51 0.724 . . . . 0.0 109.121 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.34 154.92 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.5 mmt -140.57 159.79 41.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.69 90.3 5.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.7 t -69.14 -21.23 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.1 m -55.82 -37.27 68.44 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 122.335 0.254 . . . . 0.0 111.297 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.97 -22.42 66.8 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 119.597 -0.24 . . . . 0.0 111.336 -177.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.15 -24.26 32.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.023 0.374 . . . . 0.0 110.916 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.15 -48.13 12.54 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -66.33 -22.98 66.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -171.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -73.44 -15.49 61.34 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 118.255 0.48 . . . . 0.0 112.012 -176.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.3 t -76.96 129.35 78.93 Favored Pre-proline 0 N--CA 1.45 -0.426 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.85 140.51 47.79 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.473 2.782 . . . . 0.0 111.582 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.63 -20.82 44.59 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -78.77 130.97 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -125.15 -30.19 3.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -134.81 149.45 50.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.1 t -145.27 148.17 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -146.68 120.22 9.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.3 m -131.11 156.07 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.2 t -128.34 101.56 6.28 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.8 mt -63.83 -16.1 60.46 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.328 0.651 . . . . 0.0 112.124 -174.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -75.58 -36.51 60.33 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.207 0.458 . . . . 0.0 111.576 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -104.54 -8.19 19.2 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.784 0.265 . . . . 0.0 111.662 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.64 22.82 68.8 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.466 -0.63 . . . . 0.0 113.603 175.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.37 155.86 17.02 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.342 1.071 . . . . 0.0 108.825 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.52 110.17 4.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.402 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.4 mm? -104.55 153.27 21.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.23 162.01 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -138.75 79.23 1.72 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 177.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.56 -170.78 20.04 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.5 p -115.11 28.05 8.97 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.742 0.417 . . . . 0.0 110.589 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.46 172.16 13.01 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -102.5 140.68 21.33 Favored Pre-proline 0 N--CA 1.453 -0.297 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -50.68 -36.61 51.45 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 124.416 3.41 . . . . 0.0 115.357 -175.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.2 pttt -69.49 -18.09 63.66 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.686 0.676 . . . . 0.0 110.69 -175.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.89 -34.42 16.08 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.691 -0.403 . . . . 0.0 111.498 -175.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.9 tp -70.87 -50.4 35.6 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.802 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.8 t -68.27 -22.95 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.269 -176.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -86.77 -34.33 19.64 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.011 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.33 94.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.848 -0.16 . . . . 0.0 110.634 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.81 -23.64 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.513 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.404 ' OE2' ' HE2' ' A' ' 61' ' ' LYS . 35.3 tt0 -74.71 -21.84 59.16 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -69.37 -23.46 63.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -93.2 -5.91 48.97 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.81 6.45 59.36 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -116.52 90.1 3.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.705 0.752 . . . . 0.0 110.776 -177.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.404 ' HE2' ' OE2' ' A' ' 56' ' ' GLU . 99.6 mttt -68.57 165.74 18.53 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 5' ' ' LYS . . . -158.12 117.03 3.14 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.51 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -73.89 111.62 9.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.113 0.565 . . . . 0.0 110.845 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -58.65 136.47 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.9 mt -94.3 32.16 1.59 Allowed 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.278 -0.264 . . . . 0.0 111.174 -178.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 116.972 -1.489 . . . . 0.0 109.308 177.782 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ttt . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 58.1 mt -91.65 153.36 19.75 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -176.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -156.91 78.81 0.91 Allowed 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 -174.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.2 mp -80.46 106.63 12.62 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -163.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -80.58 84.54 6.14 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 171.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.2 t -66.29 132.54 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 O-C-N 122.522 -0.111 . . . . 0.0 110.713 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -88.58 142.97 27.26 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -100.2 63.4 0.63 Allowed Glycine 0 CA--C 1.525 0.716 0 CA-C-O 119.656 -0.525 . . . . 0.0 112.047 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 57.9 mtt -68.83 -73.15 0.16 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.15 0.975 . . . . 0.0 111.307 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 46.7 p -87.35 166.33 14.94 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.751 0.31 . . . . 0.0 110.855 -177.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.9 m 47.26 32.19 2.04 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.101 0.961 . . . . 0.0 111.298 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -69.24 -2.32 10.26 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.201 0.6 . . . . 0.0 111.578 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -69.32 -37.19 77.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 122.129 -0.357 . . . . 0.0 110.618 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 65.1 m -133.12 176.41 8.53 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.7 p -92.48 155.9 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.5 0.72 . . . . 0.0 110.078 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 60.6 mtt -136.54 160.19 39.51 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.21 93.03 9.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.4 t -66.85 -12.42 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.1 m -50.14 -39.34 42.98 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.132 0.573 . . . . 0.0 111.674 -177.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -63.31 -22.74 67.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -176.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.84 -25.51 32.54 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 117.902 0.319 . . . . 0.0 110.616 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -82.46 -32.85 28.7 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 -176.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -64.5 -23.25 67.21 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -77.05 -11.98 59.88 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.612 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.1 t -78.84 129.72 72.66 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.61 136.38 73.84 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.398 2.732 . . . . 0.0 111.226 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.92 -20.9 39.64 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.98 128.75 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -125.37 -26.34 3.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -131.88 152.1 51.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.7 t -140.44 148.56 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -144.14 86.93 1.86 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.5 m -96.12 155.5 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.5 t -128.2 100.72 5.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.8 mt -64.54 -19.24 65.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.144 -174.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -83.3 -27.2 29.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -97.82 -11.44 23.29 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 119.806 -0.14 . . . . 0.0 111.167 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.08 20.55 74.91 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -109.12 156.18 20.13 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.32 110.23 6.46 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.401 ' N ' HD22 ' A' ' 41' ' ' LEU . 2.4 mm? -109.66 151.49 26.81 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.7 m -133.47 166.08 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -134.22 84.66 2.13 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.6 -172.27 23.73 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -176.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.1 p -112.73 29.32 8.04 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.643 0.777 . . . . 0.0 110.525 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.65 172.7 11.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.583 0.23 . . . . 0.0 110.724 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -103.06 157.88 32.87 Favored Pre-proline 0 N--CA 1.453 -0.308 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -57.76 -39.47 87.1 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.585 2.856 . . . . 0.0 112.352 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 pttt -72.41 -17.11 61.83 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.116 -176.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.8 -37.76 13.43 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.298 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.5 tp -76.25 -49.66 16.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.033 -176.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.71 -24.92 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 116.982 -0.099 . . . . 0.0 110.736 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -83.71 -29.81 27.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.92 -46.41 89.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.52 -23.84 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -74.06 -21.03 60.09 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -68.87 -23.34 64.2 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -92.53 -6.04 50.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.88 9.32 57.42 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -121.54 92.88 3.84 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.801 0.8 . . . . 0.0 111.546 -175.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.95 169.46 4.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -153.54 117.53 4.79 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.733 0.301 . . . . 0.0 110.608 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -71.59 110.51 6.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.492 0.717 . . . . 0.0 110.819 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -58.26 113.86 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.0 mt -82.87 34.62 0.45 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.443 0.297 . . . . 0.0 110.532 -177.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 116.885 -1.531 . . . . 0.0 109.615 -179.2 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.403 ' HG2' ' N ' ' A' ' 2' ' ' LEU . 50.4 ttp . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.403 ' N ' ' HG2' ' A' ' 1' ' ' MET . 64.2 mt -110.27 151.12 27.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -177.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.481 ' HE2' ' OE1' ' A' ' 39' ' ' GLU . 82.2 tttt -156.21 81.25 0.99 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -175.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 62' ' ' ALA . 8.3 mp -75.73 102.57 5.46 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.955 -167.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -85.48 102.86 13.84 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.4 t -65.24 135.88 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 123.271 0.628 . . . . 0.0 110.814 -177.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -77.36 146.96 36.37 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -93.41 69.38 1.52 Allowed Glycine 0 C--N 1.336 0.549 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 96.4 mtp -68.38 -51.53 43.16 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 117.027 0.413 . . . . 0.0 111.277 -177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.7 p -137.98 164.98 27.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 117.855 0.298 . . . . 0.0 110.952 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 63.8 m 46.87 52.55 11.41 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.602 0.761 . . . . 0.0 111.924 176.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -67.08 -10.59 51.56 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.286 -0.259 . . . . 0.0 111.019 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -92.3 -6.03 51.11 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 117.636 0.198 . . . . 0.0 110.668 177.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.4 m -122.59 129.25 51.7 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -95.38 154.95 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -137.7 158.98 43.23 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.415 ' HB2' ' HE3' ' A' ' 20' ' ' LYS . . . -78.11 93.61 4.56 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.4 t -66.35 -15.3 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.9 m -54.43 -35.67 63.18 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.201 0.6 . . . . 0.0 110.788 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 17' ' ' ALA . 96.6 mttt -58.58 -26.32 63.5 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 119.727 -0.177 . . . . 0.0 111.337 -177.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.69 -25.97 28.04 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 117.735 0.243 . . . . 0.0 110.71 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -83.52 -34.7 25.24 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -177.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -63.22 -22.04 66.61 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -73.37 -12.06 60.69 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 122.483 -0.135 . . . . 0.0 111.221 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 69.4 t -78.9 130.86 68.84 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -56.06 129.69 36.25 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.997 3.131 . . . . 0.0 112.226 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.33 -26.34 12.09 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 112.156 -0.377 . . . . 0.0 112.156 174.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.497 ' HA ' ' HA3' ' A' ' 44' ' ' GLY . 61.1 t -71.91 129.14 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -126.94 -23.46 3.64 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.825 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -128.33 151.59 49.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.6 t -144.38 151.51 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -140.17 96.12 3.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.7 m -96.4 156.04 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.407 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.0 t -127.54 102.13 6.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.8 mt -64.4 -18.97 65.19 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.753 -174.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -83.71 -30.63 26.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 117.821 0.282 . . . . 0.0 110.727 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -98.26 -13.82 20.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 121.53 -0.068 . . . . 0.0 110.82 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.9 19.61 65.73 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.481 ' OE1' ' HE2' ' A' ' 3' ' ' LYS . 98.9 mt-10 -102.1 157.39 16.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -178.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.29 118.95 9.15 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.661 0.267 . . . . 0.0 110.337 -177.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.77 152.7 20.56 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -133.85 164.49 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.708 0.289 . . . . 0.0 111.01 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -138.67 99.35 3.79 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 28' ' ' VAL . . . -160.74 -175.14 31.43 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.8 p -112.42 25.52 11.42 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.546 0.338 . . . . 0.0 110.226 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -77.5 170.12 17.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 122.415 -0.178 . . . . 0.0 110.956 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -88.2 156.64 51.46 Favored Pre-proline 0 N--CA 1.452 -0.356 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -56.16 -37.02 97.22 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.551 2.834 . . . . 0.0 112.468 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -70.04 -41.15 74.61 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.284 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.86 -31.32 66.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -176.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.2 tp -73.22 -60.73 2.1 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 111.461 0.171 . . . . 0.0 111.461 -178.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.1 t -69.57 -23.06 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 122.192 0.197 . . . . 0.0 111.481 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -79.02 -34.75 43.68 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.67 -55.12 37.0 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.807 -0.179 . . . . 0.0 110.882 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.63 -24.56 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -72.61 -37.41 68.1 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -72.21 -23.25 61.21 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -75.36 -4.48 39.57 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 176.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.8 4.1 58.01 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 119.246 -0.752 . . . . 0.0 113.055 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -135.22 114.11 11.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.578 1.189 . . . . 0.0 111.072 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.27 169.17 2.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' A' ' 4' ' ' LEU . . . -155.91 100.08 2.02 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.527 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -69.68 106.28 3.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.951 0.5 . . . . 0.0 111.58 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.7 m -58.78 106.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 174.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.8 mt -80.62 76.95 7.48 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 116.87 -1.538 . . . . 0.0 109.512 -178.267 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 75.6 mt -89.77 151.07 22.0 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -159.65 76.58 0.67 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -176.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.5 mp -78.43 122.78 26.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.693 0.282 . . . . 0.0 111.451 -166.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -99.48 91.37 4.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.6 130.09 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 122.469 0.308 . . . . 0.0 110.555 -175.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -78.37 146.86 34.39 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.64 55.62 1.41 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 92.1 mtp -66.77 -34.39 77.72 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.217 0.508 . . . . 0.0 110.997 -176.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.9 p -137.57 170.11 16.62 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.4 m 51.7 37.74 20.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.982 0.513 . . . . 0.0 111.635 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -67.9 -14.92 63.35 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.16 -0.338 . . . . 0.0 111.535 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -95.36 -50.56 4.96 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 118.435 0.562 . . . . 0.0 110.8 176.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.9 m -99.56 126.26 45.5 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.0 p -94.41 156.27 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 -177.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -135.89 159.64 41.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.24 95.95 2.2 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.8 t -67.74 -13.8 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.4 m -54.01 -36.35 62.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.7 0.4 . . . . 0.0 110.438 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -59.22 -23.4 62.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 119.773 -0.156 . . . . 0.0 111.078 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.26 -32.95 26.15 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.52 -36.42 60.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -66.5 -21.43 66.18 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -174.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -78.26 -17.14 57.06 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.7 t -78.64 128.06 78.44 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.845 -177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -55.44 141.43 82.24 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.703 2.935 . . . . 0.0 111.465 177.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.57 -22.6 32.32 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.7 t -76.29 129.97 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -124.69 -27.02 3.72 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -132.78 149.55 52.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.8 t -145.81 149.68 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -146.23 126.69 14.09 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 m -129.18 154.63 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-O 120.801 0.334 . . . . 0.0 110.52 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.406 ' HG ' ' HD2' ' A' ' 37' ' ' LYS . 37.5 t -128.27 104.6 7.83 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 178.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.9 mt -64.07 -23.32 67.28 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 122.593 0.357 . . . . 0.0 111.93 -173.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -84.68 -41.67 16.05 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 118.269 0.486 . . . . 0.0 110.544 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.406 ' HD2' ' HG ' ' A' ' 34' ' ' SER . 95.9 mttt -82.48 -10.99 58.79 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.789 -0.187 . . . . 0.0 110.685 -176.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.58 21.71 67.19 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -99.1 156.63 16.85 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 117.634 0.717 . . . . 0.0 110.257 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.85 108.47 4.0 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.58 149.16 24.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.3 m -135.93 162.31 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -139.15 95.49 2.95 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.34 -175.75 33.7 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -177.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.0 p -106.02 26.71 9.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 122.681 0.392 . . . . 0.0 110.515 -178.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.03 170.69 15.79 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -92.92 156.52 40.5 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.14 -50.69 12.22 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.872 3.048 . . . . 0.0 112.204 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -70.47 -30.48 67.31 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 121.126 -0.23 . . . . 0.0 110.889 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.01 -33.48 75.91 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.8 tp -74.11 -52.6 12.1 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.486 0.184 . . . . 0.0 110.61 -177.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.61 -25.46 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.813 -0.176 . . . . 0.0 111.3 -177.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -72.06 -33.14 67.73 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.083 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.25 -49.44 75.71 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.155 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 m -72.78 -23.59 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 117.705 0.229 . . . . 0.0 110.853 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -69.13 -34.11 74.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -70.85 -23.18 62.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -80.61 -8.08 59.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.86 12.56 52.62 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.569 -0.613 . . . . 0.0 111.569 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -124.51 111.17 15.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 117.777 0.788 . . . . 0.0 111.114 -176.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.72 165.62 8.14 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -162.66 79.57 0.49 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.646 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -71.35 127.92 34.18 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -60.73 135.29 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 175.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.4 mt -108.46 59.48 0.61 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.057 0 CA-C-O 117.042 -1.456 . . . . 0.0 108.944 -179.125 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ttt . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.2 mt -108.57 152.96 24.05 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -177.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.0 tttt -161.8 77.46 0.52 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -175.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.5 mp -79.08 122.51 26.31 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 121.83 -0.544 . . . . 0.0 111.77 -166.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -100.15 92.95 5.46 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 175.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.6 t -65.56 132.52 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 122.772 0.429 . . . . 0.0 111.567 -174.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -80.06 144.38 33.22 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.537 0.735 . . . . 0.0 109.751 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -97.56 63.62 0.94 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 178.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.463 ' SD ' ' HE3' ' A' ' 61' ' ' LYS . 94.2 mtp -68.09 -36.08 79.23 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.16 0.48 . . . . 0.0 111.78 -176.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 73.1 p -137.44 167.82 20.87 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 117.648 0.204 . . . . 0.0 110.611 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.3 m 47.02 49.25 15.04 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.238 0.615 . . . . 0.0 110.963 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -67.38 -14.18 62.69 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.701 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -95.57 -50.02 5.14 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.382 0.537 . . . . 0.0 110.648 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.8 m -96.06 129.38 43.35 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p -107.05 156.31 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 120.658 0.266 . . . . 0.0 110.323 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -129.55 161.53 30.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.9 91.14 0.45 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.88 -14.15 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.4 m -54.28 -36.89 64.14 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.013 0.525 . . . . 0.0 110.5 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.71 -29.25 67.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 121.357 -0.137 . . . . 0.0 111.198 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.43 -24.43 50.39 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 117.622 0.192 . . . . 0.0 110.807 -177.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.48 -39.08 20.97 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.8 tttt -67.82 -22.13 65.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -173.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -73.28 -17.78 61.28 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.657 0.662 . . . . 0.0 111.743 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.6 t -76.25 128.71 82.08 Favored Pre-proline 0 N--CA 1.449 -0.492 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -52.26 139.92 53.04 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.67 2.913 . . . . 0.0 111.691 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.88 -21.56 35.95 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 177.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -77.48 116.36 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -116.48 -24.17 7.96 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.15 148.9 51.14 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -145.89 148.25 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -146.89 120.9 9.38 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 m -131.63 155.9 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.649 -177.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.6 t -129.41 104.03 7.25 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.8 mt -64.19 -18.5 64.54 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.576 0.35 . . . . 0.0 111.081 -176.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -84.22 -29.97 26.1 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 117.462 0.119 . . . . 0.0 111.029 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -100.04 -10.6 21.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 121.924 0.09 . . . . 0.0 111.06 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.33 19.4 70.47 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -100.72 154.94 18.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.35 119.17 7.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -117.12 151.73 36.23 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.87 162.44 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -139.16 84.7 2.02 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.7 -177.45 29.85 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.9 p -93.31 28.09 2.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.037 0.535 . . . . 0.0 110.708 -178.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.05 173.97 10.0 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 122.375 -0.203 . . . . 0.0 111.063 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -107.12 156.62 37.15 Favored Pre-proline 0 N--CA 1.452 -0.337 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -56.92 -52.79 6.02 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.728 2.952 . . . . 0.0 112.906 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -71.3 -32.49 68.69 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 121.124 -0.231 . . . . 0.0 110.898 -176.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.2 -33.13 75.06 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.6 tp -71.93 -51.52 21.72 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.976 -178.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.5 t -68.94 -27.93 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 121.379 -0.128 . . . . 0.0 111.007 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -67.97 -33.18 74.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.17 -55.82 21.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.075 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.26 -23.61 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -175.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.18 -34.82 68.73 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 120.601 -0.439 . . . . 0.0 109.841 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -71.55 -23.46 61.76 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -74.83 -8.48 56.57 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.24 12.55 51.5 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -127.69 98.41 5.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 117.115 0.458 . . . . 0.0 110.347 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.463 ' HE3' ' SD ' ' A' ' 9' ' ' MET . 87.3 mttt -62.4 161.55 11.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -161.5 92.81 0.9 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.107 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -77.82 129.42 35.4 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -60.94 135.02 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.1 mt -109.34 31.33 5.84 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.5 0.32 . . . . 0.0 110.217 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 116.752 -1.594 . . . . 0.0 109.179 -178.738 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 120.676 0.274 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -164.47 79.38 0.37 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 -177.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 mp -79.27 108.91 13.13 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.824 -0.547 . . . . 0.0 112.084 -164.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -78.74 87.0 4.65 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.7 t -63.38 109.05 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -70.82 147.94 48.38 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 122.887 0.475 . . . . 0.0 110.208 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.547 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 177.747 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.5 mmt -140.38 161.24 38.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.63 127.14 35.87 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.416 HG12 ' CD2' ' A' ' 22' ' ' LEU . 22.9 t -96.63 -13.38 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.0 m -53.39 -41.43 65.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -67.32 -22.43 65.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.863 0.301 . . . . 0.0 111.697 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.05 -34.83 59.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.039 0.381 . . . . 0.0 110.871 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.416 ' CD2' HG12 ' A' ' 18' ' ' VAL . 3.8 mm? -74.3 -38.61 63.31 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -173.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -65.68 -22.07 66.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -174.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.31 -18.68 65.5 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.898 -176.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 55.1 t -80.21 129.92 67.87 Favored Pre-proline 0 N--CA 1.451 -0.423 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 72.2 Cg_exo -52.88 140.67 57.67 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.634 2.889 . . . . 0.0 111.504 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.52 -21.26 41.89 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.1 t -78.05 127.91 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.77 -24.53 3.23 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 110.638 -0.134 . . . . 0.0 110.638 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -128.05 147.0 50.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.7 t -146.12 146.62 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -149.11 131.1 15.28 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -126.81 156.13 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.3 t -128.41 101.05 6.03 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.27 -22.34 66.84 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.316 -175.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -84.92 -29.04 25.48 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.555 0.162 . . . . 0.0 111.151 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -97.85 -9.84 25.71 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.412 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.22 23.1 78.47 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -114.76 158.16 22.23 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 117.723 0.762 . . . . 0.0 110.913 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.95 110.82 6.22 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.045 0.938 . . . . 0.0 109.121 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.497 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.4 mm? -108.35 150.7 26.99 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.7 m -134.73 164.38 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -139.03 89.27 2.34 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.22 -173.99 23.08 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.0 p -113.43 28.85 8.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.969 0.507 . . . . 0.0 110.517 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.89 170.23 16.35 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -80.32 155.55 74.27 Favored Pre-proline 0 N--CA 1.452 -0.366 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -59.11 -44.97 30.44 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.489 2.792 . . . . 0.0 112.091 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.1 pttt -75.08 -29.02 60.54 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.08 76.6 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 121.233 -0.187 . . . . 0.0 110.565 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.9 tp -73.28 -51.38 17.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.619 0.247 . . . . 0.0 110.567 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.7 -23.15 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.189 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -80.78 -33.83 34.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.69 96.34 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.231 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -71.76 -25.79 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.812 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -73.92 -21.33 60.09 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -68.92 -24.32 64.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -89.68 -7.47 54.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.35 9.06 57.15 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -122.89 95.68 4.72 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.705 0.753 . . . . 0.0 110.796 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -66.88 168.15 10.28 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -155.27 117.66 4.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.252 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.21 106.94 3.03 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.158 0.583 . . . . 0.0 111.349 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.21 110.04 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.4 mt -80.96 74.44 7.95 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 CA-C-O 117.368 -1.301 . . . . 0.0 109.726 -179.195 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -147.54 83.96 1.55 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.35 170.03 9.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.346 0.594 . . . . 0.0 112.587 -173.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -151.4 96.65 2.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.61 1.164 . . . . 0.0 107.967 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 7' ' ' GLU . 33.4 t -59.77 170.9 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.483 ' N ' HG12 ' A' ' 6' ' ' VAL . 7.8 tp10 -125.43 150.97 46.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.803 0 C-N-CA 123.701 0.667 . . . . 0.0 112.225 179.079 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.4 HG22 ' N ' ' A' ' 16' ' ' MET . 10.7 p . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.687 0.28 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.4 ' N ' HG22 ' A' ' 15' ' ' VAL . 75.8 mtm -139.87 -175.33 4.18 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -122.93 95.67 4.71 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.476 ' C ' ' H ' ' A' ' 20' ' ' LYS . 13.0 t -65.43 -1.51 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 123.012 0.525 . . . . 0.0 110.034 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 m -63.79 6.61 0.15 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.322 0.649 . . . . 0.0 110.772 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.476 ' H ' ' C ' ' A' ' 18' ' ' VAL . 98.4 mttt -120.39 6.95 10.63 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.849 0.46 . . . . 0.0 110.756 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -118.51 -1.41 11.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 22' ' ' LEU . 2.7 mm? -122.81 -0.42 9.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -98.52 -12.73 20.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -85.26 -10.63 56.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.18 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -76.71 123.17 87.54 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.16 166.48 2.26 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.306 2.671 . . . . 0.0 111.207 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.81 -13.98 1.19 Allowed Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.412 -0.66 . . . . 0.0 112.54 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.8 t -79.27 159.3 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 118.373 1.087 . . . . 0.0 108.537 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -147.63 -18.56 0.37 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -146.25 163.58 35.01 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.2 t -150.92 152.6 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -144.82 152.83 40.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -153.11 178.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.5 t -147.16 102.25 3.48 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.15 -1.13 2.93 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.702 0.401 . . . . 0.0 111.745 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -116.6 1.64 12.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 117.986 0.357 . . . . 0.0 110.446 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -132.99 -10.07 3.01 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.8 -3.73 6.25 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -72.77 166.07 23.61 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 117.78 0.79 . . . . 0.0 109.883 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.413 ' C ' HD12 ' A' ' 41' ' ' LEU . . . -156.08 154.07 30.38 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.413 HD12 ' C ' ' A' ' 40' ' ' ALA . 5.3 mp -145.88 169.1 19.26 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.9 m -149.26 172.13 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -143.15 97.69 3.13 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -169.74 174.01 43.96 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.7 p -80.85 7.05 11.36 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.706 0.802 . . . . 0.0 111.844 -177.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.03 173.62 0.15 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.688 0.28 . . . . 0.0 111.084 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -122.96 162.57 38.36 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -60.19 -28.84 87.75 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.55 2.833 . . . . 0.0 111.923 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -88.18 3.32 49.75 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.398 0.279 . . . . 0.0 111.065 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.94 -0.68 6.59 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.7 tp -119.13 -0.74 11.01 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.1 t -124.09 -25.26 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -76.15 -12.69 60.15 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.87 -57.61 3.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.327 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.79 -24.02 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 110.546 -0.168 . . . . 0.0 110.546 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -79.4 -18.09 53.0 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -85.21 -20.21 30.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -83.76 -3.45 57.83 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 122.774 0.43 . . . . 0.0 110.184 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.75 2.35 72.44 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -134.0 81.93 1.95 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 117.517 0.659 . . . . 0.0 109.726 -178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -60.72 168.95 2.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 110.407 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -153.91 105.19 2.73 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -66.39 170.93 5.37 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.58 -178.86 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 120.878 0.371 . . . . 0.0 110.246 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.6 mt -136.71 5.24 2.87 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.966 0.906 . . . . 0.0 108.843 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 117.043 -1.456 . . . . 0.0 108.976 179.527 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 77.8 mt . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -155.12 79.41 1.05 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -174.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.1 mp -77.73 103.84 7.91 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.269 -163.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -80.68 100.52 8.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 171.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.9 t -60.28 147.8 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.312 1.045 . . . . 0.0 111.427 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -58.93 162.54 4.09 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.189 1.395 . . . . 0.0 107.999 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.772 0 CA-C-O 119.67 -0.517 . . . . 0.0 114.039 -168.921 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.8 mtt -140.97 159.89 41.25 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.01 88.34 7.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.9 t -69.81 -14.57 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 122.493 0.317 . . . . 0.0 110.196 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -56.6 -39.59 73.83 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 122.264 -0.273 . . . . 0.0 110.808 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.65 -21.52 66.56 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 119.569 -0.253 . . . . 0.0 111.482 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.54 -39.78 51.84 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 117.852 0.297 . . . . 0.0 110.414 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 22' ' ' LEU . 3.9 mm? -75.87 -32.65 59.81 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -177.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -60.29 -21.42 61.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 112.611 0.596 . . . . 0.0 112.611 -174.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -79.7 -17.99 52.31 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 118.157 0.435 . . . . 0.0 111.623 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.0 t -70.98 128.02 91.07 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 117.751 0.25 . . . . 0.0 110.438 -174.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 46' ' ' ALA . 50.4 Cg_exo -58.47 137.23 79.21 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.444 2.763 . . . . 0.0 110.86 177.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.08 -25.06 15.42 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.439 ' HA ' ' HA3' ' A' ' 44' ' ' GLY . 54.7 t -72.58 129.62 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -126.24 -25.91 3.44 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.737 -0.21 . . . . 0.0 110.678 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -130.42 148.61 52.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.7 t -146.51 147.65 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -146.43 129.25 16.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.43 158.72 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 120.89 0.376 . . . . 0.0 111.613 -174.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.0 t -126.86 101.93 6.8 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.6 mt -63.89 -25.26 68.07 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -173.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -85.16 -30.04 24.27 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.588 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -99.38 -11.03 21.54 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -175.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.14 24.49 76.99 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -98.6 154.73 17.71 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.76 0.78 . . . . 0.0 109.577 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.32 109.85 4.43 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.444 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.481 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.9 mm? -100.25 139.12 36.38 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.33 162.97 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -139.0 101.33 4.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 28' ' ' VAL . . . -156.73 -175.68 27.94 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -177.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.4 p -114.61 26.04 10.53 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 122.898 0.479 . . . . 0.0 109.801 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 26' ' ' PRO . . . -76.22 167.88 21.06 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.713 -0.221 . . . . 0.0 110.613 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.15 144.53 71.66 Favored Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -56.01 -37.53 96.05 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.864 2.376 . . . . 0.0 111.457 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -75.62 -33.98 60.55 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.95 -33.64 76.02 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.41 HD11 HD12 ' A' ' 22' ' ' LEU . 11.5 tp -70.19 -50.44 40.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.66 -22.57 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -82.67 -32.28 28.21 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.48 -45.38 93.95 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.9 m -73.94 -23.89 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.099 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.405 ' OE2' ' HE2' ' A' ' 61' ' ' LYS . 42.6 tt0 -70.77 -19.6 62.69 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.02 -23.74 65.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -91.45 -13.57 32.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.85 10.37 57.71 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -131.12 88.18 2.57 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -175.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.405 ' HE2' ' OE2' ' A' ' 56' ' ' GLU . 88.5 mttt -64.44 178.47 0.72 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.612 0.765 . . . . 0.0 110.227 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -154.19 101.86 2.42 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.187 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -69.19 120.41 14.99 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.715 0.406 . . . . 0.0 110.918 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.7 m -59.06 130.02 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 175.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.5 mt -83.71 34.15 0.49 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 116.851 -1.547 . . . . 0.0 109.399 -178.792 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.469 ' HG3' HD11 ' A' ' 41' ' ' LEU . 79.4 tttt -160.24 77.52 0.64 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.3 mp -81.14 127.24 32.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.532 0.333 . . . . 0.0 111.699 -166.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -99.75 96.01 7.32 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 t -66.35 107.42 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 123.228 0.611 . . . . 0.0 111.957 -175.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -78.14 148.32 34.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 174.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.622 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.545 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 60.5 mtt -145.24 161.95 38.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.67 94.35 0.78 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.64 -13.35 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.5 m -54.64 -38.24 66.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 122.674 0.39 . . . . 0.0 110.7 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.56 -23.26 67.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.54 -0.267 . . . . 0.0 111.675 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.42 -22.79 40.86 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 117.729 0.241 . . . . 0.0 111.051 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.95 -33.49 16.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.503 0.138 . . . . 0.0 111.241 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -64.41 -26.57 68.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -169.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -81.18 -9.96 59.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 119.364 0.984 . . . . 0.0 111.801 -177.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.3 t -73.61 130.67 83.37 Favored Pre-proline 0 N--CA 1.452 -0.34 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.64 140.53 65.74 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.763 2.975 . . . . 0.0 112.172 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.16 -20.98 39.86 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 119.833 -0.426 . . . . 0.0 112.121 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.1 t -68.82 130.34 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 117.578 0.689 . . . . 0.0 109.463 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -120.24 -36.98 3.13 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 43' ' ' GLU . 97.8 mttt -134.44 155.72 49.83 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.4 t -135.12 148.78 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -144.0 104.15 4.11 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.1 m -125.27 155.54 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.3 t -128.36 101.33 6.17 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.88 -18.07 63.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.301 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -83.77 -30.83 26.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.206 0.203 . . . . 0.0 110.64 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -102.96 -10.47 18.96 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -176.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.23 20.44 75.04 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -102.2 155.37 18.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.98 121.38 9.65 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.469 HD11 ' HG3' ' A' ' 3' ' ' LYS . 2.8 mm? -118.58 153.62 33.95 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.94 166.57 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 30' ' ' LYS . 32.3 tt0 -135.81 89.55 2.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.83 177.55 38.87 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -177.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.9 p -95.28 26.88 3.54 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.188 0.595 . . . . 0.0 110.11 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.05 169.71 17.47 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -110.03 158.23 35.63 Favored Pre-proline 0 N--CA 1.452 -0.351 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -55.61 -46.0 35.24 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.82 3.013 . . . . 0.0 112.796 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -74.68 -13.93 60.68 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.405 -177.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.44 -35.49 15.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.219 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tp -76.44 -48.43 19.68 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.386 0.136 . . . . 0.0 111.11 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.7 t -68.29 -23.06 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 119.619 -0.229 . . . . 0.0 111.475 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -77.54 -37.61 50.47 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.104 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.65 -48.6 81.02 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.815 -0.175 . . . . 0.0 110.913 -176.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -72.32 -26.09 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.795 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -76.77 -28.57 55.74 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.598 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -70.24 -23.57 62.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -83.59 -4.48 58.6 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 177.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.99 7.5 58.55 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -115.18 90.94 3.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 117.298 0.549 . . . . 0.0 111.237 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -66.18 114.15 5.07 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.9 88.61 2.69 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.43 141.45 38.29 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.466 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.1 m -59.3 139.67 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 123.661 0.784 . . . . 0.0 111.167 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.08 28.04 2.96 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 116.98 -1.486 . . . . 0.0 109.561 -179.163 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.411 HD12 HD22 ' A' ' 51' ' ' LEU . 67.1 mt . . . . . 0 N--CA 1.451 -0.409 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -153.81 80.08 1.14 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.7 mp -77.85 108.04 10.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.677 -164.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 14.7 tmtt? -93.06 96.77 10.27 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 174.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.2 t -64.36 133.92 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -85.34 149.04 25.73 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.648 0.379 . . . . 0.0 110.114 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.54 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 179.359 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 58.4 mtt -139.27 161.31 37.75 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.58 89.65 2.75 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.8 t -74.44 -21.97 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.7 m -57.47 -39.23 75.93 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 122.37 -0.206 . . . . 0.0 110.549 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.56 -22.41 66.96 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 119.645 -0.216 . . . . 0.0 111.533 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.78 -38.94 37.24 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.471 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 22' ' ' LEU . 3.1 mm? -73.05 -32.45 65.07 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -63.02 -21.96 66.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -175.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -70.34 -14.99 62.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.211 0.46 . . . . 0.0 111.147 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 71.9 t -78.53 127.55 80.26 Favored Pre-proline 0 N--CA 1.451 -0.413 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -175.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 52.8 Cg_exo -58.63 140.4 94.71 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 123.462 2.775 . . . . 0.0 110.975 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.76 -20.85 42.44 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.996 -0.441 . . . . 0.0 111.996 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.33 128.26 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -110.62 -42.16 4.13 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -135.47 154.96 51.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.6 t -140.46 149.41 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -139.1 99.21 3.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 m -95.76 155.87 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.7 t -127.47 98.74 5.34 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.0 mt -66.66 -19.82 65.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -173.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -84.05 -32.21 24.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.443 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -103.43 -9.85 19.06 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 117.872 0.306 . . . . 0.0 111.223 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.81 21.73 76.68 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -98.66 155.04 17.52 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.04 125.6 10.28 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.986 0.422 . . . . 0.0 111.184 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.409 HD22 ' N ' ' A' ' 41' ' ' LEU . 3.2 mm? -107.54 153.06 23.41 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 175.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.4 m -132.38 164.7 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -137.28 88.98 2.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.61 -176.61 35.72 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.8 p -117.31 29.51 7.84 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.385 0.674 . . . . 0.0 109.893 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.22 167.08 21.92 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.805 0.336 . . . . 0.0 110.854 -176.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -76.77 149.58 80.74 Favored Pre-proline 0 N--CA 1.451 -0.425 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.079 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -55.45 -49.42 16.16 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.379 2.719 . . . . 0.0 112.185 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -74.79 -19.6 60.13 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.04 -34.81 71.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.919 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.411 HD22 HD12 ' A' ' 2' ' ' LEU . 10.0 tp -75.47 -43.66 48.25 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 83.0 t -65.25 -24.84 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 123.189 0.596 . . . . 0.0 111.816 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -87.27 -28.94 22.02 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.968 0.349 . . . . 0.0 111.176 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.91 -47.02 87.48 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 122.345 -0.222 . . . . 0.0 110.991 -177.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.89 -21.32 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -68.76 -21.02 64.38 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.44 -29.15 67.73 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -83.78 -9.37 58.84 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.59 11.13 48.54 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 119.619 -0.545 . . . . 0.0 111.74 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -128.72 142.54 50.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 117.758 0.779 . . . . 0.0 110.434 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -85.23 172.45 11.15 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 171.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 5' ' ' LYS . . . -149.54 77.51 1.34 Allowed 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.11 117.68 4.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.863 -175.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -57.45 126.0 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.749 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.5 mt -84.08 31.28 0.5 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.741 0.416 . . . . 0.0 109.93 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 117.239 -1.363 . . . . 0.0 110.199 -178.284 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.422 HD22 HG11 ' A' ' 64' ' ' VAL . 60.2 mt . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 121.012 0.434 . . . . 0.0 110.437 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -148.03 78.74 1.45 Allowed 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 -169.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -77.46 114.84 16.71 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.225 -164.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 75.8 tttt -96.1 98.82 10.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.296 1.039 . . . . 0.0 108.907 175.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.4 t -61.75 115.58 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 120.843 0.354 . . . . 0.0 110.19 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -69.96 151.77 45.22 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.446 0.698 . . . . 0.0 110.032 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.653 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.91 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 69.7 mtm -144.83 160.42 41.3 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.0 90.77 4.19 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.69 -13.5 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.8 m -52.91 -37.7 61.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.12 0.568 . . . . 0.0 110.792 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -64.2 -22.35 66.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -177.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.52 ' O ' ' HB1' ' A' ' 54' ' ' ALA . . . -82.15 -25.0 34.73 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 117.858 0.299 . . . . 0.0 110.994 -178.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.12 -33.52 24.3 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 117.455 0.116 . . . . 0.0 110.862 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -63.56 -22.5 66.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -71.09 -16.13 62.56 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.599 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.475 ' CG2' ' HB2' ' A' ' 54' ' ' ALA . 72.5 t -80.32 127.31 76.69 Favored Pre-proline 0 N--CA 1.45 -0.433 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.64 141.22 97.38 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.651 2.901 . . . . 0.0 111.232 177.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.8 -19.62 50.39 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.855 -0.498 . . . . 0.0 111.855 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.0 t -74.14 123.41 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 117.387 0.593 . . . . 0.0 109.426 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -129.41 -26.67 2.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -130.6 132.12 45.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.262 0.553 . . . . 0.0 110.139 176.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 83.9 t -144.73 147.72 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -136.43 122.84 20.7 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 m -130.56 156.23 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.145 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.5 t -126.86 102.45 7.03 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.5 mt -62.71 -18.05 61.81 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.101 0.56 . . . . 0.0 111.486 -174.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -84.58 -31.46 24.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 117.597 0.181 . . . . 0.0 111.244 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -102.16 -10.39 19.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.55 21.68 77.72 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -100.3 155.64 17.67 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 117.726 0.763 . . . . 0.0 109.437 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.26 115.1 6.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.509 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.487 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.7 mm? -97.48 152.01 19.42 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.87 150.51 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -141.29 62.66 1.46 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.2 -176.83 14.57 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.3 p -98.65 26.49 5.56 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.804 0.842 . . . . 0.0 111.104 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.12 164.9 25.66 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.795 0.331 . . . . 0.0 111.097 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -82.32 135.61 47.05 Favored Pre-proline 0 N--CA 1.451 -0.413 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -56.04 -35.49 94.78 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.268 2.645 . . . . 0.0 111.833 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -74.85 -28.45 60.68 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 122.17 0.188 . . . . 0.0 111.203 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.92 -33.59 45.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 tp -64.92 -45.36 86.17 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.07 -23.28 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 122.693 0.397 . . . . 0.0 110.617 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -87.52 -29.0 21.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 122.401 -0.187 . . . . 0.0 110.989 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.52 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -58.29 -47.27 84.19 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 122.376 -0.202 . . . . 0.0 111.104 -178.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.2 m -72.37 -20.86 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -69.42 -21.29 63.76 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -69.47 -25.35 64.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -84.04 -9.73 58.41 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.03 15.38 39.2 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 178.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -130.54 144.49 51.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 117.581 0.69 . . . . 0.0 111.509 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -80.16 175.28 10.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 168.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 5' ' ' LYS . . . -148.05 78.32 1.44 Allowed 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 174.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -53.61 107.6 0.27 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.456 0.702 . . . . 0.0 111.297 -175.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.422 HG11 HD22 ' A' ' 2' ' ' LEU . 35.8 m -58.19 110.42 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 123.871 0.868 . . . . 0.0 110.03 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.7 mt -84.04 35.34 0.53 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.084 0 CA-C-O 117.091 -1.433 . . . . 0.0 109.97 -178.061 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.1 mt . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -167.14 78.78 0.19 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -174.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.4 mp -77.87 124.65 28.26 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.894 -0.503 . . . . 0.0 112.324 -165.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -101.33 90.29 4.05 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.5 t -68.15 134.33 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 122.583 0.353 . . . . 0.0 111.657 -175.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -88.72 150.2 23.09 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 173.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.667 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 178.782 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 62.3 mtm -102.01 121.81 42.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.21 82.94 5.98 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.1 t -103.0 -17.35 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.0 m -54.15 -50.66 66.46 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.622 0.369 . . . . 0.0 111.401 -175.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -67.17 -21.32 65.8 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 119.493 -0.289 . . . . 0.0 111.655 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.43 -25.23 59.31 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.092 0.405 . . . . 0.0 111.793 -176.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.04 -48.44 20.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -178.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -65.58 -20.96 66.53 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -173.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -72.47 -14.44 61.67 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.264 0.484 . . . . 0.0 111.675 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.449 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 54.5 t -74.27 134.7 76.74 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 58.8 Cg_exo -55.86 131.15 44.25 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 123.595 2.863 . . . . 0.0 111.165 177.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.36 -22.11 38.86 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.852 -0.499 . . . . 0.0 111.852 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.9 t -77.86 130.64 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -126.98 -24.77 3.41 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.781 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -127.9 148.77 50.5 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.0 t -144.98 150.06 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -145.64 125.86 13.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.1 m -131.35 156.0 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.348 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.5 t -128.72 98.8 5.11 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.51 -17.98 64.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.863 -175.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -80.48 -29.94 37.42 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.502 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -99.95 -9.56 22.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 176.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.43 22.84 78.57 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -99.1 156.41 16.96 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 117.417 0.608 . . . . 0.0 110.734 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.64 109.71 5.32 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.539 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.2 mm? -101.63 151.77 21.61 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.0 163.16 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -138.33 79.69 1.75 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.98 -172.39 17.19 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 47.6 p -117.05 28.0 8.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.683 0.393 . . . . 0.0 110.284 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.58 171.4 14.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.343 -0.244 . . . . 0.0 110.343 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 18.9 t70 -79.64 141.3 55.92 Favored Pre-proline 0 N--CA 1.454 -0.239 0 O-C-N 122.439 -0.163 . . . . 0.0 111.027 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 47' ' ' ASP . 81.6 Cg_exo -54.59 -36.99 90.69 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 123.669 2.912 . . . . 0.0 113.08 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -74.17 -35.02 63.98 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.494 -177.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.17 -33.25 75.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.799 -175.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.2 tp -67.77 -50.89 54.71 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.679 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.9 t -68.03 -30.08 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 110.553 -0.166 . . . . 0.0 110.553 -177.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -76.13 -33.73 59.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -177.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.82 -48.57 78.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.319 0.104 . . . . 0.0 110.87 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -72.37 -23.8 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -72.79 -25.57 61.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -71.22 -25.72 62.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -89.35 -4.43 58.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.88 5.1 61.31 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -108.28 90.36 3.27 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 117.157 0.479 . . . . 0.0 111.073 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -71.01 155.65 40.58 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -162.39 111.33 1.41 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.483 0.182 . . . . 0.0 110.585 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -73.91 123.0 23.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.658 0.383 . . . . 0.0 110.65 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.6 m -59.42 135.16 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.31 74.66 3.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.285 -1.34 . . . . 0.0 109.555 -179.283 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.425 HD13 HD22 ' A' ' 51' ' ' LEU . 80.3 mt . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -157.31 77.1 0.85 Allowed 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -174.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 mp -79.89 113.49 18.09 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.706 -165.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -99.45 89.63 4.24 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.417 HG22 ' HB2' ' A' ' 62' ' ' ALA . 30.8 t -66.35 132.89 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 123.597 0.759 . . . . 0.0 112.323 -174.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -91.23 147.74 22.84 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 172.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.523 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.748 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.408 ' CG2' HD22 ' A' ' 35' ' ' LEU . 14.6 p . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 69.2 mtm -99.48 119.25 37.72 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.43 88.12 6.26 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 t -100.96 -12.8 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 111.417 0.155 . . . . 0.0 111.417 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.9 m -50.36 -47.18 56.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -173.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -67.5 -22.78 65.44 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.146 -0.346 . . . . 0.0 111.771 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.06 -25.28 60.86 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 118.062 0.392 . . . . 0.0 111.094 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.3 -39.57 22.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -66.91 -25.16 66.24 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -173.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -81.25 -12.73 59.03 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.295 0.498 . . . . 0.0 112.144 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.7 t -76.28 128.07 83.44 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -54.75 139.46 77.42 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.473 2.782 . . . . 0.0 111.036 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.49 -20.25 47.73 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.3 t -76.38 131.92 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -122.86 -28.18 4.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.5 mttp -132.89 152.08 51.93 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.8 t -142.34 148.08 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -145.37 127.05 15.22 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.4 m -131.71 155.19 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 120.596 0.236 . . . . 0.0 110.483 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.4 t -128.3 112.31 14.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.408 HD22 ' CG2' ' A' ' 15' ' ' VAL . 87.9 mt -66.22 -25.27 66.83 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -175.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -83.34 -31.9 26.55 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.601 -176.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -101.2 -9.7 21.05 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 117.582 0.174 . . . . 0.0 110.982 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.72 23.15 73.94 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -94.75 156.44 16.38 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 117.646 0.723 . . . . 0.0 110.077 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.55 108.67 4.77 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.529 0.732 . . . . 0.0 110.118 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.5 mm? -101.67 150.51 23.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.105 0.962 . . . . 0.0 108.678 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.71 164.44 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -137.47 92.02 2.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.71 -172.93 29.73 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -177.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 48.9 p -117.51 29.72 7.7 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.226 0.61 . . . . 0.0 110.24 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.18 170.91 14.56 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.648 0.261 . . . . 0.0 110.747 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.86 137.28 66.21 Favored Pre-proline 0 N--CA 1.451 -0.381 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -54.54 -42.79 64.94 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.414 2.742 . . . . 0.0 112.503 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -76.02 -28.3 57.68 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.054 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.02 76.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 121.323 -0.151 . . . . 0.0 110.609 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.425 HD22 HD13 ' A' ' 2' ' ' LEU . 9.7 tp -71.18 -48.48 51.41 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.5 t -68.91 -22.79 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.47 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -85.97 -33.75 21.04 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.222 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.42 -44.61 95.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 121.416 -0.114 . . . . 0.0 111.019 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.0 m -69.8 -27.6 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.403 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -77.01 -25.25 52.43 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -69.55 -22.19 63.57 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -91.84 -6.81 50.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.34 10.63 55.64 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -124.84 89.77 3.13 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 117.646 0.723 . . . . 0.0 110.509 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.76 163.32 21.93 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.417 ' HB2' HG22 ' A' ' 6' ' ' VAL . . . -158.59 115.31 2.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.479 0.18 . . . . 0.0 110.736 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -72.39 111.57 7.7 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.449 0.3 . . . . 0.0 111.075 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.0 m -58.26 118.16 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.05 71.01 9.09 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.378 -1.296 . . . . 0.0 110.037 -178.966 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.6 mt . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -159.42 78.82 0.73 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -173.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.6 mp -79.25 102.62 8.67 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.868 0.366 . . . . 0.0 111.489 -165.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -92.48 94.03 8.87 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.5 t -65.73 136.4 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.476 1.11 . . . . 0.0 112.524 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -88.97 149.02 23.48 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.701 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.967 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 56.5 mtm -103.05 122.54 44.85 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.65 90.2 7.86 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.32 -14.76 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 122.129 0.172 . . . . 0.0 111.325 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.1 m -54.46 -47.35 73.04 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -173.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -66.74 -22.92 66.04 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.285 0.493 . . . . 0.0 112.11 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.42 -24.57 60.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 118.011 0.369 . . . . 0.0 111.295 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.77 -40.63 18.54 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -66.69 -24.06 66.21 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -172.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -80.54 -12.78 59.48 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.336 0.516 . . . . 0.0 111.974 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.1 t -73.13 128.5 87.64 Favored Pre-proline 0 N--CA 1.451 -0.416 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -54.21 131.58 45.76 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.643 2.895 . . . . 0.0 111.2 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.22 -19.85 52.16 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 119.83 -0.428 . . . . 0.0 112.05 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.4 t -74.53 129.52 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -117.77 -30.61 5.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -134.77 152.48 51.79 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.3 t -142.48 149.47 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -145.69 129.23 17.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.28 156.76 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 120.619 0.247 . . . . 0.0 110.371 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.6 t -126.69 101.38 6.61 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.3 -20.34 66.02 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -174.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -83.89 -31.13 25.87 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.424 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -101.73 -9.8 20.53 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.597 0.18 . . . . 0.0 111.382 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.14 21.85 75.79 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -96.38 156.09 16.49 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.06 125.11 12.82 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.147 0.579 . . . . 0.0 109.479 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.5 mm? -117.94 152.32 35.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.046 0.939 . . . . 0.0 108.64 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.47 165.23 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -136.68 86.44 2.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.69 -172.64 24.22 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.8 p -117.48 28.66 8.32 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.188 0.595 . . . . 0.0 110.513 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.12 169.84 17.22 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.678 0.275 . . . . 0.0 110.92 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -76.3 144.33 74.52 Favored Pre-proline 0 N--CA 1.452 -0.369 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.308 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -57.33 -38.78 93.7 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 123.294 2.663 . . . . 0.0 112.11 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -75.51 -37.19 60.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.431 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.43 -34.29 75.14 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -176.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 tp -71.52 -56.87 5.06 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.481 0.181 . . . . 0.0 110.613 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.2 t -67.64 -21.69 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 122.3 0.24 . . . . 0.0 111.542 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -86.56 -32.48 20.66 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.622 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.72 -44.33 96.74 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.668 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.6 m -68.83 -27.21 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -77.68 -21.68 51.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -69.7 -24.28 63.55 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -90.51 -7.17 53.64 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.09 0.16 61.91 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -107.65 91.05 3.49 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 117.663 0.732 . . . . 0.0 110.74 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.91 163.34 19.83 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 177.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -156.14 112.67 3.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.59 0.233 . . . . 0.0 110.982 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -71.21 108.28 4.63 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.8 m -58.27 119.52 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.9 mt -81.12 72.11 8.13 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.145 0 CA-C-O 117.181 -1.39 . . . . 0.0 109.377 -179.802 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -153.39 77.97 1.14 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -175.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 mp -78.53 101.46 7.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.316 -167.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -88.08 98.53 11.59 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.3 t -63.43 133.01 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 122.824 0.45 . . . . 0.0 110.927 -175.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -83.2 148.56 27.36 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.404 0.682 . . . . 0.0 109.715 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.57 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.69 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 72.6 mtm -150.82 162.47 40.68 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.58 91.59 0.6 Allowed 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.8 t -68.91 -14.44 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 36.0 m -52.51 -37.81 58.25 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.924 0.49 . . . . 0.0 111.352 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -62.55 -22.35 66.26 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.79 -25.66 30.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 118.04 0.382 . . . . 0.0 111.173 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.69 -35.95 51.64 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -177.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.73 -22.86 66.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -175.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -68.34 -18.06 64.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.274 0.488 . . . . 0.0 112.165 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.424 HG21 ' HA ' ' A' ' 51' ' ' LEU . 60.1 t -79.77 129.02 72.43 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-N 118.052 0.387 . . . . 0.0 110.069 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 62.2 Cg_exo -54.93 139.27 79.03 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 123.581 2.854 . . . . 0.0 111.413 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.41 -21.13 42.36 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.1 t -74.5 128.69 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -124.28 -26.9 3.88 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.793 0.27 . . . . 0.0 110.855 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -133.05 150.35 52.12 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.5 t -144.84 148.52 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -147.43 127.71 13.89 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 m -130.68 155.14 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 117.852 0.296 . . . . 0.0 110.871 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.1 t -129.02 100.07 5.51 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.98 -18.32 65.18 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.044 0.538 . . . . 0.0 112.126 -174.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -81.54 -29.89 33.34 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.927 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -103.62 -8.36 20.05 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.658 0.208 . . . . 0.0 111.229 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.03 23.47 78.07 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -96.91 155.56 16.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 117.737 0.769 . . . . 0.0 109.75 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.74 110.98 4.88 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.31 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.9 mm? -100.59 151.11 22.0 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.1 m -135.06 163.99 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 174.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -137.5 93.82 2.85 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.01 -171.22 26.68 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.9 p -114.28 28.15 8.96 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.787 0.435 . . . . 0.0 110.127 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.68 170.06 16.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.662 0.268 . . . . 0.0 110.875 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 14.9 t70 -90.61 148.56 38.91 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.487 177.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 47' ' ' ASP . 71.9 Cg_exo -57.76 -39.2 89.26 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.652 2.901 . . . . 0.0 112.915 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -75.35 -22.89 57.23 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.281 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.39 -35.09 58.81 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.315 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.424 ' HA ' HG21 ' A' ' 25' ' ' VAL . 10.7 tp -75.55 -46.01 34.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 121.32 -0.152 . . . . 0.0 111.079 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 63.7 t -67.19 -22.37 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 110.563 -0.162 . . . . 0.0 110.563 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -87.16 -30.04 21.33 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.08 -46.2 91.62 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.5 m -68.77 -19.91 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.475 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.456 ' OE1' ' HE2' ' A' ' 61' ' ' LYS . 45.7 tt0 -69.15 -20.4 64.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -68.84 -26.37 65.12 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -82.78 -11.39 58.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.9 8.14 59.39 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -132.69 101.87 5.46 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 117.286 0.543 . . . . 0.0 111.611 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.456 ' HE2' ' OE1' ' A' ' 56' ' ' GLU . 97.0 mttt -67.56 172.04 5.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -152.87 119.35 5.6 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.501 0.191 . . . . 0.0 110.62 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -68.84 109.04 3.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.512 0.725 . . . . 0.0 111.586 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 64' ' ' VAL . 30.6 m -58.81 108.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 174.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.0 mt -80.65 76.58 7.52 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 117.276 -1.345 . . . . 0.0 109.602 -177.625 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.5 mt . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -153.15 81.36 1.2 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.7 mp -75.12 103.46 5.3 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.45 -167.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -88.43 105.78 17.82 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.8 t -64.72 134.43 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 122.93 0.492 . . . . 0.0 111.146 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -85.12 146.19 27.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.617 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.708 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -147.4 161.65 40.6 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.628 0.371 . . . . 0.0 110.021 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.5 115.91 5.63 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.007 0.523 . . . . 0.0 110.36 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.7 t -69.48 -11.94 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.228 1.011 . . . . 0.0 111.239 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.6 m -48.72 -40.63 29.12 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -174.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.87 -23.37 67.32 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -174.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.9 -25.12 32.76 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.039 0.381 . . . . 0.0 110.848 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' A' ' 22' ' ' LEU . 3.9 mm? -84.29 -31.57 24.83 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -59.18 -23.2 62.04 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 121.232 -0.187 . . . . 0.0 111.428 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -72.01 -17.74 62.02 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.29 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.1 t -79.55 127.75 77.22 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -57.3 139.08 89.04 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.302 2.668 . . . . 0.0 111.112 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.01 -21.18 38.33 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.5 t -70.91 129.16 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -128.07 -27.63 2.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -131.48 150.23 52.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.6 t -146.06 151.06 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -145.31 127.83 16.04 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.1 m -131.73 156.01 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.192 -178.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.7 t -127.98 101.26 6.23 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 176.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.6 mt -66.04 -22.03 66.41 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -83.93 -31.34 25.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.386 0.539 . . . . 0.0 111.499 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -102.22 -8.5 21.25 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.61 0.186 . . . . 0.0 111.187 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.32 20.62 73.53 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -98.76 154.16 18.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.51 128.15 12.4 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.632 0.253 . . . . 0.0 110.54 -177.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.8 mm? -113.58 153.05 29.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.961 0.904 . . . . 0.0 109.456 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.08 163.28 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 174.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -141.31 95.59 2.85 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.79 -179.07 35.31 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.2 p -94.73 26.81 3.34 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.466 0.306 . . . . 0.0 110.58 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.09 174.03 10.56 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -107.92 155.73 39.44 Favored Pre-proline 0 N--CA 1.452 -0.326 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -58.89 -37.49 93.38 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.2 2.6 . . . . 0.0 111.972 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -73.98 -16.69 61.07 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 119.815 -0.135 . . . . 0.0 111.144 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.68 -33.63 14.98 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.43 HD11 HD12 ' A' ' 22' ' ' LEU . 10.9 tp -70.87 -59.64 2.68 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.546 -176.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.0 t -67.64 -22.45 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 122.19 0.196 . . . . 0.0 110.941 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -81.84 -33.72 30.52 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 122.27 -0.269 . . . . 0.0 110.532 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.11 -46.51 90.31 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.281 0.086 . . . . 0.0 110.984 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.45 -22.83 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -77.19 -22.4 52.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.381 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -70.05 -24.17 63.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -83.26 -9.05 59.34 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.82 10.56 34.78 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 119.364 -0.687 . . . . 0.0 113.063 175.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -131.8 125.65 32.41 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.589 1.195 . . . . 0.0 111.573 -177.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -69.88 167.06 18.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.579 177.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -153.82 95.64 1.9 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -66.78 105.4 1.56 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.124 0.57 . . . . 0.0 111.542 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 64' ' ' VAL . 27.0 m -58.96 109.02 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.9 mt -80.88 74.16 7.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.288 -1.339 . . . . 0.0 109.208 -179.734 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.8 mt . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -159.73 78.74 0.7 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -176.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.7 mp -77.25 103.07 6.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.73 -164.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -79.92 96.42 6.37 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.473 HG11 HG21 ' A' ' 18' ' ' VAL . 33.0 t -65.1 128.62 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 120.737 0.304 . . . . 0.0 110.368 -176.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -75.47 145.33 41.53 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.452 0.701 . . . . 0.0 110.021 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.525 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 178.232 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -149.5 160.65 43.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.35 111.82 11.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.473 HG21 HG11 ' A' ' 6' ' ' VAL . 20.9 t -68.13 -8.02 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 123.066 0.546 . . . . 0.0 110.026 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.3 m -41.84 -38.35 1.5 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.564 1.146 . . . . 0.0 112.928 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.27 -23.56 66.77 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 122.016 -0.428 . . . . 0.0 111.704 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.79 -24.25 33.51 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 22' ' ' LEU . 4.0 mm? -82.62 -34.85 27.43 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -177.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -61.86 -22.13 65.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -175.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -75.57 -15.92 60.31 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.4 t -77.67 128.93 78.27 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 118.299 0.5 . . . . 0.0 110.001 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.89 139.83 84.74 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.534 2.823 . . . . 0.0 111.112 177.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.92 -21.48 39.36 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 176.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.6 t -80.23 132.66 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -127.8 -29.95 2.56 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.513 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -133.99 152.02 51.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.1 t -144.48 150.33 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -177.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -141.83 125.94 17.36 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.0 m -133.14 158.54 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 120.462 0.173 . . . . 0.0 111.371 -175.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.7 t -126.47 104.45 8.15 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 176.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.4 mt -63.7 -20.86 66.06 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -173.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -84.1 -32.4 24.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.572 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -101.68 -9.66 20.7 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -175.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.9 24.15 72.81 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.056 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -95.79 154.4 17.24 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.96 108.72 3.85 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 41' ' ' LEU . 3.2 mm? -105.12 152.17 23.12 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.4 m -132.18 163.73 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -137.82 89.88 2.45 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -159.28 -169.83 23.1 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.7 p -118.22 28.03 8.61 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.986 0.514 . . . . 0.0 110.206 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.67 168.89 18.93 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 17.4 m-20 -78.82 154.31 78.12 Favored Pre-proline 0 N--CA 1.451 -0.412 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 47' ' ' ASP . 76.0 Cg_exo -59.02 -46.63 21.52 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.625 2.884 . . . . 0.0 112.15 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -75.74 -32.35 59.97 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.935 -0.12 . . . . 0.0 111.151 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.62 -32.43 74.08 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 121.432 -0.107 . . . . 0.0 110.755 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.2 tp -69.21 -50.97 42.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 121.155 -0.218 . . . . 0.0 110.488 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.3 t -69.35 -28.21 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 122.508 0.323 . . . . 0.0 111.077 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -75.1 -31.89 61.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.55 -54.97 40.34 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 122.43 0.292 . . . . 0.0 111.42 -177.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -72.51 -23.82 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 121.403 -0.119 . . . . 0.0 111.029 -177.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -72.74 -22.37 60.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -70.94 -25.07 62.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -79.95 -9.58 59.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.0 11.3 34.77 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 119.588 -0.562 . . . . 0.0 111.888 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -129.82 114.85 16.42 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 117.886 0.843 . . . . 0.0 110.692 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.6 169.68 3.75 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -152.54 92.94 1.73 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -68.45 104.62 1.95 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 122.947 0.499 . . . . 0.0 111.331 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 64' ' ' VAL . 26.7 m -58.24 113.53 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.05 76.25 6.79 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 CA-C-O 117.025 -1.464 . . . . 0.0 109.067 -177.282 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 N--CA 1.449 -0.506 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.483 ' HG3' HD11 ' A' ' 41' ' ' LEU . 78.3 tttt -156.31 76.41 0.9 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -175.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.0 mp -76.16 109.43 9.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -165.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.47 ' HB2' HD21 ' A' ' 65' ' ' LEU . 57.5 tttt -81.38 98.4 8.18 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.666 0.787 . . . . 0.0 109.218 173.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.4 t -70.47 107.97 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 117.797 0.271 . . . . 0.0 110.567 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -73.21 118.66 16.44 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.59 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.166 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.45 -0.453 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 74.8 mtm -142.3 160.12 40.87 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -177.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.73 92.0 5.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.38 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.6 t -70.46 -12.74 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.2 m -52.45 -42.23 63.98 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 122.927 0.491 . . . . 0.0 112.208 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -66.27 -22.26 66.3 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.36 -24.69 62.14 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.093 0.406 . . . . 0.0 110.518 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.412 HD22 ' N ' ' A' ' 22' ' ' LEU . 3.8 mm? -84.06 -35.04 24.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -65.19 -22.78 66.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -176.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -74.02 -14.51 61.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.41 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 51' ' ' LEU . 57.0 t -78.44 128.12 78.71 Favored Pre-proline 0 N--CA 1.451 -0.402 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -55.28 138.87 80.61 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.377 2.718 . . . . 0.0 111.066 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.6 -19.6 51.73 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.1 t -75.48 129.62 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -122.52 -28.27 4.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -133.26 150.4 51.92 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.0 t -145.29 149.54 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -146.36 126.42 13.72 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -131.45 156.07 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.35 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.4 t -129.2 102.91 6.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.56 -18.69 64.13 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.06 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -78.6 -29.79 46.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -100.36 -11.16 20.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.748 -0.093 . . . . 0.0 110.748 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.28 20.92 67.88 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -101.49 158.49 16.03 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.925 0.362 . . . . 0.0 110.463 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.1 110.7 5.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.483 HD11 ' HG3' ' A' ' 3' ' ' LYS . 2.9 mm? -101.07 152.65 20.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.64 162.23 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 175.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -142.23 86.46 1.97 Allowed 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.62 -173.54 26.17 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -177.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.8 p -112.59 28.1 9.06 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.623 0.369 . . . . 0.0 110.496 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.03 168.01 20.82 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -78.67 138.57 58.35 Favored Pre-proline 0 N--CA 1.45 -0.47 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -55.41 -36.44 93.99 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.266 2.644 . . . . 0.0 111.928 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -76.23 -32.7 59.04 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 121.387 -0.125 . . . . 0.0 110.72 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.35 -33.2 71.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.461 ' HA ' HG21 ' A' ' 25' ' ' VAL . 9.7 tp -65.9 -55.76 15.25 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.539 0.209 . . . . 0.0 110.757 -178.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 50.5 t -68.14 -22.96 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.738 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -75.9 -37.14 59.12 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.899 -0.321 . . . . 0.0 110.245 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.2 -47.72 83.19 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.332 0.11 . . . . 0.0 110.815 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.5 m -73.03 -25.1 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.875 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -76.07 -23.47 55.04 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -70.25 -24.98 63.16 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -79.76 -10.73 59.82 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.3 7.23 59.51 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -115.32 98.6 6.85 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -61.79 158.95 14.65 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -155.1 78.83 1.04 Allowed 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.96 139.23 40.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -58.15 137.4 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 122.612 0.365 . . . . 0.0 110.569 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 5' ' ' LYS . 85.8 mt -83.98 76.1 10.08 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.06 -1.448 . . . . 0.0 109.337 179.351 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 30.9 mt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -161.71 79.62 0.56 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -171.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.0 mp -80.13 125.39 29.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.721 -0.612 . . . . 0.0 111.838 -164.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -101.14 89.07 3.67 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 172.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.32 115.46 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 122.889 0.476 . . . . 0.0 110.47 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -70.75 148.41 47.97 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.26 0.624 . . . . 0.0 109.882 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.625 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.013 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 11.1 mmm -140.7 160.17 40.62 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.44 110.17 16.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.88 0.472 . . . . 0.0 111.247 -178.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.2 t -91.04 -16.52 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 31.6 m -55.78 -43.57 76.9 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -174.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.66 -21.6 66.1 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.305 -0.247 . . . . 0.0 111.23 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.69 -27.44 60.4 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.854 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 22' ' ' LEU . 4.1 mm? -84.88 -33.47 22.8 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.864 0.302 . . . . 0.0 111.77 -176.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -62.85 -21.7 66.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -173.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -78.03 -18.42 55.88 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -173.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.3 t -78.88 130.67 69.46 Favored Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-N 118.976 0.807 . . . . 0.0 110.224 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -55.27 141.89 80.03 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 124.071 3.181 . . . . 0.0 111.56 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.16 -21.87 39.81 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.2 t -71.29 127.68 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.24 -27.54 3.8 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.437 0.162 . . . . 0.0 111.437 -177.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -133.82 152.63 51.93 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.3 t -143.02 147.09 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.24 129.44 14.62 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.4 m -130.93 155.99 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 117.959 0.345 . . . . 0.0 110.624 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.1 t -129.4 101.32 5.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.7 mt -64.47 -20.05 65.94 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.234 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -82.3 -31.47 29.96 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 110.666 -0.124 . . . . 0.0 110.666 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -101.86 -10.03 20.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.35 21.92 78.58 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -98.95 155.56 17.35 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.589 0.694 . . . . 0.0 109.933 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.14 108.56 4.83 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.6 mm? -104.18 150.31 24.48 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.39 162.79 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 173.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -139.01 86.23 2.12 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.63 -171.01 20.35 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.8 p -115.8 28.1 8.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 122.851 0.46 . . . . 0.0 110.227 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.35 159.31 32.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 38.8 m-20 -83.82 152.77 63.39 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 47' ' ' ASP . 52.5 Cg_exo -60.24 -36.68 87.16 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.536 2.824 . . . . 0.0 112.121 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.437 ' HG2' ' H ' ' A' ' 49' ' ' LYS . 20.5 pttt -69.65 -19.65 63.61 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 119.744 -0.169 . . . . 0.0 110.758 -175.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.64 -34.79 15.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.168 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 tp -75.21 -49.48 19.24 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.911 -0.315 . . . . 0.0 111.666 -174.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.07 -25.82 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 121.201 -0.2 . . . . 0.0 110.878 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -80.95 -32.02 34.69 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.09 -45.32 94.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.538 0.335 . . . . 0.0 111.219 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.0 m -71.78 -24.03 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.004 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.4 ' OE2' ' HE2' ' A' ' 61' ' ' LYS . 50.1 tt0 -75.13 -20.95 59.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.83 -23.73 63.35 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -88.36 -7.93 55.88 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.82 12.73 49.23 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -128.15 100.82 6.0 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.94 0.87 . . . . 0.0 112.045 -175.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HE2' ' OE2' ' A' ' 56' ' ' GLU . 98.9 mttt -71.1 167.15 19.9 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -160.55 117.26 2.39 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.84 119.23 14.68 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.643 0.377 . . . . 0.0 110.913 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.2 m -59.41 117.55 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.8 mt -82.39 31.8 0.4 Allowed 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.747 0.419 . . . . 0.0 110.005 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.341 -1.314 . . . . 0.0 109.165 179.567 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 45.7 mt . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -161.64 81.15 0.58 Allowed 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 -173.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.0 mp -79.97 109.43 14.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.827 -0.546 . . . . 0.0 112.007 -166.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -83.43 90.16 7.15 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 171.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.9 t -62.05 109.65 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -70.4 146.02 50.69 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.189 0.596 . . . . 0.0 110.208 -178.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.577 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 178.96 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 11.2 mmm -137.03 160.68 38.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.231 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.05 110.45 16.59 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.995 0.518 . . . . 0.0 110.145 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.1 t -95.94 -21.02 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.9 m -56.49 -40.91 75.74 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.186 -0.321 . . . . 0.0 111.73 -176.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.54 -21.52 66.71 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 119.524 -0.274 . . . . 0.0 111.566 -177.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.99 -27.02 39.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.07 0.395 . . . . 0.0 110.689 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.44 HD12 HD11 ' A' ' 51' ' ' LEU . 3.1 mm? -85.52 -34.41 21.55 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 121.161 -0.216 . . . . 0.0 110.67 -177.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -62.55 -22.2 66.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.474 0.175 . . . . 0.0 111.474 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -79.6 -13.98 59.14 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 119.633 -0.223 . . . . 0.0 111.57 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 54.2 t -79.32 126.48 81.25 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 64.3 Cg_exo -56.67 140.9 91.49 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.682 2.921 . . . . 0.0 111.513 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.67 -21.69 39.79 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.862 -0.495 . . . . 0.0 111.862 176.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.69 129.66 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -27.47 4.75 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 121.284 -0.167 . . . . 0.0 111.05 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -133.18 153.08 51.86 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 174.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.0 t -143.06 147.42 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.96 128.52 15.07 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.71 153.84 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.904 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.2 t -131.46 100.81 5.28 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.6 mt -64.97 -19.0 65.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 121.92 0.088 . . . . 0.0 110.952 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -82.03 -31.24 31.06 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -103.05 -10.18 19.12 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.55 22.36 79.02 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -98.56 155.15 17.43 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 117.618 0.709 . . . . 0.0 109.889 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.69 108.38 4.01 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.3 mm? -108.4 150.74 26.96 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.4 m -135.64 163.1 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 174.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -138.1 93.36 2.75 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.46 -172.8 29.29 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.7 p -111.27 28.59 8.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 122.87 0.468 . . . . 0.0 109.957 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.25 173.35 9.6 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 27.9 m-20 -104.03 153.57 38.77 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 47' ' ' ASP . 57.4 Cg_exo -58.58 -36.96 96.61 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.481 2.787 . . . . 0.0 112.179 -178.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.435 ' HG2' ' H ' ' A' ' 49' ' ' LYS . 21.0 pttt -68.68 -21.03 64.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.513 -0.18 . . . . 0.0 110.513 -176.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.43 -34.27 14.91 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 121.239 -0.184 . . . . 0.0 110.725 -178.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.44 HD11 HD12 ' A' ' 22' ' ' LEU . 9.5 tp -74.68 -47.74 29.97 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.28 -176.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.0 t -68.1 -35.72 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -69.23 -31.85 70.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.46 -55.05 38.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 121.946 0.098 . . . . 0.0 110.932 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.8 -23.92 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 121.181 -0.208 . . . . 0.0 110.698 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -73.56 -23.71 60.0 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -70.6 -24.41 62.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -83.91 -7.82 59.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.19 8.53 57.68 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -125.14 94.98 4.32 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 117.829 0.814 . . . . 0.0 111.04 -176.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -67.33 168.24 10.98 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -158.18 113.71 2.7 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -67.8 120.36 14.01 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.689 0.395 . . . . 0.0 110.818 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.404 ' C ' ' H ' ' A' ' 66' ' ' ALA . 14.4 m -60.09 111.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 172.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.7 mt -80.66 33.41 0.31 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.404 ' H ' ' C ' ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 117.298 -1.334 . . . . 0.0 108.937 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 74.0 mt . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.69 0.281 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -159.97 77.74 0.66 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -177.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.71 113.52 16.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -165.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 72.3 tttt -79.39 84.95 5.24 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.196 0.998 . . . . 0.0 108.36 173.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.59 108.93 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -71.09 148.62 47.31 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.956 0.502 . . . . 0.0 110.149 -178.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.624 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.999 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.5 mmt -140.57 159.79 41.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.69 90.3 5.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.7 t -69.14 -21.23 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.1 m -55.82 -37.27 68.44 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 122.335 0.254 . . . . 0.0 111.297 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.97 -22.42 66.8 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 119.597 -0.24 . . . . 0.0 111.336 -177.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.15 -24.26 32.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.023 0.374 . . . . 0.0 110.916 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.15 -48.13 12.54 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -66.33 -22.98 66.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -171.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -73.44 -15.49 61.34 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 118.255 0.48 . . . . 0.0 112.012 -176.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.3 t -76.96 129.35 78.93 Favored Pre-proline 0 N--CA 1.45 -0.426 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.85 140.51 47.79 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.473 2.782 . . . . 0.0 111.582 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.63 -20.82 44.59 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -78.77 130.97 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -125.15 -30.19 3.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -134.81 149.45 50.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.1 t -145.27 148.17 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -146.68 120.22 9.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.403 HG12 ' HA ' ' A' ' 40' ' ' ALA . 5.3 m -131.11 156.07 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.2 t -128.34 101.56 6.28 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.8 mt -63.83 -16.1 60.46 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.328 0.651 . . . . 0.0 112.124 -174.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -75.58 -36.51 60.33 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.207 0.458 . . . . 0.0 111.576 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -104.54 -8.19 19.2 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.784 0.265 . . . . 0.0 111.662 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.64 22.82 68.8 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.466 -0.63 . . . . 0.0 113.603 175.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.37 155.86 17.02 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.342 1.071 . . . . 0.0 108.825 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.403 ' HA ' HG12 ' A' ' 33' ' ' VAL . . . -146.52 110.17 4.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.4 mm? -104.55 153.27 21.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.23 162.01 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -138.75 79.23 1.72 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 177.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.56 -170.78 20.04 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.5 p -115.11 28.05 8.97 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.742 0.417 . . . . 0.0 110.589 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.46 172.16 13.01 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.434 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 6.1 t70 -102.5 140.68 21.33 Favored Pre-proline 0 N--CA 1.453 -0.297 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -177.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 47' ' ' ASP . 74.8 Cg_exo -50.68 -36.61 51.45 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 124.416 3.41 . . . . 0.0 115.357 -175.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.421 ' HG2' ' H ' ' A' ' 49' ' ' LYS . 21.2 pttt -69.49 -18.09 63.66 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.686 0.676 . . . . 0.0 110.69 -175.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.89 -34.42 16.08 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.691 -0.403 . . . . 0.0 111.498 -175.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.9 tp -70.87 -50.4 35.6 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.802 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.8 t -68.27 -22.95 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.269 -176.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -86.77 -34.33 19.64 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.011 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.33 94.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.848 -0.16 . . . . 0.0 110.634 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.81 -23.64 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.513 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.403 ' OE2' ' HE2' ' A' ' 61' ' ' LYS . 35.3 tt0 -74.71 -21.84 59.16 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -69.37 -23.46 63.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -93.2 -5.91 48.97 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.81 6.45 59.36 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -116.52 90.1 3.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.705 0.752 . . . . 0.0 110.776 -177.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.403 ' HE2' ' OE2' ' A' ' 56' ' ' GLU . 99.6 mttt -68.57 165.74 18.53 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 5' ' ' LYS . . . -158.12 117.03 3.14 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.51 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -73.89 111.62 9.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.113 0.565 . . . . 0.0 110.845 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -58.65 136.47 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.9 mt -94.3 32.16 1.59 Allowed 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.278 -0.264 . . . . 0.0 111.174 -178.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 116.972 -1.489 . . . . 0.0 109.308 177.782 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 58.1 mt . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -156.91 78.81 0.91 Allowed 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 -174.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.2 mp -80.46 106.63 12.62 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -163.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -80.58 84.54 6.14 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 171.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.2 t -66.29 132.54 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 O-C-N 122.522 -0.111 . . . . 0.0 110.713 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -88.58 142.97 27.26 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.716 0 CA-C-O 119.656 -0.525 . . . . 0.0 112.047 -178.692 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 60.6 mtt -136.54 160.19 39.51 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.21 93.03 9.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.4 t -66.85 -12.42 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.1 m -50.14 -39.34 42.98 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.132 0.573 . . . . 0.0 111.674 -177.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -63.31 -22.74 67.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -176.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.84 -25.51 32.54 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 117.902 0.319 . . . . 0.0 110.616 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 22' ' ' LEU . 3.3 mm? -82.46 -32.85 28.7 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 -176.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -64.5 -23.25 67.21 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -77.05 -11.98 59.88 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.612 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.1 t -78.84 129.72 72.66 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.61 136.38 73.84 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.398 2.732 . . . . 0.0 111.226 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.92 -20.9 39.64 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.98 128.75 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -125.37 -26.34 3.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -131.88 152.1 51.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.7 t -140.44 148.56 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -144.14 86.93 1.86 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.5 m -96.12 155.5 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.5 t -128.2 100.72 5.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.8 mt -64.54 -19.24 65.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.144 -174.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -83.3 -27.2 29.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -97.82 -11.44 23.29 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 119.806 -0.14 . . . . 0.0 111.167 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.08 20.55 74.91 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -109.12 156.18 20.13 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.32 110.23 6.46 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.4 mm? -109.66 151.49 26.81 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.402 HG11 HD11 ' A' ' 51' ' ' LEU . 33.7 m -133.47 166.08 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -134.22 84.66 2.13 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.6 -172.27 23.73 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -176.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.1 p -112.73 29.32 8.04 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.643 0.777 . . . . 0.0 110.525 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.65 172.7 11.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.583 0.23 . . . . 0.0 110.724 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -103.06 157.88 32.87 Favored Pre-proline 0 N--CA 1.453 -0.308 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -57.76 -39.47 87.1 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.585 2.856 . . . . 0.0 112.352 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 pttt -72.41 -17.11 61.83 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.116 -176.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.8 -37.76 13.43 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.298 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.437 HD11 HD12 ' A' ' 22' ' ' LEU . 9.5 tp -76.25 -49.66 16.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.033 -176.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.71 -24.92 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 116.982 -0.099 . . . . 0.0 110.736 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -83.71 -29.81 27.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.92 -46.41 89.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.52 -23.84 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -74.06 -21.03 60.09 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -68.87 -23.34 64.2 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -92.53 -6.04 50.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.88 9.32 57.42 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -121.54 92.88 3.84 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.801 0.8 . . . . 0.0 111.546 -175.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.95 169.46 4.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -153.54 117.53 4.79 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.733 0.301 . . . . 0.0 110.608 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -71.59 110.51 6.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.492 0.717 . . . . 0.0 110.819 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -58.26 113.86 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.0 mt -82.87 34.62 0.45 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.443 0.297 . . . . 0.0 110.532 -177.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 116.885 -1.531 . . . . 0.0 109.615 -179.2 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 64.2 mt . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.496 ' HE2' ' OE1' ' A' ' 39' ' ' GLU . 82.2 tttt -156.21 81.25 0.99 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -175.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.3 mp -75.73 102.57 5.46 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.955 -167.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -85.48 102.86 13.84 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.4 t -65.24 135.88 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 123.271 0.628 . . . . 0.0 110.814 -177.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -77.36 146.96 36.37 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.549 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.209 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -137.7 158.98 43.23 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.409 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . . . -78.11 93.61 4.56 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.4 t -66.35 -15.3 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.9 m -54.43 -35.67 63.18 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.201 0.6 . . . . 0.0 110.788 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.409 ' HE3' ' HB3' ' A' ' 17' ' ' ALA . 96.6 mttt -58.58 -26.32 63.5 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 119.727 -0.177 . . . . 0.0 111.337 -177.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.69 -25.97 28.04 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 117.735 0.243 . . . . 0.0 110.71 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 22' ' ' LEU . 3.1 mm? -83.52 -34.7 25.24 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -177.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -63.22 -22.04 66.61 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -73.37 -12.06 60.69 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 122.483 -0.135 . . . . 0.0 111.221 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.404 HG12 ' HB2' ' A' ' 46' ' ' ALA . 69.4 t -78.9 130.86 68.84 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -56.06 129.69 36.25 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.997 3.131 . . . . 0.0 112.226 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.33 -26.34 12.09 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 112.156 -0.377 . . . . 0.0 112.156 174.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.523 ' HA ' ' HA3' ' A' ' 44' ' ' GLY . 61.1 t -71.91 129.14 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -126.94 -23.46 3.64 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.825 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -128.33 151.59 49.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.6 t -144.38 151.51 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -140.17 96.12 3.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.7 m -96.4 156.04 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.407 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.0 t -127.54 102.13 6.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.8 mt -64.4 -18.97 65.19 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.753 -174.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -83.71 -30.63 26.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 117.821 0.282 . . . . 0.0 110.727 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -98.26 -13.82 20.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 121.53 -0.068 . . . . 0.0 110.82 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.9 19.61 65.73 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.496 ' OE1' ' HE2' ' A' ' 3' ' ' LYS . 98.9 mt-10 -102.1 157.39 16.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -178.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.29 118.95 9.15 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.661 0.267 . . . . 0.0 110.337 -177.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 41' ' ' LEU . 3.2 mm? -101.77 152.7 20.56 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -133.85 164.49 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.708 0.289 . . . . 0.0 111.01 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -138.67 99.35 3.79 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.523 ' HA3' ' HA ' ' A' ' 28' ' ' VAL . . . -160.74 -175.14 31.43 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.8 p -112.42 25.52 11.42 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.546 0.338 . . . . 0.0 110.226 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.404 ' HB2' HG12 ' A' ' 25' ' ' VAL . . . -77.5 170.12 17.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 122.415 -0.178 . . . . 0.0 110.956 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -88.2 156.64 51.46 Favored Pre-proline 0 N--CA 1.452 -0.356 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -56.16 -37.02 97.22 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.551 2.834 . . . . 0.0 112.468 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -70.04 -41.15 74.61 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.284 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.86 -31.32 66.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -176.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.403 HD11 HD12 ' A' ' 22' ' ' LEU . 12.2 tp -73.22 -60.73 2.1 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 111.461 0.171 . . . . 0.0 111.461 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.1 t -69.57 -23.06 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 122.192 0.197 . . . . 0.0 111.481 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -79.02 -34.75 43.68 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.67 -55.12 37.0 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.807 -0.179 . . . . 0.0 110.882 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.63 -24.56 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -72.61 -37.41 68.1 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -72.21 -23.25 61.21 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -75.36 -4.48 39.57 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 176.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.8 4.1 58.01 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 119.246 -0.752 . . . . 0.0 113.055 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -135.22 114.11 11.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.578 1.189 . . . . 0.0 111.072 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.27 169.17 2.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -155.91 100.08 2.02 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.527 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -69.68 106.28 3.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.951 0.5 . . . . 0.0 111.58 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.7 m -58.78 106.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 174.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.8 mt -80.62 76.95 7.48 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 116.87 -1.538 . . . . 0.0 109.512 -178.267 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 75.6 mt . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -159.65 76.58 0.67 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -176.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.5 mp -78.43 122.78 26.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.693 0.282 . . . . 0.0 111.451 -166.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -99.48 91.37 4.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.6 130.09 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 122.469 0.308 . . . . 0.0 110.555 -175.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -78.37 146.86 34.39 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.638 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.998 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -135.89 159.64 41.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.24 95.95 2.2 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.8 t -67.74 -13.8 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.4 m -54.01 -36.35 62.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.7 0.4 . . . . 0.0 110.438 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -59.22 -23.4 62.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 119.773 -0.156 . . . . 0.0 111.078 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.26 -32.95 26.15 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.52 -36.42 60.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -66.5 -21.43 66.18 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -174.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -78.26 -17.14 57.06 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 54.7 t -78.64 128.06 78.44 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.845 -177.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 69.8 Cg_exo -55.44 141.43 82.24 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.703 2.935 . . . . 0.0 111.465 177.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.57 -22.6 32.32 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.7 t -76.29 129.97 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -124.69 -27.02 3.72 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -132.78 149.55 52.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.8 t -145.81 149.68 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -146.23 126.69 14.09 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 m -129.18 154.63 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-O 120.801 0.334 . . . . 0.0 110.52 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.5 t -128.27 104.6 7.83 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.9 mt -64.07 -23.32 67.28 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 122.593 0.357 . . . . 0.0 111.93 -173.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -84.68 -41.67 16.05 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 118.269 0.486 . . . . 0.0 110.544 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -82.48 -10.99 58.79 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.789 -0.187 . . . . 0.0 110.685 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.58 21.71 67.19 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -99.1 156.63 16.85 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 117.634 0.717 . . . . 0.0 110.257 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.85 108.47 4.0 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.461 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.9 mm? -100.58 149.16 24.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.3 m -135.93 162.31 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -139.15 95.49 2.95 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.34 -175.75 33.7 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -177.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.0 p -106.02 26.71 9.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 122.681 0.392 . . . . 0.0 110.515 -178.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.03 170.69 15.79 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -92.92 156.52 40.5 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.14 -50.69 12.22 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.872 3.048 . . . . 0.0 112.204 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -70.47 -30.48 67.31 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 121.126 -0.23 . . . . 0.0 110.889 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.01 -33.48 75.91 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.8 tp -74.11 -52.6 12.1 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.486 0.184 . . . . 0.0 110.61 -177.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.61 -25.46 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.813 -0.176 . . . . 0.0 111.3 -177.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -72.06 -33.14 67.73 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.083 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.25 -49.44 75.71 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.155 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 m -72.78 -23.59 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 117.705 0.229 . . . . 0.0 110.853 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -69.13 -34.11 74.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -70.85 -23.18 62.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -80.61 -8.08 59.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.86 12.56 52.62 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.569 -0.613 . . . . 0.0 111.569 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -124.51 111.17 15.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 117.777 0.788 . . . . 0.0 111.114 -176.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.72 165.62 8.14 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -162.66 79.57 0.49 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.646 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -71.35 127.92 34.18 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -60.73 135.29 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 175.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.4 mt -108.46 59.48 0.61 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.057 0 CA-C-O 117.042 -1.456 . . . . 0.0 108.944 -179.125 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.2 mt . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 40.0 tttt -161.8 77.46 0.52 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -175.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.5 mp -79.08 122.51 26.31 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 121.83 -0.544 . . . . 0.0 111.77 -166.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -100.15 92.95 5.46 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 175.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.6 t -65.56 132.52 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 122.772 0.429 . . . . 0.0 111.567 -174.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -80.06 144.38 33.22 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.537 0.735 . . . . 0.0 109.751 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.621 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 178.182 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 120.658 0.266 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -129.55 161.53 30.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.9 91.14 0.45 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.88 -14.15 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.4 m -54.28 -36.89 64.14 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.013 0.525 . . . . 0.0 110.5 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.71 -29.25 67.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 121.357 -0.137 . . . . 0.0 111.198 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.43 -24.43 50.39 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 117.622 0.192 . . . . 0.0 110.807 -177.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.48 -39.08 20.97 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.8 tttt -67.82 -22.13 65.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -173.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -73.28 -17.78 61.28 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.657 0.662 . . . . 0.0 111.743 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 60.6 t -76.25 128.71 82.08 Favored Pre-proline 0 N--CA 1.449 -0.492 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 82.3 Cg_exo -52.26 139.92 53.04 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.67 2.913 . . . . 0.0 111.691 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.88 -21.56 35.95 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 177.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -77.48 116.36 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -116.48 -24.17 7.96 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.15 148.9 51.14 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -145.89 148.25 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -146.89 120.9 9.38 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 m -131.63 155.9 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.649 -177.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.6 t -129.41 104.03 7.25 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.8 mt -64.19 -18.5 64.54 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.576 0.35 . . . . 0.0 111.081 -176.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -84.22 -29.97 26.1 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 117.462 0.119 . . . . 0.0 111.029 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -100.04 -10.6 21.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 121.924 0.09 . . . . 0.0 111.06 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.33 19.4 70.47 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -100.72 154.94 18.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.35 119.17 7.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.485 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.3 mm? -117.12 151.73 36.23 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -178.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.87 162.44 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -139.16 84.7 2.02 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.7 -177.45 29.85 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.9 p -93.31 28.09 2.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.037 0.535 . . . . 0.0 110.708 -178.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.05 173.97 10.0 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 122.375 -0.203 . . . . 0.0 111.063 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -107.12 156.62 37.15 Favored Pre-proline 0 N--CA 1.452 -0.337 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -56.92 -52.79 6.02 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.728 2.952 . . . . 0.0 112.906 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -71.3 -32.49 68.69 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 121.124 -0.231 . . . . 0.0 110.898 -176.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.2 -33.13 75.06 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.6 tp -71.93 -51.52 21.72 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.976 -178.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.5 t -68.94 -27.93 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 121.379 -0.128 . . . . 0.0 111.007 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -67.97 -33.18 74.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.17 -55.82 21.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.075 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.26 -23.61 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -175.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.18 -34.82 68.73 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 120.601 -0.439 . . . . 0.0 109.841 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -71.55 -23.46 61.76 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -74.83 -8.48 56.57 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.24 12.55 51.5 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -127.69 98.41 5.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 117.115 0.458 . . . . 0.0 110.347 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -62.4 161.55 11.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -161.5 92.81 0.9 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.107 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -77.82 129.42 35.4 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -60.94 135.02 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.401 ' H ' ' HB3' ' A' ' 3' ' ' LYS . 80.1 mt -109.34 31.33 5.84 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.5 0.32 . . . . 0.0 110.217 177.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.494 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 116.752 -1.594 . . . . 0.0 109.179 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.505 ' HG2' ' H ' ' A' ' 2' ' ' LEU . 9.5 ttm . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.505 ' H ' ' HG2' ' A' ' 1' ' ' MET . 72.5 mt -117.44 150.97 38.02 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.084 0.402 . . . . 0.0 110.932 -176.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -164.47 79.38 0.37 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 -177.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 mp -79.27 108.91 13.13 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.824 -0.547 . . . . 0.0 112.084 -164.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -78.74 87.0 4.65 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.7 t -63.38 109.05 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -70.82 147.94 48.38 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 122.887 0.475 . . . . 0.0 110.208 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.27 66.45 2.4 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 94.1 mtp -67.55 -36.93 81.92 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.341 0.256 . . . . 0.0 111.238 -176.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 46.7 p -138.81 166.04 25.46 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 83.2 m 48.44 36.2 6.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.034 0.534 . . . . 0.0 111.129 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -67.01 -10.81 53.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 121.857 0.063 . . . . 0.0 110.922 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -82.91 -8.84 59.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.6 m -130.05 -169.71 2.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.471 0.709 . . . . 0.0 109.335 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.8 p -139.88 154.18 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.5 mmt -140.38 161.24 38.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.63 127.14 35.87 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.416 HG12 ' CD2' ' A' ' 22' ' ' LEU . 22.9 t -96.63 -13.38 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.0 m -53.39 -41.43 65.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -67.32 -22.43 65.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.863 0.301 . . . . 0.0 111.697 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.05 -34.83 59.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.039 0.381 . . . . 0.0 110.871 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.416 ' CD2' HG12 ' A' ' 18' ' ' VAL . 3.8 mm? -74.3 -38.61 63.31 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -173.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -65.68 -22.07 66.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -174.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.31 -18.68 65.5 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.898 -176.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 55.1 t -80.21 129.92 67.87 Favored Pre-proline 0 N--CA 1.451 -0.423 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 72.2 Cg_exo -52.88 140.67 57.67 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.634 2.889 . . . . 0.0 111.504 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.52 -21.26 41.89 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.1 t -78.05 127.91 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.77 -24.53 3.23 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 110.638 -0.134 . . . . 0.0 110.638 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -128.05 147.0 50.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.7 t -146.12 146.62 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -149.11 131.1 15.28 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -126.81 156.13 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.3 t -128.41 101.05 6.03 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.27 -22.34 66.84 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.316 -175.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -84.92 -29.04 25.48 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.555 0.162 . . . . 0.0 111.151 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -97.85 -9.84 25.71 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.412 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.22 23.1 78.47 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -114.76 158.16 22.23 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 117.723 0.762 . . . . 0.0 110.913 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.95 110.82 6.22 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.045 0.938 . . . . 0.0 109.121 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.497 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.4 mm? -108.35 150.7 26.99 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.7 m -134.73 164.38 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -139.03 89.27 2.34 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.22 -173.99 23.08 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.0 p -113.43 28.85 8.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.969 0.507 . . . . 0.0 110.517 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.89 170.23 16.35 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -80.32 155.55 74.27 Favored Pre-proline 0 N--CA 1.452 -0.366 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -59.11 -44.97 30.44 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.489 2.792 . . . . 0.0 112.091 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.1 pttt -75.08 -29.02 60.54 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.08 76.6 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 121.233 -0.187 . . . . 0.0 110.565 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.9 tp -73.28 -51.38 17.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.619 0.247 . . . . 0.0 110.567 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.7 -23.15 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.189 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -80.78 -33.83 34.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.69 96.34 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.231 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -71.76 -25.79 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.812 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -73.92 -21.33 60.09 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -68.92 -24.32 64.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -89.68 -7.47 54.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.35 9.06 57.15 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -122.89 95.68 4.72 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.705 0.753 . . . . 0.0 110.796 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -66.88 168.15 10.28 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -155.27 117.66 4.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.252 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.21 106.94 3.03 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.158 0.583 . . . . 0.0 111.349 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.21 110.04 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.4 mt -80.96 74.44 7.95 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 CA-C-O 117.368 -1.301 . . . . 0.0 109.726 -179.195 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.3 mt -59.58 136.62 58.04 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -147.54 83.96 1.55 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.35 170.03 9.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.346 0.594 . . . . 0.0 112.587 -173.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -151.4 96.65 2.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.61 1.164 . . . . 0.0 107.967 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 7' ' ' GLU . 33.4 t -59.77 170.9 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.483 ' N ' HG12 ' A' ' 6' ' ' VAL . 7.8 tp10 -125.43 150.97 46.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.14 -1.87 1.24 Allowed Glycine 0 CA--C 1.527 0.803 0 C-N-CA 123.701 0.667 . . . . 0.0 112.225 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.437 ' HE3' ' HA ' ' A' ' 9' ' ' MET . 6.1 tpt -69.22 -15.08 63.3 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 117.935 0.868 . . . . 0.0 110.015 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.0 p -86.96 174.38 8.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.5 m 50.35 9.0 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.168 0.987 . . . . 0.0 113.29 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -61.6 175.84 0.57 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.078 0.399 . . . . 0.0 110.501 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 -130.05 -7.67 4.38 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 70.9 m -143.12 84.26 1.82 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.4 HG22 ' N ' ' A' ' 16' ' ' MET . 10.7 p -56.85 164.68 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.271 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.4 ' N ' HG22 ' A' ' 15' ' ' VAL . 75.8 mtm -139.87 -175.33 4.18 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -122.93 95.67 4.71 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.476 ' C ' ' H ' ' A' ' 20' ' ' LYS . 13.0 t -65.43 -1.51 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 123.012 0.525 . . . . 0.0 110.034 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 m -63.79 6.61 0.15 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.322 0.649 . . . . 0.0 110.772 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.476 ' H ' ' C ' ' A' ' 18' ' ' VAL . 98.4 mttt -120.39 6.95 10.63 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.849 0.46 . . . . 0.0 110.756 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -118.51 -1.41 11.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 22' ' ' LEU . 2.7 mm? -122.81 -0.42 9.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -98.52 -12.73 20.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -85.26 -10.63 56.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.18 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -76.71 123.17 87.54 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.16 166.48 2.26 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.306 2.671 . . . . 0.0 111.207 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.81 -13.98 1.19 Allowed Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.412 -0.66 . . . . 0.0 112.54 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.8 t -79.27 159.3 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 118.373 1.087 . . . . 0.0 108.537 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -147.63 -18.56 0.37 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -146.25 163.58 35.01 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.2 t -150.92 152.6 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -144.82 152.83 40.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -153.11 178.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.5 t -147.16 102.25 3.48 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.15 -1.13 2.93 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.702 0.401 . . . . 0.0 111.745 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -116.6 1.64 12.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 117.986 0.357 . . . . 0.0 110.446 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -132.99 -10.07 3.01 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.8 -3.73 6.25 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -72.77 166.07 23.61 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 117.78 0.79 . . . . 0.0 109.883 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.413 ' C ' HD12 ' A' ' 41' ' ' LEU . . . -156.08 154.07 30.38 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.413 HD12 ' C ' ' A' ' 40' ' ' ALA . 5.3 mp -145.88 169.1 19.26 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.9 m -149.26 172.13 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -143.15 97.69 3.13 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -169.74 174.01 43.96 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.7 p -80.85 7.05 11.36 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.706 0.802 . . . . 0.0 111.844 -177.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.03 173.62 0.15 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.688 0.28 . . . . 0.0 111.084 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -122.96 162.57 38.36 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -60.19 -28.84 87.75 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.55 2.833 . . . . 0.0 111.923 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -88.18 3.32 49.75 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.398 0.279 . . . . 0.0 111.065 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.94 -0.68 6.59 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.7 tp -119.13 -0.74 11.01 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.1 t -124.09 -25.26 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -76.15 -12.69 60.15 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.87 -57.61 3.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.327 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.79 -24.02 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 110.546 -0.168 . . . . 0.0 110.546 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -79.4 -18.09 53.0 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -85.21 -20.21 30.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -83.76 -3.45 57.83 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 122.774 0.43 . . . . 0.0 110.184 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.75 2.35 72.44 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -134.0 81.93 1.95 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 117.517 0.659 . . . . 0.0 109.726 -178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -60.72 168.95 2.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 110.407 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -153.91 105.19 2.73 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -66.39 170.93 5.37 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.58 -178.86 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 120.878 0.371 . . . . 0.0 110.246 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.6 mt -136.71 5.24 2.87 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.966 0.906 . . . . 0.0 108.843 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 117.043 -1.456 . . . . 0.0 108.976 179.527 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ttm . . . . . 0 N--CA 1.47 0.575 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 77.8 mt -86.73 152.92 22.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -155.12 79.41 1.05 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -174.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.1 mp -77.73 103.84 7.91 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.269 -163.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -80.68 100.52 8.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 171.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.9 t -60.28 147.8 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.312 1.045 . . . . 0.0 111.427 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -58.93 162.54 4.09 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.189 1.395 . . . . 0.0 107.999 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.68 44.31 0.37 Allowed Glycine 0 CA--C 1.526 0.772 0 CA-C-O 119.67 -0.517 . . . . 0.0 114.039 -168.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.587 ' CG ' ' CG ' ' A' ' 60' ' ' TYR . 95.8 mtp -63.1 -28.96 70.43 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.341 -0.506 . . . . 0.0 110.302 169.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 67.4 p -81.18 155.78 26.01 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -164.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.9 m 46.06 26.99 0.47 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.627 1.971 . . . . 0.0 113.844 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.532 ' CG ' ' H ' ' A' ' 13' ' ' HIS . 15.5 p-10 -90.66 -59.98 2.04 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 116.595 -2.042 . . . . 0.0 109.131 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.532 ' H ' ' CG ' ' A' ' 12' ' ' ASN . 75.2 m-70 -126.71 -37.41 2.15 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 122.989 0.516 . . . . 0.0 110.413 167.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.6 m -134.26 -169.47 2.33 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 114.766 -1.106 . . . . 0.0 113.489 -166.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.43 156.32 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 125.714 1.606 . . . . 0.0 107.859 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.8 mtt -140.97 159.89 41.25 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.01 88.34 7.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.9 t -69.81 -14.57 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 122.493 0.317 . . . . 0.0 110.196 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -56.6 -39.59 73.83 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 122.264 -0.273 . . . . 0.0 110.808 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.65 -21.52 66.56 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 119.569 -0.253 . . . . 0.0 111.482 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.54 -39.78 51.84 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 117.852 0.297 . . . . 0.0 110.414 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 22' ' ' LEU . 3.9 mm? -75.87 -32.65 59.81 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -177.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -60.29 -21.42 61.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 112.611 0.596 . . . . 0.0 112.611 -174.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -79.7 -17.99 52.31 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 118.157 0.435 . . . . 0.0 111.623 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.0 t -70.98 128.02 91.07 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 117.751 0.25 . . . . 0.0 110.438 -174.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 46' ' ' ALA . 50.4 Cg_exo -58.47 137.23 79.21 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.444 2.763 . . . . 0.0 110.86 177.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.08 -25.06 15.42 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.439 ' HA ' ' HA3' ' A' ' 44' ' ' GLY . 54.7 t -72.58 129.62 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -126.24 -25.91 3.44 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.737 -0.21 . . . . 0.0 110.678 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -130.42 148.61 52.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.7 t -146.51 147.65 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -146.43 129.25 16.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.43 158.72 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 120.89 0.376 . . . . 0.0 111.613 -174.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.0 t -126.86 101.93 6.8 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.6 mt -63.89 -25.26 68.07 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -173.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -85.16 -30.04 24.27 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.588 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -99.38 -11.03 21.54 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -175.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.14 24.49 76.99 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -98.6 154.73 17.71 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.76 0.78 . . . . 0.0 109.577 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.32 109.85 4.43 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.444 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.481 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.9 mm? -100.25 139.12 36.38 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.33 162.97 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -139.0 101.33 4.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 28' ' ' VAL . . . -156.73 -175.68 27.94 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -177.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.4 p -114.61 26.04 10.53 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 122.898 0.479 . . . . 0.0 109.801 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 26' ' ' PRO . . . -76.22 167.88 21.06 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.713 -0.221 . . . . 0.0 110.613 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.15 144.53 71.66 Favored Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -56.01 -37.53 96.05 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.864 2.376 . . . . 0.0 111.457 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -75.62 -33.98 60.55 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.95 -33.64 76.02 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.41 HD11 HD12 ' A' ' 22' ' ' LEU . 11.5 tp -70.19 -50.44 40.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.66 -22.57 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -82.67 -32.28 28.21 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.48 -45.38 93.95 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.9 m -73.94 -23.89 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.099 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.405 ' OE2' ' HE2' ' A' ' 61' ' ' LYS . 42.6 tt0 -70.77 -19.6 62.69 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.02 -23.74 65.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -91.45 -13.57 32.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.85 10.37 57.71 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.587 ' CG ' ' CG ' ' A' ' 9' ' ' MET . 40.7 m-85 -131.12 88.18 2.57 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -175.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.405 ' HE2' ' OE2' ' A' ' 56' ' ' GLU . 88.5 mttt -64.44 178.47 0.72 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.612 0.765 . . . . 0.0 110.227 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -154.19 101.86 2.42 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.187 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -69.19 120.41 14.99 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.715 0.406 . . . . 0.0 110.918 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.7 m -59.06 130.02 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 175.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.5 mt -83.71 34.15 0.49 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 116.851 -1.547 . . . . 0.0 109.399 -178.792 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.9 mt -90.04 151.78 21.48 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.469 ' HG3' HD11 ' A' ' 41' ' ' LEU . 79.4 tttt -160.24 77.52 0.64 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.3 mp -81.14 127.24 32.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.532 0.333 . . . . 0.0 111.699 -166.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -99.75 96.01 7.32 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 t -66.35 107.42 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 123.228 0.611 . . . . 0.0 111.957 -175.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -78.14 148.32 34.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 174.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.63 67.82 1.11 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.6 mmt -69.92 -34.75 73.89 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 117.305 0.553 . . . . 0.0 110.858 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.3 p -136.33 162.78 32.06 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.2 m 44.72 33.76 1.03 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.232 0.613 . . . . 0.0 110.603 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -68.22 -13.34 62.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.15 0.58 . . . . 0.0 111.742 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -85.35 -8.59 58.38 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.9 m -129.67 -174.95 3.44 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.0 p -140.65 154.83 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 60.5 mtt -145.24 161.95 38.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.67 94.35 0.78 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.64 -13.35 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.5 m -54.64 -38.24 66.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 122.674 0.39 . . . . 0.0 110.7 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.56 -23.26 67.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.54 -0.267 . . . . 0.0 111.675 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.42 -22.79 40.86 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 117.729 0.241 . . . . 0.0 111.051 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.95 -33.49 16.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.503 0.138 . . . . 0.0 111.241 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -64.41 -26.57 68.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -169.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -81.18 -9.96 59.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 119.364 0.984 . . . . 0.0 111.801 -177.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.3 t -73.61 130.67 83.37 Favored Pre-proline 0 N--CA 1.452 -0.34 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.64 140.53 65.74 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.763 2.975 . . . . 0.0 112.172 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.16 -20.98 39.86 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 119.833 -0.426 . . . . 0.0 112.121 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.1 t -68.82 130.34 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 117.578 0.689 . . . . 0.0 109.463 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -120.24 -36.98 3.13 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 43' ' ' GLU . 97.8 mttt -134.44 155.72 49.83 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.4 t -135.12 148.78 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -144.0 104.15 4.11 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.1 m -125.27 155.54 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.3 t -128.36 101.33 6.17 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.88 -18.07 63.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.301 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -83.77 -30.83 26.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.206 0.203 . . . . 0.0 110.64 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -102.96 -10.47 18.96 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -176.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.23 20.44 75.04 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -102.2 155.37 18.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.98 121.38 9.65 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.469 HD11 ' HG3' ' A' ' 3' ' ' LYS . 2.8 mm? -118.58 153.62 33.95 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.94 166.57 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 30' ' ' LYS . 32.3 tt0 -135.81 89.55 2.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.83 177.55 38.87 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -177.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.9 p -95.28 26.88 3.54 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.188 0.595 . . . . 0.0 110.11 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.05 169.71 17.47 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -110.03 158.23 35.63 Favored Pre-proline 0 N--CA 1.452 -0.351 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -55.61 -46.0 35.24 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.82 3.013 . . . . 0.0 112.796 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -74.68 -13.93 60.68 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.405 -177.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.44 -35.49 15.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.219 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tp -76.44 -48.43 19.68 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.386 0.136 . . . . 0.0 111.11 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.7 t -68.29 -23.06 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 119.619 -0.229 . . . . 0.0 111.475 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -77.54 -37.61 50.47 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.104 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.65 -48.6 81.02 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.815 -0.175 . . . . 0.0 110.913 -176.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -72.32 -26.09 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.795 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -76.77 -28.57 55.74 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.598 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -70.24 -23.57 62.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -83.59 -4.48 58.6 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 177.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.99 7.5 58.55 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -115.18 90.94 3.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 117.298 0.549 . . . . 0.0 111.237 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -66.18 114.15 5.07 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.9 88.61 2.69 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.43 141.45 38.29 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.466 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.1 m -59.3 139.67 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 123.661 0.784 . . . . 0.0 111.167 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.08 28.04 2.96 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 116.98 -1.486 . . . . 0.0 109.561 -179.163 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ttm . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.411 HD12 HD22 ' A' ' 51' ' ' LEU . 67.1 mt -105.2 157.37 17.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.879 0.471 . . . . 0.0 110.251 -176.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -153.81 80.08 1.14 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.7 mp -77.85 108.04 10.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.677 -164.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 14.7 tmtt? -93.06 96.77 10.27 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 174.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.2 t -64.36 133.92 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -85.34 149.04 25.73 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.648 0.379 . . . . 0.0 110.114 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.31 62.65 1.75 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 59.9 mtt -67.37 -60.89 2.21 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 117.011 0.406 . . . . 0.0 111.508 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.2 p -135.6 166.3 23.55 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.565 0.221 . . . . 0.0 110.696 -176.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.9 m 46.61 32.75 1.77 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.451 0.701 . . . . 0.0 111.076 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -68.62 -9.58 50.72 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.203 0.201 . . . . 0.0 110.504 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -77.59 -8.22 57.53 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.4 m -129.01 -175.36 3.53 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.222 0.609 . . . . 0.0 109.48 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.8 p -137.71 155.35 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 58.4 mtt -139.27 161.31 37.75 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.58 89.65 2.75 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.8 t -74.44 -21.97 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.7 m -57.47 -39.23 75.93 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 122.37 -0.206 . . . . 0.0 110.549 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.56 -22.41 66.96 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 119.645 -0.216 . . . . 0.0 111.533 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.78 -38.94 37.24 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.471 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 22' ' ' LEU . 3.1 mm? -73.05 -32.45 65.07 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -63.02 -21.96 66.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -175.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -70.34 -14.99 62.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.211 0.46 . . . . 0.0 111.147 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 71.9 t -78.53 127.55 80.26 Favored Pre-proline 0 N--CA 1.451 -0.413 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -175.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 52.8 Cg_exo -58.63 140.4 94.71 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 123.462 2.775 . . . . 0.0 110.975 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.76 -20.85 42.44 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.996 -0.441 . . . . 0.0 111.996 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.33 128.26 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -110.62 -42.16 4.13 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -135.47 154.96 51.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.6 t -140.46 149.41 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -139.1 99.21 3.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 m -95.76 155.87 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.7 t -127.47 98.74 5.34 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.0 mt -66.66 -19.82 65.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -173.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -84.05 -32.21 24.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.443 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -103.43 -9.85 19.06 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 117.872 0.306 . . . . 0.0 111.223 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.81 21.73 76.68 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -98.66 155.04 17.52 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.04 125.6 10.28 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.986 0.422 . . . . 0.0 111.184 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.409 HD22 ' N ' ' A' ' 41' ' ' LEU . 3.2 mm? -107.54 153.06 23.41 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 175.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.4 m -132.38 164.7 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -137.28 88.98 2.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.61 -176.61 35.72 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.8 p -117.31 29.51 7.84 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.385 0.674 . . . . 0.0 109.893 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.22 167.08 21.92 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.805 0.336 . . . . 0.0 110.854 -176.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -76.77 149.58 80.74 Favored Pre-proline 0 N--CA 1.451 -0.425 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.079 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -55.45 -49.42 16.16 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.379 2.719 . . . . 0.0 112.185 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -74.79 -19.6 60.13 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.04 -34.81 71.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.919 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.411 HD22 HD12 ' A' ' 2' ' ' LEU . 10.0 tp -75.47 -43.66 48.25 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 83.0 t -65.25 -24.84 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 123.189 0.596 . . . . 0.0 111.816 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -87.27 -28.94 22.02 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.968 0.349 . . . . 0.0 111.176 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.91 -47.02 87.48 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 122.345 -0.222 . . . . 0.0 110.991 -177.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.89 -21.32 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -68.76 -21.02 64.38 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.44 -29.15 67.73 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -83.78 -9.37 58.84 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.59 11.13 48.54 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 119.619 -0.545 . . . . 0.0 111.74 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -128.72 142.54 50.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 117.758 0.779 . . . . 0.0 110.434 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -85.23 172.45 11.15 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 171.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 5' ' ' LYS . . . -149.54 77.51 1.34 Allowed 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.11 117.68 4.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.863 -175.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -57.45 126.0 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.749 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.5 mt -84.08 31.28 0.5 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.741 0.416 . . . . 0.0 109.93 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 117.239 -1.363 . . . . 0.0 110.199 -178.284 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.716 ' HG2' ' H ' ' A' ' 2' ' ' LEU . 9.7 ttt . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.716 ' H ' ' HG2' ' A' ' 1' ' ' MET . 60.2 mt -79.78 161.66 25.57 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.012 0.434 . . . . 0.0 110.437 -174.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -148.03 78.74 1.45 Allowed 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 -169.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -77.46 114.84 16.71 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.225 -164.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 75.8 tttt -96.1 98.82 10.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.296 1.039 . . . . 0.0 108.907 175.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.4 t -61.75 115.58 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 120.843 0.354 . . . . 0.0 110.19 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -69.96 151.77 45.22 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.446 0.698 . . . . 0.0 110.032 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.18 52.66 1.86 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 57.2 mtt -68.32 -38.55 81.66 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.55 0.675 . . . . 0.0 111.899 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.461 ' H ' ' HE2' ' A' ' 60' ' ' TYR . 68.8 p -139.47 163.04 33.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.298 0.499 . . . . 0.0 111.25 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 64.5 m 42.17 33.68 0.41 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.232 1.013 . . . . 0.0 113.004 173.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -69.38 -7.14 34.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.034 0.379 . . . . 0.0 110.859 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -76.48 -12.8 60.1 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.2 m -131.24 -175.13 3.59 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 122.945 0.498 . . . . 0.0 109.73 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 p -132.72 154.62 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 69.7 mtm -144.83 160.42 41.3 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.0 90.77 4.19 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.69 -13.5 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.8 m -52.91 -37.7 61.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.12 0.568 . . . . 0.0 110.792 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -64.2 -22.35 66.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -177.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.52 ' O ' ' HB1' ' A' ' 54' ' ' ALA . . . -82.15 -25.0 34.73 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 117.858 0.299 . . . . 0.0 110.994 -178.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.12 -33.52 24.3 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 117.455 0.116 . . . . 0.0 110.862 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -63.56 -22.5 66.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -71.09 -16.13 62.56 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.599 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.475 ' CG2' ' HB2' ' A' ' 54' ' ' ALA . 72.5 t -80.32 127.31 76.69 Favored Pre-proline 0 N--CA 1.45 -0.433 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.64 141.22 97.38 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.651 2.901 . . . . 0.0 111.232 177.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.8 -19.62 50.39 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.855 -0.498 . . . . 0.0 111.855 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.0 t -74.14 123.41 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 117.387 0.593 . . . . 0.0 109.426 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -129.41 -26.67 2.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -130.6 132.12 45.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.262 0.553 . . . . 0.0 110.139 176.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 83.9 t -144.73 147.72 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -136.43 122.84 20.7 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 m -130.56 156.23 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.145 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.5 t -126.86 102.45 7.03 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.5 mt -62.71 -18.05 61.81 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.101 0.56 . . . . 0.0 111.486 -174.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -84.58 -31.46 24.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 117.597 0.181 . . . . 0.0 111.244 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -102.16 -10.39 19.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.55 21.68 77.72 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -100.3 155.64 17.67 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 117.726 0.763 . . . . 0.0 109.437 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.26 115.1 6.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.509 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.487 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.7 mm? -97.48 152.01 19.42 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.87 150.51 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -141.29 62.66 1.46 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.2 -176.83 14.57 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.3 p -98.65 26.49 5.56 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.804 0.842 . . . . 0.0 111.104 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.12 164.9 25.66 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.795 0.331 . . . . 0.0 111.097 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -82.32 135.61 47.05 Favored Pre-proline 0 N--CA 1.451 -0.413 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -56.04 -35.49 94.78 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.268 2.645 . . . . 0.0 111.833 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -74.85 -28.45 60.68 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 122.17 0.188 . . . . 0.0 111.203 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.92 -33.59 45.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 tp -64.92 -45.36 86.17 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.07 -23.28 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 122.693 0.397 . . . . 0.0 110.617 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -87.52 -29.0 21.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 122.401 -0.187 . . . . 0.0 110.989 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.52 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -58.29 -47.27 84.19 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 122.376 -0.202 . . . . 0.0 111.104 -178.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.2 m -72.37 -20.86 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -69.42 -21.29 63.76 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -69.47 -25.35 64.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -84.04 -9.73 58.41 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.03 15.38 39.2 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 178.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.461 ' HE2' ' H ' ' A' ' 10' ' ' THR . 64.9 m-85 -130.54 144.49 51.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 117.581 0.69 . . . . 0.0 111.509 -176.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -80.16 175.28 10.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 168.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 5' ' ' LYS . . . -148.05 78.32 1.44 Allowed 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 174.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -53.61 107.6 0.27 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.456 0.702 . . . . 0.0 111.297 -175.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.422 HG11 HD22 ' A' ' 2' ' ' LEU . 35.8 m -58.19 110.42 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 123.871 0.868 . . . . 0.0 110.03 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.7 mt -84.04 35.34 0.53 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.084 0 CA-C-O 117.091 -1.433 . . . . 0.0 109.97 -178.061 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ttm . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.1 mt -90.56 149.31 22.21 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -167.14 78.78 0.19 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -174.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.4 mp -77.87 124.65 28.26 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.894 -0.503 . . . . 0.0 112.324 -165.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -101.33 90.29 4.05 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.5 t -68.15 134.33 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 122.583 0.353 . . . . 0.0 111.657 -175.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -88.72 150.2 23.09 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 173.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.27 58.79 4.71 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.4 mmt -68.02 -34.37 76.36 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 117.222 0.511 . . . . 0.0 111.577 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.8 p -136.76 167.43 21.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 117.963 0.347 . . . . 0.0 111.009 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 67.1 m 48.2 36.23 6.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.572 0.749 . . . . 0.0 111.459 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -67.43 -15.38 63.64 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.487 0.13 . . . . 0.0 110.932 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -85.09 -8.12 58.79 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.2 m -130.81 -171.23 2.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.17 0.588 . . . . 0.0 109.682 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -82.02 158.69 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 62.3 mtm -102.01 121.81 42.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.21 82.94 5.98 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.1 t -103.0 -17.35 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.0 m -54.15 -50.66 66.46 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.622 0.369 . . . . 0.0 111.401 -175.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -67.17 -21.32 65.8 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 119.493 -0.289 . . . . 0.0 111.655 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.43 -25.23 59.31 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.092 0.405 . . . . 0.0 111.793 -176.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.04 -48.44 20.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -178.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -65.58 -20.96 66.53 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -173.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -72.47 -14.44 61.67 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.264 0.484 . . . . 0.0 111.675 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.449 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 54.5 t -74.27 134.7 76.74 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 58.8 Cg_exo -55.86 131.15 44.25 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 123.595 2.863 . . . . 0.0 111.165 177.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.36 -22.11 38.86 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.852 -0.499 . . . . 0.0 111.852 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.9 t -77.86 130.64 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -126.98 -24.77 3.41 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.781 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -127.9 148.77 50.5 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.0 t -144.98 150.06 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -145.64 125.86 13.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.1 m -131.35 156.0 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.348 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.5 t -128.72 98.8 5.11 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.51 -17.98 64.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.863 -175.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -80.48 -29.94 37.42 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.502 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -99.95 -9.56 22.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 176.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.43 22.84 78.57 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -99.1 156.41 16.96 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 117.417 0.608 . . . . 0.0 110.734 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.64 109.71 5.32 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.539 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.2 mm? -101.63 151.77 21.61 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.0 163.16 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -138.33 79.69 1.75 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.98 -172.39 17.19 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -178.128 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 47.6 p -117.05 28.0 8.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.683 0.393 . . . . 0.0 110.284 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.58 171.4 14.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.343 -0.244 . . . . 0.0 110.343 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 18.9 t70 -79.64 141.3 55.92 Favored Pre-proline 0 N--CA 1.454 -0.239 0 O-C-N 122.439 -0.163 . . . . 0.0 111.027 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 47' ' ' ASP . 81.6 Cg_exo -54.59 -36.99 90.69 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 123.669 2.912 . . . . 0.0 113.08 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -74.17 -35.02 63.98 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.494 -177.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.17 -33.25 75.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.799 -175.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.2 tp -67.77 -50.89 54.71 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.679 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.9 t -68.03 -30.08 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 110.553 -0.166 . . . . 0.0 110.553 -177.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -76.13 -33.73 59.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -177.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.82 -48.57 78.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.319 0.104 . . . . 0.0 110.87 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -72.37 -23.8 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -72.79 -25.57 61.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -71.22 -25.72 62.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -89.35 -4.43 58.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.88 5.1 61.31 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -108.28 90.36 3.27 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 117.157 0.479 . . . . 0.0 111.073 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -71.01 155.65 40.58 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -162.39 111.33 1.41 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.483 0.182 . . . . 0.0 110.585 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -73.91 123.0 23.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.658 0.383 . . . . 0.0 110.65 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.6 m -59.42 135.16 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.31 74.66 3.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.285 -1.34 . . . . 0.0 109.555 -179.283 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttt . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.425 HD13 HD22 ' A' ' 51' ' ' LEU . 80.3 mt -90.68 139.05 31.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -157.31 77.1 0.85 Allowed 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -174.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 mp -79.89 113.49 18.09 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.706 -165.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -99.45 89.63 4.24 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.417 HG22 ' HB2' ' A' ' 62' ' ' ALA . 30.8 t -66.35 132.89 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 123.597 0.759 . . . . 0.0 112.323 -174.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -91.23 147.74 22.84 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 172.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.33 78.26 1.37 Allowed Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.1 mmt -71.75 -35.58 70.16 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.891 0.346 . . . . 0.0 111.316 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 78.6 p -135.69 168.76 18.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.581 0.229 . . . . 0.0 110.985 -176.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.2 m 48.82 36.54 8.24 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.269 0.627 . . . . 0.0 110.929 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -66.37 -6.59 14.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.4 0.28 . . . . 0.0 111.374 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -83.96 -7.01 59.52 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.0 m -130.14 -175.58 3.67 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 122.982 0.513 . . . . 0.0 109.824 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.408 ' CG2' HD22 ' A' ' 35' ' ' LEU . 14.6 p -83.46 160.35 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 69.2 mtm -99.48 119.25 37.72 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.43 88.12 6.26 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 t -100.96 -12.8 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 111.417 0.155 . . . . 0.0 111.417 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.9 m -50.36 -47.18 56.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -173.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -67.5 -22.78 65.44 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.146 -0.346 . . . . 0.0 111.771 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.06 -25.28 60.86 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 118.062 0.392 . . . . 0.0 111.094 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.3 -39.57 22.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -66.91 -25.16 66.24 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -173.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -81.25 -12.73 59.03 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.295 0.498 . . . . 0.0 112.144 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.7 t -76.28 128.07 83.44 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -54.75 139.46 77.42 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.473 2.782 . . . . 0.0 111.036 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.49 -20.25 47.73 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.3 t -76.38 131.92 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -122.86 -28.18 4.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.5 mttp -132.89 152.08 51.93 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.8 t -142.34 148.08 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -145.37 127.05 15.22 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.4 m -131.71 155.19 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 120.596 0.236 . . . . 0.0 110.483 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.4 t -128.3 112.31 14.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.408 HD22 ' CG2' ' A' ' 15' ' ' VAL . 87.9 mt -66.22 -25.27 66.83 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -175.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -83.34 -31.9 26.55 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.601 -176.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -101.2 -9.7 21.05 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 117.582 0.174 . . . . 0.0 110.982 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.72 23.15 73.94 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -94.75 156.44 16.38 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 117.646 0.723 . . . . 0.0 110.077 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.55 108.67 4.77 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.529 0.732 . . . . 0.0 110.118 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.5 mm? -101.67 150.51 23.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.105 0.962 . . . . 0.0 108.678 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.71 164.44 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -137.47 92.02 2.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.71 -172.93 29.73 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -177.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 48.9 p -117.51 29.72 7.7 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.226 0.61 . . . . 0.0 110.24 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.18 170.91 14.56 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.648 0.261 . . . . 0.0 110.747 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.86 137.28 66.21 Favored Pre-proline 0 N--CA 1.451 -0.381 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -54.54 -42.79 64.94 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.414 2.742 . . . . 0.0 112.503 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -76.02 -28.3 57.68 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.054 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.02 76.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 121.323 -0.151 . . . . 0.0 110.609 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.425 HD22 HD13 ' A' ' 2' ' ' LEU . 9.7 tp -71.18 -48.48 51.41 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.5 t -68.91 -22.79 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.47 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -85.97 -33.75 21.04 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.222 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.42 -44.61 95.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 121.416 -0.114 . . . . 0.0 111.019 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.0 m -69.8 -27.6 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.403 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -77.01 -25.25 52.43 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -69.55 -22.19 63.57 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -91.84 -6.81 50.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.34 10.63 55.64 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -124.84 89.77 3.13 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 117.646 0.723 . . . . 0.0 110.509 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.76 163.32 21.93 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.417 ' HB2' HG22 ' A' ' 6' ' ' VAL . . . -158.59 115.31 2.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.479 0.18 . . . . 0.0 110.736 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -72.39 111.57 7.7 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.449 0.3 . . . . 0.0 111.075 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.0 m -58.26 118.16 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.05 71.01 9.09 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.378 -1.296 . . . . 0.0 110.037 -178.966 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.6 mt -90.87 152.96 20.54 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -159.42 78.82 0.73 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -173.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.6 mp -79.25 102.62 8.67 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.868 0.366 . . . . 0.0 111.489 -165.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -92.48 94.03 8.87 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.5 t -65.73 136.4 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.476 1.11 . . . . 0.0 112.524 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -88.97 149.02 23.48 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.5 68.52 3.1 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.4 mmt -70.15 -37.55 75.28 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.6 p -139.0 168.86 18.9 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 117.911 0.323 . . . . 0.0 111.231 -175.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 64.2 m 47.63 36.98 6.03 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.456 0.702 . . . . 0.0 111.014 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -66.99 -4.19 9.02 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 121.931 0.092 . . . . 0.0 110.843 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -86.79 -9.03 56.77 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.2 m -130.82 -173.86 3.21 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.304 0.642 . . . . 0.0 110.174 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -84.39 159.64 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 56.5 mtm -103.05 122.54 44.85 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.65 90.2 7.86 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.32 -14.76 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 122.129 0.172 . . . . 0.0 111.325 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.1 m -54.46 -47.35 73.04 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -173.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -66.74 -22.92 66.04 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.285 0.493 . . . . 0.0 112.11 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.42 -24.57 60.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 118.011 0.369 . . . . 0.0 111.295 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.77 -40.63 18.54 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -66.69 -24.06 66.21 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -172.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -80.54 -12.78 59.48 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.336 0.516 . . . . 0.0 111.974 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.1 t -73.13 128.5 87.64 Favored Pre-proline 0 N--CA 1.451 -0.416 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -54.21 131.58 45.76 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.643 2.895 . . . . 0.0 111.2 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.22 -19.85 52.16 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 119.83 -0.428 . . . . 0.0 112.05 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.4 t -74.53 129.52 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -117.77 -30.61 5.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -134.77 152.48 51.79 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.3 t -142.48 149.47 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -145.69 129.23 17.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.28 156.76 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 120.619 0.247 . . . . 0.0 110.371 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.6 t -126.69 101.38 6.61 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.3 -20.34 66.02 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -174.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -83.89 -31.13 25.87 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.424 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -101.73 -9.8 20.53 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.597 0.18 . . . . 0.0 111.382 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.14 21.85 75.79 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -96.38 156.09 16.49 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.06 125.11 12.82 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.147 0.579 . . . . 0.0 109.479 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.5 mm? -117.94 152.32 35.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.046 0.939 . . . . 0.0 108.64 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.47 165.23 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -136.68 86.44 2.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.69 -172.64 24.22 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.8 p -117.48 28.66 8.32 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.188 0.595 . . . . 0.0 110.513 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.12 169.84 17.22 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.678 0.275 . . . . 0.0 110.92 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -76.3 144.33 74.52 Favored Pre-proline 0 N--CA 1.452 -0.369 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.308 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -57.33 -38.78 93.7 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 123.294 2.663 . . . . 0.0 112.11 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -75.51 -37.19 60.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.431 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.43 -34.29 75.14 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -176.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 tp -71.52 -56.87 5.06 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.481 0.181 . . . . 0.0 110.613 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.2 t -67.64 -21.69 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 122.3 0.24 . . . . 0.0 111.542 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -86.56 -32.48 20.66 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.622 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.72 -44.33 96.74 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.668 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.6 m -68.83 -27.21 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -77.68 -21.68 51.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -69.7 -24.28 63.55 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -90.51 -7.17 53.64 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.09 0.16 61.91 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -107.65 91.05 3.49 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 117.663 0.732 . . . . 0.0 110.74 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.91 163.34 19.83 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 177.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -156.14 112.67 3.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.59 0.233 . . . . 0.0 110.982 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -71.21 108.28 4.63 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.8 m -58.27 119.52 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.9 mt -81.12 72.11 8.13 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.145 0 CA-C-O 117.181 -1.39 . . . . 0.0 109.377 -179.802 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.2 ttp . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 77.9 mt -89.12 154.43 20.17 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -153.39 77.97 1.14 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -175.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 mp -78.53 101.46 7.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.316 -167.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -88.08 98.53 11.59 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.3 t -63.43 133.01 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 122.824 0.45 . . . . 0.0 110.927 -175.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -83.2 148.56 27.36 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.404 0.682 . . . . 0.0 109.715 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.8 76.55 1.21 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.3 mmt -69.14 -74.77 0.12 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.908 0.354 . . . . 0.0 111.365 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.6 p -138.19 169.76 17.23 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.701 0.4 . . . . 0.0 110.329 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 75.6 m 49.2 37.41 11.06 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.558 0.343 . . . . 0.0 110.736 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -65.87 -4.39 6.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.29 0.636 . . . . 0.0 110.988 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -84.8 -6.32 59.35 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.558 0.343 . . . . 0.0 110.457 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.8 m -115.63 171.04 7.99 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 p -153.49 151.67 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 72.6 mtm -150.82 162.47 40.68 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.58 91.59 0.6 Allowed 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.8 t -68.91 -14.44 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 36.0 m -52.51 -37.81 58.25 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.924 0.49 . . . . 0.0 111.352 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -62.55 -22.35 66.26 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.79 -25.66 30.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 118.04 0.382 . . . . 0.0 111.173 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.69 -35.95 51.64 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -177.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.73 -22.86 66.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -175.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -68.34 -18.06 64.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.274 0.488 . . . . 0.0 112.165 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.424 HG21 ' HA ' ' A' ' 51' ' ' LEU . 60.1 t -79.77 129.02 72.43 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-N 118.052 0.387 . . . . 0.0 110.069 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 62.2 Cg_exo -54.93 139.27 79.03 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 123.581 2.854 . . . . 0.0 111.413 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.41 -21.13 42.36 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.1 t -74.5 128.69 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -124.28 -26.9 3.88 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.793 0.27 . . . . 0.0 110.855 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -133.05 150.35 52.12 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.5 t -144.84 148.52 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -147.43 127.71 13.89 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 m -130.68 155.14 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 117.852 0.296 . . . . 0.0 110.871 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.1 t -129.02 100.07 5.51 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.98 -18.32 65.18 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.044 0.538 . . . . 0.0 112.126 -174.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -81.54 -29.89 33.34 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.927 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -103.62 -8.36 20.05 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.658 0.208 . . . . 0.0 111.229 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.03 23.47 78.07 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -96.91 155.56 16.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 117.737 0.769 . . . . 0.0 109.75 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.74 110.98 4.88 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.31 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.9 mm? -100.59 151.11 22.0 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.1 m -135.06 163.99 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 174.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -137.5 93.82 2.85 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.01 -171.22 26.68 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.9 p -114.28 28.15 8.96 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.787 0.435 . . . . 0.0 110.127 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.68 170.06 16.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.662 0.268 . . . . 0.0 110.875 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 14.9 t70 -90.61 148.56 38.91 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.487 177.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 47' ' ' ASP . 71.9 Cg_exo -57.76 -39.2 89.26 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.652 2.901 . . . . 0.0 112.915 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -75.35 -22.89 57.23 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.281 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.39 -35.09 58.81 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.315 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.424 ' HA ' HG21 ' A' ' 25' ' ' VAL . 10.7 tp -75.55 -46.01 34.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 121.32 -0.152 . . . . 0.0 111.079 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 63.7 t -67.19 -22.37 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 110.563 -0.162 . . . . 0.0 110.563 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -87.16 -30.04 21.33 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.08 -46.2 91.62 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.5 m -68.77 -19.91 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.475 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.456 ' OE1' ' HE2' ' A' ' 61' ' ' LYS . 45.7 tt0 -69.15 -20.4 64.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -68.84 -26.37 65.12 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -82.78 -11.39 58.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.9 8.14 59.39 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -132.69 101.87 5.46 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 117.286 0.543 . . . . 0.0 111.611 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.456 ' HE2' ' OE1' ' A' ' 56' ' ' GLU . 97.0 mttt -67.56 172.04 5.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -152.87 119.35 5.6 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.501 0.191 . . . . 0.0 110.62 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -68.84 109.04 3.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.512 0.725 . . . . 0.0 111.586 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 64' ' ' VAL . 30.6 m -58.81 108.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 174.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.0 mt -80.65 76.58 7.52 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 117.276 -1.345 . . . . 0.0 109.602 -177.625 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.5 ttp . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.5 mt -89.25 154.21 20.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -153.15 81.36 1.2 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.7 mp -75.12 103.46 5.3 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.45 -167.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -88.43 105.78 17.82 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.8 t -64.72 134.43 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 122.93 0.492 . . . . 0.0 111.146 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -85.12 146.19 27.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.74 60.5 3.55 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.6 mtp -68.04 -64.71 0.81 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.847 0.323 . . . . 0.0 111.668 -176.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.9 p -136.66 166.12 24.3 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.539 0.209 . . . . 0.0 110.963 -176.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 82.3 m 46.73 33.96 2.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.306 0.642 . . . . 0.0 110.634 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -68.08 -4.49 13.73 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.695 0.798 . . . . 0.0 111.023 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -72.56 -8.2 53.97 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.536 0.334 . . . . 0.0 111.116 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.2 m -129.88 179.84 5.62 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.269 0.227 . . . . 0.0 110.41 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -153.12 138.8 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -147.4 161.65 40.6 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.628 0.371 . . . . 0.0 110.021 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.5 115.91 5.63 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.007 0.523 . . . . 0.0 110.36 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.7 t -69.48 -11.94 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.228 1.011 . . . . 0.0 111.239 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.6 m -48.72 -40.63 29.12 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -174.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.87 -23.37 67.32 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -174.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.9 -25.12 32.76 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.039 0.381 . . . . 0.0 110.848 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' A' ' 22' ' ' LEU . 3.9 mm? -84.29 -31.57 24.83 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -59.18 -23.2 62.04 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 121.232 -0.187 . . . . 0.0 111.428 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -72.01 -17.74 62.02 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.29 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.1 t -79.55 127.75 77.22 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -57.3 139.08 89.04 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.302 2.668 . . . . 0.0 111.112 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.01 -21.18 38.33 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.5 t -70.91 129.16 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -128.07 -27.63 2.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -131.48 150.23 52.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.6 t -146.06 151.06 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -145.31 127.83 16.04 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.1 m -131.73 156.01 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.192 -178.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.7 t -127.98 101.26 6.23 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 176.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.6 mt -66.04 -22.03 66.41 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -83.93 -31.34 25.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.386 0.539 . . . . 0.0 111.499 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -102.22 -8.5 21.25 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.61 0.186 . . . . 0.0 111.187 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.32 20.62 73.53 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -98.76 154.16 18.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.51 128.15 12.4 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.632 0.253 . . . . 0.0 110.54 -177.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.8 mm? -113.58 153.05 29.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.961 0.904 . . . . 0.0 109.456 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.08 163.28 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 174.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -141.31 95.59 2.85 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.79 -179.07 35.31 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.2 p -94.73 26.81 3.34 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.466 0.306 . . . . 0.0 110.58 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.09 174.03 10.56 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -107.92 155.73 39.44 Favored Pre-proline 0 N--CA 1.452 -0.326 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -58.89 -37.49 93.38 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.2 2.6 . . . . 0.0 111.972 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -73.98 -16.69 61.07 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 119.815 -0.135 . . . . 0.0 111.144 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.68 -33.63 14.98 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.43 HD11 HD12 ' A' ' 22' ' ' LEU . 10.9 tp -70.87 -59.64 2.68 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.546 -176.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.0 t -67.64 -22.45 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 122.19 0.196 . . . . 0.0 110.941 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -81.84 -33.72 30.52 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 122.27 -0.269 . . . . 0.0 110.532 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.11 -46.51 90.31 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.281 0.086 . . . . 0.0 110.984 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.45 -22.83 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -77.19 -22.4 52.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.381 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -70.05 -24.17 63.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -83.26 -9.05 59.34 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.82 10.56 34.78 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 119.364 -0.687 . . . . 0.0 113.063 175.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -131.8 125.65 32.41 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.589 1.195 . . . . 0.0 111.573 -177.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -69.88 167.06 18.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.579 177.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -153.82 95.64 1.9 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -66.78 105.4 1.56 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.124 0.57 . . . . 0.0 111.542 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 64' ' ' VAL . 27.0 m -58.96 109.02 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.9 mt -80.88 74.16 7.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.288 -1.339 . . . . 0.0 109.208 -179.734 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttp . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.8 mt -90.05 150.47 22.07 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -159.73 78.74 0.7 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -176.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.7 mp -77.25 103.07 6.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.73 -164.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -79.92 96.42 6.37 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.473 HG11 HG21 ' A' ' 18' ' ' VAL . 33.0 t -65.1 128.62 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 120.737 0.304 . . . . 0.0 110.368 -176.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -75.47 145.33 41.53 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.452 0.701 . . . . 0.0 110.021 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.79 59.86 1.21 Allowed Glycine 0 C--N 1.335 0.525 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 84.0 mtp -67.45 -44.92 77.48 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 117.046 0.423 . . . . 0.0 111.677 -174.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.9 p -139.01 166.53 24.26 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 82.7 m 46.95 33.62 2.33 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.058 0.543 . . . . 0.0 110.833 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -67.48 -4.6 11.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.549 0.339 . . . . 0.0 110.58 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -76.59 -9.86 58.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.064 0.146 . . . . 0.0 110.699 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.8 m -131.15 -179.63 5.45 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.9 p -149.27 138.86 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -149.5 160.65 43.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.35 111.82 11.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.473 HG21 HG11 ' A' ' 6' ' ' VAL . 20.9 t -68.13 -8.02 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 123.066 0.546 . . . . 0.0 110.026 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.3 m -41.84 -38.35 1.5 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.564 1.146 . . . . 0.0 112.928 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.27 -23.56 66.77 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 122.016 -0.428 . . . . 0.0 111.704 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.79 -24.25 33.51 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 22' ' ' LEU . 4.0 mm? -82.62 -34.85 27.43 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -177.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -61.86 -22.13 65.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -175.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -75.57 -15.92 60.31 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.4 t -77.67 128.93 78.27 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 118.299 0.5 . . . . 0.0 110.001 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.89 139.83 84.74 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.534 2.823 . . . . 0.0 111.112 177.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.92 -21.48 39.36 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 176.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.6 t -80.23 132.66 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -127.8 -29.95 2.56 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.513 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -133.99 152.02 51.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.1 t -144.48 150.33 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -177.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -141.83 125.94 17.36 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.0 m -133.14 158.54 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 120.462 0.173 . . . . 0.0 111.371 -175.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.7 t -126.47 104.45 8.15 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 176.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.4 mt -63.7 -20.86 66.06 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -173.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -84.1 -32.4 24.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.572 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -101.68 -9.66 20.7 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -175.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.9 24.15 72.81 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.056 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -95.79 154.4 17.24 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.96 108.72 3.85 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 41' ' ' LEU . 3.2 mm? -105.12 152.17 23.12 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.4 m -132.18 163.73 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -137.82 89.88 2.45 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -159.28 -169.83 23.1 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.7 p -118.22 28.03 8.61 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.986 0.514 . . . . 0.0 110.206 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.67 168.89 18.93 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 17.4 m-20 -78.82 154.31 78.12 Favored Pre-proline 0 N--CA 1.451 -0.412 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 47' ' ' ASP . 76.0 Cg_exo -59.02 -46.63 21.52 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.625 2.884 . . . . 0.0 112.15 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -75.74 -32.35 59.97 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.935 -0.12 . . . . 0.0 111.151 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.62 -32.43 74.08 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 121.432 -0.107 . . . . 0.0 110.755 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.2 tp -69.21 -50.97 42.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 121.155 -0.218 . . . . 0.0 110.488 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.3 t -69.35 -28.21 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 122.508 0.323 . . . . 0.0 111.077 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -75.1 -31.89 61.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.55 -54.97 40.34 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 122.43 0.292 . . . . 0.0 111.42 -177.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -72.51 -23.82 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 121.403 -0.119 . . . . 0.0 111.029 -177.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -72.74 -22.37 60.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -70.94 -25.07 62.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -79.95 -9.58 59.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.0 11.3 34.77 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 119.588 -0.562 . . . . 0.0 111.888 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -129.82 114.85 16.42 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 117.886 0.843 . . . . 0.0 110.692 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.6 169.68 3.75 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -152.54 92.94 1.73 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -68.45 104.62 1.95 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 122.947 0.499 . . . . 0.0 111.331 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 64' ' ' VAL . 26.7 m -58.24 113.53 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.05 76.25 6.79 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 CA-C-O 117.025 -1.464 . . . . 0.0 109.067 -177.282 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.727 ' HG2' ' H ' ' A' ' 2' ' ' LEU . 18.8 ttt . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.727 ' H ' ' HG2' ' A' ' 1' ' ' MET . 87.5 mt -87.91 151.15 23.03 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.483 ' HG3' HD11 ' A' ' 41' ' ' LEU . 78.3 tttt -156.31 76.41 0.9 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -175.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.0 mp -76.16 109.43 9.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -165.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.47 ' HB2' HD21 ' A' ' 65' ' ' LEU . 57.5 tttt -81.38 98.4 8.18 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.666 0.787 . . . . 0.0 109.218 173.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.4 t -70.47 107.97 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 117.797 0.271 . . . . 0.0 110.567 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -73.21 118.66 16.44 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -93.28 85.81 1.13 Allowed Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.6 mtt -68.93 -33.43 73.73 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 122.513 0.325 . . . . 0.0 111.395 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.9 p -136.71 170.34 16.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.748 0.309 . . . . 0.0 111.471 -175.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 64.6 m 54.84 39.22 31.35 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.771 0.828 . . . . 0.0 111.908 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -66.21 -6.86 15.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -84.77 -10.24 57.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 118.008 0.367 . . . . 0.0 110.881 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.5 m -130.3 -178.78 4.9 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.621 0.248 . . . . 0.0 110.358 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -141.09 155.0 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 74.8 mtm -142.3 160.12 40.87 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -177.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.73 92.0 5.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.38 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.6 t -70.46 -12.74 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.2 m -52.45 -42.23 63.98 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 122.927 0.491 . . . . 0.0 112.208 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -66.27 -22.26 66.3 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.36 -24.69 62.14 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.093 0.406 . . . . 0.0 110.518 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.412 HD22 ' N ' ' A' ' 22' ' ' LEU . 3.8 mm? -84.06 -35.04 24.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -65.19 -22.78 66.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -176.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -74.02 -14.51 61.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.41 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 51' ' ' LEU . 57.0 t -78.44 128.12 78.71 Favored Pre-proline 0 N--CA 1.451 -0.402 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -55.28 138.87 80.61 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.377 2.718 . . . . 0.0 111.066 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.6 -19.6 51.73 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.1 t -75.48 129.62 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -122.52 -28.27 4.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -133.26 150.4 51.92 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.0 t -145.29 149.54 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -146.36 126.42 13.72 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -131.45 156.07 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.35 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.4 t -129.2 102.91 6.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.56 -18.69 64.13 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.06 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -78.6 -29.79 46.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -100.36 -11.16 20.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.748 -0.093 . . . . 0.0 110.748 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.28 20.92 67.88 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -101.49 158.49 16.03 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.925 0.362 . . . . 0.0 110.463 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.1 110.7 5.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.483 HD11 ' HG3' ' A' ' 3' ' ' LYS . 2.9 mm? -101.07 152.65 20.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.64 162.23 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 175.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -142.23 86.46 1.97 Allowed 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.62 -173.54 26.17 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -177.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.8 p -112.59 28.1 9.06 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.623 0.369 . . . . 0.0 110.496 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.03 168.01 20.82 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -78.67 138.57 58.35 Favored Pre-proline 0 N--CA 1.45 -0.47 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -55.41 -36.44 93.99 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.266 2.644 . . . . 0.0 111.928 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -76.23 -32.7 59.04 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 121.387 -0.125 . . . . 0.0 110.72 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.35 -33.2 71.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.461 ' HA ' HG21 ' A' ' 25' ' ' VAL . 9.7 tp -65.9 -55.76 15.25 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.539 0.209 . . . . 0.0 110.757 -178.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 50.5 t -68.14 -22.96 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.738 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -75.9 -37.14 59.12 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.899 -0.321 . . . . 0.0 110.245 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.2 -47.72 83.19 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.332 0.11 . . . . 0.0 110.815 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.5 m -73.03 -25.1 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.875 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -76.07 -23.47 55.04 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -70.25 -24.98 63.16 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -79.76 -10.73 59.82 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.3 7.23 59.51 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -115.32 98.6 6.85 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -61.79 158.95 14.65 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -155.1 78.83 1.04 Allowed 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.96 139.23 40.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -58.15 137.4 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 122.612 0.365 . . . . 0.0 110.569 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 5' ' ' LYS . 85.8 mt -83.98 76.1 10.08 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.06 -1.448 . . . . 0.0 109.337 179.351 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ttm . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 30.9 mt -113.78 144.5 42.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -161.71 79.62 0.56 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -171.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.0 mp -80.13 125.39 29.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.721 -0.612 . . . . 0.0 111.838 -164.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -101.14 89.07 3.67 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 172.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.32 115.46 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 122.889 0.476 . . . . 0.0 110.47 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -70.75 148.41 47.97 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.26 0.624 . . . . 0.0 109.882 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -90.22 60.14 3.4 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 94.3 mtp -67.69 -35.76 79.41 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.898 0.349 . . . . 0.0 111.067 -177.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 44.1 p -138.2 166.23 24.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.2 m 46.71 35.07 2.82 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.237 0.615 . . . . 0.0 111.102 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -67.6 -12.97 61.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -90.54 -7.51 52.7 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.136 0.426 . . . . 0.0 109.941 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.6 m -128.7 -171.15 2.4 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.0 p -137.03 152.71 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 11.1 mmm -140.7 160.17 40.62 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.44 110.17 16.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.88 0.472 . . . . 0.0 111.247 -178.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.2 t -91.04 -16.52 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 31.6 m -55.78 -43.57 76.9 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -174.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.66 -21.6 66.1 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.305 -0.247 . . . . 0.0 111.23 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.69 -27.44 60.4 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.854 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 22' ' ' LEU . 4.1 mm? -84.88 -33.47 22.8 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.864 0.302 . . . . 0.0 111.77 -176.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -62.85 -21.7 66.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -173.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -78.03 -18.42 55.88 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -173.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.3 t -78.88 130.67 69.46 Favored Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-N 118.976 0.807 . . . . 0.0 110.224 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -55.27 141.89 80.03 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 124.071 3.181 . . . . 0.0 111.56 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.16 -21.87 39.81 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.2 t -71.29 127.68 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.24 -27.54 3.8 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.437 0.162 . . . . 0.0 111.437 -177.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -133.82 152.63 51.93 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.3 t -143.02 147.09 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.24 129.44 14.62 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.4 m -130.93 155.99 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 117.959 0.345 . . . . 0.0 110.624 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.1 t -129.4 101.32 5.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.7 mt -64.47 -20.05 65.94 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.234 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -82.3 -31.47 29.96 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 110.666 -0.124 . . . . 0.0 110.666 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -101.86 -10.03 20.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.35 21.92 78.58 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -98.95 155.56 17.35 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.589 0.694 . . . . 0.0 109.933 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.14 108.56 4.83 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.6 mm? -104.18 150.31 24.48 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.39 162.79 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 173.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -139.01 86.23 2.12 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.63 -171.01 20.35 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.8 p -115.8 28.1 8.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 122.851 0.46 . . . . 0.0 110.227 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.35 159.31 32.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 38.8 m-20 -83.82 152.77 63.39 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 47' ' ' ASP . 52.5 Cg_exo -60.24 -36.68 87.16 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.536 2.824 . . . . 0.0 112.121 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.437 ' HG2' ' H ' ' A' ' 49' ' ' LYS . 20.5 pttt -69.65 -19.65 63.61 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 119.744 -0.169 . . . . 0.0 110.758 -175.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.64 -34.79 15.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.168 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 tp -75.21 -49.48 19.24 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.911 -0.315 . . . . 0.0 111.666 -174.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.07 -25.82 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 121.201 -0.2 . . . . 0.0 110.878 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -80.95 -32.02 34.69 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.09 -45.32 94.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.538 0.335 . . . . 0.0 111.219 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.0 m -71.78 -24.03 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.004 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.4 ' OE2' ' HE2' ' A' ' 61' ' ' LYS . 50.1 tt0 -75.13 -20.95 59.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.83 -23.73 63.35 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -88.36 -7.93 55.88 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.82 12.73 49.23 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -128.15 100.82 6.0 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.94 0.87 . . . . 0.0 112.045 -175.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HE2' ' OE2' ' A' ' 56' ' ' GLU . 98.9 mttt -71.1 167.15 19.9 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -160.55 117.26 2.39 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.84 119.23 14.68 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.643 0.377 . . . . 0.0 110.913 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.2 m -59.41 117.55 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.8 mt -82.39 31.8 0.4 Allowed 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.747 0.419 . . . . 0.0 110.005 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.341 -1.314 . . . . 0.0 109.165 179.567 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 ttm . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 45.7 mt -117.18 150.09 39.31 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -161.64 81.15 0.58 Allowed 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 -173.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.0 mp -79.97 109.43 14.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.827 -0.546 . . . . 0.0 112.007 -166.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -83.43 90.16 7.15 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 171.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.9 t -62.05 109.65 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -70.4 146.02 50.69 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.189 0.596 . . . . 0.0 110.208 -178.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.78 62.09 3.37 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 92.5 mtp -68.03 -34.92 77.39 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.612 0.206 . . . . 0.0 110.998 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.2 p -138.29 165.24 27.22 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.9 m 46.09 36.75 3.3 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.017 0.527 . . . . 0.0 111.153 177.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -66.68 -12.37 58.06 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -91.43 -5.68 53.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.0 m -127.6 -169.08 1.99 Allowed 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -141.06 155.2 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 11.2 mmm -137.03 160.68 38.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.231 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.05 110.45 16.59 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.995 0.518 . . . . 0.0 110.145 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.1 t -95.94 -21.02 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.9 m -56.49 -40.91 75.74 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.186 -0.321 . . . . 0.0 111.73 -176.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.54 -21.52 66.71 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 119.524 -0.274 . . . . 0.0 111.566 -177.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.99 -27.02 39.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.07 0.395 . . . . 0.0 110.689 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.44 HD12 HD11 ' A' ' 51' ' ' LEU . 3.1 mm? -85.52 -34.41 21.55 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 121.161 -0.216 . . . . 0.0 110.67 -177.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -62.55 -22.2 66.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.474 0.175 . . . . 0.0 111.474 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -79.6 -13.98 59.14 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 119.633 -0.223 . . . . 0.0 111.57 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 54.2 t -79.32 126.48 81.25 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 64.3 Cg_exo -56.67 140.9 91.49 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.682 2.921 . . . . 0.0 111.513 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.67 -21.69 39.79 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.862 -0.495 . . . . 0.0 111.862 176.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.69 129.66 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -27.47 4.75 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 121.284 -0.167 . . . . 0.0 111.05 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -133.18 153.08 51.86 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 174.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.0 t -143.06 147.42 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.96 128.52 15.07 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.71 153.84 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.904 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.2 t -131.46 100.81 5.28 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.6 mt -64.97 -19.0 65.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 121.92 0.088 . . . . 0.0 110.952 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -82.03 -31.24 31.06 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -103.05 -10.18 19.12 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.55 22.36 79.02 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -98.56 155.15 17.43 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 117.618 0.709 . . . . 0.0 109.889 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.69 108.38 4.01 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.3 mm? -108.4 150.74 26.96 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.4 m -135.64 163.1 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 174.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -138.1 93.36 2.75 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.46 -172.8 29.29 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.7 p -111.27 28.59 8.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 122.87 0.468 . . . . 0.0 109.957 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.25 173.35 9.6 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 27.9 m-20 -104.03 153.57 38.77 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 47' ' ' ASP . 57.4 Cg_exo -58.58 -36.96 96.61 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.481 2.787 . . . . 0.0 112.179 -178.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.435 ' HG2' ' H ' ' A' ' 49' ' ' LYS . 21.0 pttt -68.68 -21.03 64.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.513 -0.18 . . . . 0.0 110.513 -176.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.43 -34.27 14.91 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 121.239 -0.184 . . . . 0.0 110.725 -178.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.44 HD11 HD12 ' A' ' 22' ' ' LEU . 9.5 tp -74.68 -47.74 29.97 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.28 -176.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.0 t -68.1 -35.72 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -69.23 -31.85 70.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.46 -55.05 38.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 121.946 0.098 . . . . 0.0 110.932 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.8 -23.92 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 121.181 -0.208 . . . . 0.0 110.698 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -73.56 -23.71 60.0 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -70.6 -24.41 62.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -83.91 -7.82 59.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.19 8.53 57.68 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -125.14 94.98 4.32 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 117.829 0.814 . . . . 0.0 111.04 -176.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -67.33 168.24 10.98 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -158.18 113.71 2.7 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -67.8 120.36 14.01 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.689 0.395 . . . . 0.0 110.818 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.404 ' C ' ' H ' ' A' ' 66' ' ' ALA . 14.4 m -60.09 111.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 172.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.7 mt -80.66 33.41 0.31 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.404 ' H ' ' C ' ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 117.298 -1.334 . . . . 0.0 108.937 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ttm . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 74.0 mt -115.71 149.84 37.77 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.69 0.281 . . . . 0.0 110.587 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -159.97 77.74 0.66 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -177.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.71 113.52 16.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -165.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 72.3 tttt -79.39 84.95 5.24 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.196 0.998 . . . . 0.0 108.36 173.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.59 108.93 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -71.09 148.62 47.31 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.956 0.502 . . . . 0.0 110.149 -178.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.02 47.17 1.83 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 86.4 mtp -67.51 -29.93 69.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.278 0.539 . . . . 0.0 110.353 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.4 p -133.17 163.48 29.19 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.7 m 45.99 33.7 1.74 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.148 0.579 . . . . 0.0 111.145 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -68.85 -19.1 64.24 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 117.855 0.298 . . . . 0.0 111.72 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -91.43 -5.78 53.8 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.0 m -127.53 -167.87 1.81 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.51 0.724 . . . . 0.0 109.121 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.34 154.92 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.5 mmt -140.57 159.79 41.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.69 90.3 5.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.7 t -69.14 -21.23 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.1 m -55.82 -37.27 68.44 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 122.335 0.254 . . . . 0.0 111.297 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.97 -22.42 66.8 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 119.597 -0.24 . . . . 0.0 111.336 -177.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.15 -24.26 32.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.023 0.374 . . . . 0.0 110.916 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.15 -48.13 12.54 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -66.33 -22.98 66.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -171.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -73.44 -15.49 61.34 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 118.255 0.48 . . . . 0.0 112.012 -176.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.3 t -76.96 129.35 78.93 Favored Pre-proline 0 N--CA 1.45 -0.426 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.85 140.51 47.79 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.473 2.782 . . . . 0.0 111.582 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.63 -20.82 44.59 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -78.77 130.97 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -125.15 -30.19 3.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -134.81 149.45 50.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.1 t -145.27 148.17 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -146.68 120.22 9.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.403 HG12 ' HA ' ' A' ' 40' ' ' ALA . 5.3 m -131.11 156.07 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.2 t -128.34 101.56 6.28 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.8 mt -63.83 -16.1 60.46 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.328 0.651 . . . . 0.0 112.124 -174.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -75.58 -36.51 60.33 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.207 0.458 . . . . 0.0 111.576 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -104.54 -8.19 19.2 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.784 0.265 . . . . 0.0 111.662 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.64 22.82 68.8 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.466 -0.63 . . . . 0.0 113.603 175.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.37 155.86 17.02 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.342 1.071 . . . . 0.0 108.825 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.403 ' HA ' HG12 ' A' ' 33' ' ' VAL . . . -146.52 110.17 4.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.4 mm? -104.55 153.27 21.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.23 162.01 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -138.75 79.23 1.72 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 177.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.56 -170.78 20.04 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.5 p -115.11 28.05 8.97 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.742 0.417 . . . . 0.0 110.589 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.46 172.16 13.01 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.434 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 6.1 t70 -102.5 140.68 21.33 Favored Pre-proline 0 N--CA 1.453 -0.297 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -177.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 47' ' ' ASP . 74.8 Cg_exo -50.68 -36.61 51.45 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 124.416 3.41 . . . . 0.0 115.357 -175.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' HG2' ' H ' ' A' ' 49' ' ' LYS . 21.2 pttt -69.49 -18.09 63.66 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.686 0.676 . . . . 0.0 110.69 -175.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.89 -34.42 16.08 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.691 -0.403 . . . . 0.0 111.498 -175.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.9 tp -70.87 -50.4 35.6 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.802 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.8 t -68.27 -22.95 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.269 -176.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -86.77 -34.33 19.64 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.011 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.33 94.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.848 -0.16 . . . . 0.0 110.634 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.81 -23.64 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.513 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.403 ' OE2' ' HE2' ' A' ' 61' ' ' LYS . 35.3 tt0 -74.71 -21.84 59.16 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -69.37 -23.46 63.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -93.2 -5.91 48.97 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.81 6.45 59.36 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -116.52 90.1 3.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.705 0.752 . . . . 0.0 110.776 -177.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.403 ' HE2' ' OE2' ' A' ' 56' ' ' GLU . 99.6 mttt -68.57 165.74 18.53 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 5' ' ' LYS . . . -158.12 117.03 3.14 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.51 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -73.89 111.62 9.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.113 0.565 . . . . 0.0 110.845 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -58.65 136.47 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.9 mt -94.3 32.16 1.59 Allowed 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.278 -0.264 . . . . 0.0 111.174 -178.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 116.972 -1.489 . . . . 0.0 109.308 177.782 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ttt . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 58.1 mt -91.65 153.36 19.75 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -176.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -156.91 78.81 0.91 Allowed 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 -174.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.2 mp -80.46 106.63 12.62 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -163.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -80.58 84.54 6.14 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 171.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.2 t -66.29 132.54 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 O-C-N 122.522 -0.111 . . . . 0.0 110.713 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -88.58 142.97 27.26 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -100.2 63.4 0.63 Allowed Glycine 0 CA--C 1.525 0.716 0 CA-C-O 119.656 -0.525 . . . . 0.0 112.047 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 57.9 mtt -68.83 -73.15 0.16 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.15 0.975 . . . . 0.0 111.307 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 46.7 p -87.35 166.33 14.94 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.751 0.31 . . . . 0.0 110.855 -177.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.9 m 47.26 32.19 2.04 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.101 0.961 . . . . 0.0 111.298 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -69.24 -2.32 10.26 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.201 0.6 . . . . 0.0 111.578 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -69.32 -37.19 77.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 122.129 -0.357 . . . . 0.0 110.618 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 65.1 m -133.12 176.41 8.53 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.7 p -92.48 155.9 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.5 0.72 . . . . 0.0 110.078 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 60.6 mtt -136.54 160.19 39.51 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.21 93.03 9.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.4 t -66.85 -12.42 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.1 m -50.14 -39.34 42.98 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.132 0.573 . . . . 0.0 111.674 -177.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -63.31 -22.74 67.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -176.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.84 -25.51 32.54 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 117.902 0.319 . . . . 0.0 110.616 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 22' ' ' LEU . 3.3 mm? -82.46 -32.85 28.7 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 -176.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -64.5 -23.25 67.21 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -77.05 -11.98 59.88 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.612 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.1 t -78.84 129.72 72.66 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.61 136.38 73.84 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.398 2.732 . . . . 0.0 111.226 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.92 -20.9 39.64 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.98 128.75 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -125.37 -26.34 3.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -131.88 152.1 51.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.7 t -140.44 148.56 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -144.14 86.93 1.86 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.5 m -96.12 155.5 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.5 t -128.2 100.72 5.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.8 mt -64.54 -19.24 65.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.144 -174.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -83.3 -27.2 29.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -97.82 -11.44 23.29 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 119.806 -0.14 . . . . 0.0 111.167 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.08 20.55 74.91 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -109.12 156.18 20.13 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.32 110.23 6.46 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.4 mm? -109.66 151.49 26.81 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.402 HG11 HD11 ' A' ' 51' ' ' LEU . 33.7 m -133.47 166.08 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -134.22 84.66 2.13 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.6 -172.27 23.73 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -176.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.1 p -112.73 29.32 8.04 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.643 0.777 . . . . 0.0 110.525 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.65 172.7 11.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.583 0.23 . . . . 0.0 110.724 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -103.06 157.88 32.87 Favored Pre-proline 0 N--CA 1.453 -0.308 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -57.76 -39.47 87.1 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.585 2.856 . . . . 0.0 112.352 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 pttt -72.41 -17.11 61.83 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.116 -176.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.8 -37.76 13.43 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.298 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.437 HD11 HD12 ' A' ' 22' ' ' LEU . 9.5 tp -76.25 -49.66 16.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.033 -176.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.71 -24.92 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 116.982 -0.099 . . . . 0.0 110.736 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -83.71 -29.81 27.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.92 -46.41 89.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.52 -23.84 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -74.06 -21.03 60.09 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -68.87 -23.34 64.2 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -92.53 -6.04 50.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.88 9.32 57.42 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -121.54 92.88 3.84 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.801 0.8 . . . . 0.0 111.546 -175.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.95 169.46 4.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -153.54 117.53 4.79 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.733 0.301 . . . . 0.0 110.608 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -71.59 110.51 6.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.492 0.717 . . . . 0.0 110.819 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -58.26 113.86 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.0 mt -82.87 34.62 0.45 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.443 0.297 . . . . 0.0 110.532 -177.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 116.885 -1.531 . . . . 0.0 109.615 -179.2 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.414 ' HG2' ' N ' ' A' ' 2' ' ' LEU . 50.4 ttp . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.414 ' N ' ' HG2' ' A' ' 1' ' ' MET . 64.2 mt -110.27 151.12 27.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -177.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.496 ' HE2' ' OE1' ' A' ' 39' ' ' GLU . 82.2 tttt -156.21 81.25 0.99 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -175.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.3 mp -75.73 102.57 5.46 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.955 -167.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -85.48 102.86 13.84 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.4 t -65.24 135.88 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 123.271 0.628 . . . . 0.0 110.814 -177.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -77.36 146.96 36.37 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -93.41 69.38 1.52 Allowed Glycine 0 C--N 1.336 0.549 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 96.4 mtp -68.38 -51.53 43.16 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 117.027 0.413 . . . . 0.0 111.277 -177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.7 p -137.98 164.98 27.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 117.855 0.298 . . . . 0.0 110.952 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 63.8 m 46.87 52.55 11.41 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.602 0.761 . . . . 0.0 111.924 176.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -67.08 -10.59 51.56 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.286 -0.259 . . . . 0.0 111.019 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -92.3 -6.03 51.11 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 117.636 0.198 . . . . 0.0 110.668 177.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.4 m -122.59 129.25 51.7 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -95.38 154.95 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -137.7 158.98 43.23 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.409 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . . . -78.11 93.61 4.56 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.4 t -66.35 -15.3 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.9 m -54.43 -35.67 63.18 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.201 0.6 . . . . 0.0 110.788 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.409 ' HE3' ' HB3' ' A' ' 17' ' ' ALA . 96.6 mttt -58.58 -26.32 63.5 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 119.727 -0.177 . . . . 0.0 111.337 -177.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.69 -25.97 28.04 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 117.735 0.243 . . . . 0.0 110.71 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 22' ' ' LEU . 3.1 mm? -83.52 -34.7 25.24 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -177.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -63.22 -22.04 66.61 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -73.37 -12.06 60.69 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 122.483 -0.135 . . . . 0.0 111.221 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.404 HG12 ' HB2' ' A' ' 46' ' ' ALA . 69.4 t -78.9 130.86 68.84 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -56.06 129.69 36.25 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.997 3.131 . . . . 0.0 112.226 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.33 -26.34 12.09 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 112.156 -0.377 . . . . 0.0 112.156 174.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.523 ' HA ' ' HA3' ' A' ' 44' ' ' GLY . 61.1 t -71.91 129.14 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -126.94 -23.46 3.64 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.825 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -128.33 151.59 49.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.6 t -144.38 151.51 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -140.17 96.12 3.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.7 m -96.4 156.04 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.407 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.0 t -127.54 102.13 6.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.8 mt -64.4 -18.97 65.19 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.753 -174.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -83.71 -30.63 26.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 117.821 0.282 . . . . 0.0 110.727 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -98.26 -13.82 20.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 121.53 -0.068 . . . . 0.0 110.82 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.9 19.61 65.73 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.496 ' OE1' ' HE2' ' A' ' 3' ' ' LYS . 98.9 mt-10 -102.1 157.39 16.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -178.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.29 118.95 9.15 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.661 0.267 . . . . 0.0 110.337 -177.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 41' ' ' LEU . 3.2 mm? -101.77 152.7 20.56 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -133.85 164.49 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.708 0.289 . . . . 0.0 111.01 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -138.67 99.35 3.79 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.523 ' HA3' ' HA ' ' A' ' 28' ' ' VAL . . . -160.74 -175.14 31.43 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.8 p -112.42 25.52 11.42 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.546 0.338 . . . . 0.0 110.226 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.404 ' HB2' HG12 ' A' ' 25' ' ' VAL . . . -77.5 170.12 17.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 122.415 -0.178 . . . . 0.0 110.956 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -88.2 156.64 51.46 Favored Pre-proline 0 N--CA 1.452 -0.356 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -56.16 -37.02 97.22 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.551 2.834 . . . . 0.0 112.468 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -70.04 -41.15 74.61 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.284 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.86 -31.32 66.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -176.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.403 HD11 HD12 ' A' ' 22' ' ' LEU . 12.2 tp -73.22 -60.73 2.1 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 111.461 0.171 . . . . 0.0 111.461 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.1 t -69.57 -23.06 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 122.192 0.197 . . . . 0.0 111.481 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -79.02 -34.75 43.68 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.67 -55.12 37.0 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.807 -0.179 . . . . 0.0 110.882 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.63 -24.56 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -72.61 -37.41 68.1 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -72.21 -23.25 61.21 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -75.36 -4.48 39.57 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 176.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.8 4.1 58.01 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 119.246 -0.752 . . . . 0.0 113.055 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -135.22 114.11 11.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.578 1.189 . . . . 0.0 111.072 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.27 169.17 2.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -155.91 100.08 2.02 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.527 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -69.68 106.28 3.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.951 0.5 . . . . 0.0 111.58 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.7 m -58.78 106.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 174.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.8 mt -80.62 76.95 7.48 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 116.87 -1.538 . . . . 0.0 109.512 -178.267 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 75.6 mt -89.77 151.07 22.0 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -159.65 76.58 0.67 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -176.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.5 mp -78.43 122.78 26.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.693 0.282 . . . . 0.0 111.451 -166.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -99.48 91.37 4.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.6 130.09 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 122.469 0.308 . . . . 0.0 110.555 -175.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -78.37 146.86 34.39 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.64 55.62 1.41 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 92.1 mtp -66.77 -34.39 77.72 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.217 0.508 . . . . 0.0 110.997 -176.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.9 p -137.57 170.11 16.62 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.4 m 51.7 37.74 20.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.982 0.513 . . . . 0.0 111.635 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -67.9 -14.92 63.35 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.16 -0.338 . . . . 0.0 111.535 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -95.36 -50.56 4.96 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 118.435 0.562 . . . . 0.0 110.8 176.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.9 m -99.56 126.26 45.5 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.0 p -94.41 156.27 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 -177.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -135.89 159.64 41.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.24 95.95 2.2 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.8 t -67.74 -13.8 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.4 m -54.01 -36.35 62.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.7 0.4 . . . . 0.0 110.438 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -59.22 -23.4 62.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 119.773 -0.156 . . . . 0.0 111.078 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.26 -32.95 26.15 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.52 -36.42 60.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -66.5 -21.43 66.18 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -174.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -78.26 -17.14 57.06 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 54.7 t -78.64 128.06 78.44 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.845 -177.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 69.8 Cg_exo -55.44 141.43 82.24 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.703 2.935 . . . . 0.0 111.465 177.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.57 -22.6 32.32 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.7 t -76.29 129.97 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -124.69 -27.02 3.72 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -132.78 149.55 52.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.8 t -145.81 149.68 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -146.23 126.69 14.09 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 m -129.18 154.63 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-O 120.801 0.334 . . . . 0.0 110.52 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.5 t -128.27 104.6 7.83 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.9 mt -64.07 -23.32 67.28 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 122.593 0.357 . . . . 0.0 111.93 -173.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -84.68 -41.67 16.05 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 118.269 0.486 . . . . 0.0 110.544 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -82.48 -10.99 58.79 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.789 -0.187 . . . . 0.0 110.685 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.58 21.71 67.19 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -99.1 156.63 16.85 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 117.634 0.717 . . . . 0.0 110.257 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.85 108.47 4.0 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.461 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.9 mm? -100.58 149.16 24.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.3 m -135.93 162.31 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -139.15 95.49 2.95 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.34 -175.75 33.7 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -177.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.0 p -106.02 26.71 9.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 122.681 0.392 . . . . 0.0 110.515 -178.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.03 170.69 15.79 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -92.92 156.52 40.5 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.14 -50.69 12.22 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.872 3.048 . . . . 0.0 112.204 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -70.47 -30.48 67.31 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 121.126 -0.23 . . . . 0.0 110.889 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.01 -33.48 75.91 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.8 tp -74.11 -52.6 12.1 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.486 0.184 . . . . 0.0 110.61 -177.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.61 -25.46 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.813 -0.176 . . . . 0.0 111.3 -177.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -72.06 -33.14 67.73 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.083 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.25 -49.44 75.71 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.155 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 m -72.78 -23.59 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 117.705 0.229 . . . . 0.0 110.853 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -69.13 -34.11 74.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -70.85 -23.18 62.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -80.61 -8.08 59.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.86 12.56 52.62 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.569 -0.613 . . . . 0.0 111.569 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -124.51 111.17 15.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 117.777 0.788 . . . . 0.0 111.114 -176.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.72 165.62 8.14 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -162.66 79.57 0.49 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.646 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -71.35 127.92 34.18 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -60.73 135.29 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 175.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.4 mt -108.46 59.48 0.61 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.057 0 CA-C-O 117.042 -1.456 . . . . 0.0 108.944 -179.125 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ttt . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.2 mt -108.57 152.96 24.05 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -177.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 40.0 tttt -161.8 77.46 0.52 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -175.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.5 mp -79.08 122.51 26.31 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 121.83 -0.544 . . . . 0.0 111.77 -166.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -100.15 92.95 5.46 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 175.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.6 t -65.56 132.52 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 122.772 0.429 . . . . 0.0 111.567 -174.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -80.06 144.38 33.22 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.537 0.735 . . . . 0.0 109.751 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -97.56 63.62 0.94 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 178.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.428 ' SD ' ' HE3' ' A' ' 61' ' ' LYS . 94.2 mtp -68.09 -36.08 79.23 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.16 0.48 . . . . 0.0 111.78 -176.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 73.1 p -137.44 167.82 20.87 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 117.648 0.204 . . . . 0.0 110.611 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.3 m 47.02 49.25 15.04 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.238 0.615 . . . . 0.0 110.963 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -67.38 -14.18 62.69 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.701 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -95.57 -50.02 5.14 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.382 0.537 . . . . 0.0 110.648 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.8 m -96.06 129.38 43.35 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p -107.05 156.31 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 120.658 0.266 . . . . 0.0 110.323 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -129.55 161.53 30.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.9 91.14 0.45 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.88 -14.15 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.4 m -54.28 -36.89 64.14 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.013 0.525 . . . . 0.0 110.5 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.71 -29.25 67.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 121.357 -0.137 . . . . 0.0 111.198 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.43 -24.43 50.39 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 117.622 0.192 . . . . 0.0 110.807 -177.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.48 -39.08 20.97 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.8 tttt -67.82 -22.13 65.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -173.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -73.28 -17.78 61.28 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.657 0.662 . . . . 0.0 111.743 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 60.6 t -76.25 128.71 82.08 Favored Pre-proline 0 N--CA 1.449 -0.492 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 82.3 Cg_exo -52.26 139.92 53.04 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.67 2.913 . . . . 0.0 111.691 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.88 -21.56 35.95 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 177.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -77.48 116.36 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -116.48 -24.17 7.96 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.15 148.9 51.14 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -145.89 148.25 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -146.89 120.9 9.38 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 m -131.63 155.9 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.649 -177.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.6 t -129.41 104.03 7.25 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.8 mt -64.19 -18.5 64.54 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.576 0.35 . . . . 0.0 111.081 -176.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -84.22 -29.97 26.1 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 117.462 0.119 . . . . 0.0 111.029 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -100.04 -10.6 21.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 121.924 0.09 . . . . 0.0 111.06 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.33 19.4 70.47 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -100.72 154.94 18.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.35 119.17 7.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.485 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.3 mm? -117.12 151.73 36.23 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -178.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.87 162.44 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -139.16 84.7 2.02 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.7 -177.45 29.85 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.9 p -93.31 28.09 2.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.037 0.535 . . . . 0.0 110.708 -178.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.05 173.97 10.0 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 122.375 -0.203 . . . . 0.0 111.063 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -107.12 156.62 37.15 Favored Pre-proline 0 N--CA 1.452 -0.337 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -56.92 -52.79 6.02 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.728 2.952 . . . . 0.0 112.906 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -71.3 -32.49 68.69 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 121.124 -0.231 . . . . 0.0 110.898 -176.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.2 -33.13 75.06 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.6 tp -71.93 -51.52 21.72 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.976 -178.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.5 t -68.94 -27.93 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 121.379 -0.128 . . . . 0.0 111.007 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -67.97 -33.18 74.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.17 -55.82 21.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.075 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.26 -23.61 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -175.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.18 -34.82 68.73 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 120.601 -0.439 . . . . 0.0 109.841 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -71.55 -23.46 61.76 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -74.83 -8.48 56.57 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.24 12.55 51.5 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -127.69 98.41 5.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 117.115 0.458 . . . . 0.0 110.347 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.428 ' HE3' ' SD ' ' A' ' 9' ' ' MET . 87.3 mttt -62.4 161.55 11.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -161.5 92.81 0.9 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.107 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -77.82 129.42 35.4 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -60.94 135.02 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.401 ' H ' ' HB3' ' A' ' 3' ' ' LYS . 80.1 mt -109.34 31.33 5.84 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.5 0.32 . . . . 0.0 110.217 177.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.494 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 116.752 -1.594 . . . . 0.0 109.179 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 72.5 mt . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 120.676 0.274 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -164.47 79.38 0.37 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 -177.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 mp -79.27 108.91 13.13 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.824 -0.547 . . . . 0.0 112.084 -164.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -78.74 87.0 4.65 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.7 t -63.38 109.05 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -70.82 147.94 48.38 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 122.887 0.475 . . . . 0.0 110.208 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.547 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 177.747 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.448 -0.56 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.5 mmt -140.38 161.24 38.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.63 127.14 35.87 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.416 HG12 ' CD2' ' A' ' 22' ' ' LEU . 22.9 t -96.63 -13.38 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.0 m -53.39 -41.43 65.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -67.32 -22.43 65.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.863 0.301 . . . . 0.0 111.697 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.05 -34.83 59.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.039 0.381 . . . . 0.0 110.871 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.416 ' CD2' HG12 ' A' ' 18' ' ' VAL . 3.8 mm? -74.3 -38.61 63.31 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -173.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -65.68 -22.07 66.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -174.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.31 -18.68 65.5 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.898 -176.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 55.1 t -80.21 129.92 67.87 Favored Pre-proline 0 N--CA 1.451 -0.423 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 72.2 Cg_exo -52.88 140.67 57.67 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.634 2.889 . . . . 0.0 111.504 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.52 -21.26 41.89 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.1 t -78.05 127.91 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.77 -24.53 3.23 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 110.638 -0.134 . . . . 0.0 110.638 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -128.05 147.0 50.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.7 t -146.12 146.62 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -149.11 131.1 15.28 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -126.81 156.13 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.3 t -128.41 101.05 6.03 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.27 -22.34 66.84 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.316 -175.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -84.92 -29.04 25.48 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.555 0.162 . . . . 0.0 111.151 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -97.85 -9.84 25.71 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.412 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.22 23.1 78.47 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -114.76 158.16 22.23 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 117.723 0.762 . . . . 0.0 110.913 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.95 110.82 6.22 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.045 0.938 . . . . 0.0 109.121 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.497 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.4 mm? -108.35 150.7 26.99 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.7 m -134.73 164.38 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -139.03 89.27 2.34 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.22 -173.99 23.08 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.0 p -113.43 28.85 8.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.969 0.507 . . . . 0.0 110.517 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.89 170.23 16.35 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -80.32 155.55 74.27 Favored Pre-proline 0 N--CA 1.452 -0.366 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -59.11 -44.97 30.44 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.489 2.792 . . . . 0.0 112.091 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.1 pttt -75.08 -29.02 60.54 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.08 76.6 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 121.233 -0.187 . . . . 0.0 110.565 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.9 tp -73.28 -51.38 17.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.619 0.247 . . . . 0.0 110.567 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.7 -23.15 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.189 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -80.78 -33.83 34.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.69 96.34 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.231 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -71.76 -25.79 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.812 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -73.92 -21.33 60.09 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -68.92 -24.32 64.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -89.68 -7.47 54.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.35 9.06 57.15 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -122.89 95.68 4.72 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.705 0.753 . . . . 0.0 110.796 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -66.88 168.15 10.28 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -155.27 117.66 4.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.252 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.21 106.94 3.03 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.158 0.583 . . . . 0.0 111.349 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.21 110.04 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.4 mt -80.96 74.44 7.95 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 CA-C-O 117.368 -1.301 . . . . 0.0 109.726 -179.195 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.3 mt . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -147.54 83.96 1.55 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.35 170.03 9.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.346 0.594 . . . . 0.0 112.587 -173.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -151.4 96.65 2.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.61 1.164 . . . . 0.0 107.967 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 7' ' ' GLU . 33.4 t -59.77 170.9 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.483 ' N ' HG12 ' A' ' 6' ' ' VAL . 7.8 tp10 -125.43 150.97 46.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.803 0 C-N-CA 123.701 0.667 . . . . 0.0 112.225 179.079 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.4 HG22 ' N ' ' A' ' 16' ' ' MET . 10.7 p . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 120.687 0.28 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.4 ' N ' HG22 ' A' ' 15' ' ' VAL . 75.8 mtm -139.87 -175.33 4.18 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -122.93 95.67 4.71 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.476 ' C ' ' H ' ' A' ' 20' ' ' LYS . 13.0 t -65.43 -1.51 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 123.012 0.525 . . . . 0.0 110.034 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 m -63.79 6.61 0.15 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.322 0.649 . . . . 0.0 110.772 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.476 ' H ' ' C ' ' A' ' 18' ' ' VAL . 98.4 mttt -120.39 6.95 10.63 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.849 0.46 . . . . 0.0 110.756 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -118.51 -1.41 11.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 22' ' ' LEU . 2.7 mm? -122.81 -0.42 9.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -98.52 -12.73 20.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -85.26 -10.63 56.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.18 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -76.71 123.17 87.54 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.16 166.48 2.26 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.306 2.671 . . . . 0.0 111.207 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.81 -13.98 1.19 Allowed Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.412 -0.66 . . . . 0.0 112.54 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.8 t -79.27 159.3 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 118.373 1.087 . . . . 0.0 108.537 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -147.63 -18.56 0.37 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -146.25 163.58 35.01 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.2 t -150.92 152.6 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -144.82 152.83 40.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -153.11 178.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.5 t -147.16 102.25 3.48 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.15 -1.13 2.93 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.702 0.401 . . . . 0.0 111.745 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -116.6 1.64 12.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 117.986 0.357 . . . . 0.0 110.446 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -132.99 -10.07 3.01 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.8 -3.73 6.25 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -72.77 166.07 23.61 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 117.78 0.79 . . . . 0.0 109.883 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.413 ' C ' HD12 ' A' ' 41' ' ' LEU . . . -156.08 154.07 30.38 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.413 HD12 ' C ' ' A' ' 40' ' ' ALA . 5.3 mp -145.88 169.1 19.26 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.9 m -149.26 172.13 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -143.15 97.69 3.13 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -169.74 174.01 43.96 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.7 p -80.85 7.05 11.36 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.706 0.802 . . . . 0.0 111.844 -177.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.03 173.62 0.15 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.688 0.28 . . . . 0.0 111.084 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -122.96 162.57 38.36 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -60.19 -28.84 87.75 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.55 2.833 . . . . 0.0 111.923 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -88.18 3.32 49.75 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.398 0.279 . . . . 0.0 111.065 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.94 -0.68 6.59 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.7 tp -119.13 -0.74 11.01 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.1 t -124.09 -25.26 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -76.15 -12.69 60.15 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.87 -57.61 3.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.327 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.79 -24.02 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 110.546 -0.168 . . . . 0.0 110.546 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -79.4 -18.09 53.0 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -85.21 -20.21 30.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -83.76 -3.45 57.83 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 122.774 0.43 . . . . 0.0 110.184 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.75 2.35 72.44 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -134.0 81.93 1.95 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 117.517 0.659 . . . . 0.0 109.726 -178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -60.72 168.95 2.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 110.407 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -153.91 105.19 2.73 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -66.39 170.93 5.37 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.58 -178.86 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 120.878 0.371 . . . . 0.0 110.246 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.6 mt -136.71 5.24 2.87 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.966 0.906 . . . . 0.0 108.843 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 117.043 -1.456 . . . . 0.0 108.976 179.527 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 77.8 mt . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -155.12 79.41 1.05 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -174.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.1 mp -77.73 103.84 7.91 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.269 -163.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -80.68 100.52 8.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 171.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.9 t -60.28 147.8 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.312 1.045 . . . . 0.0 111.427 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -58.93 162.54 4.09 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.189 1.395 . . . . 0.0 107.999 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.772 0 CA-C-O 119.67 -0.517 . . . . 0.0 114.039 -168.921 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.449 -0.476 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.8 mtt -140.97 159.89 41.25 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.01 88.34 7.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.9 t -69.81 -14.57 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 122.493 0.317 . . . . 0.0 110.196 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -56.6 -39.59 73.83 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 122.264 -0.273 . . . . 0.0 110.808 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.65 -21.52 66.56 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 119.569 -0.253 . . . . 0.0 111.482 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.54 -39.78 51.84 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 117.852 0.297 . . . . 0.0 110.414 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 22' ' ' LEU . 3.9 mm? -75.87 -32.65 59.81 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -177.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -60.29 -21.42 61.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 112.611 0.596 . . . . 0.0 112.611 -174.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -79.7 -17.99 52.31 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 118.157 0.435 . . . . 0.0 111.623 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.0 t -70.98 128.02 91.07 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 117.751 0.25 . . . . 0.0 110.438 -174.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 46' ' ' ALA . 50.4 Cg_exo -58.47 137.23 79.21 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.444 2.763 . . . . 0.0 110.86 177.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.08 -25.06 15.42 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.439 ' HA ' ' HA3' ' A' ' 44' ' ' GLY . 54.7 t -72.58 129.62 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -126.24 -25.91 3.44 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.737 -0.21 . . . . 0.0 110.678 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -130.42 148.61 52.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.7 t -146.51 147.65 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -146.43 129.25 16.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.43 158.72 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 120.89 0.376 . . . . 0.0 111.613 -174.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.0 t -126.86 101.93 6.8 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.6 mt -63.89 -25.26 68.07 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -173.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -85.16 -30.04 24.27 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.588 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -99.38 -11.03 21.54 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -175.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.14 24.49 76.99 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -98.6 154.73 17.71 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.76 0.78 . . . . 0.0 109.577 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.32 109.85 4.43 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.444 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.481 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.9 mm? -100.25 139.12 36.38 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.33 162.97 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -139.0 101.33 4.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 28' ' ' VAL . . . -156.73 -175.68 27.94 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -177.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.4 p -114.61 26.04 10.53 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 122.898 0.479 . . . . 0.0 109.801 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 26' ' ' PRO . . . -76.22 167.88 21.06 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.713 -0.221 . . . . 0.0 110.613 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.15 144.53 71.66 Favored Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -56.01 -37.53 96.05 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.864 2.376 . . . . 0.0 111.457 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -75.62 -33.98 60.55 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.95 -33.64 76.02 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.41 HD11 HD12 ' A' ' 22' ' ' LEU . 11.5 tp -70.19 -50.44 40.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.66 -22.57 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -82.67 -32.28 28.21 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.48 -45.38 93.95 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.9 m -73.94 -23.89 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.099 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.405 ' OE2' ' HE2' ' A' ' 61' ' ' LYS . 42.6 tt0 -70.77 -19.6 62.69 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.02 -23.74 65.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -91.45 -13.57 32.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.85 10.37 57.71 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -131.12 88.18 2.57 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -175.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.405 ' HE2' ' OE2' ' A' ' 56' ' ' GLU . 88.5 mttt -64.44 178.47 0.72 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.612 0.765 . . . . 0.0 110.227 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -154.19 101.86 2.42 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.187 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -69.19 120.41 14.99 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.715 0.406 . . . . 0.0 110.918 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.7 m -59.06 130.02 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 175.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.5 mt -83.71 34.15 0.49 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 116.851 -1.547 . . . . 0.0 109.399 -178.792 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 N--CA 1.449 -0.495 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.469 ' HG3' HD11 ' A' ' 41' ' ' LEU . 79.4 tttt -160.24 77.52 0.64 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.3 mp -81.14 127.24 32.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.532 0.333 . . . . 0.0 111.699 -166.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -99.75 96.01 7.32 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 t -66.35 107.42 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 123.228 0.611 . . . . 0.0 111.957 -175.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -78.14 148.32 34.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 174.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.622 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.545 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 60.5 mtt -145.24 161.95 38.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.67 94.35 0.78 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.64 -13.35 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.5 m -54.64 -38.24 66.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 122.674 0.39 . . . . 0.0 110.7 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.56 -23.26 67.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.54 -0.267 . . . . 0.0 111.675 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.42 -22.79 40.86 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 117.729 0.241 . . . . 0.0 111.051 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.95 -33.49 16.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.503 0.138 . . . . 0.0 111.241 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -64.41 -26.57 68.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -169.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -81.18 -9.96 59.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 119.364 0.984 . . . . 0.0 111.801 -177.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.3 t -73.61 130.67 83.37 Favored Pre-proline 0 N--CA 1.452 -0.34 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.64 140.53 65.74 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.763 2.975 . . . . 0.0 112.172 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.16 -20.98 39.86 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 119.833 -0.426 . . . . 0.0 112.121 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.1 t -68.82 130.34 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 117.578 0.689 . . . . 0.0 109.463 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -120.24 -36.98 3.13 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 43' ' ' GLU . 97.8 mttt -134.44 155.72 49.83 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.4 t -135.12 148.78 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -144.0 104.15 4.11 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.1 m -125.27 155.54 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.3 t -128.36 101.33 6.17 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.88 -18.07 63.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.301 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -83.77 -30.83 26.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.206 0.203 . . . . 0.0 110.64 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -102.96 -10.47 18.96 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -176.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.23 20.44 75.04 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -102.2 155.37 18.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.98 121.38 9.65 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.469 HD11 ' HG3' ' A' ' 3' ' ' LYS . 2.8 mm? -118.58 153.62 33.95 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.94 166.57 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 30' ' ' LYS . 32.3 tt0 -135.81 89.55 2.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.83 177.55 38.87 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -177.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.9 p -95.28 26.88 3.54 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.188 0.595 . . . . 0.0 110.11 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.05 169.71 17.47 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -110.03 158.23 35.63 Favored Pre-proline 0 N--CA 1.452 -0.351 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -55.61 -46.0 35.24 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.82 3.013 . . . . 0.0 112.796 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -74.68 -13.93 60.68 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.405 -177.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.44 -35.49 15.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.219 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tp -76.44 -48.43 19.68 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.386 0.136 . . . . 0.0 111.11 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.7 t -68.29 -23.06 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 119.619 -0.229 . . . . 0.0 111.475 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -77.54 -37.61 50.47 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.104 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.65 -48.6 81.02 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.815 -0.175 . . . . 0.0 110.913 -176.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -72.32 -26.09 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.795 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -76.77 -28.57 55.74 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.598 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -70.24 -23.57 62.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -83.59 -4.48 58.6 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 177.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.99 7.5 58.55 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -115.18 90.94 3.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 117.298 0.549 . . . . 0.0 111.237 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -66.18 114.15 5.07 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.9 88.61 2.69 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.43 141.45 38.29 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.466 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.1 m -59.3 139.67 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 123.661 0.784 . . . . 0.0 111.167 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.08 28.04 2.96 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 116.98 -1.486 . . . . 0.0 109.561 -179.163 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.411 HD12 HD22 ' A' ' 51' ' ' LEU . 67.1 mt . . . . . 0 N--CA 1.451 -0.409 0 N-CA-C 110.251 -0.277 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -153.81 80.08 1.14 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.7 mp -77.85 108.04 10.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.677 -164.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 14.7 tmtt? -93.06 96.77 10.27 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 174.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.2 t -64.36 133.92 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -85.34 149.04 25.73 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.648 0.379 . . . . 0.0 110.114 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.54 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 179.359 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 N--CA 1.449 -0.479 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 58.4 mtt -139.27 161.31 37.75 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.58 89.65 2.75 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.8 t -74.44 -21.97 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.7 m -57.47 -39.23 75.93 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 122.37 -0.206 . . . . 0.0 110.549 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.56 -22.41 66.96 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 119.645 -0.216 . . . . 0.0 111.533 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.78 -38.94 37.24 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.471 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 22' ' ' LEU . 3.1 mm? -73.05 -32.45 65.07 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -63.02 -21.96 66.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -175.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -70.34 -14.99 62.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.211 0.46 . . . . 0.0 111.147 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 71.9 t -78.53 127.55 80.26 Favored Pre-proline 0 N--CA 1.451 -0.413 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -175.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 52.8 Cg_exo -58.63 140.4 94.71 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 123.462 2.775 . . . . 0.0 110.975 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.76 -20.85 42.44 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.996 -0.441 . . . . 0.0 111.996 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.33 128.26 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -110.62 -42.16 4.13 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -135.47 154.96 51.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.6 t -140.46 149.41 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -139.1 99.21 3.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 m -95.76 155.87 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.7 t -127.47 98.74 5.34 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.0 mt -66.66 -19.82 65.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -173.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -84.05 -32.21 24.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.443 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -103.43 -9.85 19.06 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 117.872 0.306 . . . . 0.0 111.223 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.81 21.73 76.68 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -98.66 155.04 17.52 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.04 125.6 10.28 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.986 0.422 . . . . 0.0 111.184 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.409 HD22 ' N ' ' A' ' 41' ' ' LEU . 3.2 mm? -107.54 153.06 23.41 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 175.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.4 m -132.38 164.7 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -137.28 88.98 2.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.61 -176.61 35.72 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.8 p -117.31 29.51 7.84 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.385 0.674 . . . . 0.0 109.893 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.22 167.08 21.92 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.805 0.336 . . . . 0.0 110.854 -176.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -76.77 149.58 80.74 Favored Pre-proline 0 N--CA 1.451 -0.425 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.079 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -55.45 -49.42 16.16 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.379 2.719 . . . . 0.0 112.185 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -74.79 -19.6 60.13 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.04 -34.81 71.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.919 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.411 HD22 HD12 ' A' ' 2' ' ' LEU . 10.0 tp -75.47 -43.66 48.25 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 83.0 t -65.25 -24.84 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 123.189 0.596 . . . . 0.0 111.816 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -87.27 -28.94 22.02 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.968 0.349 . . . . 0.0 111.176 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.91 -47.02 87.48 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 122.345 -0.222 . . . . 0.0 110.991 -177.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.89 -21.32 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -68.76 -21.02 64.38 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.44 -29.15 67.73 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -83.78 -9.37 58.84 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.59 11.13 48.54 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 119.619 -0.545 . . . . 0.0 111.74 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -128.72 142.54 50.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 117.758 0.779 . . . . 0.0 110.434 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -85.23 172.45 11.15 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 171.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 5' ' ' LYS . . . -149.54 77.51 1.34 Allowed 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.11 117.68 4.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.863 -175.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -57.45 126.0 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.749 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.5 mt -84.08 31.28 0.5 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.741 0.416 . . . . 0.0 109.93 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 117.239 -1.363 . . . . 0.0 110.199 -178.284 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.422 HD22 HG11 ' A' ' 64' ' ' VAL . 60.2 mt . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 121.012 0.434 . . . . 0.0 110.437 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -148.03 78.74 1.45 Allowed 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 -169.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -77.46 114.84 16.71 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.225 -164.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 75.8 tttt -96.1 98.82 10.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.296 1.039 . . . . 0.0 108.907 175.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.4 t -61.75 115.58 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 120.843 0.354 . . . . 0.0 110.19 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -69.96 151.77 45.22 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.446 0.698 . . . . 0.0 110.032 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.653 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.91 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 p . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 69.7 mtm -144.83 160.42 41.3 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.0 90.77 4.19 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.69 -13.5 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.8 m -52.91 -37.7 61.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.12 0.568 . . . . 0.0 110.792 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -64.2 -22.35 66.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -177.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.52 ' O ' ' HB1' ' A' ' 54' ' ' ALA . . . -82.15 -25.0 34.73 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 117.858 0.299 . . . . 0.0 110.994 -178.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.12 -33.52 24.3 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 117.455 0.116 . . . . 0.0 110.862 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -63.56 -22.5 66.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -71.09 -16.13 62.56 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.599 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.475 ' CG2' ' HB2' ' A' ' 54' ' ' ALA . 72.5 t -80.32 127.31 76.69 Favored Pre-proline 0 N--CA 1.45 -0.433 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.64 141.22 97.38 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.651 2.901 . . . . 0.0 111.232 177.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.8 -19.62 50.39 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.855 -0.498 . . . . 0.0 111.855 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.0 t -74.14 123.41 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 117.387 0.593 . . . . 0.0 109.426 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -129.41 -26.67 2.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -130.6 132.12 45.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.262 0.553 . . . . 0.0 110.139 176.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 83.9 t -144.73 147.72 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -136.43 122.84 20.7 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 m -130.56 156.23 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.145 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.5 t -126.86 102.45 7.03 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.5 mt -62.71 -18.05 61.81 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.101 0.56 . . . . 0.0 111.486 -174.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -84.58 -31.46 24.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 117.597 0.181 . . . . 0.0 111.244 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -102.16 -10.39 19.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.55 21.68 77.72 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -100.3 155.64 17.67 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 117.726 0.763 . . . . 0.0 109.437 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.26 115.1 6.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.509 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.487 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.7 mm? -97.48 152.01 19.42 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.87 150.51 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -141.29 62.66 1.46 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.2 -176.83 14.57 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.3 p -98.65 26.49 5.56 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.804 0.842 . . . . 0.0 111.104 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.12 164.9 25.66 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.795 0.331 . . . . 0.0 111.097 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -82.32 135.61 47.05 Favored Pre-proline 0 N--CA 1.451 -0.413 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -56.04 -35.49 94.78 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.268 2.645 . . . . 0.0 111.833 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -74.85 -28.45 60.68 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 122.17 0.188 . . . . 0.0 111.203 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.92 -33.59 45.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 tp -64.92 -45.36 86.17 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.07 -23.28 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 122.693 0.397 . . . . 0.0 110.617 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -87.52 -29.0 21.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 122.401 -0.187 . . . . 0.0 110.989 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.52 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -58.29 -47.27 84.19 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 122.376 -0.202 . . . . 0.0 111.104 -178.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.2 m -72.37 -20.86 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -69.42 -21.29 63.76 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -69.47 -25.35 64.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -84.04 -9.73 58.41 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.03 15.38 39.2 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 178.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -130.54 144.49 51.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 117.581 0.69 . . . . 0.0 111.509 -176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -80.16 175.28 10.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 168.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 5' ' ' LYS . . . -148.05 78.32 1.44 Allowed 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 174.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -53.61 107.6 0.27 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.456 0.702 . . . . 0.0 111.297 -175.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.422 HG11 HD22 ' A' ' 2' ' ' LEU . 35.8 m -58.19 110.42 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 123.871 0.868 . . . . 0.0 110.03 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.7 mt -84.04 35.34 0.53 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.084 0 CA-C-O 117.091 -1.433 . . . . 0.0 109.97 -178.061 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.1 mt . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -167.14 78.78 0.19 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -174.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.4 mp -77.87 124.65 28.26 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.894 -0.503 . . . . 0.0 112.324 -165.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -101.33 90.29 4.05 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.5 t -68.15 134.33 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 122.583 0.353 . . . . 0.0 111.657 -175.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -88.72 150.2 23.09 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 173.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.667 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 178.782 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 62.3 mtm -102.01 121.81 42.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.21 82.94 5.98 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.1 t -103.0 -17.35 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.0 m -54.15 -50.66 66.46 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.622 0.369 . . . . 0.0 111.401 -175.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -67.17 -21.32 65.8 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 119.493 -0.289 . . . . 0.0 111.655 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.43 -25.23 59.31 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.092 0.405 . . . . 0.0 111.793 -176.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.04 -48.44 20.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -178.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -65.58 -20.96 66.53 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -173.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -72.47 -14.44 61.67 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.264 0.484 . . . . 0.0 111.675 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.449 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 54.5 t -74.27 134.7 76.74 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 58.8 Cg_exo -55.86 131.15 44.25 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 123.595 2.863 . . . . 0.0 111.165 177.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.36 -22.11 38.86 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.852 -0.499 . . . . 0.0 111.852 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.9 t -77.86 130.64 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -126.98 -24.77 3.41 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.781 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -127.9 148.77 50.5 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.0 t -144.98 150.06 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -145.64 125.86 13.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.1 m -131.35 156.0 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.348 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.5 t -128.72 98.8 5.11 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.51 -17.98 64.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.863 -175.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -80.48 -29.94 37.42 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.502 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -99.95 -9.56 22.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 176.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.43 22.84 78.57 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -99.1 156.41 16.96 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 117.417 0.608 . . . . 0.0 110.734 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.64 109.71 5.32 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.539 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.2 mm? -101.63 151.77 21.61 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.0 163.16 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -138.33 79.69 1.75 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.98 -172.39 17.19 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 47.6 p -117.05 28.0 8.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.683 0.393 . . . . 0.0 110.284 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.58 171.4 14.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.343 -0.244 . . . . 0.0 110.343 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 18.9 t70 -79.64 141.3 55.92 Favored Pre-proline 0 N--CA 1.454 -0.239 0 O-C-N 122.439 -0.163 . . . . 0.0 111.027 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 47' ' ' ASP . 81.6 Cg_exo -54.59 -36.99 90.69 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 123.669 2.912 . . . . 0.0 113.08 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -74.17 -35.02 63.98 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.494 -177.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.17 -33.25 75.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.799 -175.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.2 tp -67.77 -50.89 54.71 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.679 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.9 t -68.03 -30.08 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 110.553 -0.166 . . . . 0.0 110.553 -177.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -76.13 -33.73 59.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -177.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.82 -48.57 78.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.319 0.104 . . . . 0.0 110.87 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -72.37 -23.8 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -72.79 -25.57 61.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -71.22 -25.72 62.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -89.35 -4.43 58.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.88 5.1 61.31 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -108.28 90.36 3.27 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 117.157 0.479 . . . . 0.0 111.073 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -71.01 155.65 40.58 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -162.39 111.33 1.41 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.483 0.182 . . . . 0.0 110.585 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -73.91 123.0 23.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.658 0.383 . . . . 0.0 110.65 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.6 m -59.42 135.16 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.31 74.66 3.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.285 -1.34 . . . . 0.0 109.555 -179.283 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.425 HD13 HD22 ' A' ' 51' ' ' LEU . 80.3 mt . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -157.31 77.1 0.85 Allowed 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -174.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 mp -79.89 113.49 18.09 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.706 -165.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -99.45 89.63 4.24 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.417 HG22 ' HB2' ' A' ' 62' ' ' ALA . 30.8 t -66.35 132.89 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 123.597 0.759 . . . . 0.0 112.323 -174.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -91.23 147.74 22.84 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 172.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.523 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.748 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.408 ' CG2' HD22 ' A' ' 35' ' ' LEU . 14.6 p . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 69.2 mtm -99.48 119.25 37.72 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.43 88.12 6.26 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 t -100.96 -12.8 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 111.417 0.155 . . . . 0.0 111.417 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.9 m -50.36 -47.18 56.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -173.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -67.5 -22.78 65.44 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.146 -0.346 . . . . 0.0 111.771 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.06 -25.28 60.86 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 118.062 0.392 . . . . 0.0 111.094 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.3 -39.57 22.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -66.91 -25.16 66.24 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -173.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -81.25 -12.73 59.03 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.295 0.498 . . . . 0.0 112.144 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.7 t -76.28 128.07 83.44 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -54.75 139.46 77.42 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.473 2.782 . . . . 0.0 111.036 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.49 -20.25 47.73 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.3 t -76.38 131.92 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -122.86 -28.18 4.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.5 mttp -132.89 152.08 51.93 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.8 t -142.34 148.08 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -145.37 127.05 15.22 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.4 m -131.71 155.19 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 120.596 0.236 . . . . 0.0 110.483 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.4 t -128.3 112.31 14.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.408 HD22 ' CG2' ' A' ' 15' ' ' VAL . 87.9 mt -66.22 -25.27 66.83 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -175.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -83.34 -31.9 26.55 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.601 -176.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -101.2 -9.7 21.05 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 117.582 0.174 . . . . 0.0 110.982 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.72 23.15 73.94 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -94.75 156.44 16.38 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 117.646 0.723 . . . . 0.0 110.077 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.55 108.67 4.77 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.529 0.732 . . . . 0.0 110.118 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.5 mm? -101.67 150.51 23.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.105 0.962 . . . . 0.0 108.678 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.71 164.44 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -137.47 92.02 2.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.71 -172.93 29.73 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -177.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 48.9 p -117.51 29.72 7.7 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.226 0.61 . . . . 0.0 110.24 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.18 170.91 14.56 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.648 0.261 . . . . 0.0 110.747 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.86 137.28 66.21 Favored Pre-proline 0 N--CA 1.451 -0.381 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -54.54 -42.79 64.94 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.414 2.742 . . . . 0.0 112.503 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -76.02 -28.3 57.68 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.054 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.02 76.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 121.323 -0.151 . . . . 0.0 110.609 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.425 HD22 HD13 ' A' ' 2' ' ' LEU . 9.7 tp -71.18 -48.48 51.41 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.5 t -68.91 -22.79 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.47 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -85.97 -33.75 21.04 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.222 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.42 -44.61 95.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 121.416 -0.114 . . . . 0.0 111.019 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.0 m -69.8 -27.6 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.403 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -77.01 -25.25 52.43 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -69.55 -22.19 63.57 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -91.84 -6.81 50.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.34 10.63 55.64 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -124.84 89.77 3.13 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 117.646 0.723 . . . . 0.0 110.509 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.76 163.32 21.93 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.417 ' HB2' HG22 ' A' ' 6' ' ' VAL . . . -158.59 115.31 2.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.479 0.18 . . . . 0.0 110.736 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -72.39 111.57 7.7 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.449 0.3 . . . . 0.0 111.075 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.0 m -58.26 118.16 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.05 71.01 9.09 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.378 -1.296 . . . . 0.0 110.037 -178.966 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.6 mt . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -159.42 78.82 0.73 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -173.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.6 mp -79.25 102.62 8.67 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.868 0.366 . . . . 0.0 111.489 -165.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -92.48 94.03 8.87 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.5 t -65.73 136.4 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.476 1.11 . . . . 0.0 112.524 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -88.97 149.02 23.48 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.701 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.967 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 56.5 mtm -103.05 122.54 44.85 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.65 90.2 7.86 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.32 -14.76 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 122.129 0.172 . . . . 0.0 111.325 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.1 m -54.46 -47.35 73.04 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -173.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -66.74 -22.92 66.04 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.285 0.493 . . . . 0.0 112.11 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.42 -24.57 60.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 118.011 0.369 . . . . 0.0 111.295 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.77 -40.63 18.54 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -66.69 -24.06 66.21 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -172.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -80.54 -12.78 59.48 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.336 0.516 . . . . 0.0 111.974 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.1 t -73.13 128.5 87.64 Favored Pre-proline 0 N--CA 1.451 -0.416 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -54.21 131.58 45.76 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.643 2.895 . . . . 0.0 111.2 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.22 -19.85 52.16 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 119.83 -0.428 . . . . 0.0 112.05 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.4 t -74.53 129.52 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -117.77 -30.61 5.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -134.77 152.48 51.79 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.3 t -142.48 149.47 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -145.69 129.23 17.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.28 156.76 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 120.619 0.247 . . . . 0.0 110.371 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.6 t -126.69 101.38 6.61 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.3 -20.34 66.02 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -174.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -83.89 -31.13 25.87 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.424 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -101.73 -9.8 20.53 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.597 0.18 . . . . 0.0 111.382 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.14 21.85 75.79 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -96.38 156.09 16.49 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.06 125.11 12.82 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.147 0.579 . . . . 0.0 109.479 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.5 mm? -117.94 152.32 35.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.046 0.939 . . . . 0.0 108.64 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.47 165.23 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -136.68 86.44 2.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.69 -172.64 24.22 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.8 p -117.48 28.66 8.32 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.188 0.595 . . . . 0.0 110.513 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.12 169.84 17.22 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.678 0.275 . . . . 0.0 110.92 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -76.3 144.33 74.52 Favored Pre-proline 0 N--CA 1.452 -0.369 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.308 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -57.33 -38.78 93.7 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 123.294 2.663 . . . . 0.0 112.11 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -75.51 -37.19 60.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.431 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.43 -34.29 75.14 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -176.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 tp -71.52 -56.87 5.06 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.481 0.181 . . . . 0.0 110.613 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.2 t -67.64 -21.69 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 122.3 0.24 . . . . 0.0 111.542 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -86.56 -32.48 20.66 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.622 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.72 -44.33 96.74 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.668 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.6 m -68.83 -27.21 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -77.68 -21.68 51.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -69.7 -24.28 63.55 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -90.51 -7.17 53.64 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.09 0.16 61.91 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -107.65 91.05 3.49 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 117.663 0.732 . . . . 0.0 110.74 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.91 163.34 19.83 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 177.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -156.14 112.67 3.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.59 0.233 . . . . 0.0 110.982 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -71.21 108.28 4.63 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.8 m -58.27 119.52 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.9 mt -81.12 72.11 8.13 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.145 0 CA-C-O 117.181 -1.39 . . . . 0.0 109.377 -179.802 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 77.9 mt . . . . . 0 N--CA 1.45 -0.452 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -153.39 77.97 1.14 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -175.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 mp -78.53 101.46 7.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.316 -167.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -88.08 98.53 11.59 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.3 t -63.43 133.01 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 122.824 0.45 . . . . 0.0 110.927 -175.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -83.2 148.56 27.36 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.404 0.682 . . . . 0.0 109.715 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.57 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.69 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 72.6 mtm -150.82 162.47 40.68 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.58 91.59 0.6 Allowed 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.8 t -68.91 -14.44 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 36.0 m -52.51 -37.81 58.25 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.924 0.49 . . . . 0.0 111.352 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -62.55 -22.35 66.26 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.79 -25.66 30.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 118.04 0.382 . . . . 0.0 111.173 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.69 -35.95 51.64 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -177.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.73 -22.86 66.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -175.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -68.34 -18.06 64.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.274 0.488 . . . . 0.0 112.165 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.424 HG21 ' HA ' ' A' ' 51' ' ' LEU . 60.1 t -79.77 129.02 72.43 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-N 118.052 0.387 . . . . 0.0 110.069 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 62.2 Cg_exo -54.93 139.27 79.03 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 123.581 2.854 . . . . 0.0 111.413 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.41 -21.13 42.36 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.1 t -74.5 128.69 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -124.28 -26.9 3.88 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.793 0.27 . . . . 0.0 110.855 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -133.05 150.35 52.12 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.5 t -144.84 148.52 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -147.43 127.71 13.89 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 m -130.68 155.14 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 117.852 0.296 . . . . 0.0 110.871 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.1 t -129.02 100.07 5.51 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.98 -18.32 65.18 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.044 0.538 . . . . 0.0 112.126 -174.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -81.54 -29.89 33.34 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.927 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -103.62 -8.36 20.05 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.658 0.208 . . . . 0.0 111.229 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.03 23.47 78.07 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -96.91 155.56 16.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 117.737 0.769 . . . . 0.0 109.75 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.74 110.98 4.88 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.31 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.9 mm? -100.59 151.11 22.0 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.1 m -135.06 163.99 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 174.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -137.5 93.82 2.85 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.01 -171.22 26.68 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.9 p -114.28 28.15 8.96 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.787 0.435 . . . . 0.0 110.127 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.68 170.06 16.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.662 0.268 . . . . 0.0 110.875 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 14.9 t70 -90.61 148.56 38.91 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.487 177.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 47' ' ' ASP . 71.9 Cg_exo -57.76 -39.2 89.26 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.652 2.901 . . . . 0.0 112.915 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -75.35 -22.89 57.23 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.281 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.39 -35.09 58.81 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.315 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.424 ' HA ' HG21 ' A' ' 25' ' ' VAL . 10.7 tp -75.55 -46.01 34.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 121.32 -0.152 . . . . 0.0 111.079 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 63.7 t -67.19 -22.37 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 110.563 -0.162 . . . . 0.0 110.563 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -87.16 -30.04 21.33 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.08 -46.2 91.62 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.5 m -68.77 -19.91 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.475 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.456 ' OE1' ' HE2' ' A' ' 61' ' ' LYS . 45.7 tt0 -69.15 -20.4 64.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -68.84 -26.37 65.12 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -82.78 -11.39 58.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.9 8.14 59.39 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -132.69 101.87 5.46 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 117.286 0.543 . . . . 0.0 111.611 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.456 ' HE2' ' OE1' ' A' ' 56' ' ' GLU . 97.0 mttt -67.56 172.04 5.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -152.87 119.35 5.6 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.501 0.191 . . . . 0.0 110.62 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -68.84 109.04 3.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.512 0.725 . . . . 0.0 111.586 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 64' ' ' VAL . 30.6 m -58.81 108.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 174.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.0 mt -80.65 76.58 7.52 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 117.276 -1.345 . . . . 0.0 109.602 -177.625 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.5 mt . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -153.15 81.36 1.2 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.7 mp -75.12 103.46 5.3 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.45 -167.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -88.43 105.78 17.82 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.8 t -64.72 134.43 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 122.93 0.492 . . . . 0.0 111.146 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -85.12 146.19 27.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.617 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.708 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -147.4 161.65 40.6 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.628 0.371 . . . . 0.0 110.021 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.5 115.91 5.63 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.007 0.523 . . . . 0.0 110.36 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.7 t -69.48 -11.94 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.228 1.011 . . . . 0.0 111.239 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.6 m -48.72 -40.63 29.12 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -174.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.87 -23.37 67.32 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -174.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.9 -25.12 32.76 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.039 0.381 . . . . 0.0 110.848 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' A' ' 22' ' ' LEU . 3.9 mm? -84.29 -31.57 24.83 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -59.18 -23.2 62.04 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 121.232 -0.187 . . . . 0.0 111.428 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -72.01 -17.74 62.02 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.29 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.1 t -79.55 127.75 77.22 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -57.3 139.08 89.04 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.302 2.668 . . . . 0.0 111.112 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.01 -21.18 38.33 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.5 t -70.91 129.16 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -128.07 -27.63 2.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -131.48 150.23 52.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.6 t -146.06 151.06 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -145.31 127.83 16.04 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.1 m -131.73 156.01 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.192 -178.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.7 t -127.98 101.26 6.23 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 176.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.6 mt -66.04 -22.03 66.41 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -83.93 -31.34 25.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.386 0.539 . . . . 0.0 111.499 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -102.22 -8.5 21.25 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.61 0.186 . . . . 0.0 111.187 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.32 20.62 73.53 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -98.76 154.16 18.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.51 128.15 12.4 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.632 0.253 . . . . 0.0 110.54 -177.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.8 mm? -113.58 153.05 29.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.961 0.904 . . . . 0.0 109.456 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.08 163.28 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 174.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -141.31 95.59 2.85 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.79 -179.07 35.31 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.2 p -94.73 26.81 3.34 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.466 0.306 . . . . 0.0 110.58 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.09 174.03 10.56 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -107.92 155.73 39.44 Favored Pre-proline 0 N--CA 1.452 -0.326 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -58.89 -37.49 93.38 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.2 2.6 . . . . 0.0 111.972 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -73.98 -16.69 61.07 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 119.815 -0.135 . . . . 0.0 111.144 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.68 -33.63 14.98 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.43 HD11 HD12 ' A' ' 22' ' ' LEU . 10.9 tp -70.87 -59.64 2.68 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.546 -176.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.0 t -67.64 -22.45 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 122.19 0.196 . . . . 0.0 110.941 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -81.84 -33.72 30.52 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 122.27 -0.269 . . . . 0.0 110.532 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.11 -46.51 90.31 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.281 0.086 . . . . 0.0 110.984 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.45 -22.83 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -77.19 -22.4 52.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.381 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -70.05 -24.17 63.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -83.26 -9.05 59.34 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.82 10.56 34.78 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 119.364 -0.687 . . . . 0.0 113.063 175.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -131.8 125.65 32.41 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.589 1.195 . . . . 0.0 111.573 -177.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -69.88 167.06 18.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.579 177.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -153.82 95.64 1.9 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -66.78 105.4 1.56 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.124 0.57 . . . . 0.0 111.542 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 64' ' ' VAL . 27.0 m -58.96 109.02 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.9 mt -80.88 74.16 7.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.288 -1.339 . . . . 0.0 109.208 -179.734 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.8 mt . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -159.73 78.74 0.7 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -176.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.7 mp -77.25 103.07 6.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.73 -164.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -79.92 96.42 6.37 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.473 HG11 HG21 ' A' ' 18' ' ' VAL . 33.0 t -65.1 128.62 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 120.737 0.304 . . . . 0.0 110.368 -176.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -75.47 145.33 41.53 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.452 0.701 . . . . 0.0 110.021 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.335 0.525 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 178.232 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.9 p . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -149.5 160.65 43.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.35 111.82 11.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.473 HG21 HG11 ' A' ' 6' ' ' VAL . 20.9 t -68.13 -8.02 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 123.066 0.546 . . . . 0.0 110.026 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.3 m -41.84 -38.35 1.5 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.564 1.146 . . . . 0.0 112.928 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.27 -23.56 66.77 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 122.016 -0.428 . . . . 0.0 111.704 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.79 -24.25 33.51 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 22' ' ' LEU . 4.0 mm? -82.62 -34.85 27.43 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -177.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -61.86 -22.13 65.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -175.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -75.57 -15.92 60.31 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.4 t -77.67 128.93 78.27 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 118.299 0.5 . . . . 0.0 110.001 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.89 139.83 84.74 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.534 2.823 . . . . 0.0 111.112 177.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.92 -21.48 39.36 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 176.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.6 t -80.23 132.66 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -127.8 -29.95 2.56 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.513 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -133.99 152.02 51.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.1 t -144.48 150.33 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -177.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -141.83 125.94 17.36 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.0 m -133.14 158.54 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 120.462 0.173 . . . . 0.0 111.371 -175.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.7 t -126.47 104.45 8.15 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 176.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.4 mt -63.7 -20.86 66.06 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -173.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -84.1 -32.4 24.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.572 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -101.68 -9.66 20.7 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -175.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.9 24.15 72.81 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.056 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -95.79 154.4 17.24 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.96 108.72 3.85 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 41' ' ' LEU . 3.2 mm? -105.12 152.17 23.12 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.4 m -132.18 163.73 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -137.82 89.88 2.45 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -159.28 -169.83 23.1 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.7 p -118.22 28.03 8.61 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.986 0.514 . . . . 0.0 110.206 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.67 168.89 18.93 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 17.4 m-20 -78.82 154.31 78.12 Favored Pre-proline 0 N--CA 1.451 -0.412 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 47' ' ' ASP . 76.0 Cg_exo -59.02 -46.63 21.52 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.625 2.884 . . . . 0.0 112.15 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -75.74 -32.35 59.97 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.935 -0.12 . . . . 0.0 111.151 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.62 -32.43 74.08 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 121.432 -0.107 . . . . 0.0 110.755 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.2 tp -69.21 -50.97 42.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 121.155 -0.218 . . . . 0.0 110.488 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.3 t -69.35 -28.21 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 122.508 0.323 . . . . 0.0 111.077 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -75.1 -31.89 61.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.55 -54.97 40.34 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 122.43 0.292 . . . . 0.0 111.42 -177.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -72.51 -23.82 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 121.403 -0.119 . . . . 0.0 111.029 -177.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -72.74 -22.37 60.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -70.94 -25.07 62.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -79.95 -9.58 59.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.0 11.3 34.77 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 119.588 -0.562 . . . . 0.0 111.888 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -129.82 114.85 16.42 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 117.886 0.843 . . . . 0.0 110.692 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.6 169.68 3.75 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -152.54 92.94 1.73 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -68.45 104.62 1.95 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 122.947 0.499 . . . . 0.0 111.331 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 64' ' ' VAL . 26.7 m -58.24 113.53 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.05 76.25 6.79 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 CA-C-O 117.025 -1.464 . . . . 0.0 109.067 -177.282 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.5 mt . . . . . 0 N--CA 1.449 -0.506 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.483 ' HG3' HD11 ' A' ' 41' ' ' LEU . 78.3 tttt -156.31 76.41 0.9 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -175.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.0 mp -76.16 109.43 9.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -165.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.47 ' HB2' HD21 ' A' ' 65' ' ' LEU . 57.5 tttt -81.38 98.4 8.18 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.666 0.787 . . . . 0.0 109.218 173.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.4 t -70.47 107.97 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 117.797 0.271 . . . . 0.0 110.567 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -73.21 118.66 16.44 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.337 0.59 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.166 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.45 -0.453 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 74.8 mtm -142.3 160.12 40.87 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -177.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.73 92.0 5.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.38 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.6 t -70.46 -12.74 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.2 m -52.45 -42.23 63.98 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 122.927 0.491 . . . . 0.0 112.208 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -66.27 -22.26 66.3 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.36 -24.69 62.14 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.093 0.406 . . . . 0.0 110.518 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.412 HD22 ' N ' ' A' ' 22' ' ' LEU . 3.8 mm? -84.06 -35.04 24.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -65.19 -22.78 66.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -176.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -74.02 -14.51 61.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.41 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 51' ' ' LEU . 57.0 t -78.44 128.12 78.71 Favored Pre-proline 0 N--CA 1.451 -0.402 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -55.28 138.87 80.61 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.377 2.718 . . . . 0.0 111.066 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.6 -19.6 51.73 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.1 t -75.48 129.62 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -122.52 -28.27 4.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -133.26 150.4 51.92 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.0 t -145.29 149.54 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -146.36 126.42 13.72 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -131.45 156.07 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.35 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.4 t -129.2 102.91 6.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.56 -18.69 64.13 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.06 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -78.6 -29.79 46.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -100.36 -11.16 20.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.748 -0.093 . . . . 0.0 110.748 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.28 20.92 67.88 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -101.49 158.49 16.03 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.925 0.362 . . . . 0.0 110.463 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.1 110.7 5.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.483 HD11 ' HG3' ' A' ' 3' ' ' LYS . 2.9 mm? -101.07 152.65 20.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.64 162.23 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 175.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -142.23 86.46 1.97 Allowed 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.62 -173.54 26.17 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -177.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.8 p -112.59 28.1 9.06 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.623 0.369 . . . . 0.0 110.496 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.03 168.01 20.82 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -78.67 138.57 58.35 Favored Pre-proline 0 N--CA 1.45 -0.47 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -55.41 -36.44 93.99 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.266 2.644 . . . . 0.0 111.928 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -76.23 -32.7 59.04 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 121.387 -0.125 . . . . 0.0 110.72 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.35 -33.2 71.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.461 ' HA ' HG21 ' A' ' 25' ' ' VAL . 9.7 tp -65.9 -55.76 15.25 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.539 0.209 . . . . 0.0 110.757 -178.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 50.5 t -68.14 -22.96 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.738 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -75.9 -37.14 59.12 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.899 -0.321 . . . . 0.0 110.245 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.2 -47.72 83.19 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.332 0.11 . . . . 0.0 110.815 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.5 m -73.03 -25.1 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.875 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -76.07 -23.47 55.04 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -70.25 -24.98 63.16 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -79.76 -10.73 59.82 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.3 7.23 59.51 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -115.32 98.6 6.85 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -61.79 158.95 14.65 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -155.1 78.83 1.04 Allowed 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.96 139.23 40.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -58.15 137.4 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 122.612 0.365 . . . . 0.0 110.569 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 5' ' ' LYS . 85.8 mt -83.98 76.1 10.08 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.06 -1.448 . . . . 0.0 109.337 179.351 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 30.9 mt . . . . . 0 N--CA 1.452 -0.372 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -161.71 79.62 0.56 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -171.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.0 mp -80.13 125.39 29.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.721 -0.612 . . . . 0.0 111.838 -164.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -101.14 89.07 3.67 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 172.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.32 115.46 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 122.889 0.476 . . . . 0.0 110.47 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -70.75 148.41 47.97 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.26 0.624 . . . . 0.0 109.882 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.625 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.013 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.0 p . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 11.1 mmm -140.7 160.17 40.62 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.44 110.17 16.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.88 0.472 . . . . 0.0 111.247 -178.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.2 t -91.04 -16.52 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 31.6 m -55.78 -43.57 76.9 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -174.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.66 -21.6 66.1 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.305 -0.247 . . . . 0.0 111.23 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.69 -27.44 60.4 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.854 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 22' ' ' LEU . 4.1 mm? -84.88 -33.47 22.8 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.864 0.302 . . . . 0.0 111.77 -176.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -62.85 -21.7 66.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -173.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -78.03 -18.42 55.88 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -173.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.3 t -78.88 130.67 69.46 Favored Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-N 118.976 0.807 . . . . 0.0 110.224 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -55.27 141.89 80.03 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 124.071 3.181 . . . . 0.0 111.56 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.16 -21.87 39.81 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.2 t -71.29 127.68 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.24 -27.54 3.8 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.437 0.162 . . . . 0.0 111.437 -177.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -133.82 152.63 51.93 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.3 t -143.02 147.09 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.24 129.44 14.62 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.4 m -130.93 155.99 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 117.959 0.345 . . . . 0.0 110.624 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.1 t -129.4 101.32 5.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.7 mt -64.47 -20.05 65.94 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.234 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -82.3 -31.47 29.96 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 110.666 -0.124 . . . . 0.0 110.666 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -101.86 -10.03 20.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.35 21.92 78.58 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -98.95 155.56 17.35 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.589 0.694 . . . . 0.0 109.933 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.14 108.56 4.83 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.6 mm? -104.18 150.31 24.48 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.39 162.79 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 173.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -139.01 86.23 2.12 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.63 -171.01 20.35 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.8 p -115.8 28.1 8.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 122.851 0.46 . . . . 0.0 110.227 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.35 159.31 32.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 38.8 m-20 -83.82 152.77 63.39 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 47' ' ' ASP . 52.5 Cg_exo -60.24 -36.68 87.16 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.536 2.824 . . . . 0.0 112.121 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.437 ' HG2' ' H ' ' A' ' 49' ' ' LYS . 20.5 pttt -69.65 -19.65 63.61 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 119.744 -0.169 . . . . 0.0 110.758 -175.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.64 -34.79 15.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.168 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 tp -75.21 -49.48 19.24 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.911 -0.315 . . . . 0.0 111.666 -174.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.07 -25.82 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 121.201 -0.2 . . . . 0.0 110.878 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -80.95 -32.02 34.69 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.09 -45.32 94.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.538 0.335 . . . . 0.0 111.219 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.0 m -71.78 -24.03 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.004 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.4 ' OE2' ' HE2' ' A' ' 61' ' ' LYS . 50.1 tt0 -75.13 -20.95 59.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.83 -23.73 63.35 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -88.36 -7.93 55.88 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.82 12.73 49.23 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -128.15 100.82 6.0 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.94 0.87 . . . . 0.0 112.045 -175.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HE2' ' OE2' ' A' ' 56' ' ' GLU . 98.9 mttt -71.1 167.15 19.9 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -160.55 117.26 2.39 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.84 119.23 14.68 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.643 0.377 . . . . 0.0 110.913 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.2 m -59.41 117.55 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.8 mt -82.39 31.8 0.4 Allowed 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.747 0.419 . . . . 0.0 110.005 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.341 -1.314 . . . . 0.0 109.165 179.567 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 45.7 mt . . . . . 0 N--CA 1.452 -0.358 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -161.64 81.15 0.58 Allowed 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 -173.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.0 mp -79.97 109.43 14.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.827 -0.546 . . . . 0.0 112.007 -166.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -83.43 90.16 7.15 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 171.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.9 t -62.05 109.65 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -70.4 146.02 50.69 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.189 0.596 . . . . 0.0 110.208 -178.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.577 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 178.96 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 11.2 mmm -137.03 160.68 38.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.231 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.05 110.45 16.59 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.995 0.518 . . . . 0.0 110.145 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.1 t -95.94 -21.02 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.9 m -56.49 -40.91 75.74 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.186 -0.321 . . . . 0.0 111.73 -176.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.54 -21.52 66.71 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 119.524 -0.274 . . . . 0.0 111.566 -177.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.99 -27.02 39.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.07 0.395 . . . . 0.0 110.689 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.44 HD12 HD11 ' A' ' 51' ' ' LEU . 3.1 mm? -85.52 -34.41 21.55 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 121.161 -0.216 . . . . 0.0 110.67 -177.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -62.55 -22.2 66.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.474 0.175 . . . . 0.0 111.474 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -79.6 -13.98 59.14 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 119.633 -0.223 . . . . 0.0 111.57 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 54.2 t -79.32 126.48 81.25 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 64.3 Cg_exo -56.67 140.9 91.49 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.682 2.921 . . . . 0.0 111.513 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.67 -21.69 39.79 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.862 -0.495 . . . . 0.0 111.862 176.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.69 129.66 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -27.47 4.75 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 121.284 -0.167 . . . . 0.0 111.05 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -133.18 153.08 51.86 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 174.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.0 t -143.06 147.42 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.96 128.52 15.07 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.71 153.84 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.904 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.2 t -131.46 100.81 5.28 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.6 mt -64.97 -19.0 65.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 121.92 0.088 . . . . 0.0 110.952 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -82.03 -31.24 31.06 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -103.05 -10.18 19.12 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.55 22.36 79.02 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -98.56 155.15 17.43 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 117.618 0.709 . . . . 0.0 109.889 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.69 108.38 4.01 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.3 mm? -108.4 150.74 26.96 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.4 m -135.64 163.1 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 174.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -138.1 93.36 2.75 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.46 -172.8 29.29 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.7 p -111.27 28.59 8.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 122.87 0.468 . . . . 0.0 109.957 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.25 173.35 9.6 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 27.9 m-20 -104.03 153.57 38.77 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 47' ' ' ASP . 57.4 Cg_exo -58.58 -36.96 96.61 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.481 2.787 . . . . 0.0 112.179 -178.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.435 ' HG2' ' H ' ' A' ' 49' ' ' LYS . 21.0 pttt -68.68 -21.03 64.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.513 -0.18 . . . . 0.0 110.513 -176.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.43 -34.27 14.91 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 121.239 -0.184 . . . . 0.0 110.725 -178.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.44 HD11 HD12 ' A' ' 22' ' ' LEU . 9.5 tp -74.68 -47.74 29.97 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.28 -176.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.0 t -68.1 -35.72 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -69.23 -31.85 70.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.46 -55.05 38.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 121.946 0.098 . . . . 0.0 110.932 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.8 -23.92 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 121.181 -0.208 . . . . 0.0 110.698 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -73.56 -23.71 60.0 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -70.6 -24.41 62.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -83.91 -7.82 59.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.19 8.53 57.68 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -125.14 94.98 4.32 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 117.829 0.814 . . . . 0.0 111.04 -176.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -67.33 168.24 10.98 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -158.18 113.71 2.7 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -67.8 120.36 14.01 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.689 0.395 . . . . 0.0 110.818 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.404 ' C ' ' H ' ' A' ' 66' ' ' ALA . 14.4 m -60.09 111.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 172.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.7 mt -80.66 33.41 0.31 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.404 ' H ' ' C ' ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 117.298 -1.334 . . . . 0.0 108.937 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 74.0 mt . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 120.69 0.281 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -159.97 77.74 0.66 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -177.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.71 113.52 16.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -165.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 72.3 tttt -79.39 84.95 5.24 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.196 0.998 . . . . 0.0 108.36 173.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.59 108.93 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -71.09 148.62 47.31 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.956 0.502 . . . . 0.0 110.149 -178.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.624 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.999 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.5 mmt -140.57 159.79 41.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.69 90.3 5.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.7 t -69.14 -21.23 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.1 m -55.82 -37.27 68.44 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 122.335 0.254 . . . . 0.0 111.297 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.97 -22.42 66.8 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 119.597 -0.24 . . . . 0.0 111.336 -177.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.15 -24.26 32.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.023 0.374 . . . . 0.0 110.916 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.15 -48.13 12.54 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -66.33 -22.98 66.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -171.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -73.44 -15.49 61.34 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 118.255 0.48 . . . . 0.0 112.012 -176.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.3 t -76.96 129.35 78.93 Favored Pre-proline 0 N--CA 1.45 -0.426 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.85 140.51 47.79 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.473 2.782 . . . . 0.0 111.582 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.63 -20.82 44.59 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -78.77 130.97 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -125.15 -30.19 3.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -134.81 149.45 50.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.1 t -145.27 148.17 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -146.68 120.22 9.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.403 HG12 ' HA ' ' A' ' 40' ' ' ALA . 5.3 m -131.11 156.07 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.2 t -128.34 101.56 6.28 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.8 mt -63.83 -16.1 60.46 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.328 0.651 . . . . 0.0 112.124 -174.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -75.58 -36.51 60.33 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.207 0.458 . . . . 0.0 111.576 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -104.54 -8.19 19.2 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.784 0.265 . . . . 0.0 111.662 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.64 22.82 68.8 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.466 -0.63 . . . . 0.0 113.603 175.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.37 155.86 17.02 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.342 1.071 . . . . 0.0 108.825 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.403 ' HA ' HG12 ' A' ' 33' ' ' VAL . . . -146.52 110.17 4.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.4 mm? -104.55 153.27 21.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.23 162.01 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -138.75 79.23 1.72 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 177.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.56 -170.78 20.04 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.5 p -115.11 28.05 8.97 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.742 0.417 . . . . 0.0 110.589 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.46 172.16 13.01 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.434 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 6.1 t70 -102.5 140.68 21.33 Favored Pre-proline 0 N--CA 1.453 -0.297 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -177.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 47' ' ' ASP . 74.8 Cg_exo -50.68 -36.61 51.45 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 124.416 3.41 . . . . 0.0 115.357 -175.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.421 ' HG2' ' H ' ' A' ' 49' ' ' LYS . 21.2 pttt -69.49 -18.09 63.66 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.686 0.676 . . . . 0.0 110.69 -175.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.89 -34.42 16.08 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.691 -0.403 . . . . 0.0 111.498 -175.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.9 tp -70.87 -50.4 35.6 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.802 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.8 t -68.27 -22.95 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.269 -176.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -86.77 -34.33 19.64 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.011 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.33 94.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.848 -0.16 . . . . 0.0 110.634 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.81 -23.64 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.513 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.403 ' OE2' ' HE2' ' A' ' 61' ' ' LYS . 35.3 tt0 -74.71 -21.84 59.16 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -69.37 -23.46 63.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -93.2 -5.91 48.97 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.81 6.45 59.36 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -116.52 90.1 3.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.705 0.752 . . . . 0.0 110.776 -177.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.403 ' HE2' ' OE2' ' A' ' 56' ' ' GLU . 99.6 mttt -68.57 165.74 18.53 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 5' ' ' LYS . . . -158.12 117.03 3.14 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.51 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -73.89 111.62 9.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.113 0.565 . . . . 0.0 110.845 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -58.65 136.47 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.9 mt -94.3 32.16 1.59 Allowed 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.278 -0.264 . . . . 0.0 111.174 -178.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 116.972 -1.489 . . . . 0.0 109.308 177.782 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 58.1 mt . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -156.91 78.81 0.91 Allowed 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 -174.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.2 mp -80.46 106.63 12.62 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -163.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -80.58 84.54 6.14 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 171.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.2 t -66.29 132.54 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 O-C-N 122.522 -0.111 . . . . 0.0 110.713 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -88.58 142.97 27.26 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.716 0 CA-C-O 119.656 -0.525 . . . . 0.0 112.047 -178.692 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.7 p . . . . . 0 N--CA 1.453 -0.315 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 60.6 mtt -136.54 160.19 39.51 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.21 93.03 9.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.4 t -66.85 -12.42 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.1 m -50.14 -39.34 42.98 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.132 0.573 . . . . 0.0 111.674 -177.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -63.31 -22.74 67.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -176.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.84 -25.51 32.54 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 117.902 0.319 . . . . 0.0 110.616 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 22' ' ' LEU . 3.3 mm? -82.46 -32.85 28.7 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 -176.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -64.5 -23.25 67.21 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -77.05 -11.98 59.88 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.612 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.1 t -78.84 129.72 72.66 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.61 136.38 73.84 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.398 2.732 . . . . 0.0 111.226 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.92 -20.9 39.64 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.98 128.75 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -125.37 -26.34 3.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -131.88 152.1 51.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.7 t -140.44 148.56 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -144.14 86.93 1.86 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.5 m -96.12 155.5 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.5 t -128.2 100.72 5.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.8 mt -64.54 -19.24 65.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.144 -174.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -83.3 -27.2 29.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -97.82 -11.44 23.29 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 119.806 -0.14 . . . . 0.0 111.167 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.08 20.55 74.91 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -109.12 156.18 20.13 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.32 110.23 6.46 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.4 mm? -109.66 151.49 26.81 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.402 HG11 HD11 ' A' ' 51' ' ' LEU . 33.7 m -133.47 166.08 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -134.22 84.66 2.13 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.6 -172.27 23.73 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -176.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.1 p -112.73 29.32 8.04 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.643 0.777 . . . . 0.0 110.525 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.65 172.7 11.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.583 0.23 . . . . 0.0 110.724 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -103.06 157.88 32.87 Favored Pre-proline 0 N--CA 1.453 -0.308 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -57.76 -39.47 87.1 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.585 2.856 . . . . 0.0 112.352 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 pttt -72.41 -17.11 61.83 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.116 -176.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.8 -37.76 13.43 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.298 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.437 HD11 HD12 ' A' ' 22' ' ' LEU . 9.5 tp -76.25 -49.66 16.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.033 -176.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.71 -24.92 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 116.982 -0.099 . . . . 0.0 110.736 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -83.71 -29.81 27.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.92 -46.41 89.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.52 -23.84 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -74.06 -21.03 60.09 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -68.87 -23.34 64.2 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -92.53 -6.04 50.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.88 9.32 57.42 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -121.54 92.88 3.84 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.801 0.8 . . . . 0.0 111.546 -175.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.95 169.46 4.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -153.54 117.53 4.79 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.733 0.301 . . . . 0.0 110.608 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -71.59 110.51 6.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.492 0.717 . . . . 0.0 110.819 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -58.26 113.86 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.0 mt -82.87 34.62 0.45 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.443 0.297 . . . . 0.0 110.532 -177.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 116.885 -1.531 . . . . 0.0 109.615 -179.2 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 64.2 mt . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.496 ' HE2' ' OE1' ' A' ' 39' ' ' GLU . 82.2 tttt -156.21 81.25 0.99 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -175.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.3 mp -75.73 102.57 5.46 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.955 -167.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -85.48 102.86 13.84 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.4 t -65.24 135.88 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 123.271 0.628 . . . . 0.0 110.814 -177.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -77.36 146.96 36.37 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.336 0.549 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.209 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -137.7 158.98 43.23 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.409 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . . . -78.11 93.61 4.56 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.4 t -66.35 -15.3 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.9 m -54.43 -35.67 63.18 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.201 0.6 . . . . 0.0 110.788 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.409 ' HE3' ' HB3' ' A' ' 17' ' ' ALA . 96.6 mttt -58.58 -26.32 63.5 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 119.727 -0.177 . . . . 0.0 111.337 -177.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.69 -25.97 28.04 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 117.735 0.243 . . . . 0.0 110.71 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 22' ' ' LEU . 3.1 mm? -83.52 -34.7 25.24 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -177.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -63.22 -22.04 66.61 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -73.37 -12.06 60.69 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 122.483 -0.135 . . . . 0.0 111.221 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.404 HG12 ' HB2' ' A' ' 46' ' ' ALA . 69.4 t -78.9 130.86 68.84 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -56.06 129.69 36.25 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.997 3.131 . . . . 0.0 112.226 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.33 -26.34 12.09 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 112.156 -0.377 . . . . 0.0 112.156 174.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.523 ' HA ' ' HA3' ' A' ' 44' ' ' GLY . 61.1 t -71.91 129.14 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -126.94 -23.46 3.64 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.825 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -128.33 151.59 49.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.6 t -144.38 151.51 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -140.17 96.12 3.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.7 m -96.4 156.04 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.407 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.0 t -127.54 102.13 6.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.8 mt -64.4 -18.97 65.19 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.753 -174.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -83.71 -30.63 26.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 117.821 0.282 . . . . 0.0 110.727 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -98.26 -13.82 20.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 121.53 -0.068 . . . . 0.0 110.82 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.9 19.61 65.73 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.496 ' OE1' ' HE2' ' A' ' 3' ' ' LYS . 98.9 mt-10 -102.1 157.39 16.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -178.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.29 118.95 9.15 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.661 0.267 . . . . 0.0 110.337 -177.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 41' ' ' LEU . 3.2 mm? -101.77 152.7 20.56 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -133.85 164.49 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.708 0.289 . . . . 0.0 111.01 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -138.67 99.35 3.79 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.523 ' HA3' ' HA ' ' A' ' 28' ' ' VAL . . . -160.74 -175.14 31.43 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.8 p -112.42 25.52 11.42 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.546 0.338 . . . . 0.0 110.226 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.404 ' HB2' HG12 ' A' ' 25' ' ' VAL . . . -77.5 170.12 17.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 122.415 -0.178 . . . . 0.0 110.956 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -88.2 156.64 51.46 Favored Pre-proline 0 N--CA 1.452 -0.356 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -56.16 -37.02 97.22 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.551 2.834 . . . . 0.0 112.468 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -70.04 -41.15 74.61 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.284 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.86 -31.32 66.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -176.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.403 HD11 HD12 ' A' ' 22' ' ' LEU . 12.2 tp -73.22 -60.73 2.1 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 111.461 0.171 . . . . 0.0 111.461 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.1 t -69.57 -23.06 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 122.192 0.197 . . . . 0.0 111.481 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -79.02 -34.75 43.68 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.67 -55.12 37.0 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.807 -0.179 . . . . 0.0 110.882 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.63 -24.56 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -72.61 -37.41 68.1 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -72.21 -23.25 61.21 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -75.36 -4.48 39.57 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 176.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.8 4.1 58.01 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 119.246 -0.752 . . . . 0.0 113.055 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -135.22 114.11 11.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.578 1.189 . . . . 0.0 111.072 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.27 169.17 2.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -155.91 100.08 2.02 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.527 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -69.68 106.28 3.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.951 0.5 . . . . 0.0 111.58 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.7 m -58.78 106.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 174.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.8 mt -80.62 76.95 7.48 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 116.87 -1.538 . . . . 0.0 109.512 -178.267 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 75.6 mt . . . . . 0 N--CA 1.451 -0.388 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -159.65 76.58 0.67 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -176.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.5 mp -78.43 122.78 26.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.693 0.282 . . . . 0.0 111.451 -166.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -99.48 91.37 4.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.6 130.09 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 122.469 0.308 . . . . 0.0 110.555 -175.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -78.37 146.86 34.39 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.638 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.998 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 N--CA 1.45 -0.44 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -135.89 159.64 41.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.24 95.95 2.2 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.8 t -67.74 -13.8 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.4 m -54.01 -36.35 62.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.7 0.4 . . . . 0.0 110.438 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -59.22 -23.4 62.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 119.773 -0.156 . . . . 0.0 111.078 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.26 -32.95 26.15 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.52 -36.42 60.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -66.5 -21.43 66.18 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -174.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -78.26 -17.14 57.06 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 54.7 t -78.64 128.06 78.44 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.845 -177.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 69.8 Cg_exo -55.44 141.43 82.24 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.703 2.935 . . . . 0.0 111.465 177.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.57 -22.6 32.32 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.7 t -76.29 129.97 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -124.69 -27.02 3.72 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -132.78 149.55 52.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.8 t -145.81 149.68 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -146.23 126.69 14.09 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 m -129.18 154.63 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-O 120.801 0.334 . . . . 0.0 110.52 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.5 t -128.27 104.6 7.83 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.9 mt -64.07 -23.32 67.28 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 122.593 0.357 . . . . 0.0 111.93 -173.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -84.68 -41.67 16.05 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 118.269 0.486 . . . . 0.0 110.544 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -82.48 -10.99 58.79 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.789 -0.187 . . . . 0.0 110.685 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.58 21.71 67.19 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -99.1 156.63 16.85 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 117.634 0.717 . . . . 0.0 110.257 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.85 108.47 4.0 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.461 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.9 mm? -100.58 149.16 24.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.3 m -135.93 162.31 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -139.15 95.49 2.95 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.34 -175.75 33.7 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -177.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.0 p -106.02 26.71 9.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 122.681 0.392 . . . . 0.0 110.515 -178.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.03 170.69 15.79 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -92.92 156.52 40.5 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.14 -50.69 12.22 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.872 3.048 . . . . 0.0 112.204 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -70.47 -30.48 67.31 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 121.126 -0.23 . . . . 0.0 110.889 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.01 -33.48 75.91 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.8 tp -74.11 -52.6 12.1 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.486 0.184 . . . . 0.0 110.61 -177.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.61 -25.46 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.813 -0.176 . . . . 0.0 111.3 -177.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -72.06 -33.14 67.73 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.083 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.25 -49.44 75.71 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.155 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 m -72.78 -23.59 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 117.705 0.229 . . . . 0.0 110.853 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -69.13 -34.11 74.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -70.85 -23.18 62.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -80.61 -8.08 59.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.86 12.56 52.62 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.569 -0.613 . . . . 0.0 111.569 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -124.51 111.17 15.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 117.777 0.788 . . . . 0.0 111.114 -176.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.72 165.62 8.14 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -162.66 79.57 0.49 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.646 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -71.35 127.92 34.18 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -60.73 135.29 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 175.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.4 mt -108.46 59.48 0.61 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.057 0 CA-C-O 117.042 -1.456 . . . . 0.0 108.944 -179.125 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.2 mt . . . . . 0 N--CA 1.453 -0.303 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 40.0 tttt -161.8 77.46 0.52 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -175.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.5 mp -79.08 122.51 26.31 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 121.83 -0.544 . . . . 0.0 111.77 -166.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -100.15 92.95 5.46 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 175.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.6 t -65.56 132.52 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 122.772 0.429 . . . . 0.0 111.567 -174.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -80.06 144.38 33.22 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.537 0.735 . . . . 0.0 109.751 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.621 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 178.182 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p . . . . . 0 N--CA 1.45 -0.435 0 CA-C-O 120.658 0.266 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -129.55 161.53 30.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.9 91.14 0.45 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.88 -14.15 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.4 m -54.28 -36.89 64.14 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.013 0.525 . . . . 0.0 110.5 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.71 -29.25 67.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 121.357 -0.137 . . . . 0.0 111.198 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.43 -24.43 50.39 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 117.622 0.192 . . . . 0.0 110.807 -177.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.48 -39.08 20.97 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.8 tttt -67.82 -22.13 65.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -173.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -73.28 -17.78 61.28 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.657 0.662 . . . . 0.0 111.743 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 60.6 t -76.25 128.71 82.08 Favored Pre-proline 0 N--CA 1.449 -0.492 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 82.3 Cg_exo -52.26 139.92 53.04 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.67 2.913 . . . . 0.0 111.691 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.88 -21.56 35.95 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 177.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -77.48 116.36 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -116.48 -24.17 7.96 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.15 148.9 51.14 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -145.89 148.25 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -146.89 120.9 9.38 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 m -131.63 155.9 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.649 -177.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.6 t -129.41 104.03 7.25 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.8 mt -64.19 -18.5 64.54 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.576 0.35 . . . . 0.0 111.081 -176.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -84.22 -29.97 26.1 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 117.462 0.119 . . . . 0.0 111.029 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -100.04 -10.6 21.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 121.924 0.09 . . . . 0.0 111.06 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.33 19.4 70.47 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -100.72 154.94 18.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.35 119.17 7.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.485 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.3 mm? -117.12 151.73 36.23 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -178.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.87 162.44 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -139.16 84.7 2.02 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.7 -177.45 29.85 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.9 p -93.31 28.09 2.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.037 0.535 . . . . 0.0 110.708 -178.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.05 173.97 10.0 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 122.375 -0.203 . . . . 0.0 111.063 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -107.12 156.62 37.15 Favored Pre-proline 0 N--CA 1.452 -0.337 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -56.92 -52.79 6.02 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.728 2.952 . . . . 0.0 112.906 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -71.3 -32.49 68.69 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 121.124 -0.231 . . . . 0.0 110.898 -176.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.2 -33.13 75.06 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.6 tp -71.93 -51.52 21.72 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.976 -178.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.5 t -68.94 -27.93 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 121.379 -0.128 . . . . 0.0 111.007 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -67.97 -33.18 74.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.17 -55.82 21.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.075 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.26 -23.61 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -175.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.18 -34.82 68.73 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 120.601 -0.439 . . . . 0.0 109.841 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -71.55 -23.46 61.76 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -74.83 -8.48 56.57 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.24 12.55 51.5 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -127.69 98.41 5.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 117.115 0.458 . . . . 0.0 110.347 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -62.4 161.55 11.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -161.5 92.81 0.9 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.107 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -77.82 129.42 35.4 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -60.94 135.02 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.401 ' H ' ' HB3' ' A' ' 3' ' ' LYS . 80.1 mt -109.34 31.33 5.84 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.5 0.32 . . . . 0.0 110.217 177.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.494 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 116.752 -1.594 . . . . 0.0 109.179 -178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.505 ' HG2' ' H ' ' A' ' 2' ' ' LEU . 9.5 ttm . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.505 ' H ' ' HG2' ' A' ' 1' ' ' MET . 72.5 mt -117.44 150.97 38.02 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 118.084 0.402 . . . . 0.0 110.932 -176.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -164.47 79.38 0.37 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 -177.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 mp -79.27 108.91 13.13 Favored 'General case' 0 N--CA 1.452 -0.36 0 O-C-N 121.824 -0.547 . . . . 0.0 112.084 -164.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -78.74 87.0 4.65 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 173.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.7 t -63.38 109.05 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -70.82 147.94 48.38 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 122.887 0.475 . . . . 0.0 110.208 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.27 66.45 2.4 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 177.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 94.1 mtp -67.55 -36.93 81.92 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 122.341 0.256 . . . . 0.0 111.238 -176.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 46.7 p -138.81 166.04 25.46 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 83.2 m 48.44 36.2 6.92 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.034 0.534 . . . . 0.0 111.129 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -67.01 -10.81 53.7 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 121.857 0.063 . . . . 0.0 110.922 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -82.91 -8.84 59.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 176.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 83.6 m -130.05 -169.71 2.18 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.471 0.709 . . . . 0.0 109.335 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.8 p -139.88 154.18 23.55 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 177.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.5 mmt -140.38 161.24 38.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.63 127.14 35.87 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.416 HG12 ' CD2' ' A' ' 22' ' ' LEU . 22.9 t -96.63 -13.38 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 24.0 m -53.39 -41.43 65.91 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -174.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -67.32 -22.43 65.61 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.863 0.301 . . . . 0.0 111.697 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.05 -34.83 59.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 118.039 0.381 . . . . 0.0 110.871 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.416 ' CD2' HG12 ' A' ' 18' ' ' VAL . 3.8 mm? -74.3 -38.61 63.31 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 111.991 0.367 . . . . 0.0 111.991 -173.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -65.68 -22.07 66.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -174.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -66.31 -18.68 65.5 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.898 -176.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 55.1 t -80.21 129.92 67.87 Favored Pre-proline 0 N--CA 1.451 -0.423 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 72.2 Cg_exo -52.88 140.67 57.67 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.634 2.889 . . . . 0.0 111.504 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.52 -21.26 41.89 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 176.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.1 t -78.05 127.91 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.77 -24.53 3.23 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 110.638 -0.134 . . . . 0.0 110.638 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -128.05 147.0 50.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.7 t -146.12 146.62 18.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -149.11 131.1 15.28 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -126.81 156.13 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.3 t -128.41 101.05 6.03 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.27 -22.34 66.84 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.316 -175.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -84.92 -29.04 25.48 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.555 0.162 . . . . 0.0 111.151 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -97.85 -9.84 25.71 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 121.181 -0.208 . . . . 0.0 111.412 -177.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.22 23.1 78.47 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 177.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.3 mt-10 -114.76 158.16 22.23 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 117.723 0.762 . . . . 0.0 110.913 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -141.95 110.82 6.22 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.045 0.938 . . . . 0.0 109.121 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.497 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.4 mm? -108.35 150.7 26.99 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 -178.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.7 m -134.73 164.38 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -139.03 89.27 2.34 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.22 -173.99 23.08 Favored Glycine 0 CA--C 1.522 0.501 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -177.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.0 p -113.43 28.85 8.45 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.969 0.507 . . . . 0.0 110.517 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.89 170.23 16.35 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -178.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -80.32 155.55 74.27 Favored Pre-proline 0 N--CA 1.452 -0.366 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -59.11 -44.97 30.44 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 123.489 2.792 . . . . 0.0 112.091 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.1 pttt -75.08 -29.02 60.54 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 110.433 -0.21 . . . . 0.0 110.433 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.32 -34.08 76.6 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 121.233 -0.187 . . . . 0.0 110.565 -176.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.9 tp -73.28 -51.38 17.81 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.619 0.247 . . . . 0.0 110.567 -177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.7 -23.15 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.189 -176.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -80.78 -33.83 34.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.69 96.34 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.231 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -71.76 -25.79 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.812 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -73.92 -21.33 60.09 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -68.92 -24.32 64.28 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 -89.68 -7.47 54.56 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.35 9.06 57.15 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -122.89 95.68 4.72 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.705 0.753 . . . . 0.0 110.796 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -66.88 168.15 10.28 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -155.27 117.66 4.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.252 -178.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -69.21 106.94 3.03 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.158 0.583 . . . . 0.0 111.349 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.4 m -59.21 110.04 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 173.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.4 mt -80.96 74.44 7.95 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 CA-C-O 117.368 -1.301 . . . . 0.0 109.726 -179.195 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.8 ttt . . . . . 0 N--CA 1.471 0.621 0 N-CA-C 110.236 -0.283 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.3 mt -59.58 136.62 58.04 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -147.54 83.96 1.55 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.35 170.03 9.58 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.346 0.594 . . . . 0.0 112.587 -173.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -151.4 96.65 2.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.61 1.164 . . . . 0.0 107.967 177.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 7' ' ' GLU . 33.4 t -59.77 170.9 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.483 ' N ' HG12 ' A' ' 6' ' ' VAL . 7.8 tp10 -125.43 150.97 46.81 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 62.14 -1.87 1.24 Allowed Glycine 0 CA--C 1.527 0.803 0 C-N-CA 123.701 0.667 . . . . 0.0 112.225 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.437 ' HE3' ' HA ' ' A' ' 9' ' ' MET . 6.1 tpt -69.22 -15.08 63.3 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 117.935 0.868 . . . . 0.0 110.015 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 35.0 p -86.96 174.38 8.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.5 m 50.35 9.0 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.168 0.987 . . . . 0.0 113.29 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -61.6 175.84 0.57 Allowed 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 118.078 0.399 . . . . 0.0 110.501 -179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 38.0 m-70 -130.05 -7.67 4.38 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 70.9 m -143.12 84.26 1.82 Allowed 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.4 HG22 ' N ' ' A' ' 16' ' ' MET . 10.7 p -56.85 164.68 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.271 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.4 ' N ' HG22 ' A' ' 15' ' ' VAL . 75.8 mtm -139.87 -175.33 4.18 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -122.93 95.67 4.71 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.476 ' C ' ' H ' ' A' ' 20' ' ' LYS . 13.0 t -65.43 -1.51 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 123.012 0.525 . . . . 0.0 110.034 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 8.9 m -63.79 6.61 0.15 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.322 0.649 . . . . 0.0 110.772 178.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.476 ' H ' ' C ' ' A' ' 18' ' ' VAL . 98.4 mttt -120.39 6.95 10.63 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 122.849 0.46 . . . . 0.0 110.756 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -118.51 -1.41 11.21 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 22' ' ' LEU . 2.7 mm? -122.81 -0.42 9.07 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -98.52 -12.73 20.95 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -85.26 -10.63 56.29 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 120.059 -0.656 . . . . 0.0 110.18 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 61.0 t -76.71 123.17 87.54 Favored Pre-proline 0 N--CA 1.45 -0.46 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.16 166.48 2.26 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.306 2.671 . . . . 0.0 111.207 178.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.81 -13.98 1.19 Allowed Glycine 0 CA--C 1.526 0.769 0 CA-C-O 119.412 -0.66 . . . . 0.0 112.54 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.8 t -79.27 159.3 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 118.373 1.087 . . . . 0.0 108.537 177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -147.63 -18.56 0.37 Allowed 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -146.25 163.58 35.01 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 177.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.2 t -150.92 152.6 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -144.82 152.83 40.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 175.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 28.0 m -153.11 178.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 -177.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 36.5 t -147.16 102.25 3.48 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.5 mt -66.15 -1.13 2.93 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 122.702 0.401 . . . . 0.0 111.745 -177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -116.6 1.64 12.9 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 117.986 0.357 . . . . 0.0 110.446 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm -132.99 -10.07 3.01 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.8 -3.73 6.25 Favored Glycine 0 CA--C 1.528 0.846 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -72.77 166.07 23.61 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 117.78 0.79 . . . . 0.0 109.883 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.413 ' C ' HD12 ' A' ' 41' ' ' LEU . . . -156.08 154.07 30.38 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 176.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.413 HD12 ' C ' ' A' ' 40' ' ' ALA . 5.3 mp -145.88 169.1 19.26 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.9 m -149.26 172.13 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 176.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -143.15 97.69 3.13 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -169.74 174.01 43.96 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 81.7 p -80.85 7.05 11.36 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.706 0.802 . . . . 0.0 111.844 -177.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.03 173.62 0.15 Allowed 'General case' 0 N--CA 1.453 -0.304 0 CA-C-O 120.688 0.28 . . . . 0.0 111.084 -178.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -122.96 162.57 38.36 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -60.19 -28.84 87.75 Favored 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 123.55 2.833 . . . . 0.0 111.923 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -88.18 3.32 49.75 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.398 0.279 . . . . 0.0 111.065 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -126.94 -0.68 6.59 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 12.7 tp -119.13 -0.74 11.01 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 58.1 t -124.09 -25.26 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -76.15 -12.69 60.15 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -84.87 -57.61 3.04 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.327 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.79 -24.02 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 110.546 -0.168 . . . . 0.0 110.546 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -79.4 -18.09 53.0 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -85.21 -20.21 30.5 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -83.76 -3.45 57.83 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 122.774 0.43 . . . . 0.0 110.184 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 90.75 2.35 72.44 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 111.762 -0.535 . . . . 0.0 111.762 178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -134.0 81.93 1.95 Allowed 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 117.517 0.659 . . . . 0.0 109.726 -178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -60.72 168.95 2.03 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 120.78 0.324 . . . . 0.0 110.407 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -153.91 105.19 2.73 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -66.39 170.93 5.37 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 34.1 m -86.58 -178.86 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-O 120.878 0.371 . . . . 0.0 110.246 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.6 mt -136.71 5.24 2.87 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 123.966 0.906 . . . . 0.0 108.843 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 117.043 -1.456 . . . . 0.0 108.976 179.527 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.2 ttm . . . . . 0 N--CA 1.47 0.575 0 N-CA-C 109.789 -0.448 . . . . 0.0 109.789 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 77.8 mt -86.73 152.92 22.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 -178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -155.12 79.41 1.05 Allowed 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 -174.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.1 mp -77.73 103.84 7.91 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.269 -163.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -80.68 100.52 8.74 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 171.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.9 t -60.28 147.8 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 124.312 1.045 . . . . 0.0 111.427 -176.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -58.93 162.54 4.09 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.189 1.395 . . . . 0.0 107.999 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.68 44.31 0.37 Allowed Glycine 0 CA--C 1.526 0.772 0 CA-C-O 119.67 -0.517 . . . . 0.0 114.039 -168.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.587 ' CG ' ' CG ' ' A' ' 60' ' ' TYR . 95.8 mtp -63.1 -28.96 70.43 Favored 'General case' 0 N--CA 1.451 -0.41 0 O-C-N 122.341 -0.506 . . . . 0.0 110.302 169.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 67.4 p -81.18 155.78 26.01 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -164.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.9 m 46.06 26.99 0.47 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 126.627 1.971 . . . . 0.0 113.844 173.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.532 ' CG ' ' H ' ' A' ' 13' ' ' HIS . 15.5 p-10 -90.66 -59.98 2.04 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 116.595 -2.042 . . . . 0.0 109.131 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.532 ' H ' ' CG ' ' A' ' 12' ' ' ASN . 75.2 m-70 -126.71 -37.41 2.15 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 122.989 0.516 . . . . 0.0 110.413 167.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.6 m -134.26 -169.47 2.33 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 114.766 -1.106 . . . . 0.0 113.489 -166.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.43 156.32 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 125.714 1.606 . . . . 0.0 107.859 176.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 64.8 mtt -140.97 159.89 41.25 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.01 88.34 7.62 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.9 t -69.81 -14.57 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 122.493 0.317 . . . . 0.0 110.196 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -56.6 -39.59 73.83 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 122.264 -0.273 . . . . 0.0 110.808 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.65 -21.52 66.56 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-O 119.569 -0.253 . . . . 0.0 111.482 -177.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -76.54 -39.78 51.84 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 117.852 0.297 . . . . 0.0 110.414 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 22' ' ' LEU . 3.9 mm? -75.87 -32.65 59.81 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 110.401 -0.222 . . . . 0.0 110.401 -177.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -60.29 -21.42 61.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 112.611 0.596 . . . . 0.0 112.611 -174.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -79.7 -17.99 52.31 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 118.157 0.435 . . . . 0.0 111.623 -178.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 65.0 t -70.98 128.02 91.07 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 117.751 0.25 . . . . 0.0 110.438 -174.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 46' ' ' ALA . 50.4 Cg_exo -58.47 137.23 79.21 Favored 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 123.444 2.763 . . . . 0.0 110.86 177.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.08 -25.06 15.42 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.382 -0.687 . . . . 0.0 111.382 176.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.439 ' HA ' ' HA3' ' A' ' 44' ' ' GLY . 54.7 t -72.58 129.62 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 177.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -126.24 -25.91 3.44 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.737 -0.21 . . . . 0.0 110.678 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -130.42 148.61 52.26 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 90.7 t -146.51 147.65 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -146.43 129.25 16.27 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.759 -1.201 . . . . 0.0 107.759 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -130.43 158.72 42.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 CA-C-O 120.89 0.376 . . . . 0.0 111.613 -174.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.0 t -126.86 101.93 6.8 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 79.6 mt -63.89 -25.26 68.07 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -173.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 89.6 mt-10 -85.16 -30.04 24.27 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.588 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -99.38 -11.03 21.54 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 111.825 0.305 . . . . 0.0 111.825 -175.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.14 24.49 76.99 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -98.6 154.73 17.71 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 117.76 0.78 . . . . 0.0 109.577 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.32 109.85 4.43 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.444 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.481 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.9 mm? -100.25 139.12 36.38 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.1 m -135.33 162.97 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 177.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -139.0 101.33 4.26 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 175.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.439 ' HA3' ' HA ' ' A' ' 28' ' ' VAL . . . -156.73 -175.68 27.94 Favored Glycine 0 N--CA 1.448 -0.558 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 -177.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.4 p -114.61 26.04 10.53 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 122.898 0.479 . . . . 0.0 109.801 -179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 26' ' ' PRO . . . -76.22 167.88 21.06 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 116.713 -0.221 . . . . 0.0 110.613 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.15 144.53 71.66 Favored Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 176.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -56.01 -37.53 96.05 Favored 'Trans proline' 0 N--CA 1.449 -1.112 0 C-N-CA 122.864 2.376 . . . . 0.0 111.457 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -75.62 -33.98 60.55 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 110.373 -0.232 . . . . 0.0 110.373 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.95 -33.64 76.02 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.41 HD11 HD12 ' A' ' 22' ' ' LEU . 11.5 tp -70.19 -50.44 40.13 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 -179.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.7 t -68.66 -22.57 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -82.67 -32.28 28.21 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.48 -45.38 93.95 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.9 m -73.94 -23.89 19.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 C-N-CA 120.807 -0.357 . . . . 0.0 110.099 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.405 ' OE2' ' HE2' ' A' ' 61' ' ' LYS . 42.6 tt0 -70.77 -19.6 62.69 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.02 -23.74 65.03 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -91.45 -13.57 32.06 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.85 10.37 57.71 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 178.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.587 ' CG ' ' CG ' ' A' ' 9' ' ' MET . 40.7 m-85 -131.12 88.18 2.57 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -175.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.405 ' HE2' ' OE2' ' A' ' 56' ' ' GLU . 88.5 mttt -64.44 178.47 0.72 Allowed 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.612 0.765 . . . . 0.0 110.227 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -154.19 101.86 2.42 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.187 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -69.19 120.41 14.99 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 122.715 0.406 . . . . 0.0 110.918 178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.7 m -59.06 130.02 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 175.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.5 mt -83.71 34.15 0.49 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.109 0 CA-C-O 116.851 -1.547 . . . . 0.0 109.399 -178.792 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ttt . . . . . 0 N--CA 1.47 0.536 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.9 mt -90.04 151.78 21.48 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -178.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.469 ' HG3' HD11 ' A' ' 41' ' ' LEU . 79.4 tttt -160.24 77.52 0.64 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 -174.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.3 mp -81.14 127.24 32.44 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 122.532 0.333 . . . . 0.0 111.699 -166.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -99.75 96.01 7.32 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 175.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 t -66.35 107.42 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 123.228 0.611 . . . . 0.0 111.957 -175.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -78.14 148.32 34.18 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 174.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.63 67.82 1.11 Allowed Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 4.6 mmt -69.92 -34.75 73.89 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 117.305 0.553 . . . . 0.0 110.858 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.3 p -136.33 162.78 32.06 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 110.244 -0.28 . . . . 0.0 110.244 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 79.2 m 44.72 33.76 1.03 Allowed 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.232 0.613 . . . . 0.0 110.603 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -68.22 -13.34 62.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.15 0.58 . . . . 0.0 111.742 -177.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -85.35 -8.59 58.38 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.9 m -129.67 -174.95 3.44 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.0 p -140.65 154.83 22.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 60.5 mtt -145.24 161.95 38.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.67 94.35 0.78 Allowed 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.64 -13.35 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.5 m -54.64 -38.24 66.63 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 122.674 0.39 . . . . 0.0 110.7 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -64.56 -23.26 67.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.54 -0.267 . . . . 0.0 111.675 -177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.42 -22.79 40.86 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 117.729 0.241 . . . . 0.0 111.051 -179.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.95 -33.49 16.38 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 117.503 0.138 . . . . 0.0 111.241 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -64.41 -26.57 68.51 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 -169.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -81.18 -9.96 59.71 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 119.364 0.984 . . . . 0.0 111.801 -177.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.3 t -73.61 130.67 83.37 Favored Pre-proline 0 N--CA 1.452 -0.34 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -53.64 140.53 65.74 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.763 2.975 . . . . 0.0 112.172 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.16 -20.98 39.86 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-O 119.833 -0.426 . . . . 0.0 112.121 174.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.1 t -68.82 130.34 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 117.578 0.689 . . . . 0.0 109.463 -179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -120.24 -36.98 3.13 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.402 ' HB2' ' HB3' ' A' ' 43' ' ' GLU . 97.8 mttt -134.44 155.72 49.83 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.4 t -135.12 148.78 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -144.0 104.15 4.11 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.1 m -125.27 155.54 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 -178.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.3 t -128.36 101.33 6.17 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.2 mt -63.88 -18.07 63.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.301 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -83.77 -30.83 26.3 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.206 0.203 . . . . 0.0 110.64 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -102.96 -10.47 18.96 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -176.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.23 20.44 75.04 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 69.9 mt-10 -102.2 155.37 18.26 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.98 121.38 9.65 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.469 HD11 ' HG3' ' A' ' 3' ' ' LYS . 2.8 mm? -118.58 153.62 33.95 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.3 m -132.94 166.57 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.402 ' HB3' ' HB2' ' A' ' 30' ' ' LYS . 32.3 tt0 -135.81 89.55 2.5 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 177.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.83 177.55 38.87 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -177.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.9 p -95.28 26.88 3.54 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.188 0.595 . . . . 0.0 110.11 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.05 169.71 17.47 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.408 -0.219 . . . . 0.0 110.408 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -110.03 158.23 35.63 Favored Pre-proline 0 N--CA 1.452 -0.351 0 N-CA-C 110.281 -0.266 . . . . 0.0 110.281 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -55.61 -46.0 35.24 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.82 3.013 . . . . 0.0 112.796 -178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -74.68 -13.93 60.68 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 121.097 -0.241 . . . . 0.0 111.405 -177.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.44 -35.49 15.12 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.219 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.7 tp -76.44 -48.43 19.68 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.386 0.136 . . . . 0.0 111.11 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.7 t -68.29 -23.06 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 119.619 -0.229 . . . . 0.0 111.475 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -77.54 -37.61 50.47 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.044 -0.662 . . . . 0.0 110.104 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.65 -48.6 81.02 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 116.815 -0.175 . . . . 0.0 110.913 -176.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -72.32 -26.09 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 121.022 -0.271 . . . . 0.0 110.795 -178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -76.77 -28.57 55.74 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 120.257 -0.577 . . . . 0.0 109.598 179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -70.24 -23.57 62.93 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 48.8 mm-40 -83.59 -4.48 58.6 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 177.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.99 7.5 58.55 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -115.18 90.94 3.46 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 117.298 0.549 . . . . 0.0 111.237 -176.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -66.18 114.15 5.07 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 174.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -129.9 88.61 2.69 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -78.43 141.45 38.29 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.466 -178.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.1 m -59.3 139.67 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 123.661 0.784 . . . . 0.0 111.167 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.8 mt -95.08 28.04 2.96 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 175.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 116.98 -1.486 . . . . 0.0 109.561 -179.163 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ttm . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.411 HD12 HD22 ' A' ' 51' ' ' LEU . 67.1 mt -105.2 157.37 17.33 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.879 0.471 . . . . 0.0 110.251 -176.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -153.81 80.08 1.14 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -176.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.7 mp -77.85 108.04 10.8 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.677 -164.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 14.7 tmtt? -93.06 96.77 10.27 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 174.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 26.2 t -64.36 133.92 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -85.34 149.04 25.73 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 122.648 0.379 . . . . 0.0 110.114 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.31 62.65 1.75 Allowed Glycine 0 CA--C 1.523 0.54 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 59.9 mtt -67.37 -60.89 2.21 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 117.011 0.406 . . . . 0.0 111.508 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 32.2 p -135.6 166.3 23.55 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.565 0.221 . . . . 0.0 110.696 -176.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.9 m 46.61 32.75 1.77 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.451 0.701 . . . . 0.0 111.076 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -68.62 -9.58 50.72 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 122.203 0.201 . . . . 0.0 110.504 179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -77.59 -8.22 57.53 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 177.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 68.4 m -129.01 -175.36 3.53 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 123.222 0.609 . . . . 0.0 109.48 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.8 p -137.71 155.35 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 58.4 mtt -139.27 161.31 37.75 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -177.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.58 89.65 2.75 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.8 t -74.44 -21.97 17.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 90.7 m -57.47 -39.23 75.93 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 122.37 -0.206 . . . . 0.0 110.549 -179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.56 -22.41 66.96 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 119.645 -0.216 . . . . 0.0 111.533 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.78 -38.94 37.24 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 120.766 -0.373 . . . . 0.0 110.471 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.443 HD13 ' HA ' ' A' ' 22' ' ' LEU . 3.1 mm? -73.05 -32.45 65.07 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 110.337 -0.245 . . . . 0.0 110.337 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -63.02 -21.96 66.52 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -175.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -70.34 -14.99 62.81 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 118.211 0.46 . . . . 0.0 111.147 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.408 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 71.9 t -78.53 127.55 80.26 Favored Pre-proline 0 N--CA 1.451 -0.413 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -175.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 52.8 Cg_exo -58.63 140.4 94.71 Favored 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 123.462 2.775 . . . . 0.0 110.975 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.76 -20.85 42.44 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 111.996 -0.441 . . . . 0.0 111.996 175.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.3 t -72.33 128.26 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -110.62 -42.16 4.13 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 109.873 -0.418 . . . . 0.0 109.873 -179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -135.47 154.96 51.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 177.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.6 t -140.46 149.41 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -139.1 99.21 3.7 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.7 m -95.76 155.87 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.7 t -127.47 98.74 5.34 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.0 mt -66.66 -19.82 65.85 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -173.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -84.05 -32.21 24.97 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.581 -0.448 . . . . 0.0 111.443 -177.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -103.43 -9.85 19.06 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 117.872 0.306 . . . . 0.0 111.223 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.81 21.73 76.68 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -98.66 155.04 17.52 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -150.04 125.6 10.28 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 120.986 0.422 . . . . 0.0 111.184 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.409 HD22 ' N ' ' A' ' 41' ' ' LEU . 3.2 mm? -107.54 153.06 23.41 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 175.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.4 m -132.38 164.7 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -137.28 88.98 2.39 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -163.61 -176.61 35.72 Favored Glycine 0 N--CA 1.448 -0.53 0 N-CA-C 110.44 -1.064 . . . . 0.0 110.44 -177.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 67.8 p -117.31 29.51 7.84 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.385 0.674 . . . . 0.0 109.893 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.22 167.08 21.92 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-O 120.805 0.336 . . . . 0.0 110.854 -176.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -76.77 149.58 80.74 Favored Pre-proline 0 N--CA 1.451 -0.425 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.079 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -55.45 -49.42 16.16 Favored 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 123.379 2.719 . . . . 0.0 112.185 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.6 mtpt -74.79 -19.6 60.13 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -177.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.04 -34.81 71.62 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 120.268 -0.573 . . . . 0.0 109.919 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.411 HD22 HD12 ' A' ' 2' ' ' LEU . 10.0 tp -75.47 -43.66 48.25 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 83.0 t -65.25 -24.84 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 123.189 0.596 . . . . 0.0 111.816 -177.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -87.27 -28.94 22.02 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 117.968 0.349 . . . . 0.0 111.176 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.91 -47.02 87.48 Favored 'General case' 0 N--CA 1.449 -0.517 0 O-C-N 122.345 -0.222 . . . . 0.0 110.991 -177.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.89 -21.32 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 110.288 -0.264 . . . . 0.0 110.288 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -68.76 -21.02 64.38 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -68.44 -29.15 67.73 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.1 mm-40 -83.78 -9.37 58.84 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 98.59 11.13 48.54 Favored Glycine 0 CA--C 1.523 0.566 0 CA-C-O 119.619 -0.545 . . . . 0.0 111.74 176.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -128.72 142.54 50.97 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 117.758 0.779 . . . . 0.0 110.434 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -85.23 172.45 11.15 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 171.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 5' ' ' LYS . . . -149.54 77.51 1.34 Allowed 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.11 117.68 4.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.863 -175.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.4 m -57.45 126.0 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.749 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 94.5 mt -84.08 31.28 0.5 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 122.741 0.416 . . . . 0.0 109.93 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.092 0 CA-C-O 117.239 -1.363 . . . . 0.0 110.199 -178.284 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.716 ' HG2' ' H ' ' A' ' 2' ' ' LEU . 9.7 ttt . . . . . 0 N--CA 1.471 0.581 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.716 ' H ' ' HG2' ' A' ' 1' ' ' MET . 60.2 mt -79.78 161.66 25.57 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.012 0.434 . . . . 0.0 110.437 -174.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.4 mttt -148.03 78.74 1.45 Allowed 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 105.823 -1.917 . . . . 0.0 105.823 -169.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -77.46 114.84 16.71 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.225 -164.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.455 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 75.8 tttt -96.1 98.82 10.65 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.296 1.039 . . . . 0.0 108.907 175.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 36.4 t -61.75 115.58 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 CA-C-O 120.843 0.354 . . . . 0.0 110.19 -177.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -69.96 151.77 45.22 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.446 0.698 . . . . 0.0 110.032 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -95.18 52.66 1.86 Allowed Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 57.2 mtt -68.32 -38.55 81.66 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 117.55 0.675 . . . . 0.0 111.899 -177.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.461 ' H ' ' HE2' ' A' ' 60' ' ' TYR . 68.8 p -139.47 163.04 33.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 118.298 0.499 . . . . 0.0 111.25 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 64.5 m 42.17 33.68 0.41 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.232 1.013 . . . . 0.0 113.004 173.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -69.38 -7.14 34.84 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.034 0.379 . . . . 0.0 110.859 -178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 26.5 m170 -76.48 -12.8 60.1 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 110.444 -0.206 . . . . 0.0 110.444 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.2 m -131.24 -175.13 3.59 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 122.945 0.498 . . . . 0.0 109.73 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.5 p -132.72 154.62 40.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 69.7 mtm -144.83 160.42 41.3 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.0 90.77 4.19 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.3 t -68.69 -13.5 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.343 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 34.8 m -52.91 -37.7 61.04 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.12 0.568 . . . . 0.0 110.792 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -64.2 -22.35 66.91 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -177.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.52 ' O ' ' HB1' ' A' ' 54' ' ' ALA . . . -82.15 -25.0 34.73 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 117.858 0.299 . . . . 0.0 110.994 -178.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -84.12 -33.52 24.3 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 117.455 0.116 . . . . 0.0 110.862 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -63.56 -22.5 66.93 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -71.09 -16.13 62.56 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.599 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.475 ' CG2' ' HB2' ' A' ' 54' ' ' ALA . 72.5 t -80.32 127.31 76.69 Favored Pre-proline 0 N--CA 1.45 -0.433 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -177.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -58.64 141.22 97.38 Favored 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.651 2.901 . . . . 0.0 111.232 177.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.8 -19.62 50.39 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 111.855 -0.498 . . . . 0.0 111.855 175.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.0 t -74.14 123.41 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-N 117.387 0.593 . . . . 0.0 109.426 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -129.41 -26.67 2.5 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 175.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -130.6 132.12 45.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.262 0.553 . . . . 0.0 110.139 176.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 83.9 t -144.73 147.72 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 177.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -136.43 122.84 20.7 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 5.8 m -130.56 156.23 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.145 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 28.5 t -126.86 102.45 7.03 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.5 mt -62.71 -18.05 61.81 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 123.101 0.56 . . . . 0.0 111.486 -174.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -84.58 -31.46 24.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 117.597 0.181 . . . . 0.0 111.244 -178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -102.16 -10.39 19.67 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 111.497 0.184 . . . . 0.0 111.497 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.55 21.68 77.72 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 111.603 -0.599 . . . . 0.0 111.603 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -100.3 155.64 17.67 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 117.726 0.763 . . . . 0.0 109.437 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.26 115.1 6.06 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.509 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.487 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.7 mm? -97.48 152.01 19.42 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 32.8 m -133.87 150.51 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 177.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -141.29 62.66 1.46 Allowed 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.2 -176.83 14.57 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 -177.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 46.3 p -98.65 26.49 5.56 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.804 0.842 . . . . 0.0 111.104 -177.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.12 164.9 25.66 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 120.795 0.331 . . . . 0.0 111.097 -177.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -82.32 135.61 47.05 Favored Pre-proline 0 N--CA 1.451 -0.413 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 176.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -56.04 -35.49 94.78 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 123.268 2.645 . . . . 0.0 111.833 178.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -74.85 -28.45 60.68 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 122.17 0.188 . . . . 0.0 111.203 -176.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.92 -33.59 45.36 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.7 tp -64.92 -45.36 86.17 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 -178.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.07 -23.28 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 122.693 0.397 . . . . 0.0 110.617 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -87.52 -29.0 21.66 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 122.401 -0.187 . . . . 0.0 110.989 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.52 ' HB1' ' O ' ' A' ' 21' ' ' ALA . . . -58.29 -47.27 84.19 Favored 'General case' 0 N--CA 1.45 -0.475 0 O-C-N 122.376 -0.202 . . . . 0.0 111.104 -178.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 31.2 m -72.37 -20.86 19.94 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 N-CA-C 110.283 -0.265 . . . . 0.0 110.283 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -69.42 -21.29 63.76 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -69.47 -25.35 64.04 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 60.2 mm-40 -84.04 -9.73 58.41 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.03 15.38 39.2 Favored Glycine 0 C--N 1.337 0.594 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 178.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.461 ' HE2' ' H ' ' A' ' 10' ' ' THR . 64.9 m-85 -130.54 144.49 51.44 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 117.581 0.69 . . . . 0.0 111.509 -176.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -80.16 175.28 10.78 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 168.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 5' ' ' LYS . . . -148.05 78.32 1.44 Allowed 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 174.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -53.61 107.6 0.27 Allowed 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 123.456 0.702 . . . . 0.0 111.297 -175.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.422 HG11 HD22 ' A' ' 2' ' ' LEU . 35.8 m -58.19 110.42 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 123.871 0.868 . . . . 0.0 110.03 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.7 mt -84.04 35.34 0.53 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.084 0 CA-C-O 117.091 -1.433 . . . . 0.0 109.97 -178.061 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.7 ttm . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 109.8 -0.445 . . . . 0.0 109.8 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 25.1 mt -90.56 149.31 22.21 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -167.14 78.78 0.19 Allowed 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -174.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.4 mp -77.87 124.65 28.26 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.894 -0.503 . . . . 0.0 112.324 -165.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.9 tmtt? -101.33 90.29 4.05 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 174.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.5 t -68.15 134.33 30.34 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 122.583 0.353 . . . . 0.0 111.657 -175.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -88.72 150.2 23.09 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 173.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -86.27 58.79 4.71 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.259 -1.136 . . . . 0.0 110.259 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.4 mmt -68.02 -34.37 76.36 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 117.222 0.511 . . . . 0.0 111.577 -176.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.8 p -136.76 167.43 21.46 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 117.963 0.347 . . . . 0.0 111.009 -177.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 67.1 m 48.2 36.23 6.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.572 0.749 . . . . 0.0 111.459 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -67.43 -15.38 63.64 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.487 0.13 . . . . 0.0 110.932 -178.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -85.09 -8.12 58.79 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 75.2 m -130.81 -171.23 2.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 123.17 0.588 . . . . 0.0 109.682 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -82.02 158.69 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 176.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 62.3 mtm -102.01 121.81 42.88 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.21 82.94 5.98 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.1 t -103.0 -17.35 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 11.0 m -54.15 -50.66 66.46 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 122.622 0.369 . . . . 0.0 111.401 -175.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -67.17 -21.32 65.8 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 119.493 -0.289 . . . . 0.0 111.655 -177.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.43 -25.23 59.31 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 118.092 0.405 . . . . 0.0 111.793 -176.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.04 -48.44 20.92 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -178.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -65.58 -20.96 66.53 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 113.169 0.803 . . . . 0.0 113.169 -173.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -72.47 -14.44 61.67 Favored 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 118.264 0.484 . . . . 0.0 111.675 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.449 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 54.5 t -74.27 134.7 76.74 Favored Pre-proline 0 N--CA 1.451 -0.397 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -176.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 58.8 Cg_exo -55.86 131.15 44.25 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 123.595 2.863 . . . . 0.0 111.165 177.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.36 -22.11 38.86 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.852 -0.499 . . . . 0.0 111.852 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.9 t -77.86 130.64 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -126.98 -24.77 3.41 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 121.258 -0.177 . . . . 0.0 110.781 179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.1 mttp -127.9 148.77 50.5 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 177.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.0 t -144.98 150.06 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -145.64 125.86 13.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 176.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 20.1 m -131.35 156.0 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 C-N-CA 121.01 -0.276 . . . . 0.0 110.348 -178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.5 t -128.72 98.8 5.11 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 177.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 83.7 mt -65.51 -17.98 64.97 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.863 -175.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -80.48 -29.94 37.42 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.502 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -99.95 -9.56 22.63 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 176.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.43 22.84 78.57 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -99.1 156.41 16.96 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 117.417 0.608 . . . . 0.0 110.734 -177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.64 109.71 5.32 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.539 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.503 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.2 mm? -101.63 151.77 21.61 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.4 m -135.0 163.16 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 175.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -138.33 79.69 1.75 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -146.98 -172.39 17.19 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -178.128 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 47.6 p -117.05 28.0 8.78 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 122.683 0.393 . . . . 0.0 110.284 -178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.58 171.4 14.36 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.343 -0.244 . . . . 0.0 110.343 -178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 18.9 t70 -79.64 141.3 55.92 Favored Pre-proline 0 N--CA 1.454 -0.239 0 O-C-N 122.439 -0.163 . . . . 0.0 111.027 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 47' ' ' ASP . 81.6 Cg_exo -54.59 -36.99 90.69 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 123.669 2.912 . . . . 0.0 113.08 179.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.2 mtmt -74.17 -35.02 63.98 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.494 -177.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.17 -33.25 75.37 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.799 -175.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.2 tp -67.77 -50.89 54.71 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.679 -177.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 21.9 t -68.03 -30.08 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 110.553 -0.166 . . . . 0.0 110.553 -177.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -76.13 -33.73 59.44 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.295 -0.261 . . . . 0.0 110.295 -177.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.82 -48.57 78.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 120.319 0.104 . . . . 0.0 110.87 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.6 m -72.37 -23.8 21.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 51.8 tt0 -72.79 -25.57 61.21 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -71.22 -25.72 62.62 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -89.35 -4.43 58.08 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 -178.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.88 5.1 61.31 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -108.28 90.36 3.27 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 117.157 0.479 . . . . 0.0 111.073 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -71.01 155.65 40.58 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 172.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -162.39 111.33 1.41 Allowed 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 120.483 0.182 . . . . 0.0 110.585 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -73.91 123.0 23.42 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 122.658 0.383 . . . . 0.0 110.65 178.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.6 m -59.42 135.16 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.2 mt -95.31 74.66 3.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-O 117.285 -1.34 . . . . 0.0 109.555 -179.283 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttt . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.425 HD13 HD22 ' A' ' 51' ' ' LEU . 80.3 mt -90.68 139.05 31.09 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -157.31 77.1 0.85 Allowed 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -174.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 mp -79.89 113.49 18.09 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.706 -165.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -99.45 89.63 4.24 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.417 HG22 ' HB2' ' A' ' 62' ' ' ALA . 30.8 t -66.35 132.89 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 123.597 0.759 . . . . 0.0 112.323 -174.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -91.23 147.74 22.84 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 172.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.33 78.26 1.37 Allowed Glycine 0 CA--C 1.522 0.523 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.1 mmt -71.75 -35.58 70.16 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.891 0.346 . . . . 0.0 111.316 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 78.6 p -135.69 168.76 18.67 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-O 120.581 0.229 . . . . 0.0 110.985 -176.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.2 m 48.82 36.54 8.24 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.269 0.627 . . . . 0.0 110.929 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -66.37 -6.59 14.87 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 122.4 0.28 . . . . 0.0 111.374 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -83.96 -7.01 59.52 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 177.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.0 m -130.14 -175.58 3.67 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 122.982 0.513 . . . . 0.0 109.824 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.408 ' CG2' HD22 ' A' ' 35' ' ' LEU . 14.6 p -83.46 160.35 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 177.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 69.2 mtm -99.48 119.25 37.72 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -178.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.43 88.12 6.26 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 t -100.96 -12.8 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 111.417 0.155 . . . . 0.0 111.417 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.9 m -50.36 -47.18 56.15 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 -173.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -67.5 -22.78 65.44 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 122.146 -0.346 . . . . 0.0 111.771 -176.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.06 -25.28 60.86 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 118.062 0.392 . . . . 0.0 111.094 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -82.3 -39.57 22.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -66.91 -25.16 66.24 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 113.598 0.962 . . . . 0.0 113.598 -173.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -81.25 -12.73 59.03 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.295 0.498 . . . . 0.0 112.144 -176.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.7 t -76.28 128.07 83.44 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -54.75 139.46 77.42 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.473 2.782 . . . . 0.0 111.036 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.49 -20.25 47.73 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 176.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 66.3 t -76.38 131.92 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -122.86 -28.18 4.16 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 110.402 -0.222 . . . . 0.0 110.402 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 18.5 mttp -132.89 152.08 51.93 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.8 t -142.34 148.08 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -145.37 127.05 15.22 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 19.4 m -131.71 155.19 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-O 120.596 0.236 . . . . 0.0 110.483 -177.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.4 t -128.3 112.31 14.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.408 HD22 ' CG2' ' A' ' 15' ' ' VAL . 87.9 mt -66.22 -25.27 66.83 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -175.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -83.34 -31.9 26.55 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.601 -176.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -101.2 -9.7 21.05 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 117.582 0.174 . . . . 0.0 110.982 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.72 23.15 73.94 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -94.75 156.44 16.38 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 117.646 0.723 . . . . 0.0 110.077 -177.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.55 108.67 4.77 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 123.529 0.732 . . . . 0.0 110.118 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.5 mm? -101.67 150.51 23.04 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.105 0.962 . . . . 0.0 108.678 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.0 m -135.71 164.44 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -137.47 92.02 2.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 176.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.71 -172.93 29.73 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.324 -1.11 . . . . 0.0 110.324 -177.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 48.9 p -117.51 29.72 7.7 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.226 0.61 . . . . 0.0 110.24 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.18 170.91 14.56 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-O 120.648 0.261 . . . . 0.0 110.747 -177.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -76.86 137.28 66.21 Favored Pre-proline 0 N--CA 1.451 -0.381 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -54.54 -42.79 64.94 Favored 'Trans proline' 0 N--CA 1.449 -1.097 0 C-N-CA 123.414 2.742 . . . . 0.0 112.503 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -76.02 -28.3 57.68 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.054 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.02 76.14 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 121.323 -0.151 . . . . 0.0 110.609 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.425 HD22 HD13 ' A' ' 2' ' ' LEU . 9.7 tp -71.18 -48.48 51.41 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 45.5 t -68.91 -22.79 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.47 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -85.97 -33.75 21.04 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.222 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.42 -44.61 95.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 121.416 -0.114 . . . . 0.0 111.019 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.0 m -69.8 -27.6 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.403 -178.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -77.01 -25.25 52.43 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -69.55 -22.19 63.57 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -91.84 -6.81 50.99 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.34 10.63 55.64 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -124.84 89.77 3.13 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 117.646 0.723 . . . . 0.0 110.509 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.76 163.32 21.93 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.417 ' HB2' HG22 ' A' ' 6' ' ' VAL . . . -158.59 115.31 2.77 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.479 0.18 . . . . 0.0 110.736 -178.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -72.39 111.57 7.7 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 122.449 0.3 . . . . 0.0 111.075 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.0 m -58.26 118.16 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.6 mt -82.05 71.01 9.09 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 178.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 CA-C-O 117.378 -1.296 . . . . 0.0 110.037 -178.966 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 ttt . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 79.6 mt -90.87 152.96 20.54 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -159.42 78.82 0.73 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -173.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.6 mp -79.25 102.62 8.67 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.868 0.366 . . . . 0.0 111.489 -165.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -92.48 94.03 8.87 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.5 t -65.73 136.4 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 124.476 1.11 . . . . 0.0 112.524 -174.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -88.97 149.02 23.48 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -87.5 68.52 3.1 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.4 mmt -70.15 -37.55 75.28 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 53.6 p -139.0 168.86 18.9 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 117.911 0.323 . . . . 0.0 111.231 -175.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 64.2 m 47.63 36.98 6.03 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.456 0.702 . . . . 0.0 111.014 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -66.99 -4.19 9.02 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 121.931 0.092 . . . . 0.0 110.843 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -86.79 -9.03 56.77 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.2 m -130.82 -173.86 3.21 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 123.304 0.642 . . . . 0.0 110.174 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -84.39 159.64 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 176.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 56.5 mtm -103.05 122.54 44.85 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.65 90.2 7.86 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.065 -0.716 . . . . 0.0 109.065 178.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 25.0 t -100.32 -14.76 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 122.129 0.172 . . . . 0.0 111.325 -178.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.1 m -54.46 -47.35 73.04 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -173.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.5 mmtt -66.74 -22.92 66.04 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.285 0.493 . . . . 0.0 112.11 -176.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.42 -24.57 60.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 118.011 0.369 . . . . 0.0 111.295 -177.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.77 -40.63 18.54 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -66.69 -24.06 66.21 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 -172.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -80.54 -12.78 59.48 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 118.336 0.516 . . . . 0.0 111.974 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 53.1 t -73.13 128.5 87.64 Favored Pre-proline 0 N--CA 1.451 -0.416 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -54.21 131.58 45.76 Favored 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 123.643 2.895 . . . . 0.0 111.2 178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.22 -19.85 52.16 Favored Glycine 0 CA--C 1.525 0.671 0 CA-C-O 119.83 -0.428 . . . . 0.0 112.05 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 58.4 t -74.53 129.52 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 177.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -117.77 -30.61 5.38 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -134.77 152.48 51.79 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 85.3 t -142.48 149.47 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 -179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -145.69 129.23 17.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.28 156.76 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 CA-C-O 120.619 0.247 . . . . 0.0 110.371 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 43.6 t -126.69 101.38 6.61 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.2 mt -64.3 -20.34 66.02 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -174.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -83.89 -31.13 25.87 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 120.436 -0.506 . . . . 0.0 111.424 -177.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -101.73 -9.8 20.53 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.597 0.18 . . . . 0.0 111.382 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.14 21.85 75.79 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -96.38 156.09 16.49 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -146.06 125.11 12.82 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.147 0.579 . . . . 0.0 109.479 -178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.468 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.5 mm? -117.94 152.32 35.68 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.046 0.939 . . . . 0.0 108.64 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.8 m -134.47 165.23 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 174.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -136.68 86.44 2.21 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 176.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.69 -172.64 24.22 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.8 p -117.48 28.66 8.32 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.188 0.595 . . . . 0.0 110.513 -177.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.12 169.84 17.22 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.678 0.275 . . . . 0.0 110.92 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -76.3 144.33 74.52 Favored Pre-proline 0 N--CA 1.452 -0.369 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.308 177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -57.33 -38.78 93.7 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 123.294 2.663 . . . . 0.0 112.11 178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 mtmt -75.51 -37.19 60.3 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.431 -178.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.43 -34.29 75.14 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 -176.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 tp -71.52 -56.87 5.06 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.481 0.181 . . . . 0.0 110.613 -178.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 43.2 t -67.64 -21.69 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 122.3 0.24 . . . . 0.0 111.542 -176.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -86.56 -32.48 20.66 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.622 -178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.72 -44.33 96.74 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 121.036 -0.266 . . . . 0.0 110.668 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 28.6 m -68.83 -27.21 34.88 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -77.68 -21.68 51.68 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -69.7 -24.28 63.55 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -90.51 -7.17 53.64 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.09 0.16 61.91 Favored Glycine 0 C--N 1.338 0.644 0 N-CA-C 111.925 -0.47 . . . . 0.0 111.925 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -107.65 91.05 3.49 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 117.663 0.732 . . . . 0.0 110.74 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -66.91 163.34 19.83 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 177.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -156.14 112.67 3.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 120.59 0.233 . . . . 0.0 110.982 -178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -71.21 108.28 4.63 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 111.476 0.176 . . . . 0.0 111.476 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.8 m -58.27 119.52 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 173.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.9 mt -81.12 72.11 8.13 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.145 0 CA-C-O 117.181 -1.39 . . . . 0.0 109.377 -179.802 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.2 ttp . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 77.9 mt -89.12 154.43 20.17 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -153.39 77.97 1.14 Allowed 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 -175.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.8 mp -78.53 101.46 7.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.316 -167.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -88.08 98.53 11.59 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 174.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.3 t -63.43 133.01 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 C-N-CA 122.824 0.45 . . . . 0.0 110.927 -175.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -83.2 148.56 27.36 Favored 'General case' 0 N--CA 1.45 -0.467 0 C-N-CA 123.404 0.682 . . . . 0.0 109.715 178.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -92.8 76.55 1.21 Allowed Glycine 0 CA--C 1.523 0.57 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.3 mmt -69.14 -74.77 0.12 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 116.908 0.354 . . . . 0.0 111.365 -177.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.6 p -138.19 169.76 17.23 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.701 0.4 . . . . 0.0 110.329 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 75.6 m 49.2 37.41 11.06 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.558 0.343 . . . . 0.0 110.736 179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -65.87 -4.39 6.75 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.29 0.636 . . . . 0.0 110.988 -179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -84.8 -6.32 59.35 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.558 0.343 . . . . 0.0 110.457 178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.8 m -115.63 171.04 7.99 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.5 p -153.49 151.67 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 72.6 mtm -150.82 162.47 40.68 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.58 91.59 0.6 Allowed 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.8 t -68.91 -14.44 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 -178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 36.0 m -52.51 -37.81 58.25 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 122.924 0.49 . . . . 0.0 111.352 -177.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -62.55 -22.35 66.26 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -176.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.79 -25.66 30.25 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 118.04 0.382 . . . . 0.0 111.173 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.69 -35.95 51.64 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -177.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -66.73 -22.86 66.05 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -175.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -68.34 -18.06 64.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.274 0.488 . . . . 0.0 112.165 -176.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.424 HG21 ' HA ' ' A' ' 51' ' ' LEU . 60.1 t -79.77 129.02 72.43 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-N 118.052 0.387 . . . . 0.0 110.069 -176.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 62.2 Cg_exo -54.93 139.27 79.03 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 123.581 2.854 . . . . 0.0 111.413 178.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.41 -21.13 42.36 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 176.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.1 t -74.5 128.69 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 178.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -124.28 -26.9 3.88 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 117.793 0.27 . . . . 0.0 110.855 178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -133.05 150.35 52.12 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 57.5 t -144.84 148.52 17.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -147.43 127.71 13.89 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.2 m -130.68 155.14 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-N 117.852 0.296 . . . . 0.0 110.871 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.1 t -129.02 100.07 5.51 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.3 mt -64.98 -18.32 65.18 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.044 0.538 . . . . 0.0 112.126 -174.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -81.54 -29.89 33.34 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.324 -0.55 . . . . 0.0 110.927 -178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.3 mptt -103.62 -8.36 20.05 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.658 0.208 . . . . 0.0 111.229 175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.03 23.47 78.07 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -96.91 155.56 16.72 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 117.737 0.769 . . . . 0.0 109.75 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -147.74 110.98 4.88 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.31 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.48 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.9 mm? -100.59 151.11 22.0 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 30.1 m -135.06 163.99 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 174.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -137.5 93.82 2.85 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.01 -171.22 26.68 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 59.9 p -114.28 28.15 8.96 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.787 0.435 . . . . 0.0 110.127 -178.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.68 170.06 16.9 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 120.662 0.268 . . . . 0.0 110.875 -177.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 14.9 t70 -90.61 148.56 38.91 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.487 177.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 47' ' ' ASP . 71.9 Cg_exo -57.76 -39.2 89.26 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.652 2.901 . . . . 0.0 112.915 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -75.35 -22.89 57.23 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.281 -177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.39 -35.09 58.81 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.315 -177.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.424 ' HA ' HG21 ' A' ' 25' ' ' VAL . 10.7 tp -75.55 -46.01 34.54 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 121.32 -0.152 . . . . 0.0 111.079 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 63.7 t -67.19 -22.37 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 110.563 -0.162 . . . . 0.0 110.563 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -87.16 -30.04 21.33 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 179.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.08 -46.2 91.62 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.5 m -68.77 -19.91 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.475 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.456 ' OE1' ' HE2' ' A' ' 61' ' ' LYS . 45.7 tt0 -69.15 -20.4 64.02 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 177.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -68.84 -26.37 65.12 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -82.78 -11.39 58.31 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 94.9 8.14 59.39 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -132.69 101.87 5.46 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 117.286 0.543 . . . . 0.0 111.611 -175.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.456 ' HE2' ' OE1' ' A' ' 56' ' ' GLU . 97.0 mttt -67.56 172.04 5.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -152.87 119.35 5.6 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 120.501 0.191 . . . . 0.0 110.62 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -68.84 109.04 3.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.512 0.725 . . . . 0.0 111.586 -178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 64' ' ' VAL . 30.6 m -58.81 108.53 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 174.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 92.0 mt -80.65 76.58 7.52 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.077 0 CA-C-O 117.276 -1.345 . . . . 0.0 109.602 -177.625 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.5 ttp . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.5 mt -89.25 154.21 20.3 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -178.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -153.15 81.36 1.2 Allowed 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.7 mp -75.12 103.46 5.3 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.45 -167.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -88.43 105.78 17.82 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.8 t -64.72 134.43 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 122.93 0.492 . . . . 0.0 111.146 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -85.12 146.19 27.26 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 176.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.74 60.5 3.55 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.6 mtp -68.04 -64.71 0.81 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.847 0.323 . . . . 0.0 111.668 -176.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 42.9 p -136.66 166.12 24.3 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-O 120.539 0.209 . . . . 0.0 110.963 -176.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 82.3 m 46.73 33.96 2.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 123.306 0.642 . . . . 0.0 110.634 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.9 p-10 -68.08 -4.49 13.73 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.695 0.798 . . . . 0.0 111.023 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -72.56 -8.2 53.97 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.536 0.334 . . . . 0.0 111.116 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.2 m -129.88 179.84 5.62 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 122.269 0.227 . . . . 0.0 110.41 -179.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -153.12 138.8 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -147.4 161.65 40.6 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 122.628 0.371 . . . . 0.0 110.021 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.5 115.91 5.63 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 123.007 0.523 . . . . 0.0 110.36 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.7 t -69.48 -11.94 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.228 1.011 . . . . 0.0 111.239 -179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 80.6 m -48.72 -40.63 29.12 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -174.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.87 -23.37 67.32 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -174.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.9 -25.12 32.76 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.039 0.381 . . . . 0.0 110.848 -179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.486 HD13 ' HA ' ' A' ' 22' ' ' LEU . 3.9 mm? -84.29 -31.57 24.83 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -59.18 -23.2 62.04 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 121.232 -0.187 . . . . 0.0 111.428 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -72.01 -17.74 62.02 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.29 -179.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 68.1 t -79.55 127.75 77.22 Favored Pre-proline 0 N--CA 1.451 -0.39 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -57.3 139.08 89.04 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 123.302 2.668 . . . . 0.0 111.112 177.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.01 -21.18 38.33 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.887 -0.485 . . . . 0.0 111.887 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 55.5 t -70.91 129.16 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -128.07 -27.63 2.72 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -131.48 150.23 52.23 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.6 t -146.06 151.06 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -145.31 127.83 16.04 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.1 m -131.73 156.01 42.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.192 -178.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.7 t -127.98 101.26 6.23 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 176.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 75.6 mt -66.04 -22.03 66.41 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -83.93 -31.34 25.68 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 118.386 0.539 . . . . 0.0 111.499 -178.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -102.22 -8.5 21.25 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 117.61 0.186 . . . . 0.0 111.187 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 68.32 20.62 73.53 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.666 -0.574 . . . . 0.0 111.666 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -98.76 154.16 18.2 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.51 128.15 12.4 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 120.632 0.253 . . . . 0.0 110.54 -177.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.8 mm? -113.58 153.05 29.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 123.961 0.904 . . . . 0.0 109.456 178.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 26.9 m -135.08 163.28 36.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 174.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -141.31 95.59 2.85 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -160.79 -179.07 35.31 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -178.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.2 p -94.73 26.81 3.34 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.466 0.306 . . . . 0.0 110.58 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.09 174.03 10.56 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -107.92 155.73 39.44 Favored Pre-proline 0 N--CA 1.452 -0.326 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 177.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -58.89 -37.49 93.38 Favored 'Trans proline' 0 N--CA 1.449 -1.13 0 C-N-CA 123.2 2.6 . . . . 0.0 111.972 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -73.98 -16.69 61.07 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 119.815 -0.135 . . . . 0.0 111.144 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.68 -33.63 14.98 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.43 HD11 HD12 ' A' ' 22' ' ' LEU . 10.9 tp -70.87 -59.64 2.68 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.546 -176.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 41.0 t -67.64 -22.45 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 122.19 0.196 . . . . 0.0 110.941 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -81.84 -33.72 30.52 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 122.27 -0.269 . . . . 0.0 110.532 -178.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.11 -46.51 90.31 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 120.281 0.086 . . . . 0.0 110.984 -179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.2 m -72.45 -22.83 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -77.19 -22.4 52.45 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.381 177.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -70.05 -24.17 63.21 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 177.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -83.26 -9.05 59.34 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 176.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.82 10.56 34.78 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 119.364 -0.687 . . . . 0.0 113.063 175.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -131.8 125.65 32.41 Favored 'General case' 0 N--CA 1.453 -0.325 0 CA-C-N 118.589 1.195 . . . . 0.0 111.573 -177.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -69.88 167.06 18.15 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.579 177.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -153.82 95.64 1.9 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -66.78 105.4 1.56 Allowed 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.124 0.57 . . . . 0.0 111.542 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.42 ' O ' HG23 ' A' ' 64' ' ' VAL . 27.0 m -58.96 109.02 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 174.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.9 mt -80.88 74.16 7.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.288 -1.339 . . . . 0.0 109.208 -179.734 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.7 ttp . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 62.8 mt -90.05 150.47 22.07 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -178.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -159.73 78.74 0.7 Allowed 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 -176.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.7 mp -77.25 103.07 6.97 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.73 -164.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -79.92 96.42 6.37 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.473 HG11 HG21 ' A' ' 18' ' ' VAL . 33.0 t -65.1 128.62 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 CA-C-O 120.737 0.304 . . . . 0.0 110.368 -176.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -75.47 145.33 41.53 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.452 0.701 . . . . 0.0 110.021 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.79 59.86 1.21 Allowed Glycine 0 C--N 1.335 0.525 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 84.0 mtp -67.45 -44.92 77.48 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 117.046 0.423 . . . . 0.0 111.677 -174.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 60.9 p -139.01 166.53 24.26 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 110.356 -0.238 . . . . 0.0 110.356 -179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 82.7 m 46.95 33.62 2.33 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 123.058 0.543 . . . . 0.0 110.833 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -67.48 -4.6 11.86 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 122.549 0.339 . . . . 0.0 110.58 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -76.59 -9.86 58.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 122.064 0.146 . . . . 0.0 110.699 179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 84.8 m -131.15 -179.63 5.45 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 179.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.9 p -149.27 138.86 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -149.5 160.65 43.28 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -75.35 111.82 11.02 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.473 HG21 HG11 ' A' ' 6' ' ' VAL . 20.9 t -68.13 -8.02 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 123.066 0.546 . . . . 0.0 110.026 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.3 m -41.84 -38.35 1.5 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.564 1.146 . . . . 0.0 112.928 -176.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -62.27 -23.56 66.77 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 122.016 -0.428 . . . . 0.0 111.704 -176.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.79 -24.25 33.51 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 177.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.408 HD13 ' HA ' ' A' ' 22' ' ' LEU . 4.0 mm? -82.62 -34.85 27.43 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 -177.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -61.86 -22.13 65.26 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -175.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -75.57 -15.92 60.31 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.4 t -77.67 128.93 78.27 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 118.299 0.5 . . . . 0.0 110.001 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.89 139.83 84.74 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.534 2.823 . . . . 0.0 111.112 177.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.92 -21.48 39.36 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 176.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.6 t -80.23 132.66 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 178.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -127.8 -29.95 2.56 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.513 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -133.99 152.02 51.68 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.1 t -144.48 150.33 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -177.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -141.83 125.94 17.36 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.0 m -133.14 158.54 43.16 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-O 120.462 0.173 . . . . 0.0 111.371 -175.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.7 t -126.47 104.45 8.15 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 176.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 59.4 mt -63.7 -20.86 66.06 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -173.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -84.1 -32.4 24.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.439 -0.504 . . . . 0.0 111.572 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -101.68 -9.66 20.7 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -175.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 74.9 24.15 72.81 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.056 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -95.79 154.4 17.24 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -149.96 108.72 3.85 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 41' ' ' LEU . 3.2 mm? -105.12 152.17 23.12 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.4 m -132.18 163.73 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -137.82 89.88 2.45 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -159.28 -169.83 23.1 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.7 p -118.22 28.03 8.61 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.986 0.514 . . . . 0.0 110.206 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.67 168.89 18.93 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 17.4 m-20 -78.82 154.31 78.12 Favored Pre-proline 0 N--CA 1.451 -0.412 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 47' ' ' ASP . 76.0 Cg_exo -59.02 -46.63 21.52 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 123.625 2.884 . . . . 0.0 112.15 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -75.74 -32.35 59.97 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 116.935 -0.12 . . . . 0.0 111.151 -177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.62 -32.43 74.08 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 121.432 -0.107 . . . . 0.0 110.755 -177.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.2 tp -69.21 -50.97 42.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 121.155 -0.218 . . . . 0.0 110.488 -177.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.3 t -69.35 -28.21 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 122.508 0.323 . . . . 0.0 111.077 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -75.1 -31.89 61.29 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 110.521 -0.177 . . . . 0.0 110.521 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.55 -54.97 40.34 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 122.43 0.292 . . . . 0.0 111.42 -177.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -72.51 -23.82 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 121.403 -0.119 . . . . 0.0 111.029 -177.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.5 tt0 -72.74 -22.37 60.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -70.94 -25.07 62.57 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 176.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -79.95 -9.58 59.69 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 103.0 11.3 34.77 Favored Glycine 0 CA--C 1.523 0.57 0 CA-C-O 119.588 -0.562 . . . . 0.0 111.888 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -129.82 114.85 16.42 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 117.886 0.843 . . . . 0.0 110.692 -177.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -63.6 169.68 3.75 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -152.54 92.94 1.73 Allowed 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -68.45 104.62 1.95 Allowed 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 122.947 0.499 . . . . 0.0 111.331 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 64' ' ' VAL . 26.7 m -58.24 113.53 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 95.9 mt -80.05 76.25 6.79 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 CA-C-O 117.025 -1.464 . . . . 0.0 109.067 -177.282 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.727 ' HG2' ' H ' ' A' ' 2' ' ' LEU . 18.8 ttt . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.727 ' H ' ' HG2' ' A' ' 1' ' ' MET . 87.5 mt -87.91 151.15 23.03 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.483 ' HG3' HD11 ' A' ' 41' ' ' LEU . 78.3 tttt -156.31 76.41 0.9 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -175.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.0 mp -76.16 109.43 9.82 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 113.029 0.751 . . . . 0.0 113.029 -165.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.47 ' HB2' HD21 ' A' ' 65' ' ' LEU . 57.5 tttt -81.38 98.4 8.18 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.666 0.787 . . . . 0.0 109.218 173.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 29.4 t -70.47 107.97 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 117.797 0.271 . . . . 0.0 110.567 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -73.21 118.66 16.44 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -93.28 85.81 1.13 Allowed Glycine 0 C--N 1.337 0.59 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.6 mtt -68.93 -33.43 73.73 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 122.513 0.325 . . . . 0.0 111.395 -177.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 66.9 p -136.71 170.34 16.24 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.748 0.309 . . . . 0.0 111.471 -175.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 64.6 m 54.84 39.22 31.35 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.771 0.828 . . . . 0.0 111.908 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -66.21 -6.86 15.08 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -178.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -84.77 -10.24 57.41 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 118.008 0.367 . . . . 0.0 110.881 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.5 m -130.3 -178.78 4.9 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-O 120.621 0.248 . . . . 0.0 110.358 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -141.09 155.0 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 177.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 74.8 mtm -142.3 160.12 40.87 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 -177.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.73 92.0 5.36 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.38 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.6 t -70.46 -12.74 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.2 m -52.45 -42.23 63.98 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 122.927 0.491 . . . . 0.0 112.208 -175.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -66.27 -22.26 66.3 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -175.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.36 -24.69 62.14 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 118.093 0.406 . . . . 0.0 110.518 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.412 HD22 ' N ' ' A' ' 22' ' ' LEU . 3.8 mm? -84.06 -35.04 24.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -65.19 -22.78 66.94 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -176.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -74.02 -14.51 61.02 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.41 -177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.461 HG21 ' HA ' ' A' ' 51' ' ' LEU . 57.0 t -78.44 128.12 78.71 Favored Pre-proline 0 N--CA 1.451 -0.402 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -55.28 138.87 80.61 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 123.377 2.718 . . . . 0.0 111.066 178.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.6 -19.6 51.73 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 176.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 64.1 t -75.48 129.62 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -122.52 -28.27 4.27 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -133.26 150.4 51.92 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.0 t -145.29 149.54 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -146.36 126.42 13.72 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.3 m -131.45 156.07 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 C-N-CA 121.039 -0.265 . . . . 0.0 110.35 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 41.4 t -129.2 102.91 6.67 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.0 mt -63.56 -18.69 64.13 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 116.612 -0.267 . . . . 0.0 111.06 -176.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -78.6 -29.79 46.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -100.36 -11.16 20.5 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 110.748 -0.093 . . . . 0.0 110.748 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.28 20.92 67.88 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 110.09 -1.204 . . . . 0.0 110.09 -177.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -101.49 158.49 16.03 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 116.925 0.362 . . . . 0.0 110.463 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -143.1 110.7 5.84 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.483 HD11 ' HG3' ' A' ' 3' ' ' LYS . 2.9 mm? -101.07 152.65 20.35 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.64 162.23 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 175.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -142.23 86.46 1.97 Allowed 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -157.62 -173.54 26.17 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -177.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.8 p -112.59 28.1 9.06 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 122.623 0.369 . . . . 0.0 110.496 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.03 168.01 20.82 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -78.67 138.57 58.35 Favored Pre-proline 0 N--CA 1.45 -0.47 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -55.41 -36.44 93.99 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.266 2.644 . . . . 0.0 111.928 179.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -76.23 -32.7 59.04 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 121.387 -0.125 . . . . 0.0 110.72 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.35 -33.2 71.18 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.461 ' HA ' HG21 ' A' ' 25' ' ' VAL . 9.7 tp -65.9 -55.76 15.25 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.539 0.209 . . . . 0.0 110.757 -178.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 50.5 t -68.14 -22.96 28.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.738 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 -75.9 -37.14 59.12 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.899 -0.321 . . . . 0.0 110.245 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.2 -47.72 83.19 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.332 0.11 . . . . 0.0 110.815 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.5 m -73.03 -25.1 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 120.956 -0.298 . . . . 0.0 110.875 -178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -76.07 -23.47 55.04 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -70.25 -24.98 63.16 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 176.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -79.76 -10.73 59.82 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.3 7.23 59.51 Favored Glycine 0 CA--C 1.524 0.603 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -115.32 98.6 6.85 Favored 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -61.79 158.95 14.65 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -155.1 78.83 1.04 Allowed 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -76.96 139.23 40.07 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -58.15 137.4 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 C-N-CA 122.612 0.365 . . . . 0.0 110.569 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 5' ' ' LYS . 85.8 mt -83.98 76.1 10.08 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.104 0 CA-C-O 117.06 -1.448 . . . . 0.0 109.337 179.351 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.0 ttm . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 30.9 mt -113.78 144.5 42.88 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -161.71 79.62 0.56 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -171.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.0 mp -80.13 125.39 29.76 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.721 -0.612 . . . . 0.0 111.838 -164.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -101.14 89.07 3.67 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.375 -1.342 . . . . 0.0 107.375 172.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.32 115.46 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 122.889 0.476 . . . . 0.0 110.47 -175.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -70.75 148.41 47.97 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.26 0.624 . . . . 0.0 109.882 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -90.22 60.14 3.4 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.068 -1.213 . . . . 0.0 110.068 179.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 94.3 mtp -67.69 -35.76 79.41 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.898 0.349 . . . . 0.0 111.067 -177.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 44.1 p -138.2 166.23 24.7 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 62.2 m 46.71 35.07 2.82 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.237 0.615 . . . . 0.0 111.102 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -67.6 -12.97 61.62 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -176.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -90.54 -7.51 52.7 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.136 0.426 . . . . 0.0 109.941 176.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.6 m -128.7 -171.15 2.4 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.0 p -137.03 152.71 28.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 11.1 mmm -140.7 160.17 40.62 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.44 110.17 16.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 122.88 0.472 . . . . 0.0 111.247 -178.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.2 t -91.04 -16.52 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 177.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 31.6 m -55.78 -43.57 76.9 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -174.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.66 -21.6 66.1 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 122.305 -0.247 . . . . 0.0 111.23 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.69 -27.44 60.4 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.854 -178.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 22' ' ' LEU . 4.1 mm? -84.88 -33.47 22.8 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 117.864 0.302 . . . . 0.0 111.77 -176.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -62.85 -21.7 66.15 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -173.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -78.03 -18.42 55.88 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -173.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.3 t -78.88 130.67 69.46 Favored Pre-proline 0 N--CA 1.454 -0.232 0 CA-C-N 118.976 0.807 . . . . 0.0 110.224 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -55.27 141.89 80.03 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 124.071 3.181 . . . . 0.0 111.56 177.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.16 -21.87 39.81 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 176.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 69.2 t -71.29 127.68 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 177.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.24 -27.54 3.8 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 111.437 0.162 . . . . 0.0 111.437 -177.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -133.82 152.63 51.93 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.3 t -143.02 147.09 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.24 129.44 14.62 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.4 m -130.93 155.99 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 CA-C-N 117.959 0.345 . . . . 0.0 110.624 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 44.1 t -129.4 101.32 5.92 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.7 mt -64.47 -20.05 65.94 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.771 -0.195 . . . . 0.0 111.234 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -82.3 -31.47 29.96 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 110.666 -0.124 . . . . 0.0 110.666 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -101.86 -10.03 20.22 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.35 21.92 78.58 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -98.95 155.56 17.35 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 117.589 0.694 . . . . 0.0 109.933 -179.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -144.14 108.56 4.83 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.6 mm? -104.18 150.31 24.48 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.39 162.79 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 173.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -139.01 86.23 2.12 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.63 -171.01 20.35 Favored Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 -176.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 76.8 p -115.8 28.1 8.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 122.851 0.46 . . . . 0.0 110.227 -177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.35 159.31 32.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 38.8 m-20 -83.82 152.77 63.39 Favored Pre-proline 0 N--CA 1.452 -0.355 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 178.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 47' ' ' ASP . 52.5 Cg_exo -60.24 -36.68 87.16 Favored 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 123.536 2.824 . . . . 0.0 112.121 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.437 ' HG2' ' H ' ' A' ' 49' ' ' LYS . 20.5 pttt -69.65 -19.65 63.61 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 119.744 -0.169 . . . . 0.0 110.758 -175.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.64 -34.79 15.31 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.932 -0.307 . . . . 0.0 111.168 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 tp -75.21 -49.48 19.24 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.911 -0.315 . . . . 0.0 111.666 -174.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 40.7 t -68.07 -25.82 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 C-N-CA 121.201 -0.2 . . . . 0.0 110.878 -176.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -80.95 -32.02 34.69 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 109.718 -0.475 . . . . 0.0 109.718 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.09 -45.32 94.01 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 122.538 0.335 . . . . 0.0 111.219 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 29.0 m -71.78 -24.03 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.004 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.4 ' OE2' ' HE2' ' A' ' 61' ' ' LYS . 50.1 tt0 -75.13 -20.95 59.17 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.83 -23.73 63.35 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 177.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -88.36 -7.93 55.88 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.82 12.73 49.23 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 111.724 -0.55 . . . . 0.0 111.724 177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -128.15 100.82 6.0 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 117.94 0.87 . . . . 0.0 112.045 -175.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HE2' ' OE2' ' A' ' 56' ' ' GLU . 98.9 mttt -71.1 167.15 19.9 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 175.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -160.55 117.26 2.39 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -70.84 119.23 14.68 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.643 0.377 . . . . 0.0 110.913 179.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.2 m -59.41 117.55 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 173.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 96.8 mt -82.39 31.8 0.4 Allowed 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 122.747 0.419 . . . . 0.0 110.005 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.341 -1.314 . . . . 0.0 109.165 179.567 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 ttm . . . . . 0 N--CA 1.47 0.572 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 45.7 mt -117.18 150.09 39.31 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -178.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.7 tttt -161.64 81.15 0.58 Allowed 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 108.102 -1.074 . . . . 0.0 108.102 -173.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.0 mp -79.97 109.43 14.4 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.827 -0.546 . . . . 0.0 112.007 -166.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -83.43 90.16 7.15 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 171.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.9 t -62.05 109.65 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -177.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.0 tp10 -70.4 146.02 50.69 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.189 0.596 . . . . 0.0 110.208 -178.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.78 62.09 3.37 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 92.5 mtp -68.03 -34.92 77.39 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 116.612 0.206 . . . . 0.0 110.998 -177.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.2 p -138.29 165.24 27.22 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 72.9 m 46.09 36.75 3.3 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.017 0.527 . . . . 0.0 111.153 177.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -66.68 -12.37 58.06 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 68.6 m-70 -91.43 -5.68 53.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.0 m -127.6 -169.08 1.99 Allowed 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -141.06 155.2 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 11.2 mmm -137.03 160.68 38.21 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 110.231 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.05 110.45 16.59 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 122.995 0.518 . . . . 0.0 110.145 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.1 t -95.94 -21.02 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.9 m -56.49 -40.91 75.74 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 122.186 -0.321 . . . . 0.0 111.73 -176.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.54 -21.52 66.71 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 119.524 -0.274 . . . . 0.0 111.566 -177.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.99 -27.02 39.67 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 118.07 0.395 . . . . 0.0 110.689 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.44 HD12 HD11 ' A' ' 51' ' ' LEU . 3.1 mm? -85.52 -34.41 21.55 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 121.161 -0.216 . . . . 0.0 110.67 -177.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 80.1 tttt -62.55 -22.2 66.15 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 111.474 0.175 . . . . 0.0 111.474 -177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -79.6 -13.98 59.14 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 119.633 -0.223 . . . . 0.0 111.57 -176.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.407 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 54.2 t -79.32 126.48 81.25 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 64.3 Cg_exo -56.67 140.9 91.49 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 123.682 2.921 . . . . 0.0 111.513 178.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.67 -21.69 39.79 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.862 -0.495 . . . . 0.0 111.862 176.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 60.9 t -71.69 129.66 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.56 -27.47 4.75 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 121.284 -0.167 . . . . 0.0 111.05 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -133.18 153.08 51.86 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 174.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.0 t -143.06 147.42 20.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -146.96 128.52 15.07 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.7 m -131.71 153.84 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 120.91 -0.316 . . . . 0.0 110.904 -178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 45.2 t -131.46 100.81 5.28 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 175.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 91.6 mt -64.97 -19.0 65.75 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 121.92 0.088 . . . . 0.0 110.952 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 59.4 mt-10 -82.03 -31.24 31.06 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 -178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -103.05 -10.18 19.12 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 111.658 0.244 . . . . 0.0 111.658 -177.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.55 22.36 79.02 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -98.56 155.15 17.43 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 117.618 0.709 . . . . 0.0 109.889 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.69 108.38 4.01 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.3 mm? -108.4 150.74 26.96 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -177.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.4 m -135.64 163.1 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 174.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -138.1 93.36 2.75 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -161.46 -172.8 29.29 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.7 p -111.27 28.59 8.59 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 122.87 0.468 . . . . 0.0 109.957 -178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.25 173.35 9.6 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 27.9 m-20 -104.03 153.57 38.77 Favored Pre-proline 0 N--CA 1.451 -0.398 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 47' ' ' ASP . 57.4 Cg_exo -58.58 -36.96 96.61 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 123.481 2.787 . . . . 0.0 112.179 -178.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.435 ' HG2' ' H ' ' A' ' 49' ' ' LYS . 21.0 pttt -68.68 -21.03 64.45 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 110.513 -0.18 . . . . 0.0 110.513 -176.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -91.43 -34.27 14.91 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 121.239 -0.184 . . . . 0.0 110.725 -178.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.44 HD11 HD12 ' A' ' 22' ' ' LEU . 9.5 tp -74.68 -47.74 29.97 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.28 -176.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.0 t -68.1 -35.72 72.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 110.385 -0.228 . . . . 0.0 110.385 -177.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 18.3 tt0 -69.23 -31.85 70.69 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 110.313 -0.255 . . . . 0.0 110.313 -178.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.46 -55.05 38.23 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 121.946 0.098 . . . . 0.0 110.932 -178.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.1 m -72.8 -23.92 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 121.181 -0.208 . . . . 0.0 110.698 -178.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -73.56 -23.71 60.0 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -70.6 -24.41 62.75 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 177.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.6 mm-40 -83.91 -7.82 59.33 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.19 8.53 57.68 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.669 -0.572 . . . . 0.0 111.669 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -125.14 94.98 4.32 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 117.829 0.814 . . . . 0.0 111.04 -176.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -67.33 168.24 10.98 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -158.18 113.71 2.7 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 110.381 -0.229 . . . . 0.0 110.381 -179.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -67.8 120.36 14.01 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 122.689 0.395 . . . . 0.0 110.818 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.404 ' C ' ' H ' ' A' ' 66' ' ' ALA . 14.4 m -60.09 111.66 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 172.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.7 mt -80.66 33.41 0.31 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.404 ' H ' ' C ' ' A' ' 64' ' ' VAL . . . . . . . . 0 C--O 1.25 1.106 0 CA-C-O 117.298 -1.334 . . . . 0.0 108.937 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.5 ttm . . . . . 0 N--CA 1.471 0.605 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 74.0 mt -115.71 149.84 37.77 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 120.69 0.281 . . . . 0.0 110.587 -177.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -159.97 77.74 0.66 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 -177.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.2 mp -78.71 113.52 16.84 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 112.176 0.436 . . . . 0.0 112.176 -165.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 62' ' ' ALA . 72.3 tttt -79.39 84.95 5.24 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.196 0.998 . . . . 0.0 108.36 173.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 t -62.59 108.93 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -177.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -71.09 148.62 47.31 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 122.956 0.502 . . . . 0.0 110.149 -178.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.02 47.17 1.83 Allowed Glycine 0 CA--C 1.524 0.624 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 86.4 mtp -67.51 -29.93 69.48 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 117.278 0.539 . . . . 0.0 110.353 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 72.4 p -133.17 163.48 29.19 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.7 m 45.99 33.7 1.74 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 123.148 0.579 . . . . 0.0 111.145 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.6 p-10 -68.85 -19.1 64.24 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 117.855 0.298 . . . . 0.0 111.72 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -91.43 -5.78 53.8 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 69.0 m -127.53 -167.87 1.81 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.51 0.724 . . . . 0.0 109.121 -178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p -142.34 154.92 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 3.5 mmt -140.57 159.79 41.43 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.69 90.3 5.19 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.7 t -69.14 -21.23 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 27.1 m -55.82 -37.27 68.44 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 122.335 0.254 . . . . 0.0 111.297 -177.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.97 -22.42 66.8 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 119.597 -0.24 . . . . 0.0 111.336 -177.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.15 -24.26 32.61 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.023 0.374 . . . . 0.0 110.916 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.15 -48.13 12.54 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 -177.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -66.33 -22.98 66.28 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -171.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -73.44 -15.49 61.34 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 118.255 0.48 . . . . 0.0 112.012 -176.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 55.3 t -76.96 129.35 78.93 Favored Pre-proline 0 N--CA 1.45 -0.426 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.85 140.51 47.79 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 123.473 2.782 . . . . 0.0 111.582 179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.63 -20.82 44.59 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 177.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.8 t -78.77 130.97 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -125.15 -30.19 3.22 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -134.81 149.45 50.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 62.1 t -145.27 148.17 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -146.68 120.22 9.1 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.403 HG12 ' HA ' ' A' ' 40' ' ' ALA . 5.3 m -131.11 156.07 42.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 29.2 t -128.34 101.56 6.28 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 176.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.8 mt -63.83 -16.1 60.46 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 123.328 0.651 . . . . 0.0 112.124 -174.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -75.58 -36.51 60.33 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 118.207 0.458 . . . . 0.0 111.576 -178.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -104.54 -8.19 19.2 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-N 117.784 0.265 . . . . 0.0 111.662 -179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.64 22.82 68.8 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-O 119.466 -0.63 . . . . 0.0 113.603 175.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.37 155.86 17.02 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 118.342 1.071 . . . . 0.0 108.825 177.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.403 ' HA ' HG12 ' A' ' 33' ' ' VAL . . . -146.52 110.17 4.88 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.4 mm? -104.55 153.27 21.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.23 162.01 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -138.75 79.23 1.72 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 177.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.56 -170.78 20.04 Favored Glycine 0 C--N 1.336 0.548 0 N-CA-C 110.701 -0.959 . . . . 0.0 110.701 -176.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 72.5 p -115.11 28.05 8.97 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.742 0.417 . . . . 0.0 110.589 -177.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.46 172.16 13.01 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.434 ' HA ' ' HD3' ' A' ' 48' ' ' PRO . 6.1 t70 -102.5 140.68 21.33 Favored Pre-proline 0 N--CA 1.453 -0.297 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -177.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 47' ' ' ASP . 74.8 Cg_exo -50.68 -36.61 51.45 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 124.416 3.41 . . . . 0.0 115.357 -175.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' HG2' ' H ' ' A' ' 49' ' ' LYS . 21.2 pttt -69.49 -18.09 63.66 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.686 0.676 . . . . 0.0 110.69 -175.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.89 -34.42 16.08 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.691 -0.403 . . . . 0.0 111.498 -175.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.9 tp -70.87 -50.4 35.6 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.802 -176.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 44.8 t -68.27 -22.95 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.269 -176.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -86.77 -34.33 19.64 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.011 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.33 94.48 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.848 -0.16 . . . . 0.0 110.634 179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -70.81 -23.64 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 121.069 -0.252 . . . . 0.0 110.513 -178.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.403 ' OE2' ' HE2' ' A' ' 61' ' ' LYS . 35.3 tt0 -74.71 -21.84 59.16 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -69.37 -23.46 63.75 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -93.2 -5.91 48.97 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.81 6.45 59.36 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -116.52 90.1 3.26 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 117.705 0.752 . . . . 0.0 110.776 -177.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.403 ' HE2' ' OE2' ' A' ' 56' ' ' GLU . 99.6 mttt -68.57 165.74 18.53 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 176.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 5' ' ' LYS . . . -158.12 117.03 3.14 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.51 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -73.89 111.62 9.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.113 0.565 . . . . 0.0 110.845 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 26.8 m -58.65 136.47 22.09 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.404 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 173.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.9 mt -94.3 32.16 1.59 Allowed 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 122.278 -0.264 . . . . 0.0 111.174 -178.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.114 0 CA-C-O 116.972 -1.489 . . . . 0.0 109.308 177.782 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.0 ttt . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 58.1 mt -91.65 153.36 19.75 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -176.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -156.91 78.81 0.91 Allowed 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 -174.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.2 mp -80.46 106.63 12.62 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 -163.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -80.58 84.54 6.14 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 171.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.2 t -66.29 132.54 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 O-C-N 122.522 -0.111 . . . . 0.0 110.713 -176.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -88.58 142.97 27.26 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -100.2 63.4 0.63 Allowed Glycine 0 CA--C 1.525 0.716 0 CA-C-O 119.656 -0.525 . . . . 0.0 112.047 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 57.9 mtt -68.83 -73.15 0.16 Allowed 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 118.15 0.975 . . . . 0.0 111.307 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 46.7 p -87.35 166.33 14.94 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-O 120.751 0.31 . . . . 0.0 110.855 -177.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 61.9 m 47.26 32.19 2.04 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.101 0.961 . . . . 0.0 111.298 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -69.24 -2.32 10.26 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.201 0.6 . . . . 0.0 111.578 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.4 m-70 -69.32 -37.19 77.62 Favored 'General case' 0 N--CA 1.452 -0.371 0 O-C-N 122.129 -0.357 . . . . 0.0 110.618 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 65.1 m -133.12 176.41 8.53 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.7 p -92.48 155.9 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 123.5 0.72 . . . . 0.0 110.078 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 60.6 mtt -136.54 160.19 39.51 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 178.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.21 93.03 9.19 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 176.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.4 t -66.85 -12.42 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 41.1 m -50.14 -39.34 42.98 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.132 0.573 . . . . 0.0 111.674 -177.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -63.31 -22.74 67.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -176.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.84 -25.51 32.54 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 117.902 0.319 . . . . 0.0 110.616 -179.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.437 HD13 ' HA ' ' A' ' 22' ' ' LEU . 3.3 mm? -82.46 -32.85 28.7 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 -176.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -64.5 -23.25 67.21 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -175.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -77.05 -11.98 59.88 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.612 -177.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 64.1 t -78.84 129.72 72.66 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 -176.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.61 136.38 73.84 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.398 2.732 . . . . 0.0 111.226 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.92 -20.9 39.64 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.645 -0.582 . . . . 0.0 111.645 175.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 62.1 t -77.98 128.75 38.1 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -125.37 -26.34 3.62 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -131.88 152.1 51.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 176.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.7 t -140.44 148.56 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 87.1 tt0 -144.14 86.93 1.86 Allowed 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.5 m -96.12 155.5 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 178.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.5 t -128.2 100.72 5.95 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 175.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.8 mt -64.54 -19.24 65.51 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.144 -174.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -83.3 -27.2 29.96 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -97.82 -11.44 23.29 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 119.806 -0.14 . . . . 0.0 111.167 -177.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.08 20.55 74.91 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -109.12 156.18 20.13 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -140.32 110.23 6.46 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.489 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.4 mm? -109.66 151.49 26.81 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.402 HG11 HD11 ' A' ' 51' ' ' LEU . 33.7 m -133.47 166.08 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -134.22 84.66 2.13 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.6 -172.27 23.73 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 -176.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 38.1 p -112.73 29.32 8.04 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.643 0.777 . . . . 0.0 110.525 -176.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -74.65 172.7 11.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 120.583 0.23 . . . . 0.0 110.724 -177.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -103.06 157.88 32.87 Favored Pre-proline 0 N--CA 1.453 -0.308 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -57.76 -39.47 87.1 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 123.585 2.856 . . . . 0.0 112.352 -179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 pttt -72.41 -17.11 61.83 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.116 -176.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.8 -37.76 13.43 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.298 -178.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.437 HD11 HD12 ' A' ' 22' ' ' LEU . 9.5 tp -76.25 -49.66 16.49 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 121.014 -0.275 . . . . 0.0 111.033 -176.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.2 t -68.71 -24.92 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 116.982 -0.099 . . . . 0.0 110.736 -177.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -83.71 -29.81 27.24 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.92 -46.41 89.46 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.7 m -73.52 -23.84 19.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 178.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 80.2 tt0 -74.06 -21.03 60.09 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 177.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -68.87 -23.34 64.2 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 177.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -92.53 -6.04 50.49 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.88 9.32 57.42 Favored Glycine 0 CA--C 1.526 0.755 0 N-CA-C 111.272 -0.731 . . . . 0.0 111.272 178.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -121.54 92.88 3.84 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.801 0.8 . . . . 0.0 111.546 -175.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.95 169.46 4.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -153.54 117.53 4.79 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 120.733 0.301 . . . . 0.0 110.608 -178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -71.59 110.51 6.21 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 123.492 0.717 . . . . 0.0 110.819 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -58.26 113.86 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 89.0 mt -82.87 34.62 0.45 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 122.443 0.297 . . . . 0.0 110.532 -177.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 116.885 -1.531 . . . . 0.0 109.615 -179.2 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.414 ' HG2' ' N ' ' A' ' 2' ' ' LEU . 50.4 ttp . . . . . 0 N--CA 1.471 0.612 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.414 ' N ' ' HG2' ' A' ' 1' ' ' MET . 64.2 mt -110.27 151.12 27.77 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -177.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.496 ' HE2' ' OE1' ' A' ' 39' ' ' GLU . 82.2 tttt -156.21 81.25 0.99 Allowed 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -175.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.3 mp -75.73 102.57 5.46 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.955 -167.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -85.48 102.86 13.84 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 174.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 28.4 t -65.24 135.88 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 123.271 0.628 . . . . 0.0 110.814 -177.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -77.36 146.96 36.37 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 177.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -93.41 69.38 1.52 Allowed Glycine 0 C--N 1.336 0.549 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 96.4 mtp -68.38 -51.53 43.16 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 117.027 0.413 . . . . 0.0 111.277 -177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.7 p -137.98 164.98 27.68 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 117.855 0.298 . . . . 0.0 110.952 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 63.8 m 46.87 52.55 11.41 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.602 0.761 . . . . 0.0 111.924 176.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -67.08 -10.59 51.56 Favored 'General case' 0 N--CA 1.454 -0.263 0 O-C-N 122.286 -0.259 . . . . 0.0 111.019 -179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -92.3 -6.03 51.11 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 117.636 0.198 . . . . 0.0 110.668 177.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 82.4 m -122.59 129.25 51.7 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 p -95.38 154.95 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.8 mpt? -137.7 158.98 43.23 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.409 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . . . -78.11 93.61 4.56 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 177.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.4 t -66.35 -15.3 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.9 m -54.43 -35.67 63.18 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.201 0.6 . . . . 0.0 110.788 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.409 ' HE3' ' HB3' ' A' ' 17' ' ' ALA . 96.6 mttt -58.58 -26.32 63.5 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 119.727 -0.177 . . . . 0.0 111.337 -177.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.69 -25.97 28.04 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 117.735 0.243 . . . . 0.0 110.71 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.415 HD13 ' HA ' ' A' ' 22' ' ' LEU . 3.1 mm? -83.52 -34.7 25.24 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 -177.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -63.22 -22.04 66.61 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -176.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -73.37 -12.06 60.69 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 122.483 -0.135 . . . . 0.0 111.221 -178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.404 HG12 ' HB2' ' A' ' 46' ' ' ALA . 69.4 t -78.9 130.86 68.84 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_exo -56.06 129.69 36.25 Favored 'Trans proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.997 3.131 . . . . 0.0 112.226 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.33 -26.34 12.09 Favored Glycine 0 CA--C 1.523 0.576 0 N-CA-C 112.156 -0.377 . . . . 0.0 112.156 174.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.523 ' HA ' ' HA3' ' A' ' 44' ' ' GLY . 61.1 t -71.91 129.14 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -126.94 -23.46 3.64 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.825 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -128.33 151.59 49.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 177.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 67.6 t -144.38 151.51 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -178.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -140.17 96.12 3.0 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.7 m -96.4 156.04 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.407 -178.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.0 t -127.54 102.13 6.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 176.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 63.8 mt -64.4 -18.97 65.19 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.753 -174.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -83.71 -30.63 26.58 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 117.821 0.282 . . . . 0.0 110.727 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -98.26 -13.82 20.59 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 121.53 -0.068 . . . . 0.0 110.82 -176.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.9 19.61 65.73 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -175.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.496 ' OE1' ' HE2' ' A' ' 3' ' ' LYS . 98.9 mt-10 -102.1 157.39 16.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 -178.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -145.29 118.95 9.15 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 120.661 0.267 . . . . 0.0 110.337 -177.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.424 HD22 ' N ' ' A' ' 41' ' ' LEU . 3.2 mm? -101.77 152.7 20.56 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 175.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -133.85 164.49 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.708 0.289 . . . . 0.0 111.01 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -138.67 99.35 3.79 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 175.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.523 ' HA3' ' HA ' ' A' ' 28' ' ' VAL . . . -160.74 -175.14 31.43 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 110.201 -1.16 . . . . 0.0 110.201 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 68.8 p -112.42 25.52 11.42 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 122.546 0.338 . . . . 0.0 110.226 -178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.404 ' HB2' HG12 ' A' ' 25' ' ' VAL . . . -77.5 170.12 17.12 Favored 'General case' 0 N--CA 1.451 -0.388 0 O-C-N 122.415 -0.178 . . . . 0.0 110.956 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -88.2 156.64 51.46 Favored Pre-proline 0 N--CA 1.452 -0.356 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -56.16 -37.02 97.22 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.551 2.834 . . . . 0.0 112.468 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.1 mtpt -70.04 -41.15 74.61 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.284 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.86 -31.32 66.57 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -176.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.403 HD11 HD12 ' A' ' 22' ' ' LEU . 12.2 tp -73.22 -60.73 2.1 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 111.461 0.171 . . . . 0.0 111.461 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 24.1 t -69.57 -23.06 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 122.192 0.197 . . . . 0.0 111.481 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -79.02 -34.75 43.68 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 110.159 -0.312 . . . . 0.0 110.159 -178.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.67 -55.12 37.0 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 116.807 -0.179 . . . . 0.0 110.882 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.63 -24.56 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -175.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -72.61 -37.41 68.1 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 -179.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -72.21 -23.25 61.21 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -75.36 -4.48 39.57 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 176.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 97.8 4.1 58.01 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-O 119.246 -0.752 . . . . 0.0 113.055 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -135.22 114.11 11.98 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 118.578 1.189 . . . . 0.0 111.072 -178.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -62.27 169.17 2.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -155.91 100.08 2.02 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 116.697 -0.229 . . . . 0.0 110.527 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -69.68 106.28 3.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.951 0.5 . . . . 0.0 111.58 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.7 m -58.78 106.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 174.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.8 mt -80.62 76.95 7.48 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 116.87 -1.538 . . . . 0.0 109.512 -178.267 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.47 0.562 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 75.6 mt -89.77 151.07 22.0 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -159.65 76.58 0.67 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -176.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.5 mp -78.43 122.78 26.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 120.693 0.282 . . . . 0.0 111.451 -166.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 15.1 tmtt? -99.48 91.37 4.88 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 174.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.6 130.09 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.459 0 C-N-CA 122.469 0.308 . . . . 0.0 110.555 -175.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -78.37 146.86 34.39 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.64 55.62 1.41 Allowed Glycine 0 CA--C 1.524 0.638 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 92.1 mtp -66.77 -34.39 77.72 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 117.217 0.508 . . . . 0.0 110.997 -176.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 80.9 p -137.57 170.11 16.62 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 -178.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.4 m 51.7 37.74 20.96 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.982 0.513 . . . . 0.0 111.635 177.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -67.9 -14.92 63.35 Favored 'General case' 0 N--CA 1.451 -0.42 0 O-C-N 122.16 -0.338 . . . . 0.0 111.535 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 75.7 m-70 -95.36 -50.56 4.96 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 118.435 0.562 . . . . 0.0 110.8 176.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 72.9 m -99.56 126.26 45.5 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.0 p -94.41 156.27 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 -177.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -135.89 159.64 41.04 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.24 95.95 2.2 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.8 t -67.74 -13.8 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.4 m -54.01 -36.35 62.89 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 122.7 0.4 . . . . 0.0 110.438 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -59.22 -23.4 62.27 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 119.773 -0.156 . . . . 0.0 111.078 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -83.26 -32.95 26.15 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 110.321 -0.252 . . . . 0.0 110.321 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -75.52 -36.42 60.53 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -66.5 -21.43 66.18 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -174.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -78.26 -17.14 57.06 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 54.7 t -78.64 128.06 78.44 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.845 -177.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 69.8 Cg_exo -55.44 141.43 82.24 Favored 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.703 2.935 . . . . 0.0 111.465 177.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.57 -22.6 32.32 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 176.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 71.7 t -76.29 129.97 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -124.69 -27.02 3.72 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 178.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -132.78 149.55 52.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 61.8 t -145.81 149.68 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.2 tt0 -146.23 126.69 14.09 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.4 m -129.18 154.63 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-O 120.801 0.334 . . . . 0.0 110.52 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.5 t -128.27 104.6 7.83 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.929 -1.138 . . . . 0.0 107.929 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 49.9 mt -64.07 -23.32 67.28 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 122.593 0.357 . . . . 0.0 111.93 -173.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -84.68 -41.67 16.05 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 118.269 0.486 . . . . 0.0 110.544 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -82.48 -10.99 58.79 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.789 -0.187 . . . . 0.0 110.685 -176.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 64.58 21.71 67.19 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -99.1 156.63 16.85 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 117.634 0.717 . . . . 0.0 110.257 -178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.85 108.47 4.0 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.461 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.9 mm? -100.58 149.16 24.01 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 178.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.3 m -135.93 162.31 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -139.15 95.49 2.95 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 176.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -162.34 -175.75 33.7 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -177.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 58.0 p -106.02 26.71 9.36 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 122.681 0.392 . . . . 0.0 110.515 -178.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -76.03 170.69 15.79 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -92.92 156.52 40.5 Favored Pre-proline 0 N--CA 1.453 -0.298 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.14 -50.69 12.22 Favored 'Trans proline' 0 N--CA 1.45 -1.034 0 C-N-CA 123.872 3.048 . . . . 0.0 112.204 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -70.47 -30.48 67.31 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 121.126 -0.23 . . . . 0.0 110.889 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.01 -33.48 75.91 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.8 tp -74.11 -52.6 12.1 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.486 0.184 . . . . 0.0 110.61 -177.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.1 t -68.61 -25.46 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 CA-C-N 116.813 -0.176 . . . . 0.0 111.3 -177.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -72.06 -33.14 67.73 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.083 -179.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.25 -49.44 75.71 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.155 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 m -72.78 -23.59 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 117.705 0.229 . . . . 0.0 110.853 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -69.13 -34.11 74.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -178.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -70.85 -23.18 62.28 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 178.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -80.61 -8.08 59.49 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 95.86 12.56 52.62 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.569 -0.613 . . . . 0.0 111.569 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -124.51 111.17 15.38 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 117.777 0.788 . . . . 0.0 111.114 -176.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.72 165.62 8.14 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -162.66 79.57 0.49 Allowed 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.646 178.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -71.35 127.92 34.18 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -60.73 135.29 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 175.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.4 mt -108.46 59.48 0.61 Allowed 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 176.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.057 0 CA-C-O 117.042 -1.456 . . . . 0.0 108.944 -179.125 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.4 ttt . . . . . 0 N--CA 1.472 0.631 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.2 mt -108.57 152.96 24.05 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -177.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.494 ' HB2' ' HB2' ' A' ' 66' ' ' ALA . 40.0 tttt -161.8 77.46 0.52 Allowed 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -175.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 8.5 mp -79.08 122.51 26.31 Favored 'General case' 0 N--CA 1.454 -0.254 0 O-C-N 121.83 -0.544 . . . . 0.0 111.77 -166.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -100.15 92.95 5.46 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 175.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.6 t -65.56 132.52 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 122.772 0.429 . . . . 0.0 111.567 -174.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -80.06 144.38 33.22 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.537 0.735 . . . . 0.0 109.751 176.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -97.56 63.62 0.94 Allowed Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 178.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.428 ' SD ' ' HE3' ' A' ' 61' ' ' LYS . 94.2 mtp -68.09 -36.08 79.23 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.16 0.48 . . . . 0.0 111.78 -176.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 73.1 p -137.44 167.82 20.87 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 117.648 0.204 . . . . 0.0 110.611 -176.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 59.3 m 47.02 49.25 15.04 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.238 0.615 . . . . 0.0 110.963 176.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.9 p-10 -67.38 -14.18 62.69 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 119.535 -0.269 . . . . 0.0 111.701 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -95.57 -50.02 5.14 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 118.382 0.537 . . . . 0.0 110.648 176.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 81.8 m -96.06 129.38 43.35 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.6 p -107.05 156.31 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 CA-C-O 120.658 0.266 . . . . 0.0 110.323 -177.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 2.7 mpt? -129.55 161.53 30.28 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.9 91.14 0.45 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.0 t -68.88 -14.15 18.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.4 m -54.28 -36.89 64.14 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.013 0.525 . . . . 0.0 110.5 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -59.71 -29.25 67.99 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 121.357 -0.137 . . . . 0.0 111.198 -178.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.43 -24.43 50.39 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 117.622 0.192 . . . . 0.0 110.807 -177.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.48 -39.08 20.97 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.8 tttt -67.82 -22.13 65.18 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -173.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -73.28 -17.78 61.28 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 118.657 0.662 . . . . 0.0 111.743 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 60.6 t -76.25 128.71 82.08 Favored Pre-proline 0 N--CA 1.449 -0.492 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -176.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 82.3 Cg_exo -52.26 139.92 53.04 Favored 'Trans proline' 0 N--CA 1.449 -1.098 0 C-N-CA 123.67 2.913 . . . . 0.0 111.691 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.88 -21.56 35.95 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 177.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 75.9 t -77.48 116.36 20.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -116.48 -24.17 7.96 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -129.15 148.9 51.14 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.1 t -145.89 148.25 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -146.89 120.9 9.38 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 m -131.63 155.9 42.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.417 0 C-N-CA 121.101 -0.24 . . . . 0.0 110.649 -177.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 35.6 t -129.41 104.03 7.25 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 177.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.8 mt -64.19 -18.5 64.54 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.576 0.35 . . . . 0.0 111.081 -176.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -84.22 -29.97 26.1 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 117.462 0.119 . . . . 0.0 111.029 179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -100.04 -10.6 21.38 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 121.924 0.09 . . . . 0.0 111.06 -176.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 67.33 19.4 70.47 Favored Glycine 0 CA--C 1.523 0.551 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.0 mt-10 -100.72 154.94 18.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.35 119.17 7.57 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.485 HD22 ' N ' ' A' ' 41' ' ' LEU . 2.3 mm? -117.12 151.73 36.23 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -178.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.87 162.44 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -139.16 84.7 2.02 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 177.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -156.7 -177.45 29.85 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -177.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 62.9 p -93.31 28.09 2.33 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.037 0.535 . . . . 0.0 110.708 -178.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -75.05 173.97 10.0 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 122.375 -0.203 . . . . 0.0 111.063 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -107.12 156.62 37.15 Favored Pre-proline 0 N--CA 1.452 -0.337 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -56.92 -52.79 6.02 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 123.728 2.952 . . . . 0.0 112.906 -178.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -71.3 -32.49 68.69 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 121.124 -0.231 . . . . 0.0 110.898 -176.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.2 -33.13 75.06 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 11.6 tp -71.93 -51.52 21.72 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.976 -178.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 47.5 t -68.94 -27.93 37.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 121.379 -0.128 . . . . 0.0 111.007 -177.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -67.97 -33.18 74.15 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -178.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -63.17 -55.82 21.9 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.075 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 34.5 m -73.26 -23.61 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -175.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -72.18 -34.82 68.73 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 120.601 -0.439 . . . . 0.0 109.841 -177.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -71.55 -23.46 61.76 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 53.1 mm-40 -74.83 -8.48 56.57 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 177.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 96.24 12.55 51.5 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -127.69 98.41 5.18 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 117.115 0.458 . . . . 0.0 110.347 -177.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.428 ' HE3' ' SD ' ' A' ' 9' ' ' MET . 87.3 mttt -62.4 161.55 11.49 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -161.5 92.81 0.9 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.107 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -77.82 129.42 35.4 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 177.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -60.94 135.02 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 175.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.401 ' H ' ' HB3' ' A' ' 3' ' ' LYS . 80.1 mt -109.34 31.33 5.84 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.5 0.32 . . . . 0.0 110.217 177.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.494 ' HB2' ' HB2' ' A' ' 3' ' ' LYS . . . . . . . . 0 C--O 1.25 1.107 0 CA-C-O 116.752 -1.594 . . . . 0.0 109.179 -178.738 . . . . . . . . 1 1 . 1 stop_ save_